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Background: There have been few rigorous studies on the effects of behavioural support for helping
smokers to reduce who do not immediately wish to quit. While reduction may not have the health beneﬁts
of quitting, it may lead smokers to want to quit. Physical activity (PA) helps to reduce cravings and
withdrawal symptoms, and also reduces weight gain after quitting, but smokers may be less inclined to
exercise. There is scope to develop and determine the effectiveness of interventions to support smoking
reduction and increase physical activity, for those not ready to quit.
Objective: To conduct a pilot randomised controlled trial (RCT) [Exercise Assisted Reduction then Stop
(EARS) smoking study] to (1) design and evaluate the feasibility and acceptability of a PA and
smoking-reduction counselling intervention [for disadvantaged smokers who do not wish to quit but do
want to reduce their smoking (to increase the likelihood of quitting)], and (2) to inform the design of a
large RCT to determine the clinical effectiveness and cost-effectiveness of the intervention.
Design: A single-centre, pragmatic, pilot trial with follow-up up to 16 weeks. A mixed methods approach
assessed the acceptability and feasibility of the intervention and trial methods. Smokers were individually
randomised to intervention or control arms.
Setting: General practices, NHS buildings, community venues, and the Stop Smoking Service (SSS) within
Plymouth, UK.vii
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ABSTRACT
viiiParticipants: Aged > 18 years, smoking ≥ 10 cigarettes per day (for ≥ 2 years) who wished to cut down.
We excluded individuals who were contraindicated for moderate PA, posed a safety risk to the research
team, wished to quit immediately or use Nicotine Replacement Therapy, not registered with a general
practitioner, or did not converse in English.
Intervention: We designed a client-centred, counselling-based intervention designed to support smoking
reduction and increases in PA. Support sessions were delivered by trained counsellors either face to face or
by telephone. Both intervention and control arms were given information at baseline on specialist SSS
support available should they have wished to quit.
Main outcome measures: The primary outcome was 4-week post-quit expired air carbon monoxide
(CO)-conﬁrmed abstinence from smoking. Secondary outcomes included validated behavioural, cognitive
and emotional/affective and health-related quality of life measures and treatment costs.
Results: The study randomised 99 participants, 49 to the intervention arm and 50 to the control arm, with
a 62% follow-up rate at 16 weeks. In the intervention and control arms, 14% versus 4%, respectively
[relative risk = 3.57; 95% conﬁdence interval (CI) 0.78 to 16.35], had expired CO-conﬁrmed abstinence at
least 4 and up to 8 weeks after quit day; 22% versus 6% (relative risk = 3.74; 95% CI 1.11 to 12.60)
made a quit attempt; 10% versus 4% (relative risk = 92.55; 95% CI 0.52 to 12.53) achieved point-
prevalent abstinence at 16 weeks; and 39% versus 20% (relative risk = 1.94; 95% CI 1.01 to 3.74)
achieved at least a 50% reduction in the number of cigarettes smoked daily. The percentage reporting
using PA for controlling smoking in the intervention versus control arms was 55% versus 22%, respectively
at 8 weeks and 37% versus 16%, respectively, at 16 weeks. The counsellors generally delivered the
intervention as planned and participants responded with a variety of smoking reduction strategies,
sometimes supported by changes in PA. The intervention costs were approximately £192 per participant.
Exploratory cost-effectiveness modelling indicates that the intervention may be cost-effective.
Conclusions: The study provided valuable information on the resources needed to improve study
recruitment and retention. Offering support for smoking reduction and PA appears to have value in
promoting reduction and cessation in disadvantaged smokers not currently motivated to quit. A large RCT
is needed to assess the clinical effectiveness and cost-effectiveness of the intervention in this population.
Trial registration: ISRCTN 13837944.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment, Vol. 18, No. 4. See the NIHR Journals Library website
for further project information.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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In the UK, only 4% of those who attempt to quit smoking will still be abstinent 1 year later. This rate is
nearly quadrupled, to 15% (across the whole population), with NHS specialist Stop Smoking Service (SSS)
support. Smoking prevalence is reducing nationally, but at a slower rate among socially disadvantaged
groups than in the more afﬂuent groups, which is leading to increasing health inequalities. While the
prevalence of quit attempts is similar across all social groups, those with low socioeconomic status are less
successful in remaining abstinent. Further research is therefore required to establish better ways to increase
the reach of interventions into disadvantaged communities to increase the number of successful quitters.
Abrupt cessation is currently the preferred approach to quitting, rather than reduction (which is thought to
make quitting harder as longer gaps between each cigarette make each one more rewarding). Over half of
smokers want to reduce (or are reducing) smoking, but do not want to quit in the immediate future.
Those who do reduce, with the support of nicotine replacement therapy (NRT), are more likely to quit and
remain abstinent. Smoking reduction appeals to heavier smokers and those who are not ready to quit in
the near future, yet there is little evidence available on the clinical effectiveness and cost-effectiveness of
behavioural support for smoking reduction and cessation induction among such smokers.
There is good evidence that physical activity (PA) can inﬂuence smoking behaviour in a number of ways. In
the short term a single bout of moderate or vigorous PA can reduce cravings and withdrawal symptoms by
about 30% and delay the time until the next cigarette is smoked. Longer-term studies show mixed support
for PA as an aid for smoking cessation, but this may reﬂect poor research design. Those studies that have
shown some beneﬁcial effects involved group exercise classes, which may not appeal to many smokers.
The Exercise Assisted Reduction then Stop (EARS) intervention was therefore designed to address the
pragmatic question of whether or not a PA and smoking reduction counselling intervention, targeted at
disadvantaged smokers, would be feasible and acceptable.Objectives
1. To develop a multicomponent PA intervention aimed at helping smokers (not intending to quit in the
next month) to cut down, and then quit (if they wish), in conjunction with professionals working with
the ‘hard to reach’.
2. To qualitatively assess the acceptability of such a PA intervention, as an aid to cutting down, among
‘hard-to-reach’ smokers.
3. To qualitatively assess the acceptability of recruitment, assessment and randomisation procedures within
a pilot pragmatic randomised controlled trial (RCT), in order to compare the effects of a PA intervention
against brief advice (on SSS support to quit), among ‘hard to reach’ smokers.
4. To obtain an estimate of the intervention (PA vs. brief advice) effect size and its precision to inform
sample size calculations for a fully powered trial, from a pilot randomised trial to assess expired air
carbon monoxide (CO)-conﬁrmed abstinence at 4 weeks post quit date.
5. To assess process measures at 4, 8 and 16 weeks post baseline, including self-reported cigarettes
smoked; number of quit attempts; self-reported quality of life; mood and physical symptoms; cravings;
PA by self-report and accelerometer (in a subsample); pharmacological and behavioural support used;
and weight.
6. To estimate the resource use and costs associated with delivery of the intervention, and to pilot
methods for determining future cost-effectiveness analyses.xxiii
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SCIENTIFIC SUMMARY
xxivMethods
We carried out an individually randomised, single-centre pilot RCT comparing an integrated smoking
reduction and PA promotion intervention in addition to usual care, against usual care (which at the time of
writing was to provide information about quitting). The randomisation rate was 1 : 1 and completed via a
web-based randomisation sequence and minimised by health trainer (HT) (one of three), age (over/under
30 years), smoking dependence (high/low) and sex.
Participants were recruited through three approaches:
1. mailed invitation (with telephone reminders) via three general practitioner (GP) surgeries in the
targeted communities
2. mailed invitation (with telephone reminders) via the local SSS to residents of the targeted communities
3. a wide range of other community-based approaches (e.g. media exposure, networking, attending local
community centre events).
Participants were eligible to enter the study if they were over 18 years old, smoked at least 10 cigarettes
per day (and had done so for at least 2 years), did not want to quit in the next month, were able to
engage in moderate-intensity PA (walk without stopping for at least 15 minutes), were registered with a
GP, and did not wish to use NRT to reduce smoking. The study focus was on initially reducing smoking,
not on quitting, and so those who expressed an immediate desire to quit were referred directly to the SSS
without entering the study. Those wishing to use NRT were excluded to avoid any confounding of the
effects of PA on their smoking behaviour. We excluded those with severe mental health problems and
ongoing substance misuse who may have put the safety of the research team at risk. Given the exploratory
nature of the study, participants were required to be able to converse in English.
The primary outcome was expired air CO-conﬁrmed abstinence 4–8 weeks after quitting, among those
who made a quit attempt while involved in the study. Secondary outcomes included those reducing their
smoking by at least 50% from baseline, self-reported and objectively measured PA levels, along with
several other behavioural, emotional and cognitive variables, at 4, 8 and 16 weeks.
Extensive data on recruitment activity, time invested, response rates and randomisations rates were
recorded for all recruitment approaches for comparison.
Comprehensive qualitative work was completed in order to address issues of acceptability and feasibility
about the trial and intervention design and methods. This included the following: interviews with the HTs
early and late in the trial; ﬁdelity coding of a selection of recorded (and transcribed) intervention sessions
against an 11-item ﬁdelity coding framework based on the expected active components of the
intervention; the identiﬁcation of examples of good practice for future training from interviews with
25 completing participants to assess acceptability of the intervention and trial methods; and further
identiﬁcation of the perceived effective intervention components.
Data were collected within trial, via work sampling procedures and trial-level data collection, to inform
estimates of the resource use and associated cost for the EARS intervention. Longer-term outcomes
associated with estimates of the effectiveness of the EARS intervention and the cost-effectiveness of the
intervention compared with brief advice were explored.
The PA intervention was client centred and counselling based, with sessions taking place face to face in a
local multiuse NHS building (or by telephone) over 8 weeks, with up to a possible further 6 weeks’ support
following a quit attempt. A written EARS intervention manual was provided for the HTs, designed to build
on existing HT competencies.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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A total of 99 participants were randomised from the three recruitment approaches with a 62% follow-up
rate at 16 weeks. Sixty-two were recruited through mailed GP practice invitations (plus reminder telephone
calls of varying intensity) and 31 through mailed SSS invitation (with reminder telephone calls of varying
intensity). Depending on the intensity and time invested in following up those who did not initially respond
to the letters, we randomised between 5.1% and 11.1% of those invited, with associated researcher time
to recruit one participant varying from 18 to 157 minutes. Despite substantial time and effort, only
six participants were recruited through other community-based approaches, with an associated researcher
time of 469 minutes to recruit one participant. Participant demographics did not differ as a result of
recruitment location or approach. Recruitment targets for a pre-deﬁned disadvantaged population were
met, with 91% of the sample in social class C2-E, up to 41% demonstrating mental health problems, and
a small sample of single parents being recruited.
At baseline, 49 were randomised to the intervention arm and 50 to the usual care arm. Adherence to the
intervention was generally positive, with 88% attending at least one intervention session and 59%
attending at least four sessions. The mean number attended was four.
In the intervention and control arms, 22% versus 6%, respectively [relative risk = 3.74; 95% conﬁdence
interval (CI) 1.11 to 12.60), made a quit attempt; 14% versus 4% (relative risk = 3.57; 95% CI 0.78 to
16.35) had expired air CO-conﬁrmed abstinence 4–8 weeks post quit; at 16 weeks, 10% versus 4%
(relative risk = 2.55; 95% CI 0.52 to 12.53) achieved point-prevalence abstinence; and 39% versus 20%
(relative risk = 1.94; 95% CI 1.01 to 3.74) achieved at least a 50% reduction in the number of cigarettes
smoked daily. As the study was not powered for hypothesis testing, no inferred statistical signiﬁcance of
these results is reported.
Qualitative data from both recorded sessions and participant interviews showed that the HTs generally
delivered the planned intervention as intended following phase 1 developmental work and that it was
largely acceptable among interviewed participants. The intervention ﬁdelity analysis identiﬁed several areas
for improvement (e.g. in exploring social inﬂuences and those linked with PA) with associated implications
for updating the training course (e.g. HTs should be given more training and supervision to identify
opportunities to build motivation to increase PA and to more positively reinforce health-identity shifts).
We identiﬁed a case study that could be used in future training in which an increase in PA reinforced a
stronger positive health identity as smoking was reduced. Interviews with patients and the HTs identiﬁed
further possible adaptations and reﬁnements for future practice, and effective components of the
intervention (e.g. the process of engagement, behavioural strategies for smoking reduction, and to a lesser
extent the promotion of PA). Issues surrounding the complexities of integrating PA and smoking reduction
were highlighted and will inform reﬁnements to the process model of how people use PA to manage
smoking behaviour (and the related intervention processes).
The cost-effectiveness analysis estimated the mean cost of the EARS intervention at £192 per participant.
It also provided valuable information on how to assess the cost-effectiveness of a future phase 3 deﬁnitive
RCT, indicating the required scope of any modelling in the context of the EARS intervention. Exploratory
cost-effectiveness analyses suggested that the EARS intervention is likely to be cost-effective where it is
conﬁrmed to be low cost and where the intervention effectiveness could be demonstrated.ConclusionsImplications for future research
A larger, fully powered trial is needed to conﬁrm the effectiveness and cost-effectiveness of the EARS
intervention. The present pilot trial provided conﬁdence that from mailed invitations and follow-ups a
future trial could recruit about 17% of smokers interested in reduction but not quitting. In terms ofxxv
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xxvistafﬁng, a dedicated administrator should be used to arrange appointments and issue prior reminders,
which will add to the resources available to increase recruitment and retention. Future research should
consider the reward of vouchers or other non-monetary incentives for attending assessments to increase
study retention. Minor reﬁnements to the intervention and training of HTs may increase acceptability and
effectiveness. Further exploratory work, involving focus groups and piloting intervention adaptations is
needed (e.g. over 6 months), to assess acceptability for a more ethnically diverse sample. A larger study
would add further information about the core effective components of the intervention, and any
moderators and mediators of any effects. A follow-up of at least 6 months post intervention is needed to
provide evidence of long-term effectiveness.
We are not aware of any research on weight gain associated with smoking reduction (i.e. not cessation).
The present study suggests that this should be considered carefully in future research. If indeed reduction
is associated with weight gain then this may provide a rationale for more support for smokers to further
increase PA to minimise the risk of weight gain.Implications for health care
It is premature for any guidance for health professionals, policy makers and commissioners to be derived
from the present study because the ﬁndings provide only preliminary support for the EARS intervention
with a relatively short-term follow-up and sample from non-ethnically diverse population. The study is
timely in light of the recent National Institute for Health and Care Excellence guidelines on harm reduction
for smoking which calls for more evidence on the effects of behavioural support for smoking reduction
and cessation induction.Trial registration
This trial is registered as ISRCTN 13837944.Funding
This project was funded by the NIHR Health Technology Assessment programme and will be published in
full in Health Technology Assessment, Vol. 18, No. 4. See the NIHR Journals Library website for further
project information.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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During the course of this pilot trial a number of methodological issues arose and these were resolved.A speciﬁc section in the discussion chapter within the main report considers discrepancies in reported
methods (e.g. inclusion/exclusion criteria, sample size, outcome measurement) between different
sections such as the protocol (see Appendix 2), methods (see Chapter 2) and results (see Chapter 3).
Sequentially the protocol and methods describe what we planned to do, and the results and discussion
chapters describe what was achieved.Scientiﬁc background
Current treatment/management options for smoking cessation and
reduction, especially among disadvantaged smokers
Health service priorities for helping people to quit smoking focus on identifying a quit date with associated
abrupt cessation, involving pharmacological and behavioural support.1 After 1 year, only about 4% of
those who attempt to quit without support succeed,2 whereas in the UK that ﬁgure is almost doubled
(7%) with NHS support in primary care and almost quadrupled (15%) with the support of the NHS
specialist Stop Smoking Service (SSS).3 In recent years greater resources have been directed towards
helping disadvantaged groups (e.g. unemployed people, low-skilled manual workers and people with
mental health problems) to quit in an attempt to address growing health inequalities.4 The rate of those
attempting to quit is constant across social groups, but those from more disadvantaged backgrounds are
less likely to succeed in remaining abstinent.5 This results in a growing disparity in smoking prevalence
rates between social groups and therefore in consequent health inequalities. For example, from 2007 to
2008, among those in social class grades C2–E smoking prevalence rates reduced by only 1.3% compared
with 2.3% for grades AB–C1.6
Good-quality evidence for the effectiveness of smoking-cessation interventions for disadvantaged groups is
limited.7 Further research is needed on how best to increase the reach of interventions to those who are
less attracted to smoking-cessation services, and increase smoking-cessation success among such groups to
reduce health inequalities. It is likely that a range of options may be needed to increase the reach of
services and to reduce smoking prevalence, such as locating services in community settings with most
need,4 developing roles for NHS outreach workers [e.g. health trainers (HTs)],8 and developing complex
behaviour-change interventions that are speciﬁcally designed for disadvantaged groups.9
Abrupt cessation is the preferred treatment approach for quitting because, in theory, smokers who cut
down prior to quitting may gain greater reward from each cigarette as they become fewer and farther
between and hence ﬁnd quitting more difﬁcult.1 Yet in the English Smoking Toolkit Study, 57% of current
smokers reported that they were in the process of cutting down,6 with a variety of approaches being
used.10 While nicotine replacement therapy (NRT) is popular as an aid for smoking reduction, another
study revealed that 31% of smokers believed that sustained use of NRT was ‘very’ or ‘quite’ harmful to
health.11 Furthermore, stop-smoking advisors and managers have expressed concern that combining NRT
with smoking may have negative health consequences.12 There is clearly a need for further research on
supporting smoking reduction for those who do not wish to use NRT, among both those who do wish to
quit and those who do not. Among those who do wish to quit, smoking reduction using pharmacotherapy
and behavioural support appears to be equally as effective as abruptly quitting.13
In a US survey, interest in reduction was highest among those who were less interested in quitting and
among heavier smokers.14 However, epidemiological studies suggest that cutting down is associated with
an increased probability of trying to quit. Also, smokers who do not intend to quit in the next month, but
do cut down (with NRT), are more likely to make a quit attempt and remain abstinent at follow-up.15
Smoking reduction may increase the motivation to quit, which is highly predictive of quit attempts, and1
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2reduce smoking dependence, which is related to successful quitting.16 Motivational advice (without NRT)
can increase quit attempts lasting at least 24 hours and 7-day point prevalence abstinence at 6 months.17
Behavioural support aims to increase conﬁdence in smokers so that they can cope with cravings and
withdrawal symptoms, reduce smoking, and ultimately remain abstinent.18Evidence for the effectiveness of exercise for smoking cessation and
related outcomes
There is strong evidence that a single session of physical activity (PA) can reduce both cigarette cravings19
and withdrawal symptoms.20 It can also delay smoking21,22 and decrease puff volume during temporary
abstinence.22,23 A review of exercise interventions (vs. usual care) as an aid for long-term smoking
cessation24 identiﬁed 16 studies. However, most were methodologically limited, with seven involving fewer
than 25 participants in each arm. Of the seven that were adequately powered, three supported signiﬁcant
increases in abstinence at the end of treatment, but only one supported increased abstinence rates at
12-month follow-up. Variation in study length, type (e.g. structured group-based exercise, and PA
counselling) and content of the control condition complicated comparison of the studies in the review.
The timing of the introduction of PA also varied across studies, with some studies promoting involvement
in PA several weeks before a quit attempt. All these studies were among smokers who wished to quit, and
none with those who wished only to cut down. Almost all studies focused on the use of prescriptive
exercise sessions supervised by an exercise professional, with only a few promoting changes in daily
lifestyle activity as a way to manage cigarette cravings and withdrawal symptoms. Coupled with
epidemiological data suggesting that physically active smokers are more likely to attempt to quit,24 there is
therefore scope to explore if PA could facilitate smoking reduction and cessation induction.Possible mechanisms for how exercise might influence smoking
There are several ways in which an increase in PA may putatively facilitate smoking reduction and
cessation induction.25 In addition to smokers explicitly using short bouts of PA to cope with cravings and
withdrawal symptoms (see above), it may also help to reduce the substantial weight gain associated with
cessation.26 On average, smokers experience almost 5 kg of weight gain, with 13% gaining over 10 kg, in
the year after quitting.26 In a limited number of studies, increasing PA has been shown to be a useful
strategy to prevent weight gain among those quitting smoking,27 and its promotion is popular with
smoking-cessation practitioners.28 PA may be effective by both increasing energy expenditure and
enhancing self-regulation of emotional food snacking associated with low mood.29,30 Of relevance to the
present study, systematic reviews and prospective cohort studies suggest that people of lower
socioeconomic status and heavier smokers (among other characteristics) are at increased risk of
weight gain.31
Smoking prevalence is greater among people with mental health problems, perhaps because nicotine may
improve concentration and cognition, relieve stress, improve depressive affect and increase pleasurable
sensations.32 PA can reduce depression33 and anxiety34 and (speculatively) may replace the need to smoke.
In laboratory studies, a single session of exercise appears to reduce attentional bias to smoking cues,35 and
reduce activation in areas of the brain associated with reward seeking while viewing smoking-related
images.36 Finally, it may be reasonable to speculate that undertaking more PA may help or reinforce a shift
from the identity of a smoker to that of an exerciser, with the potential for a reduced exposure to
environments and cues associated with smoking. In a cross-sectional survey the negative association
between PA and smoking was mediated by having a physically active identity.37 Thus, by simply increasing
PA there may be implicit positive effects on smoking habits.
At least 50 cross-sectional surveys have assessed the association between self-reported PA and smoking
status,38 with most reporting a negative association. Physically active smokers are more likely than inactive
smokers to have attempted cessation in the past year.39 However, RCTs to assess the effects of a primary
care intervention to promote PA have shown that increases in PA were not associated with concurrent
reductions in smoking among the subsample of smokers in the study.40,41 This evidence questions the idea
that simply increasing PA will lead to a spontaneous change in smoking behaviour.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The relationship between PA and socioeconomic status among adults is type dependent. Disadvantaged
groups undertake less leisure-time PA but undertake more activity associated with work and active
transport (in part due to low rates of car ownership).42,43 This relationship has implications for the
effectiveness of interventions to generally increase PA.44 Systematic reviews have found that interventions
that use a set of established behaviour change techniques (especially self-regulation techniques) are more
likely to produce increases in PA than those that do not.45The role of health trainers in supporting behaviour change among
disadvantaged populations
In the UK, NHS HTs were introduced in the ‘Choosing Health’ White Paper,46 and were established to
facilitate health behaviour change in disadvantaged communities. The role of a HT ﬁts within a broader
role family called ‘health-related lifestyle advisors’, which also includes lay or peer workers or volunteers.
Their predominant function is to support health behaviour change in a way that is acceptable to target
populations and provides appropriate support to increase motivation and engage in action planning to
facilitate healthy lifestyles. HTs are trained to help smokers to develop the motivation to quit smoking (and
adopt other health behaviours) and then typically refer their clients to SSS for support to quit abruptly.
At the time of initiating this research, there was no synthesis of the effectiveness and cost-effectiveness of
HTs or ‘health-related lifestyle advisors’. A recent review of 26 studies (across a wide range of targeted
health behaviours, from promoting immunisation and breastfeeding to smoking cessation and PA)
suggested that those working in such a role, in general, have little impact on healthy lifestyle.47 Overall,
there was little evidence for effectiveness that interventions could change smoking and PA among
disadvantaged communities and the available studies lacked individuals, while methodological rigor and
reporting was not always clear.
The challenge, therefore, is to design a PA promotion intervention that explicitly helps a smoker to build a
connection between doing PA and smoking reduction among a disadvantaged population. Within the UK,
such an integrated intervention was piloted among smokers who were attempting to quit with the help of
smoking-cessation practitioners.48 There are mixed views on whether multiple behaviour changes
(e.g. increases in PA and dietary change) should be tackled simultaneously or sequentially when smokers
quit.1 Anecdotal evidence suggests that attempting to modify diet and PA while quitting is not detrimental
to successfully quitting and can be facilitative.28,49 However, an integrative approach has not been
developed or evaluated for disadvantaged smokers who do not wish to quit abruptly, but do want to
reduce smoking.Aims and objectivesThe aim of this pilot randomised controlled trial (RCT) was to evaluate the feasibility and acceptability of a
novel PA and smoking reduction counselling intervention for disadvantaged smokers who do not wish to
quit in the immediate future but do want to reduce their smoking. The pilot study also seeks to inform the
design of a full RCT of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.
The present research comprised the following to address those aims:
l the development of a theoretically based PA intervention designed to increase PA levels in smokers,
in a way that may complement and support smoking reduction and increase quit attempts and
smoking cessation
l the conduct of a pilot RCT in which the PA intervention (in addition to usual care) was compared with
usual care alone
l an examination of the feasibility and acceptability of the collection of secondary outcomes
l estimation of the intervention effect on the primary outcome
l an examination of the acceptability and feasibility of the intervention and its delivery3
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4l an examination of the acceptability and feasibility of the trial design and methods
l an evaluation of the intervention ﬁdelity from taped intervention sessions
l identiﬁcation of good practice within the intervention sessions to inform future training and delivery of
the intervention
l an evaluation of the cost of providing the PA intervention, and the conducting of exploratory
modelling to assess the framework needed for future cost-effectiveness analyses alongside a full trial.Development of the Exercise Assisted Reduction then
Stop interventionThe aim was to develop a pragmatic intervention that could improve the reach of SSS to offer another
option to reduce smoking for ‘hard to reach’ or disadvantaged smokers not ready to make an abrupt
quit attempt.
Four steps were taken prior to initiating a pilot RCT, as follows:
1. individual and focus group discussions with smoking-cessation practitioners, researchers, public health
consultants, community workers (including volunteers) and smokers to inform the EARS intervention
structure and delivery
2. reviewing literature on using exercise as an aid to quitting, and consulting with academic experts on
behaviour change for PA, smoking reduction and cessation, alone and in combination to inform the
EARS intervention principles and theoretical basis
3. development of an EARS-speciﬁc training manual to build on the existing HT manual (www.dh.gov.uk/
en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085779)
4. training EARS HTs, piloting the intervention with smokers who did not wish to quit in the immediate
future and, in response to the reviewing of recorded intervention sessions and discussions with the HTs
and smokers, adapting the intervention over a 4-month period prior to the pilot RCT for delivery in the
targeted neighbourhoods of Devonport and Stonehouse (Plymouth, UK).Exercise Assisted Reduction then Stop intervention structure and delivery
The EARS intervention was designed to involve up to 8 weeks of one-to-one support from a HT, in person
or by telephone, after an initial face-to-face session. The HT provided no supervised PA sessions but
offered subsidised access to PA opportunities (e.g. swimming, gym admission and transport subsidies to
walking events), subject to individual preference. The focus was always on making any change in PA
sustainable through motivational support.
Participants were given up to 8 weeks to cut down until they were ready to make a quit attempt. To count
as abstinent a participant needed to have set a quit date within 12 weeks of randomisation to provide
conﬁrmation of a successful 4-week cessation by the ﬁnal assessment at 16 weeks within the pilot RCT.
Anyone who was ready to set a quit date was encouraged to attend and referred to the local SSS for
support if they wished to get support. After quitting they were also offered weekly counselling to support
ongoing PA from the HT for up to a further 6 weeks.Exercise Assisted Reduction then Stop intervention principles and
theoretical basis
The intervention was client centred in that smokers (who wanted to reduce but not quit in the immediate
future) set the speed of reduction and their level of engagement in PA. The HT worked with the
participant using client-centred motivational interviewing (MI) techniques50 throughout the intervention.
The intervention was further informed by self-determination theory (SDT)51,52 which suggests that changing
smoking behaviour will be facilitated by helping the smoker to fulﬁl three core human needs: a sense of
competence or mastery, autonomy or control, and relatedness or companionship. Enhancing autonomy
and competence motivations has been shown in prior research to increase abstinence rates and lead toNIHR Journals Library www.journalslibrary.nihr.ac.uk
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there may be good synergies in combining these two intervention approaches: both focus on helping the
client to develop a sense of ownership of any change and empowerment. In addiction research, there is
evidence that a client-centred counselling approach is effective for engaging with clients, building
commitment to change,58 and increasing cognitive dissonance59 which can predict treatment outcomes.60
There is some evidence that MI is effective in treating substance abuse61 and for smoking cessation,62
albeit from generally low-quality studies with questions about treatment ﬁdelity. MI has also been shown
to be an effective intervention for increasing PA.63 The EARS intervention drew from principles of MI but
also drew on SDT and other theories of behaviour change (as below).
In particular, MI does not focus on social inﬂuences on behaviour change, but SDT-founded interventions
seek to help clients fulﬁl a need for a sense of relatedness. In the EARS intervention, techniques are
described that were used to help participants to ﬁnd social support for smoking reduction and
increasing PA.
The EARS intervention was also informed by social cognitive theory64 and control theory,65 in that it sought
to promote self-regulation by helping clients to build conﬁdence over time to reduce smoking and increase
PA. The self-regulation processes we speciﬁcally targeted were action planning, self-monitoring, review of
progress, problem solving and review of goals – together these represent a process of experiential
learning. Uniquely, this intervention also sought to help participants to use PA to self-regulate smoking by
identifying situations where it may be possible to reduce withdrawal symptoms and desire to smoke,
enhance positive mood, and break the link between environment and smoking behaviours. A range of
behaviour change techniques was matched to the above theoretical processes of change (Table 1) and
these were all included in the EARS training programme.
Finally, EARS also drew from research on stage-matched interventions66,67 to help focus the use of speciﬁc
behavioural change techniques at the appropriate time. Following an assessment of readiness to change
and perceived importance of and conﬁdence about cutting down, intervention techniques were used, as
needed, to shift participants from pre-contemplation, contemplation and planning stages to action and
maintenance, in terms of smoking reduction and quitting, and increasing PA as a way to facilitate changes
in smoking behaviour.Behavioural targets and support for action planning
The study inclusion/exclusion criteria meant that we could assume that smokers were ready to cut down
but not quit in the next month. Given the addictive nature of smoking behaviour, part of the challenge of
reducing smoking was deciding what to do and speciﬁcally how to do it. Having a clear and consciously
regulated plan was considered to be helpful in disrupting habitual, automated patterns of smoking
behaviour, and for extinguishing cigarette cravings associated with conditioned cues and environments.68,69
Initial pilot work, prior to the trial, highlighted that no two smokers had identical personal situations or
smoking and PA experiences, and that any intervention would require ﬂexibility and tailoring to an
individual’s needs.
We therefore created a set of materials to help participants to think about and discuss different possible
strategies for cutting down (see Appendix 1). Participants were encouraged to set an initial smoking
reduction goal of 50% during the ﬁrst 4 weeks, using one of four different reduction strategies70
as follows:
1. Hierarchical reduction: this involves identifying the easiest to the hardest cigarettes to give up during
the course of a typical day, and then systematically giving up either the easiest or hardest cigarettes
over time until a goal is reached.
2. Smoke-free periods: this involves identifying blocks of time through the day where the participant will
not smoke, progressively increasing the length of these periods over time.5
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TABLE 1 Processes targeted (objectives) and related content for the EARS intervention
Intervention
process/objective Intervention strategy
Behaviour change
techniques
(see Table 2
for description) Theoretical domains
Active participant
involvement
Use MI principles and
communication skills. Exhibit
empathy using Open questions,
Afﬁrmation, Reﬂections,
Summaries (OARS)
RC1, RC2, RC4,
RC7, RC8, RC9,
RC10
Knowledge; skills; identity
(e.g. social identity); capability
beliefs; beliefs about
consequences; reinforcement;
intentions; goals; memory or
attention; context/resources;
social inﬂuences; emotion;
behavioural regulation
Develop rapport,
building trust, and
shared respect and
empower the
participant to be
the primary agent
of change
Individual tailoring of techniques
and responses to the individual
participant’s existing knowledge,
skills, needs or preferences
RD1, RD2
Explore initial beliefs
about cutting down
(importance and
conﬁdence, triggers
for smoking)
Use OARS (as above) to explore
current and past smoking
behaviour, the pros and cons of
cutting down. 0–10 questions to
explore importance and
conﬁdence. Use OARS to develop
discrepancies (e.g. by exploring
possible futures)
RI1, RI2, BM3, BM9 Knowledge; capability beliefs;
beliefs about consequences;
intentions; context/resources;
social inﬂuences; emotion
Build/enhance
motivation and
conﬁdence for
cutting down
Identify strengths and barriers
(e.g. by exploring past experiences
of success and failure or asking
‘what might stop you?’). Identify
possible solutions to barriers
RC6, RI3, RI4, A2,
BM2, BS2
Desire to quit may
also be discussed
Exchange information on pros
and cons of cutting down and
barrier-solutions using the
elicit–provide–elicit
(Ask–Tell–Discuss) technique
RC2, A2, BM2, BS2
Explore initial beliefs
about PA and using it
as an aid to cutting
down (importance
and conﬁdence,
barriers to PA)
Use OARS (as above) to explore
pros and cons. Decisional balance
tool, 0–10 questions to explore
importance and conﬁdence about
introducing additional physical
activities. Use OARS to
develop discrepancies
C37 Knowledge; capability beliefs;
beliefs about consequences;
intentions; context/resources;
social inﬂuences; emotion
Identify strengths and barriers
(e.g. by exploring past experiences
of success and failure or asking
‘what might stop you?’). Identify
possible solutions to barriers
C18, C37
Build/enhance
motivation and
conﬁdence for PA
Exchange information on pros and
cons of PA and on barriers/
solutions using the elicit–provide–
elicit (Ask–Tell–Discuss) technique
C8, C31, C37
Set goals and discuss
strategies to reduce
smoking
Set SMART goals with smoker to
reduce smoking. Discuss/offer a
choice of speciﬁc strategies
BS3, BS4, BS6, BS7,
BS8, BS9
Intentions; goals; behavioural
regulation
Negotiate strategy and rate of
smoking reduction (over following
1 and 4 weeks)
C12, C23
Encourage self-monitoring of daily
smoking
BS6
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ABLE 1 Processes targeted (objectives) and related content for the EARS intervention (continued )
Intervention
process/objective Intervention strategy
Behaviour change
techniques
(see Table 2
for description) Theoretical domains
Set goals and discuss
strategies for PA
Set SMART goals with smoker to
increase PA/introduce new
physical activities. Discuss
preferences and smoker to choose
activities. Signpost to relevant
PA/exercise opportunities
C5, C7, C9, C23,
C26, C24
Intentions; goals; behavioural
regulation; context/resources
Encourage self-monitoring of daily
or weekly physical activity
(e.g. using a pedometer)
C16
Review and reﬂect on
efforts to cut down
smoking to build
conﬁdence gradually
and perceptions of
control and ability to
self-regulate
Smoker and HT review progress
with smoking reduction. Any
successes are reﬂected on
and reinforced
RC7, RC8, BM3,
BS5
Skills; identity (e.g. social
identity); capability beliefs;
beliefs about consequences;
memory or attention; context/
resources; social inﬂuences;
emotion; behavioural
regulation
Smoker and HT discuss any
setbacks (reframing to normalise
them, identifying social,
environmental or other barriers
and exploring ways to
overcome them)
A2, RI4, RC6, BS1,
BM5, BS8
Set new targets (perhaps to quit) BS3, BS4, BS5, BS6,
BS7, BS9
Reﬂection on/reinforcement of
the smoker’s skills in avoiding
or managing relapse
BM2, BM3
Reassessment/checking of
motivation/perceived beneﬁts of
reducing smoking and also of
making an attempt to quit
BM2, BM9
Review and reﬂect on
efforts to increase PA
to build conﬁdence
gradually and
perceptions of control
and ability to
self-regulate
Smoker and HT review and reﬂect
on successes in increasing PA/
introducing new physical activities
C11 Skills; identity (e.g. social
identity); capability beliefs;
beliefs about consequences;
memory or attention; context/
resources; social inﬂuences;
emotion; behavioural
regulation
Smoker and HT discuss any
setbacks (reframing to normalise
them, identifying social,
environmental or other barriers
and exploring ways to
overcome them)
C8, C28, C29, C35
Set new targets for PA C10, C6, C7, C16
Reassessment/checking of
motivation/perceived beneﬁts
of physical activity in relation to
smoking reduction, but also
discussing other personal beneﬁts
C37, C15
Integration of
concepts: building an
association between
PA and smoking
reduction
The HT introduces PA as a healthy
behaviour and aid to cutting
down and quitting. A clear
rationale is presented for how PA
might be relevant to reducing
smoking (as a distraction, as a
way to reduce withdrawal
symptoms such as stress
or cravings)
RD1, RC2, RC8, R6 Beliefs about consequences;
emotion
continued
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TABLE 1 Processes targeted (objectives) and related content for the EARS intervention (continued )
Intervention
process/objective Intervention strategy
Behaviour change
techniques
(see Table 2
for description) Theoretical domains
The HT and smoker agree to
experiment with using PA. The
smoker reﬂects on use of PA and
relates it to smoking urges and/or
to number of cigarettes smoked
C6, C11
Engage social support
to facilitate behaviour
change (both for
reducing smoking
and for physical
activity)
Exploring the possible role of
social inﬂuences as potential
barriers to change and as
potential facilitators of change is
encouraged during the
motivation, action-planning and
review stages above
A2 Social inﬂuences; emotion
Social support is conceptualised as
being either informational (e.g.
helping to make plans) practical
(e.g. providing transport), or
emotional (e.g. encouraging)
C29
Identify and reinforce
any identity shifts
towards being a more
‘healthy person’ or
‘healthy living’.
This represents a
generalisation of the
speciﬁc desire to stop
smoking or to be
more active into a
more general
self-concept of being
someone who is
healthy
Recognise and reinforce any
identity change talk using
reﬂective listening techniques
RC2, RC7, RC8,
C30
NB: Explicitly
encouraging/
reinforcing positive
changes in social
identity is not
currently a
recognised BCT
Identity (e.g. social identity);
emotion
Referral to NHS Stop
Smoking Services if
needed
Ask if ready to quit and refer to
NHS SSS if desired
RC2, RD1 Context/resources
BCT, behavioural change technique; SMART, speciﬁc, measurable, attainable, realistic and time referenced.
INTRODUCTION
83. Scheduled reduction: this involves spacing cigarettes evenly through the day (e.g. smoking every
30 minutes) and progressively increasing the time between each cigarette.
4. Planned reduction: this involves setting a target of a maximum number of cigarettes to smoke per day,
and progressively decreasing this number over time.
The strategy chosen was not ﬁxed but was used by participants in an exploratory way to discover which
was most suitable. HTs recorded any reduction plans and used these to review and update further goals in
subsequent sessions with participants as a way of encouraging self-monitoring and self-regulation. For
each strategy, the aims were to build participants’ conﬁdence to reduce smoking, to allow choice in how
they achieved this and to encourage participants to seek support from others as appropriate.Increasing physical activity
In the initial session HTs initiated a dialogue about how PA may inﬂuence smoking and may help any
reduction. This was expected to include reduction of cravings, stress reduction and using PA as a
distraction. Pilot work suggested that it was easier for the HT to focus on smoking reduction initially,NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4and then introduce and develop goals for PA as a facilitating behaviour, though this was open for
negotiation with the participant. As we did not exclude people who were already physically active, we
expected participants to vary greatly in the amount of PA they were already doing and hence the
intervention needed to be responsive to this variation.
The initial aim was to increase motivation and conﬁdence to increase PA and to build beliefs in the
reinforcing value of PA to aid smoking reduction. Later in the sessions, PA facilitation focused mainly on
encouraging the selection of options that were likely to be sustainable and accessible for the individual
participant. The focus was on moderate lifestyle activity (including walking, active transport or activities
with few barriers to engagement) and activities that were enjoyable to the participant. The HT had a
number of options to help participants increase PA, including a free low-cost MP3 player preloaded with a
10-minute spoken isometric exercise instruction track;71 a free rubber exercise band for home use; a free
pedometer (self-monitoring with pedometers has been shown to increase PA);72 and free, or subsidised,
access to local leisure and exercise facilities (e.g. for swimming or gym use). Participants were encouraged
to self-monitor the number of daily steps they achieved and set goals (both important behaviour change
techniques73), identify their use of PA in managing smoking cravings (or providing a distraction) and elicit
any other positive associations that they recognised. The focus was not only on increasing the volume of
PA and using this as an aid to reduce smoking, but also on helping participants to build a more
generalised sense of competence, control and companionship through the activities they engaged in.Training the health trainersHealth trainers were initially trained, using an intervention manual, in PA counselling (see Appendix 1)
to achieve the above aims. Table 2 shows a list of behaviour change techniques (BCTs)74,75 that the HTs
were trained to use and are linked to the main theoretical constructs (see Table 1) that underpinned
the intervention.
Intervention developmental phase with stakeholders and
test participants
Context familiarisation and initial research activity
Previous research48 had helped to build a positive working relationship with the Plymouth NHS SSS. From
the very beginning of the research and intervention development phase, meetings were held with those
offering support for smoking cessation within the SSS and public health teams. Further aﬁeld the research
team met with HTs and with those responsible for training and their management in the south-west.
We focused questions on how HTs identiﬁed and engaged with clients to promote PA and smoking
cessation. Plymouth itself did not employ HTs but similar outreach work was undertaken by public health
specialists. One stop smoking advisor who we consulted with, based in the deprived area of Devonport,
had gained extensive experience in trying to recruit smokers into a SSS. Devonport itself had received over
£50M via the Devonport Regeneration Community Partnership, over a 10-year period, to support a broad
range of environmental-, social- and health-related initiatives. We interviewed a wide range of formal and
informal community leaders about how the local community engaged in lifestyle change support
initiatives, such as employees in local leisure services and representatives of Voice of Devonport and the
Pembroke St. Housing Association.
The aim of the information gathering was to develop a strong understanding of how the communities of
Devonport and adjoining Stonehouse may respond to our planned intervention to facilitate changes in
smoking and PA. We also developed an initial compendium of PA opportunities in the local community
and further aﬁeld. All this was done over several months prior to the employment of HTs, and continued
with their input throughout the training and intervention delivery. Each HT also worked in other part-time
employment in and around Devonport and Stonehouse, and they were encouraged to work as a team,
sharing information on opportunities for PA and community recruitment. The employment of three9
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TABLE 2 Planned BCTs to be used in intervention sessions (authors’ alterations to original text in italics)
Behaviour addressed BCT (modiﬁed for the EARS protocol of delivery)
aSmoking reduction74 BM2 (boost motivation and self-efﬁcacy)
BM3 (offer feedback on current behaviour)
BM5 (offer normative information about others’ behaviour and experiences)
BM9 (elicit reasons for wanting and not wanting to stop smoking or cut down)
BM11 (measure CO)
BS1 (facilitate barrier identiﬁcation and problem solving)
BS2 (facilitate relapse prevention and coping)
BS3 (facilitate action planning/develop treatment plan)
BS4 (facilitate goal setting)
BS5 (prompt review of goals)
BS6 (prompt self-recording)
BS7 (offer to provide support with techniques for changing behaviour)
BS8 (prompt thoughts on environmental restructuring)
BS9 (help set graded tasks)
A2 (advise on/facilitate use of social support)
RD1 (tailor interventions appropriately)
RD2 (emphasise choice)
RI1 (assess current and past smoking behaviour)
RI2 (assess current readiness and ability to quit cut down)
RI3 (assess past history of quit attempts)
RI4 (assess withdrawal symptoms)
RC1 (build general rapport)
RC2 (elicit and answer questions)
RC4 (explain expectations regarding treatment programme)
RC6 (provide information where appropriate on withdrawal symptoms)
RC7 (use reﬂective listening)
RC8 (elicit client views)
RC9 (summarise information/conﬁrm client decisions)
RC10 (provide reassurance)
bPA75 C5 (goal setting – behaviour)
C6 (goal setting – to achieve possible beneﬁts from increasing PA)
C7 (action planning)
C8 (barrier identiﬁcation/problem solving)
C9 (set graded tasks)
C10 (prompt review of behavioural goals)
C11 (prompt review of achievement of beneﬁts from PA)
C12 (prompt rewards contingent on progress)
C15 (prompting generalisation of a target behaviour)
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TABLE 2 Planned BCTs to be used in intervention sessions (authors’ alterations to original text in italics)
(continued )
Behaviour addressed BCT (modiﬁed for the EARS protocol of delivery)
C16 (prompt self-monitoring of behaviour)
C18 (prompting focus on past success)
C23 (teach to use prompts/cues)
C24 (environmental restructuring)
C26 (prompt practice)
C28 (facilitate social comparison)
C29 (plan social support)
C30 (prompt identiﬁcation as role model)
C31 (prompt anticipated regret from not changing current behaviour)
C35 (relapse prevention/coping planning)
C37 (motivational interviewing)
a Speciﬁc focus on behaviour and addressing motivation (BM), speciﬁc focus on behaviour and maximising self-regulatory
capacity/skills (BS), promote adjuvant activities (A), general aspects of the interaction focusing on the delivery of the
intervention (RD), general aspects of the interaction focusing on information gathering (RI), general aspects of the
interaction focusing on general communication (RC).
b Lettered coding added here to aid identiﬁcation in Table 3 (see below).
Note: the BCTs are utilised in a highly responsive and tailored manner to the individuals’ needs and rate of change
across sessions.
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4part-time HTs (2 × 0.5 and 1 × 0.4), with one common afternoon for weekly meetings and supervision,
provided opportunities for team building, sharing good practice, and supervision.Training
The training manual and programme for initial training are shown in Appendix 1 and Appendix 5a. We
began by covering generic material in the Department of Health Training Manual for HTs, which provided
a framework for the role and for developing core competencies for supporting behaviour change. The
training then progressed to developing an understanding of the options available to aid smoking cessation
with NHS support, and behaviour change for smoking reduction and increasing PA (in its broadest sense).
The manual was largely completed prior to the beginning of training but did become more reﬁned during
and after the training. The version shown in the appendices would require further adaptation based on the
ﬁndings from the pilot trial, ahead of a larger trial.
Towards the end of the training, and leading into the start of recruitment for the pilot trial, we
opportunistically identiﬁed six test participants (through local contacts) who did not wish to quit smoking
in the immediate future. They were able to help us resolve issues such as how best to describe the study
and intervention to potential participants, how to adapt the intervention to individual differences and
needs, how to maintain a client-centred approach and encourage goal setting, how to sequence multiple
behaviour change, how to conduct assessments and how to stay in touch with participants. The
experiences of working with six test participants are shown in Table 3. In total, they attended 35 sessions
consisting of face-to-face and telephone contacts. Most sessions were digitally recorded, eight sessions
directly observed, and most were discussed with the three HTs, by AHT, TT and CGVS, with ﬁeld notes
recorded throughout. The sessions informed the learning process and intervention development, and
increasingly, leading up to the start of the actual pilot trial, increased uniform practice across the HTs.11
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INTRODUCTION
14The HTs gained encouragement and conﬁdence from these experiences, which complemented their own
working practice in their other part-time roles as a cardiac nurse, drug and alcohol service practitioner and
trainer, and occupational health promotion practitioner.
In summary, valuable lessons were learnt during this pre-pilot developmental phase. The general aims and
application of theory to practice were conﬁrmed as appropriate, with some ﬁne tuning of implementation
of the intervention and methods for conducting assessments with test participants. With input from AHT,
CGVS and TT, and drawing on the past experiences of the three HTs, the training provided an opportunity
for team building and common achievement of the core aims of the pilot study.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Chapter 2 Trial design and methodsStudy designThe EARS smoking study was a pragmatic, pilot, two-arm RCT into which disadvantaged smokers were
recruited by three distinct approaches: (1) through primary care via general practitioner (GP) invitation
letter with reminder telephone calls; (2) through NHS SSS invitation letter (aimed at those who have
previously failed to quit) with reminder telephone calls; or (3) through a variety of other community-based
approaches without a personalised invitation letter. The study compared the effect of individual PA and
smoking counselling with brief advice (on SSS support to quit) among disadvantaged smokers not wishing
to quit in the next month (see Appendix 1). Those who expressed a desire to quit post randomisation were
referred to the SSS if they wished, and continued in the study with PA support if they were in the
intervention arm. Following baseline, follow-up assessments were conducted at 4, 8 and 16 weeks in both
groups. Ethical approval for the study was granted by the NHS National Research Ethics Service Committee
South West, in the UK.Eligibility criteriaParticipants were eligible to enter the study if they were over 18 years old, smoked at least 10 cigarettes
per day (and had done so for at least 2 years), did not want to quit in the next month, were able to
engage in moderate-intensity PA (walk without stopping for at least 15 minutes), were registered with a
GP, and did not wish to use NRT to reduce smoking. The study focus was on initially reducing smoking,
not on quitting, and so those who expressed an immediate desire to quit were referred directly to the SSS
without entering the study. Those wishing to use NRT were excluded to avoid any confounding of the
effects of PA on their smoking behaviour. We excluded those with severe mental health problems and
ongoing substance misuse due the potential difﬁculties of engaging them in the intervention given the
large uncertainties and complexities of its delivery, and the fact that they may have put the safety of the
research team at risk. Given the exploratory nature of the study, participants were required to be able to
converse in English.Sample sizeGiven the lack of research involving behavioural smoking reduction interventions, the effect of our
intervention was uncertain. While the sample size of the study was primarily chosen to undertake the
feasibility objectives of the study, we also sought to obtain an estimate of the intervention impact (relative
to control).76 Using data from a recent meta-analysis of trials of smoking cessation15 we undertook a
scenario analysis in order to examine the precision of the effect size estimation based on different pilot trial
sample sizes and plausible effect sizes (Table 4). A sample size target of 120 (60 per group) was initially
selected for this pilot.
Recruitment
Recruitment for the study was over a 12-month period between May 2011 and May 2012. We planned to
recruit 50% of participants through primary care via GP invitation letters from three identiﬁed GP surgeries
(on the basis that this has been shown to be a successful approach77) in two very socially deprived wards
in Plymouth (Indices of Multiple Deprivation 2010 values = 52–59.9, placing them in within the 3% ‘most
deprived’ in England). GP practice lists were searched based on cursory inclusion/exclusion criteria
[including smoking status, incidents of physical health conditions (especially in the previous 12 months)15
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
TABLE 4 Scenario analysis of impact on estimation of effect size precision given differing sample sizes and plausible
effect sizes
Control quit ratea
Sample sizeb
(control–intervention ratio) Effect size; relative risk
Precision of effect size estimate
(95% CI)c
5% 60 (1 : 1); 60 (1 : 1) 2.00; 4.00 0.19 to 20.89; 0.47 to 33.72
5% 120 (1 : 1); 120 (1 : 1) 2.00; 4.00 0.52 to 7.63; 1.18 to 13.46
5% 160 (1 : 1); 160 (1 : 1) 2.00; 4.00 0.63 to 6.38; 1.28 to 11.41
CI, conﬁdence interval.
a Based on the meta-analysis of control arm quit rates in Health Technology Assessment report.
b Combined intervention and control group sample size.
c Based on a 2-sided Fischer’s exact test.
TRIAL DESIGN AND METHODS
16that may contraindicate moderate-intensity PA and current serious mental illness or drug dependence]
(see Appendix 3). A list of potential participants was generated and invitation letters sent with a postal
reminder 1 week later. To ensure that nobody was discriminated against on the grounds of illiteracy,
telephone calls were made to non-responders to check that they had received and understood the
invitation. If there was no reply on the ﬁrst call a message was left to enquire if the invitation had been
received and to leave a contact number for further information. Up to four more calls were made but no
further messages were left, to avoid harassment. Interested participants were screened for eligibility (see
inclusion/exclusion criteria) by telephone before being invited to attend a baseline assessment.
The aim in the pilot RCT was to recruit participants of whom at least 75% were in social class C2–E (www.
nrs.co.uk/lifestyle.html), 30% were single parents and 20% had a mental health problem. This operational
deﬁnition of disadvantaged was based on the high prevalence of smoking among these subpopulations.5
We planned to recruit the other 50% of participants by a variety of community-based approaches to
maximise the chances of reaching disadvantaged smokers. One approach involved sending invitation
letters (with a postal reminder 1 week later) to those on the database of the Plymouth SSS who had failed
to successfully quit with the service within the past 2 years. Other planned community recruitment
approaches included media engagement, attendance and networking with local community centre groups
including housing trusts and parent and toddler groups, distribution and display of ﬂyers, cascading
information through workplaces, and opportunistic recruitment of people with a mental health problem
[through the local Improving Access to Psychological Therapies (IAPT) service]. Interested participants
contacted the research team directly (in person or by telephone) or indirectly by returning contact details
with a request for further information. Following screening to determine eligibility, a time for attending a
baseline session was arranged.
As an incentive for completing data collection at baseline, and at weeks 8 and 16, participants were
offered a small ﬁnancial incentive on each occasion for returning an accelerometer after wearing it for a
7-day period. Initially this was £10 for each occasion, but was increased to £30 later in the study to
investigate whether or not this improved data collection and the likelihood of participants returning
the device.Randomisation and concealmentFollowing screening and baseline data collection, the researcher phoned the trial manager who then
allocated smokers using a password-protected web-based randomisation system set up and managed by
the UKCRC accredited Peninsula Clinical Trials Unit (PenCTU). Randomisation was 1 : 1 and minimised
(in order to ensure balance between the two arms) by age (30 years and under/over 30), sex, HT (one of
three), and smoking dependence (high = smokes ﬁrst cigarette within 30 minutes of waking; low = smokesNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4ﬁrst cigarette later). To maintain concealment, the minimisation algorithm retained a stochastic element.
On occasion when two potential participants were closely acquainted, at random, only one of the pair
was selected for inclusion in the study to avoid contamination. If the individual was randomised to the
intervention arm then both were permitted to attend sessions together but only the individual randomised
provided data.Data collection
Baseline data collection
At baseline the following data were collected: participant demographic information (i.e. age, sex, marital
status, cohabiting with other smokers, parental status, employment status, age of leaving full-time
education, ethnicity, weight and height), smoking history (age started smoking, longest period of cessation
in last year, attempts at cutting down, cessation aids used in past year, use of SSS) (Table 5). A more
detailed schedule and content of assessments is shown in the study protocol (see Appendix 2).
Given that baseline and follow-up assessments were conducted by a researcher who also provided the
intervention, it was not possible to blind outcome assessment. This decision was made to provide a more
seamless interaction with participants who had no prior experience of engaging in a research study and
with whom it may have been particularly challenging to remain in contact. One of the aims of the process
evaluation was to examine whether or not this was indeed important for participants.TABLE 5 Secondary outcomes (cognitive, behavioural and emotional/affective) assessed at baseline and
weeks 8 and 16
Variable
Cognitive Physical activity Conﬁdence for undertaking PA
SOC to use PA to control smoking
Smoking Conﬁdence for and importance of quitting
Behavioural Physical activity Accelerometer data
7-day PA recall
Smoking Self-reported cigarettesa
Expired CO
Number of quit attempts made
Cessation aids used
Alcohol consumption Alcohol consumption
Emotional/affective Withdrawal symptoms MPSS
Strength of desire to smoke Self-reported cravings and strength of urge to smoke
Quality of life EQ-5D
Nicotine dependence FTND
Subjective stress PSS
Smoking satisfaction mCEQ
Weight
CO, carbon monoxide; EQ-5D, European Quality of Life-5 Dimensions; FTND, Fagerström Test for Nicotine Dependence;
MPSS, Mood and Physical Symptoms Scale; mCEQ, modiﬁed Cigarette Evaluation Questionnaire; PSS, Perceived Stress
Scale; SOC, stages of readiness to change.
a Used to calculate percentage reducing by 50% at follow-ups.
17
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
TRIAL DESIGN AND METHODS
18Feasibility outcomes
The following feasibility outcomes were identiﬁed: participant recruitment rate (the proportion of those
invited, via different methods, who agreed to take part), follow-up and outcome data collection rates, ﬂow
of smokers through the trial from each location [e.g. numbers of smokers recruited, number ineligible
(with reasons), number declined, numbers failing to continue with data collection]; number of those
deciding to quit who chose to use a SSS; number who chose to quit who could be tracked on a weekly
basis [and hence inform the number with 4 weeks’ expired air carbon monoxide (CO) conﬁrmed
abstinence], and demographic characteristics of the sample relative to a disadvantaged deﬁnition.Primary outcome
The primary outcome is expired air CO-conﬁrmed abstinence [< 10 parts per million (p.p.m.)] using a
Micro+ Smokerlizer (Bedfont Scientiﬁc Ltd, Maidstone, Kent, UK) using standardised procedures, with a
self-reported time since last cigarette, at 4 weeks post quit. The outcome is binary, that is to say abstinent
or not abstinent (those lost to follow-up are assumed to be still smoking78). Participants with an expired air
CO reading ≥ 10 p.p.m. and those whose self-report data did not conﬁrm their quit status were assumed
to have started smoking again. The EARS intervention aimed to reduce smoking with the hope that a quit
attempt and successful quitting might follow.Secondary outcomes
Secondary outcomes included the number of participants reducing their self-reported smoking levels by at
least 50% along with several other cognitive, behavioural and emotional outcomes outlined in Table 5.Cognitive variables
Participants were asked at baseline, 8 weeks and 16 weeks how conﬁdent they were in their ability to
(1) do at least 30 minutes of moderate-intensity PA on most days of the week over the next 6 months and
(2) walk continuously for 15 minutes at a brisk pace, using a 7-point response scale from ‘not at all
conﬁdent’ (1) to ‘extremely’ (7). Stage of readiness to use PA to control smoking was assessed by
participants ticking one from ﬁve options as follows: (1) I do not use physical activity as a way of controlling
my cigarette smoking and I do not intend to start; (2) I do not use physical activity as a way of controlling
my cigarettes smoking but I’m thinking of starting; (3) I use physical activity once in a while as a way of
controlling my cigarette smoking, but not regularly; (4) I use physical activity regularly as a way of
controlling my cigarette smoking, but only started within the past 6 months; (5) I use physical activity
regularly as a way of controlling my cigarette smoking and have been doing so for longer than 6 months.
Responses reﬂected being in the pre-contemplation, contemplation, planning, action, or maintenance
stage, respectively. All the above questions have been previously used.67
To assess beliefs about quitting smoking the following questions were asked using a 7-point response scale
from ‘not at all’ (1) to ‘extremely’ (7): How important is it for you to stop smoking permanently and
completely in the next six months?; how conﬁdent are you that you can stop smoking permanently and
completely in the next six months?; an important person in your life thinks you should quit smoking;
how conﬁdent are you that over the next week (except at baseline when we referred to ‘over the next
4 weeks’) you will smoke only half the number of cigarettes you smoked at the time of entry into the study?Behavioural measures
Physical activity data were collected using a tri-axial GT3X accelerometer (Actigraph, Pensacola, FL, USA).
Data were recorded using a 1-second epoch, over a 7-day period. Self-reported PA was collected using the
7-day PA recall questionnaire.79 Minutes of moderate to vigorous PA (MVPA) and average nightly sleep
were recorded, and minutes of light activity were derived. Minutes of MVPA and energy expenditure were
calculated. Smoking status was recorded by the question (1) How many cigarettes, cigars, or pipes, have
you usually smoked each day over the past week (recorded in numbers smoked or grams/ounces of loose
tobacco)? Those who reported no smoking in the past week (with expired air CO conﬁrmation of
< 10 p.p.m.) at 16 weeks were deﬁned as not smoking at that point and we used this to report 16-week
point prevalence abstinence. Alcohol consumption was assessed to monitor changes in another lifestyleNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4behaviour often associated with smoking, using two questions taken from the World Health Organization’s
(WHO) validated AUDIT alcohol screening tool:80 (1) How often do you have a drink containing alcohol?
(0, ≤ 1 per month; 2–4 times per month; 2–3 times per week;≥ 4 times per week); (2) How many drinks
containing alcohol do you have on a typical day when you are drinking? (1–2; 3–4; 5–6; 7–9;≥ 10); and
the addition of the third question: how many drinks containing alcohol have you had in the past week?
(1–2; 3–4; 5–6; 7–9;≥ 10).Emotional/affective measures
Strength of urge to smoke and time spent with those urges over the past week were assessed using two
items (1–6 point response scale)81 and withdrawal symptoms assessed using an adapted 9-item Mood and
Physical Symptoms Scale (MPSS).82 Quality of life is assessed using the European Quality of Life-5
Dimensions (EQ-5D).83 Smoking dependence was assessed using the Fagerström Test for Nicotine
Dependence (FTND).84,85 Subjective stress was assessed using the 4-item Perceived Stress Scale (PSS),86 to
monitor any changes associated with smoking reduction or increasing PA. Satisfaction from smoking was
assessed using the 10-item modiﬁed Cigarette Evaluation Questionnaire (mCEQ),87 as we expected that the
pleasure derived from smoking may reduce with increased PA participation.
All questionnaire data were scanned and manually checked using Teleform Scanning software (Cardiff
Software, Digital Vision, Highland Park, IL, USA). A second researcher double-checked 10% of the entered
data against the raw data and if more than a 1% error was found, all questionnaire data would have been
manually rechecked. The data were stored on a secure institutional server.Statistical analysisWe report the ﬂow of participants through this study according to the Consolidated Standards of
Reporting Trials (CONSORT) guidelines for non-pharmaceutical interventions.88 Given that this was a pilot
study, the primary approach to data analysis is descriptive (i.e. proportions, means and standard deviations,
or median and interquartile ranges) for primary and secondary outcomes at baseline and follow-up for
each of the two groups reported. However, to inform the power of a future deﬁnitive trial we also
calculated an estimate of the intervention (vs. control) effect size [relative risk (RR)] and its precision [95%
conﬁdence interval (CI)] for the primary outcome (i.e. continuous expired air CO-conﬁrmed abstinence at
4 weeks post quit), and other dichotomous smoking-related outcomes (e.g. point prevalence abstinence
and proportion reducing by at least 50% at 16 weeks). Participants lost to follow-up were assumed to still
be smoking the same amount as at baseline.Qualitative data collection and analysisThe methods, procedures, data analysis and ﬁndings are reported in Chapter 5.Cost-effectiveness data collection, analysis and modellingWithin-trial data collection was used to estimate resource use associated with the delivery of the EARS
intervention. Items of resource use were combined with published unit cost data to estimate the cost of
the EARS intervention, per participant. Evidence review, on modelling methods used to assess
cost-effectiveness of smoking-cessation interventions, informed the development of a framework for
cost-effectiveness analyses. We present the initial stages of development of a decision-analytic model
to compare EARS with brief advice over the longer term. Exploratory cost-effectiveness analyses are
undertaken, using assumptions on inputs for effectiveness of EARS. The methods, procedures, data
analysis and ﬁndings are reported in Chapter 6.19
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This chapter reports on:
l participant recruitment
l participant characteristics for the total sample and across treatment arms
l study attrition and associated factors
l bias in self-reported PA
l changes in outcomes over time, by treatment arm
l intervention adherence and its association with outcomes.Participant recruitmentThe ﬂow of participants from invitation letter via GP surgery and SSS, and via other community
approaches, is shown in the CONSORT diagrams (Figure 1, up to randomisation, and Figure 2,
after randomisation).
Process of recruitment
We began by focusing recruitment on mailed invitations from GP practices and the SSS. This was done to
ensure that the research team initially gained conﬁdence in the trial methods and intervention delivery,
including the invitation and recruitment rate. Mailed invitations were done in batches of about 100 from
each GP practice, or the SSS, to reduce the burden on associated GP practice screening and administration
time, and to establish a steady ﬂow of willing participants into the study. The aim was to recruit
60 participants from GP mailed invitations: 30 from SSS-mailed invitations and 30 from other community
approaches. As Figure 3 shows, we remained on target during the ﬁrst 6 months for recruiting the
planned 120 participants. By this time we had exhausted the patient database of eligible smokers in one
GP surgery and began recruiting from another surgery. Recruitment slowed prior to the Christmas period,
and the new surgery also wanted to screen all participants before mailing an invitation rather than waiting
to screen any willing participants who had responded to the invitation. This required additional time
between identifying potential participants and mailing invitations. At this time we also allocated
one HT/researcher to other community recruitment activity, which we anticipated would have greater
uncertainty with recruitment rates. We revised our recruitment target, as shown in Figure 3,
to 100 participants at this point.
Overall, there was a higher percentage of smokers contacted through the SSS who were ineligible to enter
the study, likely due to the extra level of screening that took place through GP practice recruitment. The
reasons for ineligibility were similar across recruitment methods and are shown in Table 6. The most
common reason for ineligibility was due to the individual having already quit smoking, suggesting
out-of-date records in both GP practices and the SSS.
Different amounts of effort were involved in following up participants invited by letter from the three GP
surgeries and the SSS. The maximum effort involved telephoning, on up to ﬁve occasions, all smokers who
had not responded to an initial invitation letter and postal reminder. If there was no response a message
was left with contact details for the study on the ﬁrst call, but not on subsequent calls to avoid
harassment. The percentage of the total sample recruited, by recruitment method, is shown in Table 7.
Recruitment by letter and reminder telephone calls (from GP or SSS)
In terms of response rates, we were able to substantially increase the proportion of people invited by letter
who were randomised, from about 7% to 11%, by making up to ﬁve reminder telephone calls. A lack of
availability of staff prevented us from making reminder telephone calls to all those initially invited,21
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Total invitations sent
(primary care)
n = 846
No response
n = 781
Attempted
contact by
telephone
n = 485
Baseline
arranged
n = 46
Baseline arranged
n = 84
Attended baseline
n = 66
Attended baseline
n = 6
CONSENT RECEIVED/RANDOMISED
n = 99
Attended baseline
n = 31
Baseline arranged
n = 6
Baseline arranged
n = 33
Baseline
arranged
n = 38
Baseline
arranged
n = 25
Baseline
arranged
n = 8
Attempted
contact by
telephone
n = 137
No response
n = 334
Responses
received
n = 65
Declined: n = 22
Ineligible: n = 5
Unable to
contact: n = 6
Declined: n = 5
Ineligible: n = 19
Incorrect
information:
n= 2
Deceased: n = 1 Unable to
contact: n = 33
Declined: n = 35
Ineligible: n = 20
Incorrect
information:
n = 41
Unable to
contact: n = 192
Declined: n = 156
Ineligible: n = 49
Incorrect
information:
n = 42
DNA: n = 18 DNA: n = 0
Ineligible: n = 0
Ineligible: n = 4 Ineligible: n = 0
DNA: n = 2
Responses
received
n = 58
Total invitations sent
(Stop Smoking Services)
n = 392
Response from
community (to
leaflets, word of
mouth, etc.)
n = 6
FIGURE 1 Consolidated Standards of Reporting Trials chart showing recruitment approaches, and participant flow,
up to randomisation. DNA, did not attend.
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22particularly to those invited from the SSS. The associated researcher time to recruit one participant ranged
from approximately 20 minutes for those who responded directly to the letter invitation up to
approximately 150 minutes for completing reminder telephone calls to those who did not initially respond
to the letter invitation.Community recruitment without invitation letter
A variety of approaches were attempted to recruit participants other than by letter as summarised in
Table 8. Our efforts focused on workplaces with a high proportion of manual and unskilled workers,
educational sites (in an effort to recruit single parents), local media, opportunistic referral through the IAPT
to target people with depression and anxiety, and a wide range of other community sites andNIHR Journals Library www.journalslibrary.nihr.ac.uk
CONSENT RECEIVED/RANDOMISED
n = 99
Intervention
n = 49
Control
n = 50
Week 4 follow-up
n = 40 (35 data sets)
Week 4 follow-up
n = 38 (34 data sets)
Lost contact: n = 7
Withdrew: n = 5
• personal circumstances,
  e.g. illness (n = 3)
• didn’t want to be in
  control group (n = 1)
• reason unknown (n = 1)
Lost contact: n = 2
Withdrew: n = 7
• personal circumstances,
  e.g. illness (n = 3)
• delay prior to
  intervention too long
  (n = 1)
• financial reimbursement
  insufficient (n = 1)
• reason unknown (n = 1)
Lost contact: n = 1
Withdrew: n = 2
• personal circumstances,
  e.g. illness (n = 2)
Lost contact: n = 6
Withdrew: n = 1
• reason unknown (n = 1)
Lost contact: n = 4
Withdrew: n = 0
Lost contact: n = 3
Withdrew: n = 0
Week 8 follow-up
n = 33 (29 data sets)
Week 8 follow-up
n = 35 (31 data sets)
Week 16 follow-up
n = 30 (full data)
Week 16 follow-up
n = 31 (full data)
FIGURE 2 Consolidated Standards of Reporting Trials chart showing recruitment approaches, and participant flow,
after randomisation. DNA, did not attend.
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4organisations in Devonport and Stonehouse. We estimate that at least 46 hours of dedicated time by the
HTs/researchers resulted in the six participants recruited via these approaches.
Participant characteristics across recruitment methods
Table 9 shows the demographic characteristics of those recruited by GP and SSS invitation letter and via
other community approaches without an invitation letter. Given the small number of participants recruited
via other community approaches, any comparison with approaches involving an invitation letter are
meaningless. Comparisons of the characteristics of participants recruited by invitation letter from the GP
versus the SSS appear to show little difference.
We also compared the characteristics of those recruited after an immediate response to the invitation
letter with those recruited in response to a subsequent reminder letter and reminder telephone call23
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FIGURE 3 Participant recruitment accrual graph over the duration of the study.
TABLE 7 Participant recruitment by recruitment method
(n=99)
Recruitment method n (%)
Primary care 62 (62.6)
Letter only 31 (31.3)
Letter plus reminder telephone calls 31 (31.3)
SSS 31 (31.3)
Letter only 24 (24.2)
Letter plus reminder telephone calls 7 (7.1)
Community (without invitation letter) 6 (6.1)
TABLE 6 Reasons for ineligibility (community not shown,
0% ineligible)
Reasons Primary care SSS
Health/physical (%) 15.8 20.5
Already quit (%) 57.9 53.8
Smokes < 10 cigarettes per day (%) 10.5 10.4
Close friend or relative of somebody
already in the trial (%)
0.0 5.1
Currently using NRT (%) 5.3 5.1
Under 18 years old (%) 0.0 5.1
Wants to quit immediately (%) 10.5 0.0
TRIAL RESULTS: QUANTITATIVE RESULTS
24as shown in Table 10. The numbers were fairly small for some categories of response but there appeared
to be little difference between contact methods, suggesting that making the additional effort to recruit
participants does not necessarily increase the reach of the intervention to more disadvantaged participants
or increase generalisability.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 8 Community recruitment sites and activity, other than by letter
Recruitment sites Recruitment activity
Workplace site
Local adult education and
training provider
Flyers and packs in the refectory. Contact at the centre distributed packs
Post ofﬁce MDEC Information cascaded through managers to all employees in team brieﬁngs
Educational site
Local primary school Article in parent newsletter
Mother/toddler groups;
several local children’s centres
Mother/toddler groups visited through Sure Start. Posters and packs left, packs
given out during groups
Community site/organisation
Job centre (Devonport) 100 packs given out over several periods in a week
Local community hub cafe Local health promotion sessions and food bank session attended
Local community co-operative
organisation
Flyers and posters given out for the Guildhall and workers based there
YMCA (community-run gym) Posters on display. Fitness manager promoted study to users of the Stonehouse
gym. HTs attended a children’s session; one pack given out.
Local gym Gym instructors gave out ﬂyers and packs
Local social club Central contact gave out several packs and reply sheets
Public health Posters and packs given to the local health club in Devonport
Three local housing
associations
180 ﬂyers distributed through mailboxes in housing association residences in
Plymouth; ﬂyers distributed and attendance at residents’ meetings. Posters, ﬂyers
and packs left at site for visitors
Neighbourhood managers
(city council)
HT met with managers in Devonport and Stonehouse. Information distributed
Local community learning
centre
Information and ﬂyers displayed. HT attended information sessions
Other
Local library Flyers and posters on display.
Heart Radio/Plymouth Sound/
Radio Devon/newspaper
Radio chat about the study and news advert in paper
Word of mouth First 60 trial participants asked to invite friends/acquaintances to join study
Individual contacts (e.g.
Church of England minister,
local day support facility
member, publican)
Posters displayed by contacts
IAPT Service, Plymouth Met and encouraged psychological well-being practitioners. Left ﬂyers to be
distributed. Encouraged by e-mail
MDEC, Manual Data Entry Centre.
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TABLE 9 Baseline demographics and smoking characteristics by recruitment method
Baseline characteristic Primary care (N = 62) SSS (N = 31) Community (N = 6)
Sex, n (%)
Male 28 (45.2) 13 (41.9) 2 (33.3)
Female 34 (54.8) 18 (58.1) 4 (66.7)
Age (years), mean (SD);
median (IQR)
45.9 (11.4);
47.1 (38.0 to 55.0)
47.1 (11.7);
48.9 (38.3 to 56.9)
50.8 (8.6);
49.6 (44.3 to 58.2)
Ethnicity, n (%)
White British 58 (93.6) 31 (100) 6 (100)
Other 4 (6.5) 0 (0) 0 (0)
Cohabiting status, n (%)
Cohabiting 35 (56.5) 12 (38.7) 3 (50.0)
Not cohabiting 27 (43.6) 19 (61.3) 3 (50.0)
Children under 16 years, n (%)
Yes 16 (25.8) 9 (29.0) 3 (50.0)
No 46 (74.2) 22 (71.0) 3 (50.0)
Single parent,a n (%)
Yes 2 (3.2) 2 (6.5) 2 (33.3)
Employment status, n (%)
Employed 37 (59.7) 13 (41.9) 4 (66.7)
Not employed 25 (40.3) 18 (58.1) 2 (33.3)
Job status, n (%)
A to C1 5 (8.1) 2 (6.5) 2 (33.3)
C2 to E 32 (51.6) 11 (35.5) 2 (33.3)
Unemployed 25 (40.3) 18 (58.1) 2 (33.3)
Age (years) on leaving education,
mean (SD); median (IQR)
16.3 (2.1);
16.0 (15.0 to 16.3)
16.2 (1.6);
16 (15 to 16)
16.0 (1.3);
15.5 (15.0 to 17.3)
Age (years) on starting smoking,
mean (SD); median (IQR)
14.5 (3.6);
14.0 (13.0 to 16.0)
14.6 (3.1);
15.0 (12.0 to 16.0)
16.8 (3.0);
17.0 (13.8 to 20.0)
Does partner or other cohabitant smoke, n (%)
Yes 20 (32.3) 10 (32.3) 1 (16.7)
No 20 (32.3) 5 (16.1) 2 (33.3)
Not applicable 22 (35.5) 16 (51.6) 3 (50.0)
BMI (kg/m2), mean (SD), n;
median (IQR)
27.6 (6.5), 62;
26.5 (22.2 to 31.3)
28.9 (6.6), 30;
27.7 (22.5 to 35.0)
29.9 (4.1), 6;
30.2 (26.5 to 33.3)
Indicated mental health problem,b n (%)
Yes 24 (38.7) 16 (51.6) 1 (16.7)
No 38 (61.3) 15 (48.4) 5 (83.3)
Duration of smoking (years),
mean (SD); median (IQR)
31.5 (12.2);
33.1 (22.2 to 40.0)
32.5 (13.0);
36.4 (23.3 to 43.1)
34.0 (8.9);
34.1 (29.9 to 42.2)
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ABLE 9 Baseline demographics and smoking characteristics by recruitment method (continued )
Baseline characteristic Primary care (N = 62) SSS (N = 31) Community (N = 6)
Previous use of SSS, n (%)
Yes 17 (27.4) 22 (71.0) 2 (33.3)
No 45 (72.6) 9 (29.0) 4 (66.6)
Satisfaction with previous use of SSS
(if used) (scale 1–11); mean (SD), n
7.3 (3.28), 17 8.9 (2.3), 21 10.5 (0.7), 2
Did the participant make a quit attempt lasting 24 hours or more in the past year, n (%)
Yes 17 (27.4) 18 (58.1) 2 (33.3)
No 45 (72.6) 13 (47.9) 4 (66.6)
Did the participant cut down before previous cessation,c n (%)
Yes 1 (5.9) 4 (22.2) 0 (0.0)
No 16 (94.1) 14 (77.8) 2 (100.0)
Total n 17 18 2
Used cessation aids as part of a quit attempt in previous 12 months,d n (%)
Yes 11 (64.7) 17 (94.4) 1 (50.0)
No 6 (35.3) 1 (5.6) 1 (50.0)
Total n 17 18 2
Used cessation aids not as part of a quit attempt in previous 12 months, n (%)
Yes 8 (17.8) 10 (26.3) 3 (75.0)
No 37 (82.2) 3 (73.7) 1 (25.0)
Total n 45 13 4
BMI, body mass index; IQR, interquartile range; SD, standard deviation.
a All single parents female apart from one male, recruited through SSS. As a percentage of women (up to
aged 47 years – the oldest parent with a child under 16 years) the % of female single parents across all recruitment
methods was 17%.
b Answered ‘moderately’ or ‘extremely’ anxious or depressed to item 5 of the EQ-5D questionnaire.
c Includes only smokers who have stopped smoking for at least 24 hours’ in past year.
d At least 24 hours’ reported abstinence.
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TABLE 10 Baseline demographics and smoking characteristics by contact method
Baseline characteristic
Contact methode
Letter (N = 55)
Letter and reminder
telephone call (N = 38)
Sex, n (%)
Male 25 (45.5) 16 (42.1)
Female 30 (54.6) 22 (57.9)
Age (years), mean (SD); median (IQR) 47.3 (11.7);
48.9 (38.0 to 55.5)
44.9 (11.0);
46.0 (38.1 to 53.6)
Age (years), n (%)
30 and under 6 (10.9) 7 (18.4)
31 and over 49 (89.1) 31 (81.6)
Ethnicity, n (%)
White British 53 (96.4) 36 (94.7)
Other 2 (3.6) 2 (5.3)
Cohabiting, n (%) 27 (49.1) 20 (52.6)
Children under 16, n (%) 15 (27.3) 10 (26.3)
Single parent,a n (%) 2 (3.6) 2 (5.3)
Employment status, n (%)
Employed 29 (52.7) 21 (55.3)
Not employed 26 (47.3) 17 (44.7)
Job status, n (%)
A to C1 5 (9.1) 2 (5.6)
C2 to E 24 (43.6) 19 (50.0)
Unemployed 26 (47.3) 17 (44.7)
Age (years) on leaving education,
mean (SD); median (IQR)
16.2 (1.8);
16.0 (15.0 to 16.0)
16.4 (2.1);
16.0 (15.0 to 16.3)
BMI (kg/m2), mean (SD), n; median
(IQR)
28.0 (6.0), 54;
27.3 (22.5 to 33.0)
28.1 (7.3), 38;
26.4 (22.2 to 31.3)
Indicated mental health problem,b n (%)
Yes 22 (40.0) 18 (47.4)
No 33 (60) 20 (52.6)
Age (years) on starting smoking, mean
(SD); median (IQR)
14.9 (3.5);
14 (13 to 16)
14.1 (3.3)
14 (12 to 16)
Does partner or other cohabitant smoke, n (%)
Yes 20 (36.4) 10 (26.4)
No 11 (20.0) 14 (36.8)
Not applicable 24 (43.6) 14 (36.8)
Duration of smoking (years), mean
(SD); median (IQR)
32.4 (12.8);
35.8 (22.6 to 42.3)
30.9 (11.9);
32.0 (24.8 to 40.0)
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TABLE 10 Baseline demographics and smoking characteristics by contact method (continued )
Baseline characteristic
Contact methode
Letter (N = 55)
Letter and reminder
telephone call (N = 38)
Previous use of SSS, n (%)
Yes 28 (50.9) 11 (28.9)
No 27 (49.1) 27 (71.1)
Satisfaction with previous use of SSS
(if used) (scale 1–11), mean (SD), n
8.6 (2.6), 27 7.2 (3.3), 11
Did the participant make a quit attempt lasting 24 hours or more in the past year, n (%)
Yes 25 (45.5) 10 (26.4)
No 30 (54.5) 28 (73.6)
Did the participant cut down before previous cessation,c n (%)
Yes 3 (12.0) 2 (20.0)
No 22 (88) 8 (80.0)
Total n 25 10
Used cessation aids as part of a quit attempt in previous 12 months,d n (%)
Yes 20 (80.0) 8 (80.0)
No 5 (20.0) 2 (20.0)
Total n 25 10
Used cessation aids not as part of a quit attempt in previous 12 months, n (%)
Yes 10 (33.3) 8 (28.6)
No 20 (66.7) 20 (71.4)
Total n 30 28
BMI, body mass index; IQR, interquartile range, SD, standard deviation.
a Applies to participants recruited through primary care and SSS only. As a percentage of women (up to aged 47 years –
the oldest parent with an under 16-year-old child) the percentage of female single parents across all recruitment
methods was 17%.
b Answered ‘moderately’ or ‘extremely’ anxious or depressed to item 5 of the EQ-5D questionnaire.
c Includes only smokers who have stopped smoking for at least 24 hours in past year.
d At least 24 hours’ reported abstinence.
e Those recruited through SSS and primary care only, other community approaches not applicable.
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treatment armsTable 11 shows the demographic characters of those randomly assigned to the control and intervention
arms. There appeared to be minimal difference between the groups.
Overall, the sample was 57% female and 96% white British; 50% were living with someone else, 28%
had a child under 16 and 91% were in social class C2–E (of whom 46% were unemployed). On average,
the sample was 47 years of age, left school at 16 years and started smoking at 14.7 years and had thus
been smoking for 32 years. In the past, 41% had used a SSS, with a generally high level of satisfaction
with the support received. In the past year, 37% had made a quit attempt lasting 24 hours or more, of
whom very few had cut down beforehand, and most had used some kind of cessation aid.29
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TABLE 11 Baseline demographics and smoking characteristics by treatment arm
Baseline characteristic Control, n (%) Intervention, n (%)
Sex
Male (N = 43) 21 (48.8) 22 (51.2)
Female (N = 56) 29 (51.2) 27 (48.8)
Age (years), mean (SD); median (IQR) 46.0 (11.1);
47.0 (38.2 to 54.3)
47.2 (11.6);
47.8 (38.5 to 56.5)
Ethnicity
White British (N = 95) 48 (50.5) 47 (49.5)
Other (N = 4) 2 (50.0) 2 (50.0)
Cohabiting status
Cohabiting (N = 50) 29 (58.0) 21 (42.0)
Not cohabiting (N = 49) 21 (42.9) 28 (57.1)
Children under 16 years
Yes (N = 28) 17 (60.7) 11 (39.3)
No (N = 71) 33 (46.5) 38 (53.5)
Single parenta
Yes (N = 6) 3 (50.0) 3 (50.0)
Employment status
Employed (N = 54) 28 (51.9) 26 (48.1)
Not employed (N = 45) 22 (48.9) 23 (51.1)
Job status
A to C1 (N = 9) 4 (44.4) 5 (55.6)
C2 to E (N = 45) 24 (53.3) 21 (46.7)
Unemployed (N = 45) 22 (48.9) 23 (51.1)
Age left education (years), mean (SD);
median (IQR)
16.4 (2.2);
16.0 (15.0 to 16.3)
16.2 (1.5);
16.0 (15.0 to 16.0)
Indicated mental health problemb
Yes (N = 41) 19 (46.3) 22 (53.7)
No (N = 58) 31 (53.4) 27 (46.6)
Does partner or other cohabitant smoke?
Yes (N = 31) 21 (67.7) 10 (32.3)
No (N = 27) 13 (48.1) 14 (51.9)
Not applicable (N = 41) 16 (39.0) 25 (61.0)
Age on starting smoking (years), mean (SD);
median (IQR)
14.7 (4.1);
14.0 (12.0 to 16.0)
14.6 (2.8);
14.0 (13.0 to 16.0)
Duration of smoking (years), mean (SD);
median (IQR)
31.3 (12.3);
32.7 (21.7 to 40.0)
32.6 (12.2);
34.7 (24.9 to 43.6)
Previous use of SSS
Yes (N = 41) 20 (48.8) 21 (51.2)
No (N = 58) 30 (51.7) 28 (48.3)
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ABLE 11 Baseline demographics and smoking characteristics by treatment arm (continued )
Baseline characteristic Control, n (%) Intervention, n (%)
Satisfaction with previous use of SSS
(if used) (scale 1–11), mean (SD), n
7.9 (3.3), 19 8.6 (2.3), 21
Did participant make a quit attempt lasting 24 hours or more in past year?
Yes (N = 37) 20 (54.1) 17 (45.9)
No (N = 62) 30 (48.4) 32 (51.6)
Did the participant cut down before previous cessation?c
Yes (N = 5) 4 (80.0) 1 (20.0)
No (N = 32) 16 (50.0) 16 (50.0)
Total n 20 17
Used cessation aid as part of a quit attempt in previous 12 monthsd
Yes (N = 29) 17 (58.6) 12 (41.4)
No (N = 8) 3 (37.5) 5 (62.5)
Total n 20 17
Used cessation aid not as part of a quit attempt in previous 12 months
Yes (N = 21) 9 (42.9) 12 (57.1)
No (N = 41) 21 (51.2) 20 (48.8)
Total n 30 32
IQR, interquartile range; SD, standard deviation.
a All single parents female apart from one male, randomised to the control arm.
b Answered ‘moderately’ or ‘extremely’ anxious or depressed to item 5 of the EQ-5D questionnaire.
c Includes only smokers who have stopped smoking for at least 24 hours in past year.
d At least 24 hours’ reported abstinence.
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4TStudy attrition and associated factorsThis section refers to capturing complete data at follow-up assessments. Table 12 shows the number of
participants who we were able to assess after baseline at week 4, 8 and 16 weeks, by treatment arm. The
4-week assessment was conducted by telephone (or in person for those in the intervention arm, if still in
contact) and focused only on capturing a limited data set. There was a minimal difference in attrition
between the two arms of the trial. Much of the attrition occurred within the ﬁrst 4 weeks, and then
levelled off over time. At the longest follow-up of 16 weeks we were able to collect data from 61% and
62% of participants in the intervention and control arms, respectively. The ﬁgures were 55% and 58% for
collecting follow-up data at both 8 and 16 weeks. In subsequent tables showing data collected over time
the values were derived from the number of participants shown below or fewer if there were any missing
data for individual variables, as shown.
We examined what, if any, factors inﬂuenced study attrition. Table 13 shows that attrition was about
double for those recruited by a reminder telephone call through GP practice invitation compared with
those who responded to the initial invitation letter.
Table 14 shows that those completing data collection at 16 weeks were fairly similar to those who
did not. Any apparent differences were probably due to small numbers in different categories for
categorical variables.31
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TABLE 13 Withdrawal by recruitment method
Recruitment method Withdrawal before ﬁnal follow-up, n (%)
Primary care (N = 62) 25 (40.3)
Letter (N = 31) 8 (25.8)
Telephone reminder (N = 31) 17 (54.8)
SSS (N = 31) 11 (35.5)
Letter (N = 24) 9 (37.5)
Telephone reminder (N = 7) 2 (28.6)
Community (N = 6) 2 (33.3)
Overall (N = 99) 38 (38.4)
TABLE 14 Baseline demographics and smoking characteristics by withdrawal statusa
Baseline characteristic Withdrew, n (%) Did not withdraw, n (%)
Sex
Male (N = 43) 14 (32.6) 29 (67.4)
Female (N = 56) 24 (42.9) 32 (57.1)
Age (years), mean (SD), n;
median (IQR)
44.2 (10.9), 38;
43.7 (37.5 to 53.6)
48.1 (11.4), 61;
50.0 (39.6 to 56.3)
Age (years)
≤ 30 (N = 13) 5 (38.5) 8 (61.5)
≥ 31 (N = 86) 33 (38.4) 53 (61.6)
Ethnicity
White British (N = 95) 37 (39.0) 58 (61.1)
Other (N = 4) 1 (25.0) 3 (75.0)
Cohabiting status
Cohabiting (N = 50) 18 (36.0) 32 (64.0)
Not cohabiting (N = 49) 20 (40.8) 29 (59.2)
Children under 16 years
Yes (N = 28) 13 (46.4) 15 (53.6)
No (N = 71) 25 (35.2) 46 (64.8)
Single parent
Yes (N = 6) 4 (66.7) 2 (33.3)
Employment status
Employed (N = 54) 20 (37.0) 34 (63.0)
Not employed (N = 45) 18 (40.0) 27 (60.0)
Job status
A to C1 (N = 9) 3 (33.3) 6 (66.7)
C2 to E (N = 45) 17 (37.8) 28 (62.2)
Unemployed (N = 45) 18 (40.0) 27 (60.0)
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4continued
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ABLE 14 Baseline demographics and smoking characteristics by withdrawal statusa (continued )
Baseline characteristic Withdrew, n (%) Did not withdraw, n (%)
Age on leaving education (years),
mean (SD), n
16.1 (1.2), 38 16.4 (2.2), 61
BMI (kg/m2), mean (SD), n; median (IQR) 28.3 (7.0), 38;
27.6 (22.2 to 33.5)
28.0 (6.0), 60;
27.0 (22.5 to 31.9)
Indicated mental health problemb
Yes 18 (43.9) 23 (56.1)
No 20 (34.5) 38 (65.5)
Age on starting smoking (years),
mean (SD); median (IQR)
14.5 (4.3); 14 (12 to 16) 14.8 (2.9); 14 (13 to 16)
Does partner or other cohabitant smoke?
Yes (N = 31) 9 (29.0) 22 (71.0)
No (N = 27) 14 (51.9) 13 (48.1)
Not applicable (N = 41) 15 (36.6) 26 (63.4)
Duration of smoking (years), mean
(SD); median (IQR)
29.7 (12.6);
30.2 (22.2 to 39.9)
33.3 (11.9);
35.8 (23.4 to 43.1)
Previous use of SSS
Yes (N = 41) 15 (36.6) 26 (63.4)
No (N = 58) 23 (39.7) 35 (60.3)
Satisfaction with previous use of SSS
(if used) (scale 1–11), mean (SD), n
7.3 (2.8), 15 8.9 (2.7), 25
Did the participant make a quit attempt lasting 24 hours or more in the past year?
Yes (N = 37) 14 (37.8) 23 (62.2)
No (N = 62) 24 (38.7) 38 (61.3)
Did the participant cut down before previous cessation?c
Yes (N = 5) 2 (40.0) 3 (60.0)
No (N = 32) 12 (37.5) 20 (62.5)
Total n 14 23
Used cessation aids as part of a quit attempt in previous 12 monthsd
Yes (N = 29) 9 (31.0) 20 (69.0)
No (N = 8) 5 (62.5) 3 (37.5)
Total n 14 23
Used cessation aids not as part of a quit attempt in previous 12 months
Yes (N = 21) 6 (28.6) 15 (71.4)
No (N = 41) 18 (43.9) 23 (56.1)
Total n 24 38
BMI, body mass index; IQR, interquartile range; SD, standard deviation.
a Withdrawal deﬁned as non-attendance at Week 16.
b Answered ‘moderately’ or ‘extremely’ anxious or depressed to item 5 of the EQ-5D questionnaire.
c Includes only smokers who have stopped smoking for at least 24 hours in past year.
d At least 24 hours’ reported abstinence.
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Table 15 shows that those completing data collection for PA and smoking-related variables at 16 weeks
were fairly similar to those who did not. Any apparent differences were probably due to small numbers in
different categories for categorical variables.
Bias in self-reported physical activity
Baseline data were available from both accelerometer-measured and self-reported minutes of PA for
65 participants (across both arms). Of these, 41 participants (63%) self-reported a greater number of
minutes of MVPA than their equivalent accelerometer-measured data indicated. Figure 4 plots the
difference between mean accelerometer-measured and mean self-reported MVPA by the overall mean
MVPA derived from the means of both measures. Over-reporting was greatest for those participants
completing the most daily MVPA based on the average of both methods.ABLE 15 Baseline smoking and PA and accelerometer data by withdrawal statusa
Variable Withdrew (N = 38) Did not withdraw (N = 61)
Smoking and PA data
Self-reported cigarettes smoked per day,
mean (SD), n; median (IQR)
21.2 (15.2), 38;
19.7 (14.3 to 25.3)
21.8 (13.8), 61;
18.9 (14.7 to 24.5)
Expired air CO (p.p.m.), mean (SD), n 19.5 (8.4), 37 17.1 (7.8), 61
FTND, mean (SD); median (IQR) 6.0 (2.0);
6.5 (4.0 to 7.0)
5.3 (2.1);
6 (3.0 to 7.0)
Readiness to use PA as a way of controlling
smoking, ACTION and MAINTENANCE stage, n (%)
3 (7.9) 6 (9.8)
Self-reported minutes of moderate and vigorous
physical activity over previous 7 days, mean (SD), n;
median (IQR)
415 (530.5), 38;
268 (0 to 594)
573 (694.3), 60;
338 (173 to 540)
Accelerometer data
Minutes spent in moderate/vigorous/very vigorous
activity per day, mean (SD), n; median (IQR)
34 (26.8), 19;
33 (9 to 48)
31 (23.7), 47;
27 (42 to 16)
Step counts, mean (SD), n; median (IQR) 8200 (3667.6), 19;
7303 (5570 to 10541)
7500 (3501.8), 47;
7426 (4534 to 9853)
IQR, interquartile range, SD, standard deviation.
a Withdrawal deﬁned as non-attendance at week 16.T0
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FIGURE 4 Plot of the difference (accelerometer minus recall diary) between MVPA as recorded by accelerometer and
by self-report against the mean of both measures.
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36Changes in outcomes over time, by treatment arm
Table 16 presents data for the primary smoking-related outcomes. A greater proportion of those in the
intervention arm made a quit attempt and had reduced their smoking by at least 50% at week 16. The RR
for being abstinent at 4 weeks after quitting and at 16 weeks (point prevalence) was 3.57 and 2.55,
respectively, but the CI included 1.0. Also, the RR for having reduced smoking by at least 50% by
week 8 was 1.91 but the CI included 1.0.
Table 17 presents data for smoking-related variables at each assessment by treatment condition, for only
those completing assessments. We did not plan to conduct inferential statistics so none are presented.
With no differences at baseline, there appeared to be greater reductions among the intervention group in
cigarettes smoked, expired air CO, cravings and withdrawal symptoms (MPSS) for cigarettes, strength of
desire to smoke and withdrawal symptoms, and increases in importance and conﬁdence in quitting, and
conﬁdence in reducing cigarettes smoked by 50%. Nicotine dependence (FTND) and satisfaction with
smoking scales (mCEQ) also appeared to reduce more in the intervention arm.
Data for item 2 (‘How soon after waking up do you smoke your ﬁrst cigarette?’) of the FTND, at baseline
and follow-up assessments, are shown by condition in Table 18.
Table 19 shows the number (%) of participants at each stage of readiness to use PA as a way of controlling
smoking, in each arm of the trial over time. In summary, as expected, few reported that they were actually
using PA (i.e. in action and maintenance stage) as a way of controlling their smoking at baseline, but at 4,
8 and 16 weeks the percentage in the intervention arm versus control were 36% versus 23%, 55% versus
22% and 37% versus 16%, respectively, among those completing follow-up assessments.ABLE 16 Smoking outcome by treatment arm
Smoking Intervention (N = 49) Control (N = 50) RR (95% CI)
Self-reported quit attempt during study,a n (%)
Yes 11 (22.5) 3 (6.0) 3.74 (1.11 to 12.60)
No 38 (77.6) 47 (94.0)
Conﬁrmed quit at 4 weeks post quit date,a,b n (%)
Yes 7 (14.3) 2 (4.0) 3.57 (0.78 to 16.35)
No 42 (85.7) 48 (96.0)
Self-reported non-smoking at week 16,a,c n (%)
Yes 5 (10.2) 2 (4.0) 2.55 (0.52 to 12.53)
No 44 (89.8) 48 (96.0)
Reduction of smoking by 50% or more by week 8,a n (%)
Yes 15 (30.6) 8 (16.0) 1.91 (0.89 to 4.10)
No 34 (69.4) 42 (84.0)
Reduction of smoking by 50% or more by week 16,a n (%)
Yes 19 (38.8) 10 (20.0) 1.94 (1.01 to 3.74)
No 30 (61.2) 40 (80.0)
a All smokers lost to follow-up assumed to be still smoking at same level.
b Includes participants who resumed smoking prior to week 16; quit conﬁrmed by CO reading < 10 p.p.m. at least 4 weeks
after quit date.
c All seven participants who self-reported as non-smoking at week 16 had a CO reading of < 10 p.p.m. at week 16. All
seven participants who self-reported as non-smoking at week 16 had one or two CO readings of < 10 p.p.m. at 28 days
or more after their quit attempt date.TNIHR Journals Library www.journalslibrary.nihr.ac.uk
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ABLE 18 Fagerström Test for Nicotine Dependence responses to item 2 (dependence: ‘how soon after waking up
o you smoke your ﬁrst cigarette?’) at baseline and follow-up
Response, n (%)
Baseline Week 8 Week 16
Intervention Control Intervention Control Intervention Control
Within 5 minutes 20 (40.8) 24 (48.0) 3 (12.5) 9 (30.0) 3 (13.6) 11 (37.9)
6–30 minutes 20 (40.8) 18 (36.0) 10 (41.7) 11 (36.7) 8 (36.4) 8 (27.6)
31–60 minutes 7 (14.3) 4 (8.0) 3 (12.5) 7 (23.3) 4 (18.2) 6 (20.7)
After 60 minutes 2 (4.1) 4 (8.0) 8 (33.3) 3 (10.0) 7 (31.8) 4 (13.8)
Total, N 49 50 24 30 22 29
ABLE 19 Stage of readiness to use PA as a way of controlling smoking at baseline and follow-up
or attenders only)
Stage, n (%)
Baseline Week 4 Week 8 Week 16
Intervention Control Intervention Control Intervention Control Intervention Control
Pre-
contemplation
6 (12.2) 3 (6.0) 2 (6.1) 5 (14.7) 3 (10.3) 6 (18.8) 6 (20.0) 6 (19.4)
Contemplation 34 (69.4) 36 (72.0) 8 (24.2) 14 (41.2) 5 (17.2) 12 (37.5) 6 (20.0) 10 (32.3)
Planning 3 (6.1) 8 (16.0) 11 (33.3) 7 (20.6) 5 (17.2) 7 (21.9) 7 (23.3) 10 (32.3)
Action 4 (8.2) 2 (4.0) 11 (33.3) 3 (8.8) 16 (55.2) 6 (18.8) 11 (36.7) 4 (12.9)
Maintenance 2 (4.1) 1 (2.0) 1 (3.0) 5 (14.7) 0 (0) 1 (3.1) 0 (0) 1 (3.2)
Total, N 49 50 33 34 29 32 30 31
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4T
d
T
(fTable 20 presents data for body mass index (BMI), weight, sleep and PA-related variables at each
assessment by treatment condition, for only those completing assessments. The mean weight for the
intervention arm increased by 5.3 kg over 16 weeks, while the mean weight in the control arm did not
change. There appeared to be a difference in median minutes of daily self-reported MVPA between the
intervention and control arms of 21 minutes (60 minutes vs. 39 minutes) and 5 minutes (35 minutes vs.
30 minutes) at 8 and 16 weeks, respectively. The proportion of participants who self-reported that they did
30 minutes or more of MVPA was 21 percentage points greater in the intervention arm versus the control
arm (76% vs. 55%) at 8 weeks, and 5 percentage points greater (57% vs. 52%) at 16 weeks. There were
small increases in conﬁdence to exercise for 30 minutes per day for the next 6 months at 8 weeks but not
at 16 weeks in the intervention relative to the control arm.
Table 21 presents data for PA, measured by accelerometer, at each assessment by treatment condition, for
only those completing assessments. There appeared to be a difference in median minutes of objectively
assessed MVPA between the intervention and control arms of 14 minutes (36 minutes vs. 22 minutes) at
8 weeks but none at 16 weeks (20 minutes vs. 23 minutes). Comparing the two arms, 62% in the
intervention arm versus 35% in the control arm did 30 minutes or more of MVPA per day at 8 weeks and
38% versus 33%, respectively, did so at 16 weeks.39
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Table 22 presents data for EQ-5D and perceived stress at each assessment by treatment condition, for only
those completing assessments. There appeared to be little or no difference between the treatment
conditions over time.
Table 23 presents data for alcohol-related variables at each assessment by treatment condition, for only
those completing assessments. There appeared to be no difference between the treatment conditions over
time, though any interpretation was difﬁcult given the small sample size.
Intervention adherence and its association with outcomes
The number of sessions attended by the 49 participants in the intervention arm is shown in Table 24.
Overall, the mean [standard deviation (SD)] number of sessions attended was 4.2 (2.7) support sessions
(56% face to face, 44% by telephone), with a range from 0 to 8.
Using a median split, 20 participants were identiﬁed as low attenders (0–3 sessions) and 29 as high
attenders (4–8 sessions). The demographic characteristics are shown in Table 25 and the baseline smoking
and PA-related variables are shown in Table 26. The sample size was too small to statistically identify
demographic and baseline determinants of intervention adherence.
The relationship between level of intervention participation and smoking-related variables is shown in
Tables 27 and 28. There appeared to be a greater proportion of participants who reduced the number of
cigarettes smoked by at least 50% among those who attended more sessions of the intervention, and a
trend towards a greater proportion of high attenders making a quit attempt. Comparison of the number
of cigarettes smoked and FTND at follow-up assessments was limited because of the small numbers of
participants who completed assessments in the low-treatment adherers.ABLE 22 European Quality of Life-5 Dimensions and perceived stress at baseline and follow-up, by treatment
roup (for attenders only)
Variable Baseline Week 8 Week 16
EQ-5D, mean (SD), n
Intervention 0.75 (0.29), 49 0.78 (0.24), 29 0.75 (0.29), 30
Control 0.75 (0.27), 50 0.80 (0.24), 31 0.75 (0.29), 31
PSS, mean (SD), n; median (IQR)
Intervention 6.0 (4.07), 49; 4.0 (2.0 to 6.3) 4.3 (3.8), 28; 2.5 (1.3 to 5.0) 5.1 (4.8), 30; 2.50 (0.0 to 6.0)
Control 5.5 (4.2), 50; 4.0 (2.0 to 6.0) 4.6 (4.2), 32; 3.0 (1.0 to 5.0) 4.2 (4.5), 31; 2.0 (1.0 to 4.0)
IQR, interquartile range; PSS, Perceived Stress Scale; SD, standard deviation.T
g43
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
ABLE 23 Alcohol use at baseline and follow-up
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44TTABLE 24 Frequency of intervention sessions attended
Number of sessions Frequency
0 6
1 5
2 4
3 5
4 6
5 6
6 4
7 6
8 7
Variable
Baseline Week 8 Week 16
Intervention Control Intervention Control Intervention Control
How often do you have a drink containing alcohol?, n (%)
Never 9 (18.4) 6 (12.0) 4 (13.8) 4 (12.5) 6 (20.0) 4 (12.9)
Once a month or less 11 (22.5) 15 (30.0) 10 (34.5) 10 (31.3) 9 (30.0) 10 (32.3)
2–4 times per month 17 (34.7) 9 (18.0) 11 (37.9) 4 (12.5) 7 (23.3) 7 (22.6)
2–3 times per week 6 (12.2) 14 (28.0) 1 (3.5) 12 (37.5) 4 (13.3) 6 (19.4)
4 or more times per week 6 (12.2) 6 (12.0) 3 (10.3) 6 (2.3) 4 (13.3) 4 (12.9)
Total N 49 50 29 32 30 31
How many drinks containing alcohol do you have on a typical day when you are drinking?, n (%)
One or two 10 (25.0) 13 (29.6) 8 (32.0) 9 (32.1) 10 (41.7) 10 (37.0)
Three or four 10 (25.0) 10 (22.7) 7 (28.0) 9 (32.1) 8 (33.3) 9 (33.3)
Five or six 9 (22.5) 8 (18.2) 5 (20.0) 3 (10.7) 2 (8.33) 5 (18.5)
Seven to nine 7 (17.5) 8 (18.2) 2 (8.0) 4 (14.3) 3 (12.5) 1 (3.7)
10 or more 4 (10.0) 5 (11.4) 3 (12.0) 3 (10.7) 1 (4.2) 2 (7.4)
Total N 40 44 25 28 24 27
How many drinks containing alcohol have you had in the past week?, n (%)
None 11 (27.5) 14 (31.8) 9 (36.0) 8 (28.6) 6 (25.0) 10 (37.0)
One or two 7 (17.5) 7 (15.9) 2 (8.0) 4 (14.3) 5 (20.8) 4 (14.8)
Three or four 3 (7.5) 4 (9.1) 6 (24.0) 5 (17.9) 3 (12.5) 5 (18.5)
Five or six 5 (12.5) 1 (2.3) 2 (8.0) 2 (7.1) 2 (8.3) 3 (11.1)
Seven to nine 3 (7.5) 3 (6.8) 0 (0) 1 (3.6) 1 (4.2) 2 (7.4)
Ten or more 11 (27.5) 15 (34.1) 6 (24.0) 8 (28.6) 7 (29.2) 3 (11.1)
Total N 44 44 25 28 24 27
Note: data not collected at 4-week follow-up.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 25 Baseline demographics and smoking characteristics by intervention participation
Baseline characteristic
Low attendance
[0–3 sessions; n (%)]
High attendance
[4–8 sessions; n (%)]
Sex
Male (N = 22) 7 (31.8) 15 (68.2)
Female (N = 27) 13 (48.2) 14 (51.9)
Age (years), mean (SD), n; median (IQR) 44.4 (13.5), 20;
47.6 (33.6 to 55.9)
49.2 (9.9), 29;
50.0 (40.8 to 58.5)
Age (years)
≤ 30 (N = 6) 4 (66.7) 2 (33.3)
≥ 31 (N = 43) 16 (37.2) 27 (62.8)
Ethnicity
White British (N = 47) 20 (42.6) 27 (57.5)
Other (N = 2) 0 (0) 2 (100)
Cohabiting status
Cohabiting (N = 21) 7 (33.3) 14 (66.7)
Not cohabiting (N = 28) 13 (46.4) 15 (53.6)
Children under 16 years
Yes (N = 11) 3 (27.3) 8 (72.7)
No (N = 38) 17 (44.7) 21 (55.3)
Single parenta
Yes (N = 3) 1 (33.3) 2 (66.7)
Employment status
Employed (N = 26) 11 (42.3) 15 (57.7)
Not employed (N = 23) 9 (39.1) 14 (60.9)
Job status
A to C1 (N = 5) 1 (20.0) 4 (80.0)
C2 to E (N = 21) 10 (47.6) 11 (52.4)
Unemployed (N = 23) 9 (39.1) 14 (60.9)
Age on leaving education (years),
mean (SD), n; median (IQR)
16.0 (0.9), 20;
16.0 (15.0 to 16.0)
16.3 (1.8), 29;
16.0 (15.0 to 16.5)
BMI (kg/m2), mean (SD), n;
median (IQR)
29.7 (5.8), 20;
29.4 (24.8 to 33.9)
27.8 (6.0), 29;
26.7 (22.2 to 32.3)
Indicated mental health problemb
Yes (N = 23) 8 (34.8) 15 (65.2)
No (N = 26) 12 (46.2) 14 (53.8)
Age on starting smoking (years),
mean (SD); median (IQR)
14.8 (3.4);
13.5 (13.0 to 16)
14.5 (2.4);
14 (13 to 16)
Does partner or other cohabitant smoke?
Yes (N = 9) 5 (55.6) 4 (44.4)
No (N = 14) 4 (28.6) 10 (71.4)
Not applicable (N = 25) 11 (44.0) 14 (56.0)
continued
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ABLE 25 Baseline demographics and smoking characteristics by intervention participation (continued )
Baseline characteristic
Low attendance
[0–3 sessions; n (%)]
High attendance
[4–8 sessions; n (%)]
Duration of smoking (years), mean (SD);
median (IQR)
29.6 (14.2);
33.6 (16.6 to 41.0)
34.7 (10.4);
34.7 (26.6 to 44.4)
Previous use of SSS
Yes (N = 21) 9 (42.9) 12 (57.1)
No (N = 28) 11 (39.3) 17 (60.7)
Satisfaction with previous use of SSS
(if used) (scale 1–11), mean (SD), n
8.1 (2.6), 9 9.0 (2.1), 12
Did the participant make a quit attempt lasting 24 hours or more in the past year?
Yes (N = 17) 10 (58.8) 7 (41.2)
No (N = 32) 10 (31.3) 22 (68.7)
Did the participant cut down before previous cessation?c
Yes (N = 1) 1 (100.0) 0 (0.0)
No (N = 16) 9 (56.3) 7 (43.7)
Total n 10 7
Used cessation aids as part of a quit attempt in previous 12 monthsd
Yes (N = 12) 7 (58.3) 5 (41.7)
No (N = 5) 3 (60.0) 2 (40.0)
Total n 10 7
Used cessation aids not as part of a quit attempt in previous 12 months
Yes (N = 12) 4 (33.3) 8 (66.7)
No (N = 20) 6 (30.0) 14 (70.0)
Total n 10 22
IQR, interquartile range; SD, standard deviation.
a All single parents female apart from one male, randomised to the control arm.
b Answered ‘moderately’ or ‘extremely’ anxious or depressed to item 5 of the EQ-5D questionnaire.
c Includes only smokers who have stopped smoking for at least 24 hours in past year.
d At least 24 hours’ reported abstinence.
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ABLE 26 Baseline data for smoking and PA related variables by intervention participation
Baseline characteristic
Low attendance
(0–3 sessions; N = 20)
High attendance
(4–8 sessions; N = 29)
Self-reported composite cigarettes per day,
mean (SD), n; median (IQR)
20.0 (9.4), 20;
19.6 (13.4 to 29.2)
22.8 (16.8), 29;
17.0 (12.5 to 25.9)
Expired air CO (p.p.m.), mean (SD) 20.3 (7.5) 15.5 (7.0)
FTND, mean (SD); median (IQR) 5.9 (1.9); 6.5 (5 to 7) 5.3 (2.1); 5 (4 to 7)
Readiness to use PA as a way of controlling smoking,
ACTION and MAINTENANCE stage, n (%)
3 (15.0) 3 (10.3)
Self-reported moderate PA, n (%)
Yes (N = 41) 17 (41.5) 24 (58.5)
No (N = 8) 3 (37.5) 5 (62.5)
Self-reported MVPA over previous 7 days (minutes),
mean (SD) n; median (IQR)
614 (628.0), 20;
343 (120 to 1205)
468 (603.2), 29;
310 (128 to 490)
Time spent in objectively assessed MVPA
per day (minutes), mean (SD) n; median (IQR)
31 (34.7), 10;
15 (10 to 49)
33 (18.3), 24;
33 (18 to 45)
Step counts per day, mean (SD), n; median (IQR) 7555 (3306.2), 10;
7090 (4531 to 10,001)
7347 (2715.3), 24;
7307 (5126 to 8860)
IQR, interquartile range; SD, standard deviation.
ABLE 27 Smoking-cessation outcomes by level of intervention participation
Variable
Intervention high
attenders (N = 29)
Intervention low
attenders (N = 20) RR (95% CI)
Self-reported quit attempt during study,a n (%)
Yes 10 (34.5) 1 (5.0) 6.90 (0.96 to 49.71)
No 19 (65.5) 19 (95.0)
Conﬁrmed quit at 4 weeks post quit date,a,b n (%)
Yes 6 (20.7) 1 (5.0) 4.14 (0.54 to 31.8)
No 23 (79.3) 19 (95.0)
Self-reported non-smoking at week 16,a,c n (%)
Yes 4 (13.8) 1 (5.0) 2.76 (0.33 to 22.89)
No 25 (86.2) 19 (95.0)
Reduction of smoking by 50% or more by week 8,a n (%)
Yes 13 (44.8) 2 (10.0) 4.48 (1.13 to 17.74)
No 16 (55.2) 18 (90.0)
Reduction of smoking by 50% or more by week 16,a n (%)
Yes 18 (62.1) 1 (5.0) 12.41 (1.80 to 85.65)
No 11 (37.9) 19 (95.0)
a All smokers lost to follow-up assumed to be still smoking at same level.
b Includes participants who resumed smoking prior to week 16; quit conﬁrmed by CO reading < 10 p.p.m. at least 4 weeks
after quit date.
c All seven participants who self-reported as non-smoking at week 16 had a CO reading of < 10 p.p.m. at week 16. All
seven participants who self-reported as non-smoking at week 16 had one or two CO readings of < 10 p.p.m. at 28 days
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4T
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quantitative dataOverall summaryThe main aim of this pilot study (to conduct a pilot RCT in which a PA intervention in addition to usual
care was compared with usual care alone, in a largely disadvantaged sample) was achieved. We were able
to recruit a largely socially disadvantaged sample, and conduct follow-up assessments with over 60% of
those randomised. Recruitment by invitation letter (from the GP and the SSS) was the most effective and
efﬁcient approach. Our efforts to recruit a sample of 120 over 12 months proved to be slightly ambitious
relative to the 1.4 full-time equivalent HTs/researchers available and challenges faced in recruiting
participants other than by invitation letter.
Recruitment closed with 99 participants having been randomised. The study provided valuable
information on the feasibility and acceptability of data collection methods and intervention. There was
evidence that the intervention was able to reduce smoking and increase short-term PA, albeit without
inferential statistics.
Information on changes in related outcomes suggests that the intervention impacted in expected ways to
some extent. Data collected provide valuable information for conducting a phase 3 trial, and for making
minor reﬁnements of the intervention and methods. The following discussion provides a more detailed
analysis and reﬂection on the research methods and intervention, to inform future research.Design and methods
Recruitment
Table 29 shows a summary of our targets for recruiting a ‘hard to reach’ or disadvantaged sample against
what we achieved and indicates that we exceeded our targets. Most of the sample were unemployed or in
social class C2–E. Despite considerable effort (see Methods) fewer single parents entered the study than
expected. The target was possibly unrealistic, but there was also some resistance from single parents who
anecdotally found it difﬁcult to give up the time to engage in the study, particularly during school holiday
time. We did not have ethical approval or the resources to systematically identify the participants’ mental
health status at the time of entering the study, though we asked the GP surgery to screen out possible
participants with an unstable mental illness who may have placed the HTs at risk. As a result, we used two
criteria (i.e. items from the EQ-5D and MPSS) to determine to the extent to which our sample had a
mental health problem, as shown in Table 29.
We believe that this target would not have been achieved in less socially deprived parts of Plymouth.
Efforts to recruit through the local IAPT service resulted in only one participant being recruited who had
mild to moderate depression. Success with this approach may depend on the personnel involved in the
service and operational procedures. At the time we engaged with the IAPT service, it was facing a period
of signiﬁcant disruption and change as it was being taken out of the NHS. Also, a single meeting with the
psychological well-being practitioners was insufﬁcient for them to make EARS recruitment a priority.
Finally, we set no speciﬁc target but aimed to recruit an ethnically diverse sample. Plymouth has very low
ethnic diversity and the four participants in the sample we did recruit were of Eastern European origin.
One attended sessions with her husband who acted as a translator, and the others had no difﬁculties
engaging in the study.49
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TABLE 29 Recruitment targets for a disadvantaged population
Target samples Target for recruitment Actually recruited
Unemployed or social class C2-E 75% 91%
Single parent 30% 17%a
Mental health problem (EQ-5D item) 20% 41%b
Mental health problem (MPSS item) 20% 19%c
a Among females up to aged 47 years.
b Moderately/extremely anxious or depressed from the EQ-5D.
c Very or extremely depressed from the MPSS.
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50There were several other indicators that the sample were disadvantaged and treatment resistant: (1) the
mean school leaving age was 16 years; (2) they were, on average, heavy smokers (smoking over 21
cigarettes per day) with a long history of smoking (over 32 years) and high nicotine dependence; and
(3) almost 60% reported that they had not used NHS SSS support to attempt to quit in the past. Also,
the EQ-5D sample mean of 0.75 indicated a generally poor health status.
Our recruitment involved two methods: by invitation letter (from the GP and the SSS) and by other
community-based approaches. We initially aimed to recruit 60 by GP invitation letter, 30 by SSS invitation
letter and 30 by other community-based approaches. Considerable effort went into trying other
community-based approaches, but this resulted in few participants being recruited. We had hoped to
contrast the characteristics of those recruited by these two approaches (invitation letter vs.
community-based approaches) but insufﬁcient numbers made this impossible. We recruited only
participants who were registered with a GP and this may have limited the recruitment of homeless people
and the most disadvantaged smokers. We felt that this was necessary to minimise risk to the participant
(from increasing PA) and to the HT, and ensure that we were able to keep in contact with participants
over the duration of the study. Invitation letters from the GP and SSS led to similar response rates and
sample characteristics. We therefore believe that disadvantaged smokers can be recruited, from areas with
high social deprivation, by invitation letter and reminder telephone calls (to ensure that those with low
levels of literacy are not excluded). There did appear to be little difference in demographic characteristics
between those responding to the initial letter and those drawn into the trial through an additional
reminder telephone call. Given the additional effort required to complete reminder telephone calls,
recruitment of a sample may be possible by a single letter if the target population is large enough.
Recruitment rates were similar across three GP surgeries and the local NHS SSS, which provides conﬁdence
that at least 5–8% of those invited can be recruited by a single mailed invitation.
The response and recruitment rates are reported with an assumption that all those invited were smoking
(at least 10 cigarettes) and still living at the address to which the invitation was sent. However, it appeared
that we had incorrect information for about 10% of those we invited, and a further 10–15% were
ineligible, so there is uncertainty about the correct denominator to use in calculating recruitment rates.
Only 10–30% (varying across letter and telephone invitation from the GP and SSS) actually declined to
take part, so the 5–8% ﬁgure for recruitment rate could be higher or lower depending on the quality of
patient records kept with regard to smoking status. We identiﬁed participants from the respective
databases that had been recorded as smoking in the past 2 years, and this may have introduced some
inaccuracy. We did consider asking the GP surgery team to identify potential participants but the practice
managers advised against this owing to time pressures. If the intervention became accepted as standard
practice it may well be appropriate to opportunistically recruit smokers in surgeries.
Self-reported data were somewhat veriﬁed by accelerometer data, though, as is often the case,
participants typically over-reported their involvement in moderate-intensity PA. This was especially true ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
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intensity PA; nevertheless, almost 50% and 65% of the participants achieved ≥ 30 minutes of at least
moderate-intensity PA per day recorded by accelerometer and self-report respectively (albeit the two
measures captured data over 2 different weeks). Based on self-reported accounts, this volume of activity
was largely due to daily walking and involvement in manual work, with little leisure-time PA. We did not
exclude participants from the study who were already physically active (e.g. achieving at least 150 minutes
of weekly MVPA), but did exclude those who were unable to walk for at least 15 minutes. This may have
led to a more active sample than in the general population of smokers with a similar demographic
background but we were keen to recruit only those who could increase their activity in response to the
intervention. We made an effort to avoid highlighting that the study was about exercise and PA in
recruitment materials and the participant information sheet, to avoid recruiting only those more interested
in PA and run the risk of failing to meet our recruitment targets. In summary, we think that the sample
was probably representative of smokers living in the catchment areas in terms of PA.Randomisation
At the end of the baseline assessment, randomisation took place by the researcher telephoning either TT
or AT, who were in a different location and expecting the call. They were logged into a website managed
by the Peninsula Clinical Trials Unit and quickly entered minimisation details and revealed a unique ID
number and assigned the participant to a treatment arm within the trial. There were no difﬁculties in this
procedure. Randomisation procedures resulted in no baseline differences in the sample characteristics. In
order to minimise the number of sessions with participants for data collection, the accelerometer (to
objectively assess PA) was given to participants post randomisation, with a request to return it, after
wearing it for 1 week, in a stamped addressed envelope or in person when attending their ﬁrst
intervention session. There were no differences between treatment arms in the amount of PA recorded
by accelerometer at baseline, suggesting that this approach did not introduce any bias.Study attrition (assessment completion)
Considerable effort went into maintaining contact with participants in both arms, particularly at the
16-week follow-up. Although for a disadvantaged sample capturing data from over 60% of the sample
was encouraging, we do feel that this could be improved with the involvement of a trial administrator to
make telephone calls and possibly manage a technology reminder system with messages sent to mobile or
home telephones prior to appointments. This would not work for a proportion of participants who
changed their telephones on a regular basis and those who had no telephone, but could be successful for
the majority. In our pilot study we had budgeted for 0.3 full-time equivalent (fte) of administrative support
over the duration of the study, but with complexities associated with managing the trial 45 miles away
from Exeter, we ended up employing a 1.0 fte administrator for the ﬁnal third of the project, who was
based in Exeter. The HTs were responsible for arranging all appointments and any rearrangements for all
assessments and intervention sessions. With only 1.4 fte of HT resource budgeted for the study, the
attrition rate was very encouraging.
Of the 38 participants who did not complete the 16-week assessment, 30 had dropped out by week 4,
and these were evenly split between the control and intervention arms. Those failing to complete 4-week
follow-up assessments in the intervention arm also attended few intervention sessions. Also, there is some
anecdotal evidence that those in the control arm who failed to complete the 4-week assessment were
disappointed that they were not going to receive the intervention. Thus, reasons for study attrition
appeared to be different in each arm of the study. Later in the trial we did offer to provide a single session
with control participants after the week 16 assessment to provide them with information given to those in
the intervention arm. This would not be possible in a study with an even longer follow-up assessment, and
so additional messages to highlight the importance of completing follow-up assessments, in the participant
information sheet prior to entering the study, may be needed.
In our analysis of factors associated with study attrition (following recruitment by GP letter), the
withdrawal rate was twice as high among those recruited through reminder telephone calls as among51
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52those recruited by just an initial letter. This was not the case for those recruited by a SSS invitation letter or
reminder call and the relatively small numbers of participants involved may limit our conﬁdence in this
ﬁnding. One may expect that the effort required to recruit disadvantaged participants would be linked to
study attrition as suggested by the GP invitation ﬁgures. The only other indication of any bias in attrition
rates was that 33% of males and 43% of females failed to complete the 16-week assessment. Overall,
though, attrition was similar from both arms of the trial.Measures and measurement issues
Primary outcome
The original intention was to encourage all participants who wished to quit smoking to agree to be
referred to the local NHS SSS. Support for those in the intervention arm from the HT was also planned. We
allowed participants to begin any quit attempt up until week 12 to ensure that we had a further period of
4 weeks (up until week 16) to have an expired air CO veriﬁed 4-week period of abstinence. Participants in
the control group, at baseline and subsequent assessments, were also reminded that if they did plan to
quit they should notify the HT/researcher and that the SSS was available to support them. These planned
procedures were to ensure some control over capturing quit attempts and post-quit monitoring. In fact,
we identiﬁed only two participants who contacted and used the support of the NHS SSS. Also, some
participants wished to quit without further support from the HT. This created a challenge for collecting
data on our ﬂexible primary outcome, namely expired air CO continuous conﬁrmed abstinence (captured
on a weekly basis).
Thus, data we report for our primary outcome (i.e. number achieving 4 weeks’ expired air CO-conﬁrmed
continuous abstinence) are not as rigorous as we had planned. We had expected all participants to attend
the SSS and be monitored weekly. However, those reported to have quit ﬁtted the following criteria:
(1) we were aware of their planned quit date and could therefore prospectively follow their progress; and
(2) we recorded an expired air CO value of < 10 p.p.m. between 4 and 8 weeks after the quit date and
participants self-reported that they had not smoked more than ﬁve cigarettes since quitting.
Point prevalence data at week 16 conﬁrmed the data reported for 4-week continuous abstinence, with the
exception of two intervention participants who had lapsed in week 15.
The difﬁculty of capturing data for our primary outcome was also due to the nature of the sample:
scheduled assessments were routinely missed and rearranged (for a wide range of reasons). We make
recommendations in the ﬁnal chapter to address this issue, but this pilot study has provided valuable
information on how to work with disadvantaged smokers and capture a ﬂexible outcome.
Although participants were excluded from the study if they wanted to quit in the coming month at the
time of entry into the study, one participant decided to quit only 1 week after starting the intervention. On
average, it was 7 weeks before those participants who decided to quit began their attempt and it is not
clear if the participants’ awareness that the intervention contact was due to ﬁnish after 8 weeks inﬂuenced
this. Some participants needed longer than 8 weeks but, overall, a target to reduce (and, if desired, to
quit) over 8 weeks was appropriate. The client-centred approach of the intervention certainly aimed to
allow participants to decide if and when they wished to quit.Other smoking-related measures
We aimed to assess the proportion in each arm of the trial who reduced the number of cigarettes smoked
by at least 50% at 8 and 16 weeks. In our sample, approximately 60% smoked only, or predominantly,
self-rolled cigarettes, with no one smoking pipes, and approximately 35% smoking only, or predominantly,
factory-made cigarettes. The remaining 5% smoked a roughly equal combination of self-rolled and
factory-made cigarettes. Given the intention to assess this outcome we decided to nevertheless create a
common variable, namely number of cigarettes smoked at each assessment. We decided to base our
conversion from grams of tobacco to number of cigarettes based on Laugeson89 who reported that 0.45 gNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4was equivalent to one factory-made cigarette, following a rigorous laboratory assessment of number of
puffs and nicotine inhalation. Also, for those reporting the number of factory-made cigarettes smoked,
there was inevitably some random measurement error. Participants were encouraged to use a range of
recall prompts to indicate how many cigarettes were typically or had recently been smoked (see detailed
description of measures in Chapter 2), including number of packs consumed each day, number of
cigarettes smoked in the morning, afternoon and evening, or in speciﬁc situations. The precise number of
cigarettes smoked in the present study therefore has measurement error but data collection and
conversion procedures were consistent across time and treatment arms.Physical activity measures
We used the self-reported 7-day recall of PA to capture the type, intensity, frequency and volume, which
has been widely used in trials and has been shown to be sensitive to changes as a result of behaviour
change interventions. This measure tended to show over-reporting of MVPA when compared with
accelerometer data. This was particularly true among the most active, perhaps because the most active
tended to be those in manual labour who reported doing up to 10 hours of MVPA per day, whereas in
reality this probably included some periods of inactivity. The value of using the self-report measure is
that we were able to capture data from 60 participants at weeks 8 and 16. In contrast, just 44% and
39% participants provided a minimum of 3 days of accelerometer data during weeks 8 and 16,
respectively. These accelerometer compliance ﬁgures are comparable with those from previous research
with adult populations.
After recruiting the ﬁrst 60 participants, we realised that a number of accelerometers had not been
returned, at a cost of c. £250 each. In an attempt to avoid this, and to maximise compliance with wearing
it, we initially provided a payment of £10 in exchange for returning the device after each complete week
of wearing it: a total of £30 for wearing it for a period of 7 days at baseline, week 8 and week 16. This
was then increased to £30 after each week of wearing. Overall, 13 were not returned, and all of the
missing accelerometers were administered before the increase in payment for its return. It seems
reasonable to assume that the increase in payment did impact on the successful returning of the
accelerometers. The logistics of reimbursing participants was also complex and challenging. Some
participants did not have bank accounts or preferred cash payments, and the research team had to set up
a cash ﬂoat. Eventually we worked out systems with the university for processing claims (in bulk) and
reimbursing expenses from the ﬂoat.
In any future study the use of 24-hour wrist-worn GENEActiv (Activinsights, Cambridgeshire, UK)
accelerometers (c. £120 each) is recommended to increase compliance and minimise ﬁnancial loss.
Both self-report and accelerometer data suggested that both groups were less active at week 16 than at
baseline. Reactivity in trials is common, with participants tending to do more PA, possibly due to a
heightened awareness of researchers’ interest in this behaviour. These ﬁndings must be interpreted with
caution given that alternative explanations such as withdrawal of more active participants may have
inﬂuenced the results.Intervention engagementThere was clearly considerable variability in participant engagement in the intervention, with 40% having
fewer than four sessions, including 12% who had none, and 58% having four or more sessions. In this
pilot trial we did not specify an a priori intervention dose in order to conduct sensitivity analysis, but did
complete some exploratory analyses of the effects of dose received on smoking outcomes. The sample size
limited our conﬁdence in suggesting a dose–response relationship but the data suggest the presence of a
relationship between intervention attendance and smoking reduction at 8 and 16 weeks.53
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54Our decision to be ﬂexible in offering sessions face to face or by telephone was clearly justiﬁed, with only
a slightly larger proportion involving the former.
Nine participants claimed subsidies relating to PA, ranging from £1.50 to £91. Activities subsidised
included paying for public transport to help them reach (or return from) walking routes, enrolling in gym
memberships and paying for swimming sessions at a local facility. Also, one received money to purchase a
pair of training shoes.
The factors inﬂuencing intervention engagement are examined in much more detail in Chapter 5, and we
provide further overall discussion in the ﬁnal chapter.Outcomes among control and intervention participantsAs a pilot study we did not seek to contrast outcomes between the control and intervention participants at
follow-up but we were keen to identify whether or not there were indications of changes in smoking and
PA outcomes that related to our intervention aims.Smoking outcomes
Prior to the study we presented a scenario analysis in which 5% in the control arm would be expired air
CO-conﬁrmed abstinent at 4 weeks post quit. The present study revealed that 6% attempted to quit and
4% were abstinent 4 weeks later (and at 16 weeks) in the control arm, thus supporting our estimation.
As Table 4 shows, different scenarios were created to show the impact of sample size, effect size (RR) and
precision of effect size estimate. On this basis we initially aimed to recruit 120 participants. Owing to
previously discussed difﬁculties in recruitment and on the basis of an interim analysis of our accrual chart
over the ﬁrst 8 months of recruitment, a new recruitment target of 100 participants was set. With a ﬁnal
sample of 99 participants, the RR of having expired air CO-conﬁrmed abstinent at 4 weeks post quit,
making a quit attempt, and reducing the number of cigarettes smoked by at least 50% at 16 weeks also
provided support for positive changes in smoking in favour of the intervention arm. There appears to be a
good case for conducting a larger study to conﬁrm these effects with greater conﬁdence.Other smoking-related outcomes
There were also reductions in mean expired air CO in the intervention arm, as well as more favourable
beliefs about importance of quitting and conﬁdence to quit, and cutting down smoking by 50% within
4 weeks, across the study. There were also favourable changes in cigarette cravings and withdrawal
symptoms and satisfaction from smoking. While the study was not powered to conduct inferential
statistical analyses to compare changes relative to the control these ﬁndings suggest that the intervention
could be effective. The intervention aimed to increase the importance of quitting and conﬁdence to quit
through participant-centred support, without directly focusing on quitting. We expected that by increasing
conﬁdence to reduce smoking, participants would develop the motivation to quit. Smoking reduction has
not been promoted in the past for fear of increasing cravings and withdrawal symptoms between
cigarettes, hence increasing satisfaction with the fewer cigarettes smoked. The present data provide no
evidence of this; in fact, the opposite appears to be the case. The study was not powered to statistically
examine the mediating role of changes in PA on smoking-related outcomes but the link between PA and
smoking is further discussed in Chapter 5.Physical activity and related outcomes
The intervention aimed to both increase PA in general but also enhance the perceived value of doing PA
as an aid for reducing smoking. Results from both the accelerometer and the self-report measures show
that over 50% of the sample were already doing at least 150 minutes per week of MVPA at baseline.
This may have reduced the scope of the intervention to substantially increase PA, but self-reported and
accelerometer data for moderate PA at the 8-week assessment did appear to be greater in the intervention
arm compared with the control participants (albeit among only those providing data). Also, a greaterNIHR Journals Library www.journalslibrary.nihr.ac.uk
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proportion who reported using PA as an aid for controlling smoking also increased considerably more in
the intervention arm than in the control. Everson-Hock, Taylor and Ussher67 reported that 22% of smokers
attempting to quit, with the support of a NHS SSS, were using PA as a smoking-cessation aid. The present
study suggests that an identical proportion of control participants (who wanted to reduce but not quit)
were using PA as an aid. In contrast, at 4 and 8 weeks in the intervention arm, 36% and 55% respectively
were using PA as an aid. Everson et al.67 also reported a signiﬁcant association between self-efﬁcacy to do
PA and stage of readiness to use it as an aid for cessation. The present study suggested that conﬁdence to
do 30 minutes of PA over the next 6 months and to walk briskly for 15 minutes per day also tended to be
greater in the intervention arm than in control participants at weeks 4 and 8. The study was not powered
to explicitly link changes in PA with changes in smoking-related cognitions but a larger study may permit
this. Overall, the present study does suggest that some changes in PA and related outcomes, such as a
sense of competence, did occur, which links well with the change in processes we expected to see as a
result of the intervention.
In terms of duration of apparent changes in PA after the intervention, all measures of PA indicated a
return to baseline levels, albeit from means and proportions among only those who completed a 16-week
assessment. An alternative explanation is that the most active did not return to complete the 16-week
assessment. Given that most study attrition took place up to week 4, this explanation seems unlikely. We
may therefore conclude that any changes in PA were short-lived and had dissipated by week 16, though
this was not statistically conﬁrmed. While this may be regarded as disappointing and similar to other PA
intervention evaluations, it also provides some evidence that the EARS intervention did lead to short-term
increases in PA. The HTs did focus on increasing PA to aid smoking reduction and cessation induction
rather than long-term sustained increases in PA. Also, because the sample had relatively high levels of PA
at baseline, it is perhaps not surprising that longer-term changes would be not be sustained.
There appears to be differences in weight at follow-up between the groups and in terms of change over
time. These results could be due to differential withdrawal from the study. Given the potential importance
of weight gain as a deterrent to quitting and remaining abstinent, further analyses in a larger study should
explore changes in weight while controlling for baseline factors and missingness.Intervention adherence and its impact on outcomesAlthough limited by small numbers, the ﬁnding that those who attended more sessions were more likely
to have favourable smoking outcomes does suggest that the intervention worked for those who were
willing and able to engage. Of the 29 participants who did have at least four sessions with the HT, 45%
and 62% had reduced by at least 50% by weeks 8 and 16, respectively, and 34% made a quit attempt.
This compares with no more than 10% of participants who had fewer than four intervention sessions,
who either quit or reduced by at least 50%.
Finally, the duration of the intervention, for those who did attempt to quit, ranged from 1 to 12 weeks,
with a mean of 7 weeks. We designed the intervention and study with an expectation that participants
would engage in up to eight weekly sessions, with the belief that if they had not decided to quit by the
end of that period then they probably would not quit at all. However, in the interests of giving
intervention participants a sense of autonomy, the period over which the intervention was offered was
increased so that a quit attempt could occur no later than 4 weeks prior to the ﬁnal 16-week assessment.
A few participants were not ready to quit after 8 weeks, but were ready in later weeks. Extending or being
ﬂexible with the intervention period should therefore be considered in any future study.55
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Chapter 5 Process and qualitative evaluationIntroductionA range of qualitative approaches were used in the early pre-trial phase of the study to capture
information to inform the development of the intervention and trial methods. These were described
in Chapter 1.
The focus of this chapter is on deriving qualitative information from a range of sources to assess the
feasibility and acceptability of the intervention and trial methods, and suggest how the intervention and
trial methods could be improved. Within the constraints of completing this report, it was not possible to
report a full assessment of intervention processes, but these will be examined in future outputs.
The main aims and forms of data collection are shown in Table 30, with a letter Y indicating which aim
was matched against which method. Further details about the respective methods are described in the text
below. The ﬁndings will then be presented for each method of data collection. The ﬁnal section will
summarise and discuss the ﬁndings in relation to our stated aims.
We recognised a two-stage change process in which (1) HTs were asked to deliver a multicomponent
intervention to facilitate behaviour change, and (2) participants engage in, and respond to, the
intervention. The qualitative evaluation described below sought to identify, through the various methods, if
the multicomponent intervention was appropriate in the ﬁrst instance, and secondly whether or not what
was offered was effective.Taped sessions between health trainers and
intervention participants
Background/rationale
Detailed description of what was delivered is important in the evaluation of complex interventions.90
In order for such interventions to work, they must be well delivered and poor delivery may lead to
underestimation of intervention effects. Understanding the ﬁdelity compared with the manual is important
for interpretation. For behavioural interventions in particular, variations in delivery quality can strongly
mediate intervention effectiveness.91,92 Knowledge about what was delivered allows one to test and reﬁne
the underlying theory of behaviour change or process model. Understanding ﬁdelity allows reﬁnement of
the intervention and training procedures for future use by identifying elements that are less well delivered
and where there is scope for improvement. Variations in delivery can also be positive and such practitioner
innovations can be used to enhance the intervention. A range of qualitative and quantitative methods
have been developed for assessment of delivery, including the use of qualitative research methods and the
use of checklists to score transcripts or recordings of intervention consultations.92–94Aims
We sought to use recordings of consultations between participants and HTs to (a) check the quality of
intervention delivery (what content was delivered and how it compared with the manual) and (b) identify
speciﬁc areas for improvement in the EARS intervention and its training course.Methods
Design
The intended intervention processes for the EARS intervention are described in Chapter 1. These were
used as a basis for generating items for a checklist to assess intervention delivery and ﬁdelity. Following a57
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TABLE 30 A summary of aims and data collection methods
Aims
Data collection methods
Taped sessions
between HTs and
intervention
participants
Interviews with
control and
intervention
participants at
the end of the
study
Interviews
with HTs both
early and late
in the study
Describe the
story of a
participant who
successfully
engaged in the
intervention
Identify the acceptability of the
trial methods (across trial arms)
Y Y
Identify the acceptability
of the intervention and
possible adaptations
Y Y
Identify the components of
the intervention perceived to
be effective
Y Y Y Y
Examine treatment ﬁdelity in
relation to the planned
intervention described in
the manual
Y Y
Generate ideas to inform future
training of practitioners
Y Y Y
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58brief scoring-standardisation procedure, the checklist was applied to a purposive selection of consultation
recordings and descriptive analyses were used to summarise the data.
A more detailed qualitative analysis, linking data from all of the above data sources (individual participant
feedback with feedback from the HTs and the consultation recordings), will be conducted to examine
the relationships between intervention delivery and smoking reduction and to reﬁne the process model.
However, this work is outwith the remit of the Health Technology Assessment (HTA)-funded research and
so is not reported here.Sampling frame
All consultation sessions were audio recorded subject to informed consent. Consent for this was taken on
the main study consent form and this was checked verbally prior to starting the ﬁrst consultation. A
sample of four participants for each of the three HTs (12 participants in total) was selected to provide
examples from early, late and in the middle of the study period (to smooth out any HT practice effects).
For each client, three (out of a possible eight) consultations were selected for coding to provide
examples of intervention techniques from early-stage motivation through to later-stage progress reviewing/
relapse prevention.Measures and procedure
To assess intervention ﬁdelity (and at the same time quantify delivery in terms of predeﬁned manualised
elements), we used the Dreyfus system for assessing skill acquisition (Figure 5)95 to score recorded
consultations with respect to a HT’s skill in delivering each of the 12 intervention processes (see Table 31).
A scoring checklist and instructions were developed and these are provided in Appendix 5c. The checklist
was applied initially by three researchers with expertise in behaviour change (AT, TT, CGVS) to a sample of
six consultations from two participants. Scores were compared and reasons for any discrepancies were
discussed to produce a consensus about how to apply the scoring system.
Two researchers (TT, CGVS) then each scored consultation data from two participants for each of the three
HTs (using three consultations per participant) to produce an overall intervention ﬁdelity rating for eachNIHR Journals Library www.journalslibrary.nihr.ac.uk
Competence level Scoring Examples
Incompetent
0
1
2
3
4
5
6
Absence of feature and/or highly inappropriate performance
Minimal use of feature and/or inappropriate performance
Evidence of competence, but numerous problems
Competent, but some problems or inconsistencies
Good features, but minor problems or inconsistencies
Very good features, minimal problems or inconsistencies
Excellent performance
Competent
Proficient
Expert
Novice
Advance
beginner
FIGURE 5 The Dreyfus model of skill acquisition.95
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4item and for each HT (see Table 31). This was done by listening to the set of (three) recorded consultations
for each participant, reading the transcripts of the same consultations and then rating the ﬁdelity for
each item on the checklist. Because of limitations in time and resources, we did not conduct formal
inter-rater reliability checks; this would have required both researchers to rate ﬁdelity for around 20–30
participants each. However, we did split the coding for each HT between the two researchers, so that each
researcher coded two participants for each HT. The average score for the HT is therefore the average of
the scores given by two coders.Analysis and interpretation
Descriptive data were extracted and reported to highlight areas of good or bad practice in delivering the
intended intervention processes. Owing to the clear descriptions associated with each score (see checklist
scoring instructions in Appendix 5c) and the steps taken to establish a consensus between coders on the
approach to scoring, interpretation of scores is relatively straightforward. Scores of 0 or 1 represented poor
delivery (or no delivery) of the intended process. A score of 3 or more was considered to represent
reasonable quality of intervention delivery. Scores of 5 or 6 represented very high (expert-level) quality,
which we were not expecting to see very often with our trainers delivering this novel intervention for the
ﬁrst time. It was accepted that for item 9 (seeking to identify and reinforce shifts in identity), the
opportunities to deliver this process would be scarce and so a lower score (1.5 or more) was considered
acceptable for this item. Item 12 (referral to smoking-cessation services) was scored as either 0 or 1
(yes or no) and so is reported separately.
Examples of good intervention practice were highlighted as the coders went through the consultation
transcripts and these will be collated and used as examples in future training for the EARS intervention
(either in their current form as audio recordings and transcripts, or by conversion into video example using
actors to play the roles of practitioner and participant).Results
Table 31 shows the intervention ﬁdelity scores for each item on the checklist, broken down by HT and
by coder.
The average scores for each item for each HT differed by –0.9 to +0.8 points (out of 6) with an average
difference of 0.0. Hence, there seemed to be a reasonable level of agreement between coders about the
quality of intervention delivery for all of the intervention processes.
One additional item (IF12: referral to smoking-cessation services if appropriate) was coded either as Yes or
No (and so is not shown above). In all but one of the 12 cases examined this was scored as Yes, indicating
high ﬁdelity for this intended process.59
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TABLE 31 Intervention ﬁdelity scores for each process, with breakdown by trainer and by coder
Mean score
IF1 IF2 IF3 IF4 IF5 IF6 IF7 IF8 IF9 IF10 IF11
4.0 3.3 2.2 3.6 2.9 3.4 2.6 2.9 1.5 1.8 1.3
HT1 mean 3.9 3.5 2.4 3.9 2.9 3.5 2.6 3.0 2.4 2.3 1.5
HT2 mean 4.3 2.8 1.9 3.0 2.9 3.3 2.4 2.5 0.8 1.4 1.3
HT3 mean 4.0 3.6 2.4 4.0 3.0 3.5 2.8 3.3 1.5 1.8 1.0
Coder 1 mean 3.6 3.6 2.4 3.3 2.8 3.2 2.4 3.2 1.9 1.8 1.3
Coder 2 mean 4.5 3.0 2.0 3.9 3.1 3.7 2.8 2.7 1.2 1.8 1.2
IF1, active participant involvement; IF2, motivation building (smoking); IF3, motivation building (PA); IF4, set goals
(smoking); IF5, set goals (PA); IF6, review/problem solving (smoking); IF7, review/problem-solving (PA); IF8, integration of
concepts; IF9, reinforce health-identity shifts; IF10, manage social inﬂuences (smoking); IF11, manage social inﬂuences (PA).
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60Overall, intervention ﬁdelity was deemed to be acceptable, but with clear room for improvement in
some areas:
l All three HTs demonstrated a high level of skill in the use of client-centred counselling techniques.
However, the delivery intervention elements related to promoting PA (IF3, IF5 and IF7) were generally
scored lower than elements relating to promoting smoking reduction (IF2, IF4, IF6). This probably
reﬂects the primary aim of the intervention and difﬁculties in introducing ideas about PA in this context
(see sections below on this).
l The sample was more active than expected and this created uncertainty for the HTs regarding how
best to further increase PA.
l The scores for IF10 and IF11 (identifying and seeking to manage social inﬂuences) were considerably
lower than expected, falling well below the criterion (3 or more) for good delivery. This was due to a
lack of exploration of social inﬂuences, rather than poor delivery style.
l For IF9 (reinforcing any changes in identity), the score met our lower criterion of 1.5: this was
expected, as (a) this was not a key focus of the training and (b) few opportunities arose to do this.
When such opportunities did arise, however, they were not always reinforced and so the training could
be improved to increase sensitivity of the HTs to this issue.
The mean overall scores across the eleven scales for HT1, HT2 and HT3 were 2.9, 2.4 and 2.8, respectively,
suggesting no large differences in overall ﬁdelity scores. However, although HT2 performed well on IF1,
she did slightly less well on six of the other 10 scores relative to HT1 and HT3. It would be inappropriate to
explore these differences in more detail for risk of breaking anonymity but the scores do support the
sensitivity of the scales used to assess intervention ﬁdelity. In the future the scales could be used to
highlight training and supervision needs and in a larger study to link HT performance with smoking and
PA outcomes.Interviews with control and intervention participants
Aims
The aims of conducting interviews with control and intervention participants at the end of the study
were to:
l identify the acceptability of the trial methods (across trial arms)
l identify the acceptability of the intervention and possible adaptations
l identify the components of the intervention perceived to be effective.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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research, and to procedures such as randomisation and to different forms of data collection. The methods
described below aimed to consider acceptability and feasibility with this in mind.Methods
Recruitment and sampling
All trial participants had consented at baseline to being approached by an independent qualitative
researcher to capture their experiences associated with the study and with the intervention, for those in
that arm of the study.
During the delivery of the intervention, the research team regularly discussed the progress of individual
participant progress and the nature of engagement with the intervention. We were particularly keen to
identify intervention participants who appeared to have beneﬁtted from the intervention and be examples
of good practice, possibly for future use in training. As many participants as possible who engaged with
the intervention were interviewed by TT.
Control participants were selected at random. Participants sampled were contacted by telephone and a
convenient time to conduct the interview by telephone was arranged. No participants who were contacted
declined to be interviewed. Verbal consent was obtained for the interviewed to be digitally recorded. All
interviews were digitally recorded and transcribed verbatim for further analysis.Interviews
Participants were interviewed within 16 weeks of completing the study. The interviews followed the guide
shown in Figure 6 for control and intervention participants, respectively.GENERIC QUESTIONS
•
•
•
•
How they heard about/came into the study and why
How clear were the explanations of what would be involved
Acceptability of data collection
Understanding of randomisation
•
•
Did they change their smoking
behaviour? How? Why?
Did they change their physical
activity levels? How? Why?
•
•
•
•
•
•
•
•
•
•
Did they change their smoking behaviour?
How? Why? (Why not?)
Did they change their physical activity
levels?
How? Why? (Why not?)
Acceptability of the intervention
Time commitments, procedures, style of
delivery, intensity
Perceived benefits
Positive techniques, own behaviour
change
Utility of PA as a smoking reduction aid
Multiple behaviour change
CONTROL INTERVENTION
FIGURE 6 Generic and trial arm-specific interview guide.
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62Data analysis
Interview transcripts were analysed used the qualitative software package NVivo (version 9.2, QSR
International, Southport, UK). The data were organised using a basic thematic analysis to provide a simple
descriptive-level overview of the participants’ views and experiences. In-depth qualitative analysis
procedures were not used here. However, these data will be analysed in more depth alongside the
participant interviews and consultation recordings, using framework analysis6 to generate an integrated
analysis of processes of behaviour change in the EARS intervention. This in-depth analysis will be reported
as part of the PhD of one of the researchers (TT). The participant characteristics of those interviewed from
both arms of the trial are shown in Table 32.TABLE 32 Characteristics of participants who were interviewed at the end of the study
Characteristics
Control (n = 10)
(20% of sample)
Intervention (n = 15)
(30% of initial sample)
Demographics
Age, mean (SD) 46 (11) years 52 (11) years
Sex (male/female) 5/5 8/7
Deprivation indicators
Social class 50% unemployed (5/10) 40% unemployed (6/15)
50% in C2–E work (5/10) 60% in C2–E work (9/15)
0% in A–C1 work (0/10) 0% in A–C1 (0/15)
Single parenthood 10% (1/10) 0% (0/10)
Baseline data
Smoking characteristics
Mean (SD) tobacco per day 17.4 (8.7) g 18.4 (12.5) g
FTND (SD) 5.3 (1.9) 4.9 (1.7)
MVPA (self-report)
Mean (SD) minutes per week 595 (757) 401 (644)
20% at 0 (2/10) 27% at 0 (4/15)
40% at 100–499 (4/10) 60% at 100–499 (9/15)
30% at 500–999 (3/10) 7% at 500–999 (1/15)
10% at > 2000 (1/10) 7% at >2000 (1/15)
Quit attempt in past year 50% (5/10) 33% (5/15)
Outcomes
Quit attempt 0% (0/10) 33% (5/15)
4 weeks’ CO-conﬁrmed abstinent NA 80% (4/5)
50% reduction 20% (2/10) At least 33% (4/11)a
No change 80% (8/10) At least 26% (4/15)a
Recruitment
Avenue (GP : SSS : community) 5 : 5 : 0 (50% : 50% : 0%) 7 : 6 : 2 (47% : 40% : 13%)
Type (letter : telephone : other) 7 : 3 : 0 (70% : 30% : 0%) 6 : 7 : 2 (40% : 47% : 13%)
NA, not applicable.
a No data on 50% reduction for three participants.
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The aim of this section is to give participants a voice in the research through quotes that may capture the
rich diversity of perceptions in this sample of hard-to-reach smokers. We engaged with a wide variety of
smokers in terms of literacy and ability to grasp the methods and aims of the intervention. Nowhere else in
the document is this captured. This portrayal of diversity also serves to provide important information for
future researchers and intervention trainers.Acceptability and feasibility of methods used to recruit, randomise and
assess participants
Clarity of invitation to take part in the trial
Targeting a population with expected low levels of literacy meant keeping the invitation as simple as
possible without compromising the individuals’ understanding of what was being offered to them. Overall,
the responses revealed a clear and concise understanding of what was being offered. For example:© Que
Health
provid
addres
SciencTT: So how clear was the information that you had?Int: Very. Very clear.TT: So how much did the information that you had read, how much did it match what you actually
received in terms of the support and things like that?Int: Oh erm exactly . . . .
Female, aged 60–65 years, unemployed, moderate smoker, interventionThere were a couple of examples of where a participant reported misunderstanding, or elements of the
study that surprised them. This included explanations of the requirements to wear an accelerometer, and
confusion over the randomisation procedure:Int: The leaflet was kind of vague, it told you what it was actually based on but it didn’t tell you
about you were going to get split into two groups. I don’t think it mentioned anything about wearing
the accelerometer – was it called . . .?Int: No I didn’t know that, I thought ‘cause [the HT] rang up somebody else and they said, ‘You are in
this section [trial arm],’ so I don’t know if they’d done any background research and said, ‘Well, she’ll
be good in this group,’ or, ‘she’ll be good in that group’.TT: OK, right. So it doesn’t sound like that was explained to you properly then.Int: No, no not at all.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionAnother example of confusion arose surrounding the payment for wearing and returning the
accelerometer where the individual thought that rather than them getting paid for wearing and returning
it, they had to pay the study. [Note: during the course of the study, a number of accelerometers were not
being returned so we increased the reward for returning them from £10 to £30 in exchange for wearing it
for 1 week and returning it].Int: Yeah, well, because [the HT] hadn’t mentioned it at the beginning, so I didn’t know anything
about it, and then when it had been changed [the HT] said, ‘Oh, just to let you know that it’s gone
from £10 to £30’. And I thought that I had to pay her and [the HT] said, ‘Why?!’63
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NIHRTT: So that wasn’t made very clear to you.Int: No!
Female, aged 30–35 years, unemployed, moderate smoker, controlWhile this may demonstrate a high level of motivation for taking part in the study, it suggests
that explanation of the reimbursement structure and randomisation may need a clearer explanation.
This was the ﬁrst time that most participants had engaged in a research trial and more practical
explanations to participants of the need for and process of randomisation are suggested by
these ﬁndings.Appeal of the invitation and support for reduction
The novel approach of actively promoting support for reduction in smoking was shown to be well received
by the majority of the sample. Many framed the appeal of reduction against the alternative of stopping
abruptly. The appeal of reducing appeared to stem from an underlying desire to change behaviour but,
owing to a lack of conﬁdence in stopping abruptly, reduction seemed like a much more manageable
approach to tackling their smoking behaviour:Yeah, I think yes, I think that was probably it, the reduction thinking. Well you know, rather than sort
of go cold turkey and completely stop I thought, ‘Oh you know, you could help me reduce it,’ which
you did, so you know that obviously it worked.
Female, aged 60–65 years, unemployed, moderate smoker, interventionTT: What was it about that then that appealed to you?Int: Erm [coughs] it’s easier than cutting it out altogether, I guess it should be easier actually. But . . .
well I needed to try something as opposed to nothing, that’s what appealed to me.
Male, aged 60–65 years, unemployed, moderate smoker, interventionWell it . . . I didn’t feel as if I was undermined in any way you know, until it’s to stop altogether you
know. I felt that it was, well, maybe an easier solution.
Female, aged 60–65 years, employed full-time, moderate smoker, interventionOne individual explicitly expressed this notion as reason for coming into the study, revealing that cutting
down would be a good idea at a time when they feel they are not ready to stop:TT: Cutting down, is that something that perhaps appealed to you?Int: Yeah it did as well, because I thought, ‘I don’t really want to, I am not ready to stop yet,’ and I
thought cutting down is quite good. I tend to smoke if I am a bit stressed. I use it as an excuse to
smoke so [laughs] I thought, ‘You know, that’s quite a good way to do it really is just cut down
bit by bit’.
Female, aged 35–40 years, employed part-time, moderate smoker, controlFor some, past experiences of failed quitting heightened the appeal of support for reduction as a novel
approach to tackling their smoking behaviour:Well, for three or four years I’ve been trying to give up smoking [and] last month [I] done ten months,
and then I had a smoke. The year before six months, the year before that was four months, and it’s
always a quit, you know, stop, go on to nicotine gum and lozenges and patches and whatsoever. This
one appealed to me because you cut down, you know, every week you cut down two cigarettes a
week and you just cut down and cut down and I eventually got down to none.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterJournals Library www.journalslibrary.nihr.ac.uk
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control over their own behaviour compared with a message around abrupt quitting. For some, it was clear
that a pervading message of the need to ‘stop smoking’ would have completely alienated them from
engaging in the study:© Que
Health
provid
addres
SciencWell, [the HT] said to me, ‘We are not here to make you stop smoking, make you stop smoking. We
are here to at least try and cut you back, if we can help you just to cut down, cut down by whatever,
just to help you cut down, we are happy with just helping you cut down.’ And I thought, ‘Well, this is
someone talking to me that’s not saying, ‘We can stop you smoking. We can do this,’ ’ but [the HT]
was saying, ‘We can help you to cut down. We may in time be able to stop you smoking,’ and I said,
‘Well, that’s a very sensible attitude to take,’ because someone telling me, ‘I’m going to stop you
smoking,’ I’d tell them to . . . go away! So that’s what made me do it initially, because they weren’t
threatening me that they could stop me smoking. But even at this time, there is no one that can tell
me, ‘I can stop you smoking,’ you know what I mean?
Male, aged 55–60 years, unemployed, heavy smoker, interventionThere was also evidence to suggest that smokers can feel saturated and alienated by the ‘hard sell’ of the
abrupt quit message. The invitation was designed, as was the intervention, to be supportive and client
centred and a step away from traditional services, and the supportive and pressure-free nature of the
invitation was well received:You know, I say, when [the HT] gave me the leaflet I thought, ‘Yeah, all right, I’ve heard all this
before,’ and I thought, ‘Well, here we go with the hard sell’. But [they were] totally different. [They
were] so relaxed, so friendly, and that’s what pushed me towards it. If [they] had tried to come across
with the hard sell I would most probably have just ignored [them] and said cheerio. But I think just
approaching people in a friendly manner . . . I mean, sometimes it helps.
Male, aged 55–60 years, employed full-time, heavy smoker, interventionOh, I expected the trial to be like, ‘Oh, you’ve got to do this, you’ve got to do that,’ you know! And
it wasn’t nothing like that because I said to my chap, I said, ‘If I go down there and they say, ‘You’ve
got to give up smoking now,’ I’m saying no, I can’t do that!’ But [the HT] wasn’t nothing like it, [the
HT] was really nice. I said to her, ‘I can do what I can do.’ I said, ‘You can set me out some tasks and I
will try and do them.’ So that’s what [the HT] done for me.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterThe intention of providing a supportive and pressure-free message seems to have been achieved and
effective in engaging with the targeted population.
For one individual, they recognised both the reduction and the PA support side of the intervention as
being something they would like to take advantage of:I was actually thinking about doing something to help myself so when it came up and then it said
about the smoking reduction I thought it was like a bonus that I can get healthy and reduce my
smoking at the same time.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionThis was a relatively isolated case in responding to the appeal of the invitation, but this was to be expected
due to the intentional ‘down-playing’ of the PA side of the intervention in an attempt not to alienate the
less active, or to recruit only those most interested in PA.65
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It became apparent that the invitation itself had a motivating effect on people’s desire for change. As was
expected, most smokers were already contemplating, and had been for some time, the idea of changing
their smoking behaviour. The invitation acted as a prompt to change their smoking habits:NIHROh exactly, exactly, it actually gave me the push that I needed [laughs] just getting the letter and
then, you know, yeah it just gave me the kick that I needed. I’d been thinking about it for a long time
but never doing anything about it. As I say, the first getting the letter was the kick that I needed. I
mean I could really have stopped in the next couple of years, I don’t know about that one but I hope I
would have done, but it was just that initial for the letter coming through the door and I thought,
‘Yeah, I would do that’.
Female, aged 60–65 years, unemployed, moderate smoker, interventionUm, well, because I recently tried to give up smoking a few months before I started and obviously it
didn’t happen, but I was on the smoking replacement stuff, and I just thought, ‘You know, I’ll give
anything a try,’ if you know what I mean. So when I got the letter I just thought, ‘Oh yeah, I’ll go for
that’. You know, it was just something that I immediately thought, ‘Yeah, I want to do it’.
Female, aged 35–40 years, employed part-time, moderate smoker, interventionMotivations for taking part
Not surprisingly, a common motivation was health related, either through personal health or through ill
health of family or friends. Although there is little evidence to suggest that cutting down smoking has
signiﬁcant health beneﬁts, it was perceived by people to offer health beneﬁts with quitting still an
underlying long-term goal:Because I have had a few friends who have died of cancer and that recently, see? So it’s getting more
of a thing to, like, try [cutting down].
Male, aged 45–50 years, employed full-time, moderate smoker, controlBecause I keep on having a permanent cough and it won’t go away. And the doctor has given me
this, that and the other but he said, ‘Your cough ain’t going unless you give up smoking’. So it really
is . . . it irritates my throat and that’s why I cough all the time.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterOh, I’d been thinking for about a year I must give up smoking, it’s expensive and it’s not healthy, it’s
antisocial and you know, all these things, but never quite doing anything about it.
Female, aged 60–65 years, unemployed, moderate smoker, interventionThe last person also mentioned the ﬁnancial cost of smoking as a motivating factor, a motive that was
borne out in other dialogues:TT: So you weren’t necessarily interested in quitting altogether, but just the idea of reducing was quite
a good idea for you, was it?Int: Yeah, I was averaging about 20 a day and being on a pension I went over it and I thought, ‘This is
getting too expensive. I am going to have to knock it on the head’.
Male, aged 60–65 years, employed full-time, heavy smoker, intervention, successful quitterUnsuccessful and negative previous experiences of using NRT and other medicinal therapies emerged as a
strong theme linked positively to motivation for taking part. It was envisaged that the intervention would
offer a novel alternative to the use of NRT, and people’s description of past experiences seemed to conﬁrm
this particular aspect of the intervention.Journals Library www.journalslibrary.nihr.ac.uk
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SciencUmm [sighs] well I suppose the fact that I’d been on the 3-month course [varenicline] . . . I started
smoking again [on holiday] and when I got back and this cropped up I thought, ‘Well you know,
anything I can do to help,’ you know, ‘stop people smoking including myself,’ I thought, ‘Well I’ll take
part in it,’ you know and whether it was going to be of any use to me personally or not at the end of
the day I thought I’d just wait and find out.
Male, aged 55–60 years, employed full-time, heavy smoker, controlOh I’ve tried a couple of times to cut out smoking totally ‘cause I’ve tried the smoking aids and all the
things you know, the puffer and the patches and that hasn’t worked, so I thought, ‘Oh well, I’ll give
this a try then try and cut down,’ yeah.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionThere were a couple of reports of people taking part through altruistic motivation and the interest of
being part of a research study:I just thought I’d see. I don’t know, it just sort of appealed really, and also I suppose out of interest of
a scientific enquiry.
Male, aged 45–50 years, employed full-time, moderate smoker, interventionWell, I’m up at the uni anyway, and helping out with studies is a good idea.
Female, aged 30–35 years, unemployed, moderate smoker, controlThere was an isolated example of somebody coming forward to enter the study because of the incentives
offered to the intervention group in terms of subsidised leisure facility access:Well obviously I thought I might be one of the lucky ones that would get the support, obviously they
had gym membership and obviously I was still wanting to do all of that as well so, and obviously
where I am it costs too much a month to actually go to the gym, so . . .
Female, aged 35–40 years, unemployed, moderate smoker, controlIt appeared that some participants were only taking part for the ﬁnancial incentive offered for returning
the accelerometer:Well, I’m not sure. I mean, I’ve spoken to a few people who’s been on it and when it was first
mentioned, somebody said, ‘Oh you get £30 at the end of the 3 months.’ I said, ‘So you did it for the
£30?’ He said, ‘Well, yeah.’ I said, ‘Well, how sad is that? That’s really sad. So are you going to pack
up smoking?’ ‘Oh, no.’ You know, which I think is rather sad. I would just cut out the incentive of
any money.
Male, aged 55–60 years, employed full-time, heavy smoker, interventionWe are also aware of one participant who withdrew because the ﬁnancial incentive was ‘not enough’.Randomisation: understanding the process and acceptability
Participating in a RCT was a new experience for the majority of the participants. With the exception of the
one example discussed earlier, the procedure was well understood by those interviewed, albeit explained
and understood in a variety of terminology:[The HT] said to me that there’s going to be two groups and after we’d had the discussion about the
whole thing, they [phoned] somebody in Exeter and they would allocate me to a particular group.
Female, aged 50–55 years, employed full-time, moderate smoker, control67
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NIHRYeah, yeah. No, the person who was mentoring me at the time, he said, ‘You may be lucky, you may
not. It depends’.
Male, aged 60–65 years, employed full-time, heavy smoker, intervention, successful quitterThe effect of the randomisation procedure on motivation to remain in the study (reluctance to remain in
the study if not receiving any support) showed no particular inﬂuence either way. Some people showed no
disappointment in being allocated to the control arm, while some did:TT: Right, and how was that for you? Was it a disappointment or was it . . .?Int: No, no, not at all, no, it was fine. I was just interested to see what would happen actually!
Female, aged 50–55 years, employed full-time, moderate smoker, controlYeah, I was a bit gutted by it but like you say, they did explain to me beforehand that that may
be the case.
Male, aged 25–30 years, unemployed, heavy smoker, controlThe HTs also revealed that participants were on the whole ‘disappointed’ to be allocated to the control
condition, with one participant immediately withdrawing from the study as a result.Acceptability and feasibility of data collection methods
Within our methods we carefully considered the amount and type of data collection, given the nature of
the target population, with a few participants with low levels of literacy. As a result all data collection
forms were administered and completed by the HT. Particularly intrusive questions (e.g. probing too deeply
about mental health) were eliminated in an attempt not to alienate or cause suspicion or defensiveness in
the participants.
On the whole, the feeling was that the number and type of questions was acceptable, and that the HTs/
researchers helped them understand the questions.Yeah, no, it was fine, it was all good. Nothing I found offensive or anything, or you know, noseyfied
or anything like that, no, it was fine.
Female, aged 35–40 years, employed part-time, moderate smoker, interventionNo if they had all stayed at the same amount of time that I was there for the first one [baseline
assessment] then yeah I would have been like, ‘Oh my God,’ but no, they got better as they went on.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionThey explained it really quite well and that and yeah, it was good. It was good, I quite enjoyed it.
Male, aged 45–50 years, employed part-time, moderate smokerWell I mean yeah, the questions were all right, you were given enough time to answer and I think
some of them gave you a choice of answers so you only had to pick at the relevant one that matched
my own situation, so it was pretty easier to answer.
Male, aged 55–60 years, employed full-time, heavy smoke, controlThere were some expressed difﬁculties with Likert scales and multiple option questions:Um, yeah, I found them all right. They were quite . . . I think there was probably like maybe too
many options within the answers, sort of 1 to 10 or something like that. And I was either sort of
right at the end, in the middle, or right at the beginning. I was either one rather than sort of anything
in between.
Female, aged 30–35 years, unemployed, moderate smoker, controlJournals Library www.journalslibrary.nihr.ac.uk
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Male, aged 60–65 years, employed full-time, heavy smoker, intervention, successful quitterSome questions appeared individually inappropriate, perhaps due to a misunderstanding of the question
or because some of the questions were rather abstract and difﬁcult for some participants; feedback from
the HTs implied that some of the questions were more difﬁcult to ask and explain than others (e.g. with
the mCEQ):Well, some of them I thought quite amusing but I said to [the HT] on a couple of occasions, ‘How can
I answer this? I don’t do things like that!’
Male, aged 60–65 years, employed full-time, heavy smoker, intervention, successful quitterIf I remember the questions, yeah, I think they were very random! I mean, some of them I had a bit
of a chuckle at, what [the HT] would ask me, like!
Male, aged 25–30 years, unemployed, heavy smoker, controlOne difﬁculty we faced was tailoring the questionnaires to include the situation of making a quit attempt.
This was difﬁcult as several of the questions became non-applicable in the light of a quit attempt, but also
varied depending on their smoking behaviour since they made their quit attempt. This was reﬂected in one
participant’s observations following a quit attempt:The only one grouse I had was in the forms that you’ve got, that you fill in saying if you have
depression and if you have [this and that] and all the rest, [but] there is no form for when you quit
smoking. So half the forms when I quit smoking were no good to me at all [ . . . ] so you want us to
quit and when you do quit, there’s no form saying, how do you feel? That’s the only thing that I feel
was wrong with it.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterMethods for measuring PA and potential problems associated with wearing an accelerometer on an
elasticated waistband was of interest to the study. Most described it as comfortable and wearing it
became a routine:Do you know what, surprisingly, it wasn’t as uncomfortable as I thought it was, although the belt
itself is really comfortable, the elasticated belt. I mean, you couldn’t even feel it was there most of
the time. I mean, you didn’t even know it was there until you hit against it or brushed against it with
your wrist.
Male, aged 25–30 years, unemployed, heavy smoker, controlA few participants had an issue with remembering to put it on, or returning it to the researchers:Remembering to put it on as well, sometimes I would walk around for an hour then think, ‘Ah! I’ve
got to put that thing on,’ like, you know?
Male, aged 55–60 years, unemployed, heavy smoker, interventionYeah, yeah, it was fine. The only sort of thing, as I say, I was like, I’d wear it for the day and then I’d
put it on my bedside and then forget all about it! And because you’ve rung, I’ve now remembered I
need to send it back.
Female, aged 30–35 years, unemployed, moderate smoker, controlThe possibility of daily automated text message reminders to accompany the accelerometer was explored
with those who expressed trouble remembering to put it on. The responses highlighted that it would be
acceptable and useful, but should be optional:69
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70TT: Would maybe a text in the morning have been useful or something like that, or would that haveNIHRbeen a bit intrusive?Int: Um, I’m not sure really. I mean, I would say, it sounds like something that’s intrusive but when
you have got a memory like mine, it would have helped, so it’s a bit of a hard one. I suppose that
one’s an individual case. Maybe it’s a question that should be asked at the beginning of the thing
when you get given the band to wear.
Female, aged 30–35 years, unemployed, moderate smoker, controlA few participants in active professions found that the accelerometer could become obstructive:Yeah, I wore one I think for the first couple of weeks and then [the HT] gave me another one but
where I was working it kept on catching, so I didn’t wear the second one. See I work on a building
site, see, so there was a lot of bending over and like I just climbed down from the loft now, it was
getting quite irritable like, on my side. So I didn’t wear the second one.
Male, aged 45–50 years, employed full-time, moderate smoker, controlOne participant thought that it was frustrating to wear the accelerometer and get no feedback on how
they had done. Perhaps the use of it could be better described and understood in the future with an
example of the type of graphical information it provided (on a sheet of paper) rather than individual
feedback. Overall, the pedometer provided some feedback. The administrative challenge of downloading
individual information from the accelerometer would be considerable.You wear it for a week, you give it to them . . . no, no, no, they get feedback, obviously, but it would
help or it would have been nice. You wear it for a week, what for? I don’t know. It monitors my
body. OkayOK, thank you. But monitors what? Monitors . . . I wore it three times and I don’t
know why.
Male, aged 55–60 years, unemployed, heavy smoker, interventionLocality of assessments
Assessments took place in a centralised and well-known health service building and, where appropriate,
at the participant’s GP surgery. From those interviewed there were no complaints about the location
of sessions.
One of the successful quitters in the study praised the location of the sessions as the SSS was based in the
same building, and so when he did decide to make a quit attempt the process was relatively seamless.
Only two of the quitters did make use of the SSS, so this was not relevant for many participants.Yeah. I would just like to mention that at the [centre] where it was held, to actually stop smoking and
then getting the nicotine aids things, it’s made a damn sight easier because you are in the hospital
and they have got a non-smoking unit there. So I saw this [stop smoking advisor], prescription,
straight away, for gum, nicotine gum, patches and all the rest of it, you know. Because the location is
brilliant because you did not have to go away and find somewhere, go to my surgery.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterAcceptability and feasibility of the intervention
Intensity of support
Behavioural support for helping people who do not want to quit in the immediate future to cut down is a
new area of research and little is known about the amount of support required. A major consideration was
the frequency, duration and length of time over which the support should take place, and the mode ofJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4delivery. The pre-pilot development work resulted in a very ﬂexible style of intervention delivery, with a mix
of face-to-face sessions and telephone support sessions.
There was support for weekly sessions, which some participants found to be acceptable:© Que
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Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterI think it was probably about right, I don’t think, you know, it didn’t seem onerous particularly being
part of the study.
Male, aged 45–50 years, employed full-time, moderate smoker, interventionWell I think I, all the ideas were there but you know I thought it was probably enough.
Male, aged 60–65 years, unemployed, moderate smoker, interventionNo, it was just right, I saw [the HT] on a Tuesday morning at 10 and I was more or less out of there
by 11, just before. Yeah, no, I was happy with that, that was fine.
Female, aged 35–40 years, employed part-time, moderate smoker, interventionThe lengths of the sessions were generally acceptable as well:No, I think it was OK. It was mostly an hour a week, sometimes it went a bit longer, but no it
was fine.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionThe mixture of face-to-face contact and telephone support was generally well received by those
interviewed, allowing for increased ﬂexibility and engagement with the support around continually
changing circumstances for some:[The HT] always used to ring me. Because some days I couldn’t make it and I just said to [them], ‘Can
I speak to you on the phone instead?’ And then we’d do the paperwork over the phone because I
was working quite a bit then.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterHaving the telephone contact appeared to play an important part of the perceived support participants
experienced, whether or not they used it, having been provided with the HT’s telephone number and
being told they could always telephone if they had any problems.I always had the mobile number anyway, not that I needed it, but they said you know whenever I did
need it for anything.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionI think it worked really well because I always had [the HT] on the other end of the phone, if I needed
her, do you know what I mean? You know, [the HT] was always there for me and so they really
helped me a lot.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterNo, no it was fine it was fine. I mean when, well, they were always there at the end of the phone
whoever you were dealing with, that was quite nice, if you had to change an appointment or what
have you they were always there.
Female, aged 60–65 years, employed full-time, moderate smoker, intervention71
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72The overall feeling regarding the intensity of the intervention was generally mixed. There was no report
from those interviewed that the support was too intensive or overbearing, but there was a recurring theme
that the support could have been more intensive than once a week:NIHRMaybe erm a little more often to see somebody. I mean as I say I was fine, but maybe some people
would like that little bit more . . . even a phone call maybe just to see how you’re getting on
[in between sessions].
Female, aged 60–65 years, unemployed, moderate smoker, interventionWe were doing regular meetings but I found if there had have been a little bit more contact
like maybe just a phone call like halfway through the week . . . I think as well the weekly
meetings maybe like a midweek telephone call to give you that little bit of encouragement
and everything.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionSome participants reported that not only was the support not intensive enough, but it could have gone on
for longer to support further behaviour change:I would say the only thing is, I mean like now I’ve done it and everything, it was too short and it
wasn’t intense enough . . . I mean, [the HT] was excellent and I am personally saying my idea is that if
it was more intense it would be more helpful. It would be better.
Male, aged 55–60 years, unemployed, heavy smoker, interventionErm I think . . . if you got people to give up smoking I think it would be, you know, a longer period of
time would be better.
Male, aged 60–65 years, unemployed, moderate smoker, interventionThere was some evidence to suggest that participants were not receiving the weekly level of support that
was intended.Well, when I say that, without being rude, I mean . . . my counsellor was very good but I saw [them]
once every few weeks, of a couple of weeks maybe or maybe I saw [them] like next week, then I
wouldn’t see [them] for two weeks, or three weeks maybe, or two weeks, you know what I mean?
Male, aged 55–60 years, unemployed, heavy smoker, interventionThere was a period when it was sort of four, eight and sixteen weeks was it I can’t remember what
the time was but erm, yeah, maybe say every two weeks would have been helpful to some people.
Female, aged 60–65 years, unemployed, moderate smoker, interventionSome instances of limited contact were due to staff illness, the three HTs all working part-time and on
different days, and HTs being fairly rigidly assigned to individual participants (to maintain continuity). Field
and meeting notes did reveal a large variability in participants’ abilities to stick to regular scheduled
meetings depending on unpredictable and changeable personal circumstances. One participant withdrew
from the study before receiving any intervention support sessions due to a delay between the baseline
assessment and the ﬁrst intervention session. Fortunately, these difﬁculties were few and participants
generally appreciated the intensity and ﬂexibility of support received.Style of delivery
The EARS client-centred intervention was designed to maximise adherence among a traditionally service
resistant group. The HTs were trained to establish a strong rapport and engage participants in taking
control of any behaviour change. We were keen to understand how this worked and was perceived
by participants.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4There was good support for the HTs and the strong rapport they developed with the participants
interviewed, with discussions around the targeted behaviours moving forwards in an individualised way.© Que
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SciencYeah, fine. [The HT’s] all right. Yeah, [they’re] lovely. I used to go down and see them or they used to
ring me if I was too busy at work or something. Yeah, they was fine. I got on really well with them.
They was a good help.
Female, 50–55 years, employed full-time, moderate smoker, intervention, failed quitter)But [the HT] was very good at what they done, you know what I mean? [The HT] was, I mean, like
first, like most people with a doctor or something like that, ‘How are you feeling? How’s your
problem?’ Well with [the HT], with their consulting ways, it was like, ‘How’s your week been? Have
you had a good time? Did you do anything?’ then you had a 5-minute chat, only about basics like,
you know, blah blah blah, and then slowly they brought in the smoking, you know, and what I was
doing and the conversation. They was very good at what they done.
Male, aged 55–60 years, unemployed, heavy smoker, intervention[The HT] was a brilliant help, [they were] fantastic to be honest.
Male, aged 45–50 years, unemployed, heavy smoker, interventionThe skill of the HTs in developing and maintaining good relationships with the participants was widely
acknowledged among those interviewed. Advanced interpersonal skills were a high priority for the
appointment of the HTs within the trial and they appeared to be effective:Well I mean, there was never any question, you know, it was always like, ‘You know it’s down to
you,’ you know, so no, I found it, you know . . . really quite good actually you know, I thought they
were there was no question but lots of support I guess, and interest.
Male, aged 60–65 years, unemployed, moderate smoker, intervention[The HT] said it was entirely up to me, what I was doing, and yeah, they were a good help, that’s all I
can say, really. [The HT] was a good help.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterInt: Oh totally, like my decisions, I wasn’t pressurised into it at all. I was encouraged and I was
supported but I wasn’t pressurised.TT: Did you feel like you were in control of your decisions then about how much to cut down?Int: All the time, yeah, all the time.
Female, aged 60–65 years, unemployed, moderate smoker, interventionOh yeah, I was in control. I mean, I told [The HT] how many I was going to cut down a week or a day
and they said, ‘OK, well that’s the goal you are going for.’
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterOh no, not at all, [the HT] gave me some useful, like, suggestions and how to plan what I was going
to do. But no, [the HT] was never like suggesting, ‘You are going to do this, you’re going to do that,’
no, never like that, no.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionParticipants experienced a very client-centred style of delivery, one which was not threatening and placed
them ﬁrmly in control of the decision-making process. There was also repeated evidence of people
responding well to the strongly supportive and non-directive nature of the intervention delivery:73
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74NIHRWell, no one likes people telling them what to do really, do they, unless it was discussed, so it was a
study about me and my smoking habits then obviously it’s got to come from me and not someone
else, ‘cause everyone’s different ain’t they with smoking and everything.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionIt’s all down to the person but as I say, I’m not weak-minded and people can’t tell me to stop
smoking but [the HT], the way they put things across to me, explained things, and, you know? They
brought me down to earth in a nice way.
Male, aged 55–60 years, unemployed, heavy smoker, intervention[The HT] was just, you know, not advising me but . . . [the HT] wasn’t even telling me, [the HT] was
just saying, ‘You do what you think best,’ and ‘Do what you can do,’ they said. But they did say to
me to get out a bit more because I never did go out very much. No, it was from me. They didn’t
force it on to me, they just advised.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterYeah, I mean, it was advice, it was good advice. [The HT] used to say, ‘We are not pushing you to
stop smoking, but if you want to cut down, this is the ways you can do it.’ I had the forms each week
down there each time like, and it was always good advice, it was always pleasant. There was no hard
pressure, no hard sell.
Male, aged 55–60 years, employed full-time, heavy smoker, interventionTT: I wonder how well would the intervention have worked if it was a bit more directive?Int: Yeah I, yeah I probably wouldn’t have reacted you know in the same way, yeah. Because I think
it’s something, it’s nice to talk to somebody one to one but at the end of the day it’s yourself that
must be in control and be able to say, you know, ‘Well yeah, this is okayOK, I can do this,’ or, ‘I can
do that,’ but what do you know sort of to be told that you should be do this, you should do that,
because it’s up to each and every one of us to decide.
Female, aged 60–65 years, employed full-time, moderate smoker, interventionKey to promoting ownership and supporting people in taking control of their own behaviour change is
eliciting the individuals’ own solutions to problems. The HTs mostly prompted participants to reﬂect on
behaviours and consequences, and identify solutions:Yes I did, yes, and as I said you know you didn’t, they weren’t intrusive, they weren’t saying,
‘You must do this,’ or . . . they were helpful and just made suggestions, but it’s probably things that
you would have thought about yourself but their suggestions were what you were thinking really, you
know, the ones that reacted, but it was nice to know that they weren’t sort of saying, ‘Well you
should do this, you should do that,’ you know, it was a one-to-one thing, it was very good.
Female, aged 60–65 years, employed full-time, moderate smoker, interventionSupport was voiced for the non-judgemental nature of the intervention, which was designed to avoid
failure and always reframe any failures as learning experiences or opportunities for reﬂection:The next fortnight that I saw [the HT], they said, ‘How did you get on?’ and I showed them the sheet
and they said, ‘Well, you kept to your goal.’ And that was it. They didn’t tell me off a lot or belabour
me or . . . I did try and keep to my goal [but] a couple of days I missed out, you know.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4© Que
Health
provid
addres
SciencYeah I think, you know, there wasn’t, I didn’t have any sort of great pressure or anything, you know,
I mean there was no, ‘You are a bad person, you must quit,’ sort of thing or attitude if you know
what I mean.
Male, aged 45–50 years, employed full-time, moderate smoker, interventionOne participant favourably compared the different approach with other support they have received in
the past:I wasn’t told, you know, ‘You should be doing, this you should be doing that,’ like when I have, when
I’ve gone to other places to try and give up smoking [laughs] yeah, ordered to do things, you know
what I mean, we just talked about things, talked about ideas.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionMultiple behaviour change
Fundamental to the intervention structure was its aim of addressing two behaviours simultaneously, an
approach that is not widely advocated in behaviour change literature, and in most cases avoided, for those
wishing to quit. The complementary nature of the two behaviours (one a ‘stopping’ and one a ‘starting’
behaviour) meant that it was postulated that addressing the two behaviours alongside each other could
be acceptable.
Resulting from the pre-pilot work and work with early intervention participants, the behaviours were
introduced sequentially with smoking behaviour taking precedence over PA behaviours. How acceptable
this was to participants and how much they engaged with the idea was of particular interest, especially
how they viewed the utility of using PA to inﬂuence their smoking behaviour.
While it was difﬁcult to explicitly elicit from participants how difﬁcult or challenging they found it to try
changing two behaviours simultaneously, there was qualitative evidence that participants actively engaged
in the process of using PA as a way of managing and inﬂuencing their smoking habits:I did make some changes, yeah, and when I do go out for a walk with the dog I don’t
take my cigarettes with me and I could be out for hours, so I don’t bother taking my fags
with me.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterWell, there was the exercise thing, getting out and being more active and stuff, which I am quite an
active person anyway. I walk everywhere and you know, I am not a sitty-home person. I might
want to do it once a week but I’m sort of like an active person anyway. Yeah, things like that helped
me. You know, the gym helped.
Female, aged 35–40 years, employed part-time, moderate smoker, interventionPhysical activity was important in highlighting the negative health consequences of smoking and this
appeared to change the way some people thought about their smoking habits:As I say, doing exercises and that, you feel healthier and then obviously if you are doing exercises and
silly things like that, you feel healthier and then when you go to put a cigarette in your mouth, it’s
obviously psychological, you’re going, ‘Oh no, I am wasting myself going in the gym for that hour,’ if
you know what I mean, ‘to go and have a cigarette now’.
Male, aged 55–60 years, unemployed, heavy smoker, interventionThere was also support for an ‘identity shift’ from a smoker to an exerciser, and the value attached to
being active:75
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76NIHRYeah, well as I say, it did help and not only that, you see, getting confident was . . . in this gym, it was
state-of-the-art, you know, I tell you if I was still smoking there is no way I could use some of those
machines that I’ve been using, the rowing machine and the boxing machine thing. No way I could
use those if I was smoking! I’d just be coughing my lungs up.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterAnd I found out it’s a drug in a way ‘cause when you go to a gym you come back out you feel great
for it and then smoking, you don’t even think about smoking ‘cause you’ve gone in there and
you’ve done like an hour and a half workout, the last thing you want to do is come out and have
a cigarette.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionPhysical activity was an acceptable way for some of distracting themselves from smoking and coping with
the cravings:Erm, well it’s still difficult to cut down the cigarettes I’ve got to agree, but if I walk more then I don’t
need to, you know, I don’t want to smoke, put it that way.
Female, aged 60–65 years, employed full-time, moderate smoker, interventionWell, I get about a bit more now because I never used to get out very much but yeah, I get out a bit
more now with the dog and that, and [the HT] said, you know, [the HT] said, ‘Go out walking and try
and keep your mind off cigarettes,’ which I did do . . . Yeah, I take the dog out and I do things, you
know? Definitely. Yeah, it works, most definitely works, yeah. It’s something there to stop me . . .
yeah, to stop me from thinking about it, distraction, yeah.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterI’m doing my exercises three afternoons a week. And that takes my mind off the smoking. It takes
your mind off of smoking actually, the exercise. It really does.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterWhen [the HT] was trying to put across all the activity side, I found [that when] I was engrossed in
doing something, which may have been whatever, I didn’t smoke so much [ . . .]. But then, if I wasn’t
doing anything I was smoking.
Male, aged 60–65 years, employed full-time, heavy smoker, intervention, successful quitterIt did become clear that PA was not necessarily the primary way in which people would control their
smoking behaviour. It was continually aligned with other ‘distraction’ activities which participants would
engage in to manage their smoking behaviour. PA was, for many, just another way to keep busy:Well I like walking so you know, I’d go out for a walk you know or something like that or, you know,
read a book; anything to take your mind off it really, break the routine, ‘cause that’s what smoking
is really.Erm well, keeping myself busy basically, because if I am doing other things I am not smoking so
much. I go swimming too you know, but first thing I do when I get up in the morning is have a
cigarette you know, so if you can cut that one out you know a good part of the, it is a different sort
of day so instead of, you know, having a cup of tea and having a cigarette I would do something for
an hour or so.
Male, aged 60–65 years, unemployed, moderate smoker, interventionSome participants did see more beneﬁt in PA as a way of distracting themselves from smoking than
other activities:Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4© Que
Health
provid
addres
SciencIt’s more effective because if you’re sat down reading or anything you’ve still got that opportunity to
think about a cigarette, whereas when I’m like huffing and puffing along to the aerobics the last
thing I want to do is stick a cigarette in my mouth.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionIn one case, the participant had made explicit links between PA and the potential for gaining weight while
cutting down their smoking:I made myself cut down but I haven’t put on any weight, you know, and I think that’s how I explain it
[PA], you know, ‘cause some of my friends who have cut down smoking the first thing you hear
about is putting on weight, putting on weight, putting on weight, and I haven’t, so I’ve cut down on
my cigarettes – well, I have and I haven’t put on any weight whatsoever you know, nothing like that
has changed at all.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionOn the whole, those interviewed found the idea of addressing behaviours simultaneously acceptable, to
varying degrees. There were cases where the promotion of PA was not completely appropriate, and
people failed to see how the two behaviours linked together. This was particularly the case if the
participant already viewed himself or herself as being highly active.No I didn’t you see, you know [the HT] was telling me about exercises and I mean I do dance and I do
swim and I do walk you know this sort of thing, and I am a pretty sort of active person anyway to do
an exercise to, ‘cause I think that was one of the sort of objectives of it to up your exercise to lessen
your smoking, but with me that didn’t or wouldn’t have worked because if I’d really wanted a
cigarette I’d have done my exercise and then had a cigarette, so [coughs] it didn’t stop me from
smoking if you know what I mean, to do more exercise.
Female, aged 60–65 years, unemployed, moderate smoker, interventionFor one individual, PA may have reduced their desire for a cigarette while actually doing it, but heightened
their desire for a cigarette afterwards:Int: I said to [the HT] you know, the truth of the matter is that whenever I actually have a cigarette,
whenever I did physical exercise at the end of it I would sort of in some case smoke more [laughs] if that
makes sense. It was sort of a reward you know.TT: OK, that’s interesting. So for you, you don’t find that sort of doing something active tends to lessen
your desire for a cigarette then.Int: Well when I’m doing it, but not afterwards, no.
Male, aged 45–50 years, employed full-time, moderate smoker, interventionPossible further adaptations
When invited to offer thoughts on possible adaptations to the intervention to help improve the experience
or further support behaviour change, on the whole very little was suggested. Most participants interviewed
were very satisﬁed with what they had received. As discussed earlier, the possibility for more intensive
support over a longer time period was the most pervading suggestion.
One individual suggested that group support, for both smoking reduction and increasing PA, might be helpful:I think the only thing I could suggest really is if you did it in a group format so you’ve got other
people to keep up with as well.
Male, aged 60–65 years, unemployed, moderate smoker, intervention77
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78One of those interviewed, who was a successful quitter, highlighted that they felt a lack of support, or
perhaps interest, when they had actually made a quit attempt. Implying more dedicated support for those
who do quit could be involved in the intervention. This was part of the intervention design, but was
possibly not executed as well as it could have been:NIHRSo you want us to quit and when you do quit, there’s no form saying, How do you feel? That’s the
only thing that I feel was wrong with it.
Male, aged 60–65 years, unemployed, moderate smoker, intervention, successful quitterThe idea of more monitoring and feedback was something that appealed to one participant:Int: I guess I quite like the, you know, being able to monitor how much you walked in a day and that
sort of thing . . . more of that maybe, you know, more of the science.TT: OK that’s interesting. More of the science, more of the sort of numbers and figures and changes
and things like that.Int: Yeah, absolutely.
Male, aged 45–50 years, employed full-time, moderate smoker, interventionSimilarly, another participant suggested the use of more informative materials, as well as materials for
providing options of things that people could try, with information around the beneﬁts, pros and cons of
different activities:Int: I know like a lot of people are able to get out and about, like to be active, so when people think,
‘Oh,’ when we sort of, something about like your fitness people always assume like when the gym
and everything . . . but there are other ways you can stop smoking so I think like giving them some
suggestion about how to, ‘cause I think that would be a good thing.TT: OK, like a big list of options of different things that people could try something like that?Int: Yes, just like put next to it like the benefits you get from it, like a 10-minute walk, ‘This could do
this for you,’ and then maybe just put in what smoking would do. Say like you done a 20-minute
walk and then say you’ve got more oxygen in your lungs and something, and then give them a chart
like at the end that, ‘If you have a cigarette this will come down by this much.’
Female, aged 25–30 years, employed part-time, moderate smoker, interventionWhile this was something that was intentionally avoided in this study for fear of overloading participants
with information and taking away a sense of control over their decisions, it would perhaps be worth
exploring ways of introducing this in future research.Dual role of the researcher/health trainer
We intended to maximise retention in the intervention and trial by streamlining recruitment, data
collection and intervention delivery through contact with one HT/researcher throughout the trial. While this
resulted in a less rigorous trial without the possibility of blinding outcome assessors, we wanted to assess
the possible merits of this. The feedback was in favour of a dual dole and thus a single person to deliver
the intervention and conduct assessments.Two people doing different things, no, I think it would be better with just one person, yeah.
Female, aged 50–55 years, employed full-time, moderate smoker, intervention, failed quitterJournals Library www.journalslibrary.nihr.ac.uk
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SciencI wouldn’t, yeah, I wouldn’t have liked that no, it was nice because the girls were very friendly and so
no, I think the one person doing everything was better from my point of view.
Female, aged 60–65 years, unemployed, moderate smoker, interventionYeah, the first [HT] I met that was fine because I didn’t see them again [due to sickness] I saw another
[HT], I didn’t, yeah I didn’t mind that but I think personally I would have liked to have seen the same
person each time.
Female, aged 60–65 years, employed full-time, moderate smoker, interventionNo, I liked the thought that it was [the HT], you know, every week. I wouldn’t have . . . because I got
used to [the HT], you know, do you know what I mean? I wouldn’t like the thought of seeing
somebody new every week or anything like that. That was nice.
Female, aged 35–40 years, employed part-time, moderate smoker, interventionSome participants went further, expressing why they felt it would be more productive to just have one
person completing all the roles, expressing that some of the data collection involved quite personal aspects
and this helped in building conﬁdence and rapport in the relationship:I don’t think it would have been fair, because obviously the questions could become a bit more
personal to you instead of a whole general kind of thing. So I think the way that it was run like by the
researcher and the intervention I think that was actually quite good.
Female, aged 25–30 years, employed part-time, moderate smoker, interventionI am not sure because some of the questions are quite personal aren’t they on there, and it’s how you
are feeling and things, you know, and I don’t know, I just liked it was the one person to do
everything, you build up a bit of a rapport.
Male, aged 40–45 years, employed part-time, very heavy smoker, interventionHowever, none of those interviewed had experienced research with an independent researcher and
practitioner, so it is difﬁcult to evaluate their comments when there is a lack of an experiential
frame of reference.Feedback from health trainers
Aims
Our aims were:
l to assess acceptability and feasibility by capturing the experiences of the HTs in delivering the research
and the intervention with a focus on what is working well/badly and what could be improved and
identifying barriers to delivery
l to capture the HTs understanding of the fundamental driving principles behind the intervention in
terms of:
¢ how the intervention is supposed to work (the process model)
¢ participant engagement (i.e. client centred, non-judgemental, self-paced reduction) and
¢ engagement of the HTs and participants with the idea of using PA to assist smoking-reduction
approaches to eliciting change (i.e. speciﬁc BCTs and processes involved).Methods
Design
Qualitative research was conducted using a basic thematic analysis of individual face-to-face interviews to
elicit and describe the HTs’ experiences and views about delivering the intervention.79
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80Sampling frame
An opportunity sample consisting of all three part-time HTs (with a dual role of also collecting data)
employed in the study was used to maximise the diversity of opinions in the data. Interviews were
conducted both early in the study (1–2 months after starting to deliver the intervention in the pilot trial, to
capture experiences of the training course while they were still fresh in the HTs’ memories), and in the last
1–2 months of the 16-month pilot trial (to capture any changes in practice or opinion following extended
experience of delivering the intervention).Measures and procedure
Semi-structured, individual, face-to-face interviews were conducted within a few months of completing the
training and at the end of the intervention period using topic guides developed by AT, CGVS and TT,
designed to elicit data relating to the aims above. The ﬁrst interview started with general questions about
the HTs’ experiences of delivering the intervention and then asked speciﬁc questions about the training
course, recruitment processes, intervention delivery (what was working well or badly) and the HTs’
understanding of the different intervention processes. The second interview (at the end of the intervention
phase) asked about their ongoing experiences in delivering the intervention and how these might have
changed since the initial interview. The interviews were digitally recorded and transcribed verbatim.Analysis
The data were organised using a basic thematic analysis to provide a simple descriptive-level overview of
the HTs’ views. In-depth qualitative analysis procedures were not used here. However, these data will be
analysed in more depth alongside the participant interviews and consultation recordings, using framework
analysis96 to generate an integrated analysis of processes of behaviour change in the EARS intervention.
This in-depth analysis will be reported as part of the PhD of one of the researchers (TT).Results
Feedback was organised under three main themes (training, recruitment and intervention, and trial
delivery). A summary is provided below and a selection of quotes pertaining to each section is presented in
Appendix 5a–c. Ideas for improvement in training, recruitment and the intervention are collated at the end
of the Results section.The training course (see Appendix 5)
Overall, the training was well received and valued in building the necessary skills for delivering both the
research and the intervention. The training was an exploratory process to help formulate the intervention,
drawing on the individual skills and experiences that the HTs brought to the training; they were all
involved in some form of health promotion work in their other part-time employment. The developmental
nature of the training gave the HTs an impression that the training process was somewhat disjointed, but
equally one HT valued the opportunity to be able to contribute to the intervention development.
When asked ‘what worked well?’ the HTs identiﬁed practice sessions (with volunteer clients) and reﬂecting
on recorded consultations, having an intervention manual, and getting formative feedback from a health
psychologist as important. There were differences of opinion about how many practice sessions were
useful, apparently based on the differences in individual learning styles.
One aspect that the HTs found particularly difﬁcult was the initial assessment of their ‘instincts’ for the
intervention (a simulated client interview in session 2 of the training). The intention was to allow the
training team to adapt the training to the existing skill levels of the trainees. However, this was perceived
to be challenging and disconcerting by the HTs but useful, nonetheless, for the research team.
The several months between the end of training and the start of intervention delivery, due to the logistics
of taking occupancy of an ofﬁce in an NHS facility and delays caused by co-ordinating the recruitment
process, was a frustration. However, it was clear that the HTs’ conﬁdence in using the techniques
increased greatly with practice and their use of these became more ‘automatic’ as time went on.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Ideas for improvement in the training course included:
l having more content for what to do beyond the initial motivation stage
l having a longer session on motivational interviewing or client-centred approaches and techniques
l practising the protocol for collecting the research data/baseline assessments
l having a short self-reﬂection period built in at the end of each session
l having the ﬁdelity scale available from the outset to provide a steer on what was expected
l having the trainers model the intended delivery style
l providing a much clearer structure to the training to ‘put the cogs right in the correct order’
l guidance on working with smokers with other substance misuse issues
l including training on how to how to rein people in if they go off track
l reinforcing the idea that a client-centred approach still allows the HT the opportunity, with the
participant’s consent, to offer (or exchange) information
l guidance on how to deal with people who are already active
l including more supervision and formative feedback, particularly in the early stages of delivery.
These suggested changes will be very useful in designing the training course for future implementations of
the EARS intervention.Recruitment (see Appendix 5)
The HTs recognised the relative efﬁciency of recruiting participants through GP and SSS invitation letters
after identifying smokers on surgery databases. There were minor initial teething problems in working with
surgeries. In contrast, recruiting without an invitation letter from the community was much harder, with
many of the strategies used producing few participants. There was a belief that approaching existing
group leaders as advocates (rather than directly approaching individuals) could be more promising but that
it may take more time to build relationships within the community. The study timeline may therefore have
placed constraints on what could be achieved.
When asked ‘What attracted participants to the study?’, the HTs identiﬁed a desire to reduce smoking as
the primary factor, along with an interest in the research itself and the idea of getting one-to-one support.
All the HTs felt that potential participants were ‘not hearing the physical activity side of it’. Reasons
reported for non-participation included having other priorities, a lack of time, illness or a lack of interest in
reducing smoking.
Making contact with potential participants by telephone was reported to be acceptable, but there were
mixed views from different HTs: one felt she was intruding into people’s lives ‘like a salesman’. All HTs
reported that this process was time-consuming, as they often needed to make several calls to get hold of
the participant.
The most difﬁcult part of the recruitment process was the disappointment expressed by participants who
were allocated to the control group. It was noted that increasing the study-completion payment later in
the study might have helped with this. No major problems were reported regarding access,
non-attendance or workload for participants after they were enrolled.
Suggestions for improvement included:
l offering the intervention to controls at the end of the study to counteract the sense of disappointment
(possibly in a group format or as a condensed version)
l developing a strategy for what to say if someone else answers the telephone
l not focusing on PA during the recruitment stage as it ‘sort of confuses people’
l having a more prolonged engagement with workplaces, perhaps via occupational health professionals
or existing public health team contacts, which could help recruitment.81
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82Delivering the intervention (see Appendix 5)
The HTs reported no problems in using most of the intended intervention techniques, including exploring
a typical day; encouraging self-monitoring (which was seen as particularly useful); problem solving;
empathy-building/person-centred counselling; exploring importance (including pros and cons and using
1 to 10 scales); exploring conﬁdence; using motivational interviewing techniques (including afﬁrmation and
reﬂective listening); reviewing progress; assessing existing smoking; offering alternative strategies for
smoking reduction; setting realistic/SMART (Speciﬁc, Measurable, Attainable, Realistic, Time-referenced)
goals (usually verbally, or with the HT writing them down) and making coping plans.
When asked ‘what worked well?’, the HTs identiﬁed regular contact, encouraging self-monitoring, MI
(client-centred) techniques, pedometers and offering a choice of clear behavioural strategies for
smoking reduction.
In terms of delivering the PA aspect of the intervention, the HTs felt that that most people were willing to
try to do some PA. However, making the link between PA and smoking reduction was easier for some
participants than others. The idea that PA could help to reduce cravings was not generally well understood
or accepted. However, the idea that PA could provide a distraction was felt to be more useful/more easily
accepted by participants. The HTs also tried to encourage people to do experiments to test the link, with
mixed success. Other strategies were sometimes useful (e.g. focusing on the general health beneﬁts,
addressing misconceptions about what PA entails). The need for individually tailored strategies was
highlighted by all three HTs:NIHREverybody’s very, very different aren’t they, sort of, receptive to different things.Tailoring the intervention applied to assessing motivation, identifying and addressing barriers, trying to
make the link between PA and smoking reduction and deciding which behavioural strategy (or mix of
strategies) to use. One HT reported that making the link to PA was often easier for these participants,
although it was not clear why this might be.
For the ‘harder-to-reach’ participants (e.g. those with higher levels of mental health problems or low
literacy or analytic skills), ﬂexible tailoring of the intervention seemed to be particularly important although
this did not seem to diminish the chances of a successful intervention.
There were mixed views about delivering the process measures alongside intervention sessions (NB: this
was also noted as being a potentially difﬁcult process when reviewing the consultation recordings).
Some HTs felt that this was not a problem, but others identiﬁed a ‘tension between the HT and the
researcher role’.
All the HTs felt that the short timescale of the intervention (8 weeks) was a limitation and would have
liked to have more ﬂexibility to maintain contact with participants who were starting to make progress.
Encouraging engagement of social support (which was identiﬁed by the intervention ﬁdelity analysis as
largely lacking) was identiﬁed as being potentially problematic/provocative as not everyone had good
sources of (positive) support. This was also identiﬁed as not being high on the agenda, perhaps reﬂecting
a lack of emphasis on this during the training. Similarly, the issue of identity change was not considered to
be a major element of the intervention process.
Overall, the HTs reported feeling very positive about their experiences in being part of the research study
and delivering the intervention. They felt that this was a job they would enjoy doing and would apply for it
again if it the opportunity arose.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Ideas for improvement included:
l Consider using a solution-focused approach rather than a problem-solving approach.
l Possibly encourage participants to take a longer-term personal appraisal of the beneﬁts of PA, rather
than any acute effects.
l Include training on how to avoid or minimise dependence/reliance on the HT.
l Use text reminders as a useful way to remind people about appointments.
l Include training on how to deal with passive resistance (participants who avoid engagement by
agreeing/going along with the HT, but then do not make the changes discussed).
l There was a further suggestion that some type of debrieﬁng supervision might be useful, where the
HTs could discuss difﬁcult cases or their own feelings about certain difﬁcult clients.
l Finally, there was also a suggestion from one HT that at the baseline interviews, there was a tension
between the need to build empathy at this stage and the need not to engage therapeutically. This
might result in some contamination of the control group (albeit quite low level).The intervention at work: John’s storyThis case study illustrates an individual who fully engaged with the intervention and was successful in
changing both smoking and PA. The identity of the individual referred to is concealed through careful
removal or modiﬁcation of any information that may break this anonymity, while also maintaining a true
story captured from taped sessions and reference to other data collected at the respective assessments.
The case was selected to provide an example of how smoking reduction could be facilitated by PA, both
implicitly and explicitly, and how a HT supported the process of changing two behaviours concurrently.Participant description
John is a male aged between 55 and 65 years old who, at the start of the study, was unemployed and
smoking around 20 roll-your-own cigarettes per day. He reported walking for around 1 hour per day,
mainly ﬁrst thing in the morning to go to the shops, and also to see friends who lived nearby. Walking
was John’s main form of activity as he suffers from some health problems (joint related) that mean he
ﬁnds it difﬁcult to do much else. He once worked as a painter and decorator but had to stop because of
these limitations. John looks after younger members of his family on one day of the week and has a
partner who also smokes, but lives across town.
When he was younger, John used to take part in several types of activity, such as swimming and weight
lifting, but had not done anything similar in many years.
John heard about the study via a letter invitation from the SSS and responded directly to the invitation.
The invitation appealed to him thanks to the approach of cutting down, as he had experienced numerous
attempts to quit abruptly over the previous years with varying degrees of success.Early engagement with the intervention
Coming in to the ﬁrst intervention session, John had completed a week of self-monitoring his smoking
behaviour, recording when and how many he smoked. He found this activity to be particularly
thought-provoking, highlighting patterns in his smoking behaviour he had not previously considered:© Que
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SciencHT: I don’t know. You obviously do something slightly different at the weekend, isn’t it, because both
weekends are exactly the same.John: Yeah. Until you brought this sheet out I didn’t realise that.83
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84And with further exploration of perceived challenges for smoking reduction:NIHRHT: Anything you think you are going to find hard or difficult about trying to reduce?John: Well, as I say, it’s those three in the morning and after a meal. That’s basically . . . I’ve got used
to sitting at a bar without having a cigarette but no, it’s just the three in the morning with two cups
of coffee, and after a meal. They’re the only ones I really enjoy.The HT gave John a chance to reﬂect on his smoking behaviour:HT: So the other ones, why do you think you have the other ones?John: Habit, I think. Just because it’s there . . . except for those three first thing in the morning.
The taste gets me. ‘Cor, Jesus, why am I doing this? I’m not enjoying this,’ but I’m still doing it.After discussion about techniques and approaches to cut down, John adapted his own way to approach
cutting down, which did not exactly ﬁt any of the four strategies the HT had identiﬁed. He broke his
day down into morning, afternoon and evening and began thinking about which cigarettes would be
easiest to cut down (hierarchical reduction) and times of the day he would not smoke (smoke-free
periods), and talked about extending the time between when he smoked (scheduled reduction).John: The evening I could cut out.HT: Which ones?John: The evening ones, yeah. I could cut them out. But the first three, the first three I’ll have, with
my coffee, and then one an hour after that.John lacked conﬁdence to cut down the ﬁrst three cigarettes in the morning, and recognised the strong
association between his morning coffee and cigarettes. The morning cigarettes would be the last ones
John would tackle, and the ones he was least conﬁdent about cutting out.
Early discussions about PA revolved around John’s walking habits. He did not smoke when he walked, but
he had not made this connection, and there was little engagement in any idea to increase PA at this stage.
The HT provided him with a pedometer and he agreed to monitor the step counts. Surprisingly, John
raised the possibility of using a gym.
John left the ﬁrst session with a goal, after the ﬁrst three cigarettes in the morning, to extend the period
between cigarettes to at least an hour and a half and cut out smoking in the evening. He also planned to
obtain information about opportunities at the local sports centre.Early progress
John returned to the next session having completed another week of self-monitoring and achieved his
smoking reduction goals, having smoked only about 13 cigarettes a day.I always buy 25 grams. I used to have, um, two packets but I cut down to one packet. Well, it’s only
since I’ve been here with you, is that I have reduced my smoking.John revealed he now had no intentions of using any kind of gym, despite the discussion of the ﬁrst
session, and was happy to continue walking:Journals Library www.journalslibrary.nihr.ac.uk
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SciencHT: If you went to the gym, what sort of things would you like to do?John: Nothing, thank you very much . . . Look, and that’s the gym down the road from me, you
know. There are friends of mine that do it for ten pounds a session. No, I’m not . . . I keep walking,
me. Simple as that.But he expressed an interest in swimming:Um, when the weather gets a bit more better, I go down to Devil’s Point [in the sea] and swim and
it’s free.With some prompted reﬂection on the use of the pedometer, the HT did well in reframing John’s
perception that he wasn’t particularly active:HT: Ten thousand steps classifies you as an active person, very active, so you’ve done it there, you’ve
gone over it there, you almost . . . you are doing it most days. And ten thousand steps is
approximately five miles.John: Don’t feel like that.HT: So that’s good, isn’t it?John: Yeah. Only thought I’d done a couple a day, couple and a half.HT: No, two thousand steps is one miles so you have done really well there.John: Well, I’ve got five thousand on here today. See, I don’t mind walking.He set and discussed strategies and goals for how to cut down further, making plans on how to deal with
the cigarettes early in the morning:Well, one cup of coffee, one cigarette, and carry on . . . Yeah, so what I am going to do is
just have one cup of coffee and then get in the shower a bit quicker, get into the bathroom a
bit quicker.When John came back for the next session, he had cut down to 11 cigarettes a day, and had bought only
a 12.5-g packet of tobacco over the past week. He was still breaking his daily smoking routine down into
morning, afternoon and evening blocks:So this is Tuesday, four [morning], three [afternoon], four [evening].A breakthrough was revealed at this point where he managed to smoke only two cigarettes ﬁrst thing
in the morning despite his early convictions these were the ones he enjoyed the most and would ﬁnd
the hardest:I’d say you sort of get a jolt – ‘Oh, I could do with a cigarette!’ – and then if you can get over it you
don’t think about it until the next jolt. But this morning it did! For my cups of coffee in the morning.
So I had two [cigarettes].From here John’s conﬁdence changed as he began to break habits he thought he would not be able to.
Later, though, he discussed a day when he had smoked three cigarettes immediately in the morning, and
he expressed guilt:I felt . . . well, I enjoyed them, I have got to admit. I enjoyed them but I felt I’d let myself down.85
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86The change in the way John appraised his smoking behaviour was starting to shift. He had continued his
walking routines, and made decisions to try and increase his walking:NIHRYeah. I mean, instead of going [a] library, I suppose I could walk up to [a] library [further away] . . .
I suppose I could do that, you can just use the same card.Every week, John would take diary sheets from the HT to record his smoking and his pedometer steps
(which he would often have to remind the HT to get for him):HT: Now, what do you want to do for next week then?John: Ohhhh, I will try cutting to three [in the morning], two [in the afternoon], three [in the evening] . . .
you will give me another one of these sheets?The goal setting and self-monitoring complemented each other well for John, and reviewing the records
he had kept at the beginning of each session allowed the HT to focus on achievements and explore
reasons for any setbacks:HT: Right, what were the aims? You were going to try to maintain between seven and eight daily,
weren’t you?John: Yeah.HT: [reviewing diary sheet kept by John] Three, four, five, brilliant. Three, six, seven, four, five, six,
seven, two, three, six, two, five, six, four, six, seven, two, four, brilliant!John: I cut down those on there because I have been busy.John’s desire to take on any more activity was limited, but with some skilful probing by the HT he reﬂected
on when he had quit smoking or reduced, and had been able to be more active and feel healthier:John: By the time I get up the top of there [lives up four flights of stairs] I’m going [panting], especially if
I’ve been smoking quite heavily.HT: Yeah. And what are you like then when you’ve had a period when you have not been smoking?John: Oh fine, I’ve run up ‘em.HT: Do you feel any different from reducing? Can you notice any difference in how you feel yourself?John: I’m very . . . I’m not getting out of breath climbing up all the stairs so much.Changes in confidence/importance
By week 5 of the intervention John had cut down to about seven cigarettes a day, and was rolling thinner
ones. In the mornings he had cut down to simply one cigarette with his morning coffee. When asked
what he would like to achieve over the next 4 weeks he revealed that he would like to stop completely,
but expressed concern about gaining ‘about three-quarters of a stone at the moment’.
At this point the HT identiﬁed opportunities to revisit the link between PA and smoking again:HT: Gosh, yeah, you have definitely increased your steps haven’t you, as well? But you find that being
more active and having things to distract yourself in the afternoon, it’s easier to reduce?John: Yeah.Journals Library www.journalslibrary.nihr.ac.uk
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local swimming pool:© Que
Health
provid
addres
SciencHT: You’ve done some swimming?John: Yeah. I done ten lengths of the pool up at . . . what’s it? At [name of pool].The support and interest from the HT, and greater awareness of improving health, appeared to give John
conﬁdence to try activities he had done in the past.
At the following session (6 weeks after baseline), John made the decision that he would like to quit,
triggered by a health warning:Sunday, we run for a bus you know . . . and we run for the bus and I was coughing and spluttering
and I said, ‘That’s it, I’m quitting from tomorrow.’ I was really coughing and spluttering, and that was
just running for a bus. [He did not smoke again that day].This prompted him to discuss options for quitting with the HT, and John was one of the few participants
who took up support from the SSS:HT: Yeah, absolutely, you want me to contact Smoking Cessation?John: Yeah, I’ve decided. What’s the point in giving up one day and smoking the next and giving
up . . . no.John did engage with the SSS and made it successfully to 4 weeks post quit without smoking. He did not
use any NRT prior to quitting but did with the SSS. While being referred to the SSS, an opportunity came
up to join a local gym as part of a local health initiative. In conﬁrming how far John’s conﬁdence had
changed and progressed, he joined along with others:So I said, ‘A couple of us, us and myself, would you take me on?’ And they said, ‘We don’t advertise
it but yes, you can join, two pounds a month.’ And I said, ‘I’ll have some of that!’ So I go three times
a week now, three mornings a week, and I’m doing my exercises three afternoons a week. And that
takes my mind off the smoking.The use of the gym and the new exercise routine adopted by John helped him to reinforce his identity of a
non-smoker:Yeah, well as I say, it did help and not only that, you see, getting confident was . . . in this gym, it was
state-of-the-art, you know, I tell you if I was still smoking there is no way I could use some of those
machines that I’ve been using, the rowing machine and the boxing machine thing. No way I could
use those if I was smoking! I’d just be coughing my lungs up.John also found a sense of relatedness and companionship through starting exercise classes, which would
have supported his identity shift:But I must admit, it’s going to these classes with other people, it gives you a goal, a dream, to get
fitter and fitter!The change was further emphasised by John going out and buying his own exercise equipment for use in
his home:87
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NIHRYeah. I’d been down to Argos to buy one of these blow-up balls where you put your back on it and
do sit-ups, and I bought some of these weights that you can alter. It’s doing something.And towards the end, John explicitly made the link between smoking and exercise:John: It takes your mind off of smoking actually, the exercise. It really does. And not only that, the more
you get into it, and the heavier weights you lift, and all these fantastic machines they’ve got down
there, there is no way you would be able to do it – well, I wouldn’t be able to do it, I’m
[55–65 years old] – there’s no way I would be able to do it if I was smoking. I would be out of breath and
coughing and spluttering. That running for the bus proved that.When asked if the two behaviours worked for him, he responded very positively:They fit together very well, you know. Because I mean, I’ve always swum in the sea all my life but
as I say, I’ve been smoking for 51 years so yeah. To be honest with you, it’s habit. I find myself now
going to get a cigarette and I think, oh, flippin’ heck, I don’t smoke! And it’s just habit, it’s 51 years
of habit.Although it was a struggle for John to engage with the activity side of the intervention at the beginning,
he voiced strong support for the effect it did have:Well no, I do two miles every morning and I have done for ages, for years, I walk two miles every
morning but now I am doing it in half the time since I’ve been going to the gym. But I would never
have thought of going to a gym or these exercises, pilates they call it? Pilates classes, I wouldn’t be
doing any of that, I would never have thought of doing it, until I got involved with you people, and
this healthy heart thing.And not only that, but after engaging in PA John reported weight loss:John: Well, I’ve lost over two stone, so yeah.Int: Two stone?! Congratulations, that really must feel great.And ﬁnally, the change in habit and desire was perhaps best illustrated in the following lines:And I get that urge now, not as strong at all as I used to. I mean, I don’t wake up in the morning and
get my coffee and think I need a fag. I just don’t do it any more.Reflection
In a case study such as John’s, one is never sure if such a change would have occurred without the
intervention. Nevertheless, the story portrays the person’s priorities for smoking reduction, and strategies
used, and the limited initial success with introducing PA. By promoting thoughts about the link between
PA and smoking John appeared to leave the sessions with ideas to think about and develop on his own.
The client-centred HT support is also identiﬁed, and this helped to build John’s motivation and conﬁdence
to reduce smoking and ﬁnd and enjoy PA behaviour within a different personal identity.Chapter summaryThe overall aims of the qualitative work were to capture as much information, from participants and the
vicarious and personal experiences of HTs, about the acceptability and feasibility of the trial methods and
intervention delivered in this pilot study to inform a larger study.Journals Library www.journalslibrary.nihr.ac.uk
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Overall the trial methods were acceptable for the participants (in both arms of the trial) and the HTs largely
endorsed the procedures.
Recruitment through mailed invitation was the preferred recruitment method by the HTs as it was less time
intensive, and was well received and understood by interviewed participants.
There was scope for a reﬁnement of a few questions in the assessments, but overall the data collection
was largely acceptable across both arms.
While there was support from the participants for a dual role of the researcher and HT (with little or no
experience of other procedures), the HTs found the dual role to be challenging at times, and possibly
detrimental to intervention delivery. In appraising intervention ﬁdelity during recorded sessions, a noticeable
change in session dynamics occurred, which seemed to interrupt any therapeutic relationship with
participants receiving the intervention. Speciﬁcally, a tension was identiﬁed between the patient-centred
style of intervention and the more rigid structure of questioning associated with the researcher role.
A limitation is that we know less about the views of those participants who withdrew from the study or
were unable to be contacted for interview.Acceptability of the intervention and possible adaptations
On the whole, the intervention, offered in a central NHS facility (within 1 mile of most participants’
residences), was acceptable. The HTs did suggest that other locations may target speciﬁc hard-to-reach
groups (e.g. single parents), but this may introduce contamination across trial arms if several people who
were closely acquainted came into the study together and were randomised to different treatment arms.
The intensity of the intervention and type of support being offered was very well received by those
engaging in it. Telephone support was shown to be particularly valued as a ﬂexible option, but the quality
of a session may have been interrupted if the call was made in undesirable locations. Strong support was
found for the client-centred approach for engaging with those who otherwise may have been more
service resistant.
An important adaptation which emerged from both the HTs and the participants interviewed is that
extending the duration of the intervention could be effective in producing further behaviour change.
A number of suggestions were made for improving the training, intervention and trial delivery procedures.What were the perceived effective components of the intervention?
Across both behaviours, self-monitoring and individual tailoring of techniques to the individual’s
circumstances and preference were frequently reported as being the most effective tools for promoting
and eliciting change.
In Nicotine Assisted Reduction then Stop (NARS) studies,15 a reduction strategy is rigidly adopted in
conjunction with NRT use. In EARS we introduced the different reduction strategies to enable participants
to choose how to reduce and in time to use PA to support this reduction.
Support to reduce smoking and the promotion of different behavioural strategies for cutting down
appeared to be one of the most effective components of the intervention. Although people may not have
engaged with the reduction strategies precisely as they were intended, and they were not speciﬁcally
prescribed to people, they took what meaning they could from the strategies and applied it to their
own circumstances.89
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90There was a strong focus on smoking reduction over PA promotion, which was reﬂected in all three
components of this qualitative work. The intervention was primarily promoted as a smoking reduction
study to avoid recruiting only those interested in PA and exercise. There was evidence that PA and
smoking behaviour were not always linked together in the way that was envisaged, and the HTs did ﬁnd
this difﬁcult for some participants, especially those who were already physically active. This will be explored
in greater depth outside this report. Quite often, the HTs expressed difﬁculty in promoting PA when
participants’ main motivations were to cut down smoking, at least initially. In terms of the ﬁdelity scores,
increasing motivation for smoking change was greater than for PA and linking PA and smoking also had a
low ﬁdelity rating. PA was outweighed by a focus on smoking behaviour, but was one of the many ways
participants kept themselves busy to distract themselves from smoking. For some participants, a failure to
support an increase in PA may not have resulted in changes in smoking, but for many this was not
the case.Did the intervention delivered match that described in the intervention
manual (i.e. treatment fidelity)?
Intervention ﬁdelity was examined and deemed to be acceptable overall in the context of a pilot study.
The intervention ﬁdelity scores for the different process elements indicated a need to modify the training
course to (a) increase the emphasis on identiﬁcation and management of social inﬂuences, (b) sensitise the
HTs to recognise and reinforce shifts in identity and (c) to reinforce techniques for introducing and
integrating PA more into the intervention process.
The examination of intervention ﬁdelity was facilitated by the development of a clear process model
(see Table 1) and was useful in highlighting speciﬁc areas where the intervention training could be
improved. However, a limitation is that we were not able to formally test the inter-rater reliability or validity
of the intervention ﬁdelity checklist. The existing data could be used to do this, but further resources and
time would be required. An additional limitation was the ﬁdelity measure’s limited scope in for judging
the style and process of engagement, which other data revealed the participants were very pleased with.
A valid and reliable measure of intervention ﬁdelity would be very useful for both training and quality
assurance purposes if the EARS intervention is used in future projects or implemented more widely.What can we learn from a case study?
The case study highlighted the issues surrounding the promotion of PA to support reduction and
eventually cessation. This example shows that the effect of PA on an individual’s smoking behaviour may
be unpredictable but can be complementary to an attempt to reduce and then quit smoking. For this
individual PA was simply a distraction technique to begin with but grew to represent a shift in the
participant’s identity away from that of a smoker. The use of this and other case studies would help in
future training to help understand how this subtle process can be supported.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Chapter 6 Economic analysisIntroductionIn this chapter we present preliminary research on the estimation of intervention costs, economic
outcomes, and the development of (an analytical framework) for future cost-effectiveness analyses (CEAs).
The research on aspects of the economic analysis are undertaken and presented here to support further
development of, and research on, the EARS intervention. The primary questions most relevant for the
economic analysis are:
l What is the estimated resource use and cost associated with the EARS intervention?
l What is the estimated mean cost of EARS per participant?
l What type of framework is best suited to the assessment of cost-effectiveness of EARS in a full future
economic evaluation alongside a trial?
l What recommendations to future research in economic evaluation can be made on the basis of the
pilot trial results?
In the following sections we consider each of these above areas of research.Estimating the resource use and subsequent cost of the
Exercise Assisted Reduction then Stop interventionThe EARS intervention has been described in detail in previous sections of this report (see Chapter 1).
Within the pilot RCT, and exploratory research alongside the trial, data have been collected to inform on
the resource use associated with delivery of the intervention, compared with brief advice (control).
The main components of resource use for EARS intervention are HT time, supervisory time input
(supervision of HT) from more senior/experienced staff, consumables (e.g. exercise aids), subsidies for PA
related opportunities, intervention-related resources required for training of HTs in the delivery of the EARS
intervention, and the ongoing costs associated with recruitment of participants (clients) for the EARS
intervention. These main components were determined by earlier development work on the format and
structure of the EARS intervention and its delivery. A further area of potential resource use, although
uncertain, is the use of the NHS SSS and other smoking-cessation aids.Resource use data collection on Exercise Assisted Reduction then
Stop delivery
Health trainer time input to Exercise Assisted Reduction then Stop
Health trainers are the primary delivery point for the EARS intervention. For the current analyses, and
based on experience within development research, and within the pilot RCT, HTs on delivery of EARS are
expected to be employed on Agenda for Change Band 497 (salary mid point assumed for base-case
analyses). It is assumed here that the EARS intervention, delivered by HTs, would be implemented in a way
that placed EARS within a broader provider environment, where EARS was one of the interventions
available, for example integrated with other NHS SSSs or health promotion services.
Health trainer time input is for speciﬁc EARS-related contact time, participant-level contacts
(e.g. face-to-face meetings, telephone contacts), participant-related non-contact time/activities
(e.g. planning, organising and preparation for participant contact), supervision time, and other more
general activities related to recruitment of caseload and service development. Within the pilot trial,91
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92electronic records were kept by HTs to record the duration of each contact as well as the frequency of
administrative contacts speciﬁc to participants (e.g. email, text messaging, written letter). HTs were also
asked to record those who did not attend, and the uptake of ﬁnancial subsidies. To assess the level of
participant-related HT time for non-contact activities, a work-sampling approach can be used.98 In the pilot
trial a work-sampling form was developed, in consultation and with design input from the trial
co-ordinator and the three HTs employed on the trial, in order to improve ease of use and acceptability.
The work-sampling form was piloted and tested over a 2-week period in the trial (completed by two of the
three HTs); HTs recorded the number of minutes they spent on each of the speciﬁed areas of work activity
over the days worked in the data collection period (see Appendix 9 for the form used).
In order to assess the level of HT time unrelated to intervention delivery (e.g. recruitment activity, service
development), activity logs for trial recruitment activities and training activity were reported/recorded by
the trial co-ordinator.Other resource use in Exercise Assisted Reduction then Stop intervention
Data on supervisory time input, assumed to be from more senior staff (Agenda for Change Band 6),
exercise aids, and resources required for training of HTs in the EARS approach, were recorded by the trial
co-ordinator (trial team).Estimated costs associated with delivery of Exercise Assisted Reduction
then Stop intervention
Data on units of resource use associated with the EARS intervention are combined with unit costs, or cost
estimates, in order to estimate the mean participant-level costs for the EARS intervention. For base-case
analyses an assumption is made on annual caseload per HT (EARS), at 250 participants, assuming that a
participant is allocated to an EARS HT for approximately 8 weeks (see Appendix 9). This assumption is
based on experience within the pilot trial, and estimates from the trial team.
Table 33 reports the summary detail associated with resource use for delivery or the EARS intervention.
Using these data (see Appendix 9 for further details) results in an estimate of cost at £192.17 per person
entering the EARS intervention/service.
Sensitivity analysis (Exercise Assisted Reduction then Stop intervention cost)
Where allowance is made for difference in use of the NHS SSS, and pharmacotherapies, assuming that
50% of those making a quit attempt use these interventions (see Appendix 9 for detail/assumptions) the
estimate of the EARS intervention cost is £242.62 per participant (i.e. an increase of £50.45 per
participant). However, there is no strong evidence in the pilot trial of a difference (signiﬁcant difference) in
use of services, with two EARS participants and no controls reporting use of services/interventions. A future
full RCT will further inform this point.Limitations with estimate of Exercise Assisted Reduction then Stop
intervention cost
Data on resource use are from the pilot RCT, and subject to uncertainty. Data collection methods via HT
electronic records have successfully recorded speciﬁc contact activity of HTs at a participant level. However,
in the pilot trial, while the methods for work sampling were developed (for future use), the data collection
was limited. Therefore, work-sampling data, although indicating that a signiﬁcant proportion of time is
required for non-contact and general activities, do not accurately report on the magnitude of time to
allocate to the EARS intervention. Training logs have been used, together with the records/input of the trial
co-ordinator, to estimate the resource use for training, assuming a caseload of 250 participants per year
per full-time HT; however, there is uncertainty in this estimate. Of note, the training cost per participant is
a small component (∼3%) of the estimated intervention cost, and therefore the level of uncertainty
introduced here is not likely to impact on any ﬁndings from this exploratory research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 33 Estimate of mean HT/EARS intervention resource use and cost per participant
Resource use (type)
Mean units of resource
per participant
Unit
cost (£)
Mean
cost (£)
Traininga NA 6.12
Recruitment (assuming 1.25 hours’ HT time per participant)a 75 minutes 27 per hourb 33.75
Intervention deliverya
HT to participant contact time 136 minutesc
HT to participant-related non-contact time
(assuming 1 : 1 ratio of contact–non contact time)
136 minutesc
Total estimated participant-level HT time 272 minutes 27 per hourb 122.40
HT supervision (by HT manager/locality lead trainer) 10 minutesd 38 per houre 6.33
HT supervision (HT time) 10 minutesd 27 per hourb 4.50
Exercise aidsf NA 19.07
Estimated total mean cost 192.17
NA, not applicable.
a Further details provided in Appendix 9b.
b Curtis et al.,97 (PSSRU) 2011, based on salary structure of worker employed on NHS scale Agenda for Change Band 4,
per hour face-to-face contact, £27 (see table 11.4, p. 158). Note that while the PSSRU reference was not speciﬁc to
the HT role the salary structure is regarded similar and other costs assumed to be appropriate/similar. This estimate
of cost (per hour) for HT also includes allowance for salary on-costs, and management/capital overheads (www.
healthtrainersengland.com/about-us/regional-strategy-and-action-plan/careers-and-training/job-descriptions).
c Contact time estimate based on electronic reporting within trial after exclusion of research related activities. Assumptions
for non-contact time outlined in Appendix 9a [in brief, assumed 1 : 1 ratio of contact–non contact time, based on
preliminary data from work sampling, combined with trial co-ordinator records (future research required to endorse
this assumption)].
d Assumption based on documentation of experiences by trial manager, who fulﬁlled the role of HT locality lead trainer
and work sampling where HT recorded minutes of supervision over a 2-week period.
e Curtis et al.,97 (PSSRU) 2011, based on salary structure of worker employed on NHS scale Agenda for Change Band 6,
per hour face-to-face contact, £38 (see table 11.8, p. 162). As previously, PSSRU reference represents a similar salary
structure and assumed appropriateness of other costs. Estimate of cost for HT also includes allowance for salary
on-costs, and management/capital overheads.
f From within-trial participant-level recording of resources used. Includes pedometer, MP3 players, exercise bands,
subsidised exercise.
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Exercise Assisted Reduction then Stop intervention
Introduction
In this section we present a narrative summary of key published studies informing on modelling methods
for CEAs in a smoking-cessation context.Evidence review: decision-analytic models for use in cost-effectiveness
analyses on smoking cessation (Exercise Assisted Reduction then
Stop-type intervention)
To inform on the framework for future CEAs for the EARS intervention, as part of a full RCT with
economic evaluation, here we set out a general overview of the current literature reporting on modelling
methods used in the context of CEAs in this area (smoking cessation).
The aim of this review is to provide an outline of the key studies in this area, to inform the structure and
development of a modelling framework suitable for assessing the cost-effectiveness of the EARS
intervention, and to inform on data required to populate such a model.93
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94A recent review by Bolin99 has reported on economic evaluations for smoking-cessation interventions,
providing helpful insights on modelling methods used to assess cost-effectiveness. An earlier review by
Woolacott et al.,100 undertaken as part of a study assessing NRT, is also helpful in outlining methods used
to model smoking cessation. A number of other prominent HTA studies have also reported on modelling
methods for smoking cessation.15,101 Here we present a summary of these reviews/studies. In addition,
to supplement the insights from these studies, we have undertaken a literature search (from 2002 to
September 2012) to identify any further models in smoking cessation published in the cost-effectiveness
literature (see Appendix 9 for detail on the literature search strategy). We identify 11 studies that we set
out in this evidence review (see Table 34), nine of which are discussed in summary detail.Summary of reviews
Woolacott et al.100 present a narrative review of ﬁfteen economic evaluations (published 1986–2001) of
smoking cessation. Included studies considered pharmacological aids delivered as part of face-to-face
interventions, that is to say in addition to advice or counselling. The review of methods used in the
included studies (n = 15) offers guidance in terms of potential data requirements (and sources); however,
recommendations by the authors do not extend to modelling methods. The review highlights some of the
salient issues associated with undertaking economic evaluation in this ﬁeld, particularly challenges and
limitations in the data available to inform CEAs studies.
Bolin99 documents a formal systematic review that identiﬁes 30 studies (identiﬁed from 1995) using a
mathematical modelling framework, applying simulation techniques, to assess smoking-cessation
therapies. Most of the identiﬁed studies used a Markov-type modelling approach, and most were
cohort-based models rather than individual-level simulation models. The review charts the development of
the included mathematical models chronologically. Particular emphasis is given to a widely adapted model,
the Beneﬁts of Smoking Cessation on Outcomes (BENESCO) model,102 which was used in 10 of the 30
modelling studies identiﬁed. The BENESCO model is used by Bolin et al.99 as a point of reference to frame
the review of the studies identiﬁed, with commentary presented/organised around central considerations
of ‘model structure’, ‘data’ used to drive and to populate the model, and on the approach taken towards
assessing ‘uncertainty/consistency’. The critique of models offered by Bolin et al.99 concludes that, while
the modelling methods published to date are reasonable, there is scope for improvement. The suggestion
is that a more complex modelling framework (than that currently reported) may be helpful, and that
models could consider heterogeneity in more detail.
A further review from Ronckers et al.103 was identiﬁed as potentially useful. This review considered the
results from 14 model-based economic evaluations, reanalysing cost-effectiveness ratios, by applying
standardised methods for estimating costs and effects. Ronckers et al.103 do not offer commentary on
modelling methods (in terms of model type and structure) and so this study is not considered further here.Summary of model-based cost-effectiveness analysis studies in
smoking cessation
Table 34 presents summary detail on 11 studies using modelling methods in CEAs for smoking-cessation
interventions. Here we provide an outline on nine of these studies. Further detail is provided in
Appendix 9d. The models by Feenstra et al.104 and Hurley and Matthews105 are not discussed further here,
given the particular perspective in these studies, that is to say from a Dutch and Australian perspective,
respectively, and their focus on national evaluations. The BENESCO model, presented by Howard et al.102
has been used in multiple settings and populations and is presented, albeit in slightly different forms, in
other papers. Given that these papers document the same underlying model, the focus in the current
review is on the original paper.
Fiscella and Franks106
Fiscella and Franks106 undertake CEA on NRT (patches) using a decision tree model, populated with
effectiveness data from a meta-analysis of published RCTs. This study considers mortality by smoking
status, using observational data from Doll et al.111 on mortality rates for British doctors. The analysis appliesNIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 34 Summary of included studies
Study
(country/setting) Year Perspective
Intervention(s)
considered
Modelling
(evaluation)
methods
Summary
measure of
cost-effectiveness
Fiscella and
Franks106 (UK)
1996 US payer Transdermal NRT,
counselling alone
Decision tree (stochastic) Cost per QALY
Orme et al.107 (UK)
(HECOS model)
2001 UK NHS Pharmacological, GP
advice, group therapy,
willpower alone
Cohort-level Markov
(deterministic)
Cost/LYS and cost per
death averted and
costs, LYS and deaths
averted are presented
in disaggregated form
(cost consequence)
Woolacott et al.100
(UK)
2002 England and
Wales NHS
NRT, bupropion vs.
advice
Decision tree
(deterministic)
Cost per LYS,
cost per QALY
Godfrey et al.108
(UK)
2005 English NHS Actual practice: different
service conﬁgurations,
stafﬁng, interventions
Decision tree
(deterministic) and uses
the model by Orme –
cohort-level Markov
(deterministic) to
estimate cost saving of
smoking-related disease
Cost per LYS
Feenstra et al.104
(Netherlands)
2005 Third-party
payer
Five face-to-face
smoking-cessation
interventions including
current practice
Cohort-level Markov
continuous time,
(deterministic)
Cost per 1000
quitters
Hurley et al.105
(Australia)
2007 Australian
health care
National tobacco
campaign, no campaign
Cohort-level Markov
(deterministic)
Cost savings and LYG
(dominance of
intervention)
Howard et al.102
(USA/multicountry)
(BENESCO model)
2008 US health
care
Varenicline vs. US
pharmacological aids
Cohort-level Markov
(deterministic)
Cost per QALY
NICE109 (UK) 2008 UK NHS Brief intervention and
referral for smoking
cessation
Decision tree
(deterministic)
Cost per quitter
Wang et al.15 (UK) 2008 NHS/Personal
and Social
Services
Cut down to quit
(CDTQ) with NRT
Decision tree
(deterministic), ﬁnal
QALY outcome
using continuous
analytical methods
Cost per QALY
Coleman et al.101
(UK)
2010 UK NHS NRT, bupropion,
varenicline, no
intervention
Cohort-level Markov
(deterministic)
Cost per QALY
Bauld et al.110 (UK) 2011 UK NHS Pharmacy and group-
based counselling, no
intervention/self-help
Trial outcomes: decision
tree (deterministic)
alongside trial. Final
outcomes: Markov
extrapolation for
estimation of
ﬁnal outcomes
Cost per QALY, cost
per additional quitter
HECOS, Health and Economic Consequences of Smoking; LYG, life-year gained; LYS, life-year saved; NICE, National
Institute for Health and Care Excellence; QALY, quality-adjusted life-year.
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96health-state values (from the US National Health Interview survey) to estimate quality-adjusted life-years
(QALYs). This early model considers the impact of abstinence on smoking status by estimating the rates of
mortality among former smokers and using these estimated rates with those of current smokers (from
national data) to determine life expectancy by the age and sex proﬁle of interest. Both life extension (in
terms of life-years gained) and the QALY gains associated with abstinence are considered.
The model presents its results in terms of age and sex, and the base-case results presented account for
both background rate of quit (2.5% per annum) and lifetime probability of relapse (35%).Woolacott et al.100Woolacott et al.100 use the same methods as Fiscella and Franks106 to determine the beneﬁts relating to
quitting (i.e. LYGs from Doll et al.111 and the health-related quality of life values reported by Fiscella and
Franks106). This study evaluates the cost-effectiveness of NRT and bupropion sustained release versus advice
in the England and Wales NHS, using a simple decision-tree framework to model outcomes and associated
costs. The options considered in the model comprise advice alone, counselling alone, advice plus NRT,
advice plus bupropion sustained release, and advice plus NRT plus bupropion sustained release.
The modelled effectiveness outcome for each intervention was the 12-month continuous quit rate. The
approach for estimating the relative effectiveness of each intervention was to apply the odds ratio (OR) of
the intervention relative to the control rate for advice or counselling alone. In the main, ORs were
estimated using appropriate, high-quality methods of evidence synthesis including meta-analysis of RCT
data, statistical pooling and adjusted indirect comparisons. The authors include all relevant costs associated
with the intervention, which are presented with units of resource use. The methods used for converting to
life-year and QALY gains are similar to those of Fiscella and Franks.106Health and Economic Consequences of Smoking model, Orme et al.107Orme et al.107 present the Health and Economic Consequences of Smoking (HECOS) model developed for
WHO. It is a Markov model estimating the costs and consequences (QALYs) associated with a quit attempt
over time. The model uses a hypothetical cohort of the UK smoking population, moving through annual
cycles, with their costs and QALYs model using health states by smoking status (current smoker, recent
quitter, long-term quitter), a long term quitter being deﬁned as someone who has been abstinent from
smoking for more than 1 year. The model uses a lifetime time horizon, and applies the relative risk of ﬁve
main smoking diseases [chronic obstructive pulmonary disease (COPD), asthma, coronary heart disease
(CHD), stroke, and lung cancer] to calculate smoking-related mortality.112 The model uses a set of
equations to model smoking-related mortality, and death from non-smoking related causes are not
considered in the model.Godfrey et al.108Godfrey et al.108 report CEAs on NHS SSS, post implementation, considering how variation in process
measures (e.g. different service conﬁgurations, stafﬁng, intensity of interventions) impact on cost per
client, cost per life-year gained and cost per life-year saved. The focus of the analyses is on cost and
resource use at the level of the individual service. Participant-level costs (in terms of cost per
person setting a quit date and cost per life-year gained) are estimated from aggregate data using
regression methods.
The analysis is primarily based on survey data on the cost of various SSS providers, with data from 58 out
of 92 SSSs and outcomes (biochemically validated 4-week cessation rates) from routine Department of
Health monitoring. Data from Doll et al.113 are used to determine the gains due to life extension of a
long-term quitter at 4 weeks. Interestingly, Godfrey et al.108 make use of the HECOS epidemiological
model107 to calculate the future health-care savings attributable to cessation. The authors conduct
regression analyses (using simple ordinary least squares methods) to examine the impact of deprivation
levels on cost per client setting a quit date and on the cost-effectiveness ratio (cost per life-year saved).NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Howard et al.102Howard et al.102 use a cohort-level Markov model structure with annual cycles to simulate the lifetime
costs and consequences of a one-time course of varenicline versus existing smoking-cessation strategies
(bupropion, NRT and unaided quitting) from a US payer perspective. The resulting BENESCO model (which
is based on the HECOS model107) is currently one of the most frequently adapted models for other
populations and settings.114 The model simulates the movement of a hypothetical cohort of male or female
smokers aged 18–34, 35–64 and 65+ and cost-effectiveness is estimated over a range of potential time
horizons (2, 5, 10 and 20 years) in addition to lifetime. The model uses epidemiological data and hazard
ratios for smokers and non-smokers from the Cancer Prevention study II trial112 to determine smoking-
attributable morbidity and mortality (determined as a proportion of total population morbidity/mortality).
Disease events are mutually exclusive in any given year (i.e. the model allows only one diagnosis per year),
but relevant comorbid states and recurrent events (stroke, CHD) are allowed. The published study (to our
knowledge) does not provide technical detail on how the modelling framework is operationalised.
Health-state values (QALY weights) for the non-morbid health states are taken from Fiscella and Franks;106
however, disease-speciﬁc health-state values are used to calculate the QALYS associated with years of life
in each of the morbid health states (COPD, asthma, CHD, stroke, and lung cancer). Only direct medical
costs relating to the intervention were included in the model.
Unlike the HECOS model, which was restricted to deterministic sensitivity analysis, the BENESCO model
was set out and populated with data to run in a probabilistic way (to consider uncertainty in parameter
inputs simultaneously). Later studies applying the BENESCO model to different settings include an update
of the US BENESCO model to account for an extended course of treatment.115National Health and Care Excellence model, to inform National Health and
Care Excellence Public Health Guidance109The model employed/presented by the National Institute for Health and Care Excellence (NICE)109
employed a decision-tree approach to evaluate brief interventions in smoking referral. The model is used
by NICE to evaluate the cost-effectiveness of opportunistic brief advice by GPs and brief (30-minute)
nurse-led interventions both in primary care and in hospitals. Both interventions were considered as
stand-alone interventions with the option of subsequent referral to secondary smoking services. The
perspective of the analysis is NHS and Personal and Social Services and the model adopts a lifetime time
horizon. The decision-tree model is speciﬁcally set out to consider an initial 12-month model cycle,
after with the model adopts the approach used by Fiscella and Franks106 and Godfrey et al.108 to estimate
life expectancy using data from Doll,111,113 and QALYs using data from an unpublished survey of
15,000 smokers (obtained via administration of the EQ-5D).
The initial 12-month model cycle, including modelling of the probability of successful quit at 12 months,
is based on an evidence synopsis116 and effectiveness data (assumptions) that are distinct from the
modelling of outcomes thereafter. The model uses effectiveness data on interventions considered, and it
applies/assumes a background quit rate of 1% in the model. The authors note that relapse rates beyond
12 months were approximated using 8-year follow-up data of participants in a UK-based RCT of the
nicotine patch.117
The model is run for different age- and sex-speciﬁc cohorts/analyses (aged 30, 40, 50 and 60 years).
Resource units and costs (NHS and Personal and Social Services perspective, price year 2004–5118) relevant
to the delivery of the intervention are documented fully; an additional sensitivity analysis considers the
discounted cost savings due to smoking related morbidity using data from Godfrey et al.108 Extensive
univariate sensitivity analysis of key parameters is undertaken, including variation by effectiveness rates,
background quit rate and the length of intervention. In addition, the authors discuss how contextual
factors, that is to say level of tobacco dependence, previous exposure to brief interventions, and socio-
economic group, might affect projected incremental cost-effectiveness ratios (ICERs).97
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98Wang et al.15Wang et al.15 use a decision-tree modelling framework to consider a range of interventional questions
involving multiple scenarios, and different levels of decision-maker. The model estimates the probability that
a smoker/population will reach 12 months’ continuous abstinence if NRT is offered within a ‘cut down to
quit’ programme using a deterministic decision tree. Wang et al.15 model the impact of cutting down with
NRT versus an abrupt quit. The ‘full’ model developed by Wang et al.15 allowed a simulated cohort of
smokers to follow different treatment pathways prior to an ‘abrupt’ quit or ‘cut down’ attempt and provides
the most complete representation of the decision problem in policy terms. Modelled pathways include NRT
over the counter, prescription NRT and smokers’ clinic NRT. The model framework considers the staging of
different therapies. The model uses data from Doll111 to predict life expectancy (mortality) over time.
This study extrapolates modelled outcomes to ﬁnal (lifetime) outcomes by considering two components of
QALY gained: those gained due to abstinence (assumed to be realised immediately), and those gained due
to extension in life (considered to be at age 65). In the latter case, years of life saved is estimated by
applying an arbitrary ‘socio-economic’ adjustment (subtracting 2 years from the life-years gained)
projections of Doll111 to correct for deprivation indices. The two components – abstinence and life
extension – are then summed to form the total QALY gain. Wang et al.15 therefore consider quality of life
over the life course.Coleman et al.101The HTA report presented by Coleman et al.101 uses a Markov modelling approach, with cohort-level
analyses, to examine the cost-effectiveness of relapse prevention initiatives in smoking cessation. The
perspective of the model was lifetime, arranged in 6-month model cycles. The risk of smoking-related
disease is calculated for current, never and former smokers using the observational data from Doll et al.111
The epidemiologically driven model derives ratios for mortality rates (by smoking status) and uses
prevalence data/rates to attribute/decompose standard population mortality rates by smoking (Figure 7).
The structure of the model is based on a simple Markov process, but with some complexities. For instance,
the likelihood of an individual being a smoker or former smoker and of developing comorbidities varies
with their age, based on the prevalence of smoking status from the Health Survey for England.119 RRs of
diseases by smoking status are used to decompose the population-based prevalence rates of ﬁve major
smoking related diseases. Further detail on prediction of mortality by smoking status is given in the next
section [see Modelling mortality: mortality rate by smoking status, and projection of life expectancy
(life-years) over time].Bauld et al.110The model by Bauld et al.110 is a two-stage model, ﬁrstly using a decision-tree model, based on clinical
evidence from a single observational study, and thereafter using a Markov model to estimate longer-term
outcomes. The decision-tree framework has a time horizon of 1 year and was developed to assess theLC Recent quitter
Dead
SmokerFormer smoker
CHD
MI
Stroke
COPD
LC
CHD
MI
Stroke
COPD
IGURE 7 Example of cohort-level simulation (simple schematic) used by Coleman et al.101 Status by age and
ex category. CHD, chronic heart disease; COPD, chronic obstructive pulmonary disease; LC, lung cancer;
F
s
MI, myocardial infarction.
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support with NRT. The target population consisted of current smokers who were clients of one of two
Glasgow NHS SSSs. The 1-year time horizon for the decision tree corresponded to the follow-up period of
the observational study for reporting sustained abstinence. The short-term decision tree is used to estimate
the incremental cost per quitter for both services compared with self-quit attempts at 52 weeks.
Thereafter, the model uses a four-state Markov modelling approach in cohort analyses to model outcomes
and costs over time. The model uses a longer-term lifetime time horizon, and applies mortality rates from
Scottish mortality life tables, relapse data from published sources, and estimates of QALYs using
health-state values from a published study.120 The Markov model uses data from Yudkin et al.,117 giving
8-year follow-up data from a RCT of NRT versus control, to establish the number of long-term quitters.Overview
The models identiﬁed in the literature are either decision-tree or Markov-type models, or a combination of
the two frameworks. Decision-tree models have been used to model the ﬁrst 12 months of the model time
frame, typically an intervention related time period (and/or post intervention duration), in order to establish
the probability of 12-month sustained abstinence. The complexity of the modelling of short-term abstinence
was in many cases dependent upon the nature of the interventions being compared and the trial evidence
available. The scope of the models (in terms of treatment strategies and referral pathways considered)
tended to be more comprehensive if the model was produced to inform speciﬁc policy contexts.
A signiﬁcant number of the cohort-level Markov models identiﬁed101,102,104,105,107 were population-based
smoking-cessation models developed to guide budget-holders and policy makers in their decision-making.
In general, these models replicated national populations, explicitly modelled individual smoking-related
diseases using data from epidemiological registries and used simulation methods (typically cohort-level
Markov models with multiple states and time dependency) to determine the beneﬁts of quitting smoking.
The evidence review has been used to inform planning for model development related to EARS, and here we
outline considerations on structure and data, speciﬁcally around the outcomes used, the modelling of
abstinence and relapse (data inputs) and the use of available data to inform on mortality data/rates in order
to model life-years and related QALYs. We also consider, in brief, issues related to data inputs on resource
use and associated cost, and the way models had presented outcomes and considered issues related to
uncertainty (structural and parameter uncertainty in modelling methods) and consistency (model validation).Data inputs
For comparative purposes, we looked at the key parameters for the main studies of interest. Table 35
provides a summary of data inputs used in the model for the key effectiveness parameters from the
included studies (see Appendix 9 for further details).
Smoking status – smoking cessation
The primary outcome in any smoking-cessation clinical effectiveness study is the quit rate (sometimes
referred to as the abstinence rate) at a deﬁned period of follow-up. In RCTs, the metric which is the
preferred standard for reporting effectiveness is the expired air CO-conﬁrmed quit; outcomes are usually
reported at 4 weeks post quit as a minimum and frequently at 6 months and 1 year. However, the
gold-standard criteria for smoking-cessation trials is the Russell standard,78 which identiﬁes criteria over and
beyond biochemical veriﬁcation for validating a quit attempt; most notably, a sustained period of abstinence
is required to provide conﬁdence in long-term quit, and those who decline to be followed up should be
treated as smokers. Reported 12-month abstinence rates varied across studies in the range of 1.7–37%.Relapse rates
Beyond trial end points, there is a dearth of high-quality longitudinal data with regards to the risk of
reuptake (relapse) or its corollary, long-term quit (abstinence) rates. Models have responded to this
particular challenge by using study/trial evidence when available. The majority of studies included in this
review made an assumption about the lifetime relapse rate; relapse and abstinence were considered to be99
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
TA
B
LE
35
C
o
m
p
ar
is
o
n
o
f
d
at
a
in
p
u
ts
u
se
d
in
m
o
d
el
s
d
es
cr
ib
ed
(b
as
e-
ca
se
d
at
a
in
p
u
ts
/a
ss
u
m
p
ti
o
n
s)
D
at
a
in
p
u
ts
St
u
d
ie
s
Fi
sc
el
la
an
d
Fr
an
ks
1
0
6
O
rm
e1
0
7
W
an
g
1
5
B
au
ld
1
1
0
W
o
o
la
co
tt
1
0
0
N
IC
E1
0
9
H
o
w
ar
d
1
0
2
(B
EN
ES
C
O
)
G
o
d
fr
ey
1
0
8
C
o
le
m
an
1
0
1
Ba
ck
gr
ou
nd
ra
te
of
qu
it
pe
r
ye
ar
2.
5%
1%
N
ot
st
at
ed
1.
5%
1%
1%
(0
.5
–
2%
)
5%
2%
(1
–
4%
)
2%
12
-m
on
th
ab
st
in
en
ce
ra
te
(o
r
ot
he
r
sh
or
t-
te
rm
qu
it
ra
te
,
as
sp
ec
iﬁ
ed
)
Ph
ys
ic
ia
n
co
un
se
lli
ng
4%
;
co
un
se
lli
ng
an
d
N
RT
pa
tc
h
7.
9%
In
cl
ud
in
g
ba
ck
gr
ou
nd
qu
it
gr
ou
p
ad
vi
ce
3%
;
gr
ou
p
th
er
ap
y
9%
C
D
TQ
w
ith
N
RT
5.
33
%
(m
et
a-
an
al
ys
is
);
ab
ru
pt
qu
it
w
ith
N
RT
16
%
2.
5%
ph
ar
m
ac
y
in
te
rv
en
tio
n;
5.
5%
gr
ou
p
in
te
rv
en
tio
n
Ex
cl
ud
in
g
ba
ck
gr
ou
nd
qu
it:
3%
br
ie
f
ad
vi
ce
;
9%
co
un
se
lli
ng
;
15
%
N
RT
In
cl
ud
in
g
ba
ck
gr
ou
nd
qu
it:
1.
7–
4%
fo
r
ra
ng
e
of
br
ie
f
in
te
rv
en
tio
ns
co
ns
id
er
ed
W
ith
N
RT
15
.4
%
M
ea
n
es
tim
at
e
=
13
.6
%
fo
r
po
pu
la
tio
n
at
te
nd
in
g
SS
Ss
23
–
37
%
fo
r
in
te
rv
en
tio
ns
co
ns
id
er
ed
(n
ot
e:
al
lp
ha
rm
ac
eu
tic
al
)
Li
fe
tim
e
re
la
ps
e
ra
te
(a
pp
lie
d
at
12
m
on
th
s
un
le
ss
ot
he
rw
is
e
st
at
ed
)
35
%
30
%
30
%
re
la
ps
e
at
12
m
on
th
s
Re
la
ps
e
ra
te
s
up
to
8
ye
ar
s
po
st
qu
it
fr
om
pu
bl
is
he
d
st
ud
y.
1
1
7
A
pp
ea
rs
to
be
36
%
if
pr
ob
ab
ili
tie
s
ca
n
be
su
m
m
ed
40
%
(3
0–
50
%
)
re
la
ps
e
at
12
m
on
th
s
Re
la
ps
e
ra
te
s
up
to
8
ye
ar
s
po
st
qu
it
fr
om
pu
bl
is
he
d
st
ud
y1
1
7
Re
la
ps
e
ra
te
s
up
to
10
ye
ar
s
po
st
qu
it
fr
om
tw
o
di
ff
er
en
t
ob
se
rv
at
io
na
l
st
ud
ie
s.
6.
3%
pe
r
ye
ar
fo
r
ﬁ
rs
t
2–
5
ye
ar
s
in
cl
us
iv
e,
1
2
2
2%
fo
r
ye
ar
s
6–
10
in
cl
us
iv
e
(V
et
er
an
’s
af
fa
irs
no
rm
at
iv
e
st
ud
y1
2
3
)
54
%
re
la
ps
e
at
12
m
on
th
s
V
ar
ie
d
as
su
m
pt
io
ns
in
ab
se
nc
e
of
lo
ng
-t
er
m
in
fo
rm
at
io
n
ab
ou
t
th
e
ef
ﬁ
ca
cy
of
re
la
ps
e
pr
ev
en
tio
n
in
te
rv
en
tio
ns
lo
ng
te
rm
.
2%
re
la
ps
e
pe
r
ye
ar
ECONOMIC ANALYSIS
100
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4time dependent in only a few cases.102,109,110 Woolacott et al.100 present a review of relapse rates and refer
to a variation from 0% to 50% by intervention. Coleman et al.101 report a high-quality systematic review
of RCTs to inform on rate of relapse (abstinence) (short-term relapse rate). Etter and Stapleton121 report a
high-quality systematic review of RCTs of NRT with follow-up of 1 year or more after start of treatment.
They present ﬁndings from 12 included trials, with follow-up over 2–8 years, with an average of 4.3-years’
follow-up. The overall relapse rate reported by Etter and Stapleton,121 between 12 months and ﬁnal
follow-up, was 30.0% (95% CI 23.5% to 37.5%); this rate did not differ between NRT and control groups
or length of initial NRT treatment.
Modelling mortality: mortality rate by smoking status, and projection of life
expectancy (life-years) over time
The beneﬁts of abstinence, and quit, are clearly set out in terms of differences in life expectancy.111,113
In the modelling literature reviewed here, many of the studies15,100,101,106,108,109 used published data from the
prospective study of UK male doctors reported by Doll et al.111,113 Doll et al.111,113 report the smoking habits for
former, non- and current smokers of male doctors at different ages and time periods, and compared the
reduction in risk associated with quitting. It is the only UK study to date which has sufﬁciently long follow-up
to allow for extrapolation; a similar approach is evidenced in Nurses’ Health Study in the USA.125 Data from
Doll et al.111,113 provide expected differences in life expectancy by smoking status, including by time since quit.
An alternative method for extrapolating to ﬁnal outcomes is to model mortality/morbidity in terms of the
number of fatal/non-fatal events conditional on sustained quit (smoking status). Bauld et al.110 use a
cohort-level Markov model to provide a representation of smoking-related death, but the model does not
account for morbidity (health events) directly. Non-fatal morbidity (e.g. non life-threatening asthma
exacerbations, wheeze) is not considered within the model. However, the simple and parsimonious
approach used by Bauld et al.,110 while predicting outcomes appropriate for CEAs, demonstrates that
methods can be extended to predict outcomes related to smoking-related health events. The model
presented by Coleman et al.101 models smoking status over time, using population mortality data adjusted
via ratios for relative mortality by smoking status derived from Doll et al.111 Coleman et al.101 also model
speciﬁc health events related to smoking status over time. Figure 7 presents the model structure used by
Coleman et al.101 In the current evidence review, the method used by Coleman et al.101 to model mortality
by smoking status is considered as a prominent and appropriate method for use in a future EARS
smoking-cessation model, and is considered further in the next section of the economic analysis. Below,
we outline the basic approach used by Coleman et al.101 to model mortality rates by smoking status.
This approach is adapted, for use in EARS analyses, to allow for modelling of mortality rate over time by
smoking status, and by time since quit. Coleman et al.101 apply a similar approach, to that described here
for all-cause mortality, to disease-speciﬁc annual mortality rates (see Figure 7).
Coleman et al.101 estimate mortality rates for categories of smokers (s), former smokers (f) and never
smokers (n) by decomposing the population mortality estimate (referred to as Q). We outline this approach
below; for clarity, we assign our own notation and let E = the actual mortality rate for each category of
smoker, determined by subscripts s, f, and n for the categories of smokers above. We therefore rewrite the
Coleman equation, which must be satisﬁed across three unknowns (Ec, En, Ef), as
EcPc þ EnPn þ EfPf ¼ Q ð1Þ
where Pj = the prevalence of smokers across categories of smokers ( j = s, f, n).
The RR [the correct term for these RRs is age-speciﬁc mortality rate ratios (calculated as the RR of death in
former and non-smokers vs. current smokers) and not mortality odds ratios (MORs) as labelled by
Coleman et al.]101 Where the probability is small, and n is large, note that the RR can approximate the
MOR] of mortality for never and former smokers are deﬁned as
En/Ec ¼ RRn and Ef/Ec ¼ RRf ð2Þ101
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102Substituting in allows us to write (1) in terms of 1 unknown, Ec:
EcPc þ EcRRn þ EcPf ¼ Q ð3Þ
Rearranging to solve in terms of Ec:
Ec ¼ Q/½Pc þ RRnPn þ RRfPf ð4Þ
Coleman et al.101 illustrate this with an example for a 44-year-old smoker by substituting the prevalence of
smoking across categories of smoker [Pc = 0.26, Pf = 0.21, Pn = 0.53] and actual mortality [Q = 0.002144]
into (1) to give:
Ec0.26þ En0.21þ 0.530.21 ¼ 0.002144 ð5Þ
Substituting the RRs (where RRn = 0.7143 and RRf = 0.571):
ðEc0.26Þ þ ðEc0.210.7143Þ þ ðEc0.530.571Þ ð6Þ
Solving in terms of Ec:
0.002144/½0.26þ ð0.210.17423Þ þ ð0.53þ 0.571Þ
Ec ¼ 0.0020
Using the deﬁnition of RR to solve for Ef and En:
Ef ¼ RRfEc ¼ 0.5710.0020 ¼ 0.0021 ð8Þ
En ¼ RRnEc ¼ 0.71430.0020 ¼ 0.0017 ð9ÞQuality-adjusted life-year weights, and estimation of quality-adjusted
life-years over time
Modelling methods described here have adjusted mortality data over time using health-state values (QALY
weights) in order to estimate QALYs by treatment strategy, and to compare incremental QALY gains by
treatment (Table 36). Within the literature review undertaken here, we identify a recent study presenting
health-state values (QALY weights) by smoking status.126 Vogl et al.126 present health-state values obtained
by use of EQ-5D within the Health Survey for England119 by age (year of life as opposed to decile of life),
sex and smoking status for the English population.Relevance of resource use and costs
All studies discussed here considered costs directly relevant to the intervention, and the majority used a
unit costing approach and reported units of resource separately from cost. The majority of included models
considered the costs of treating the main smoking-related diseases, either in the base case or in the
sensitivity analysis (notable exceptions being studies by Wang et al.15 and Woolacott et al.100). In terms of
the smoking-related diseases, lung cancer, myocardial infarction, stroke, and COPD were typically included,
and diseases such as CHD and asthma more seldom. The epidemiological methods for determining
smoking-attributable disease differed, as discussed by Bolin et al.99 in their review. There was a tendency
for studies to report cost-effectiveness both with and without the future cost of lifetime smoking-related
diseases, with discounting of costs only usually applied in the latter. No study considered the possibility of
higher future lifetime costs (‘survivor’ costs) of treating former smokers relative to continuing smokers,
despite this being an area of contention in the literature.127,128NIHR Journals Library www.journalslibrary.nihr.ac.uk
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104Uncertainty
All models discussed above reported some attempt to consider uncertainty in input parameters. This typically
included a series of univariate analyses, but in addition many studies apply best-/worst-case scenarios to
examine the potential cost-effectiveness of smoking-cessation interventions. Probabilistic sensitivity analysis
(PSA) was not widely reported in the literature. Discounting of future outcomes and costs was a common
consideration in sensitivity analysis, as one of the challenges facing public health interventions, where the
payoff from current investment may be many years into the future, is the fact that discounting reduces the
estimated magnitude of health gains. For example, Coleman et al.101 highlight that 1 QALY today is worth
approximately 0.25 QALYs in 40 years’ time, where a discount rate of 3.5% per year is applied.Conclusions/reflections
The literature overview presented above outlines how the current literature has been used to inform the
structure and development of a CEA model, and to inform the identiﬁcation of data to populate a model,
for application in estimating the cost-effectiveness of the EARS intervention.
The review here has not identiﬁed modelling studies that have put emphasis on interventions with a
speciﬁc focus on PA as a key component of the intervention, as is the case with EARS. This may be due to
the nature of the literature review and its consideration of speciﬁc smoking-cessation interventions, rather
than searching more broadly on PA. However, as the main outcome of interest for EARS is the quit rate,
the model set out for EARS (in the next section), draws on the previously published models for smoking
cessation. It may be that in a future, more comprehensive systematic search of the literature, and in further
development of the modelling framework set out in this report, the use of PA data could be integrated
into a more complex model structure.
A speciﬁc consideration for EARS is that the target population is a disadvantaged target treatment
population. The models identiﬁed to inform on the smoking-cessation analyses were not in disadvantaged
populations, nor is there a speciﬁc focus in the evidence base around abstinence, relapse or mortality, on a
hard-to-reach population. In only one of the models described above is there a focus/reference to a
speciﬁc target population, with Bauld et al.110 considering NHS smoking services in Glasgow, highlighting
higher levels of social deprivation in its description of baseline characteristics of clients entering one of two
community-based interventions. Therefore, the modelling development in this report draws on the current
evidence that relates to a broader smoking-cessation target group.
A further feature of the EARS intervention is the targeting of smokers who do not wish to make an abrupt quit
attempt (as trial inclusion criteria). In our review of the literature we identiﬁed only one study15 that explicitly
examined the costs and consequences of ‘cutting down’. In that study, Wang et al.15 did not consider the
long-term beneﬁts of cutting down, in terms of additional beneﬁts to life-year gains and QALY gains.
In the literature considered here on modelling methods for smoking cessation, there is a reliance/emphasis
on use of data on mortality by smoking status from Doll111,113 and on data from Fiscella and Franks106 to
inform QALY values. The recently published study by Vogl et al.126 provides a useful contribution/addition
to the literature on health-state (QALY) values by smoking status. Vogl et al.126 publish health-state values
by age and sex and smoking status based on data obtained in the Health Survey for England119 through
use of the EQ-5D (generic preference-based health status measure).
In the following section we document the development of a smoking-cessation model, a simple model to
inform exploratory analyses and to set the foundations for future cost-effectiveness analyses for EARS,
alongside a future full RCT. Using the ﬁndings from the EARS pilot trial (as presented in Chapter 3 and
Chapter 4) we also present illustrative CEAs.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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then Stop intervention
Development of a framework for cost-effectiveness analysis:
model development
Statement of the problem/objective of research
A modelling framework is needed to predict longer-term outcomes from end points in smoking-cessation
trials, in this instance to predict longer-term outcomes from effectiveness data in the trial comparing the
EARS intervention with brief advice. The model set out here is developed to estimate the impact of
smoking status over time on mortality and QALYs, in order to inform on estimates of the cost-effectiveness
of the EARS intervention compared with brief advice. The model developed and presented here is a simple
model, aligned to the current exploratory research and pilot RCT of the EARS intervention. The model
development research set out here seeks to inform on a framework for CEA that will be appropriate for a
future CEA alongside a full RCT of the EARS intervention.Perspective/viewpoint
The model developed is aligned to a UK policy context, and the primary perspective of the analysis is that
of the third-party payer, that is to say UK NHS and Personal and Social Services, consistent with the
commonly applied analytical ‘reference case’ recommended by NICE in the UK.129 The framework
developed here can be applied to a broader analytical perspective, where additional detail, complexity and
data inputs are added to the simple model presented here, for exploratory purposes.Model type and rationale for structure
A Markov-type model has been developed to estimate the cost-effectiveness of smoking-cessation
interventions. The model structure has been informed by a review of the literature describing modelling
methods used in assessment of the cost-effectiveness of interventions in smoking cessation (discussed/
presented above). The model developed here is a simple Markov model, a cohort simulation model, with
an annual cycle length and a lifetime time horizon for analysis (up to maximum age 85 years); both of
these model characteristics are informed by review of the literature and are consistent with methods used
for assessment of cost-effectiveness in smoking-cessation interventions. The model includes two health
states for smoking status: either ‘smoker’ or ‘former smoker’, and death/dead (Figure 8). It is assumed
at the start of the model that people will be in one of the two states for smoking status, with
former smokers being recent quitters (i.e. at least 4 weeks post quit and 3–4 months post EARS
intervention/comparator).
The model considers a starting cohort of people, by age group (decile age bands) and sex, with a distribution
across smoking status, either smoker or former smoker, and predicts future status over time (in each cycle) inSmoker Ex-smoker
Cohort characteristics modelled over time:
Cohort enters the model based on distribution by
age, gender, smoking status (smoker, ex-smoker):
•
•
•
Age (in decile bands)
Time since quitting
Smoking status
Dead
FIGURE 8 Model structure/schematic for the EARS model.
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106these states, or death. For the CEAs, cohorts with differing start point distributions (all other characteristics
being equal) are modelled over time, with cost and consequences estimated and compared between
competing interventions.
The model is structured to allow transitions from former smoker (successful quitters) to smoker, using a
risk of relapse in each of the ﬁrst eight 1-year cycles of the model, and people can continue to be in states
for ‘smoker’ and ‘former smoker’ (continued abstinence) in each cycle of the model. The current model
does not allow for transition from ‘smoker’ to ‘former smoker’ (spontaneous quit) in each cycle of the
model (as evidenced in Figure 8 – this could be included, e.g. 2% quit rate in literature, Coleman et al.101).
Each person faces a risk of death in each model cycle. The main driver in the model is differential mortality
rates by smoking status, with comparison of life years in each health state, and difference in life
expectancy and QALYs over time, being the focus of comparisons by differing starting distribution
(smoking status) for subsequent CEAs.
The primary outcomes, and economic end points, of interest in this development modelling are number of
long-term quitters (12 months and beyond), that is to say cost per quitter, the cost per life-year gained,
and cost per QALY gained. The model therefore aims to estimate, in the ﬁrst instance, smoking status over
time, life-years and QALYs in the cohorts considered for comparison in CEAs.
The model does not model smoking-related morbidity directly; however, people are given a health-state
value, according to smoking status, age and sex, using published data (see discussion of Vogl et al.126 in
Health-related quality of life/quality-adjusted life-years, below), and in such a way differences in
health-related quality of life/QALYs are estimated over time, by cohort distribution (smoking status). The
model does not estimate costs associated with smoking-related morbidity, although there is an opportunity
to develop the model in this direction for future analyses. In the present model, sensitivity analyses
consider differential costs by comparison interventions through the use of a cost associated with death,
smoking-related death, where estimated costs are assumed to capture additional health care expenditures
associated with treating smoking-related diseases.Modelling smoking status over time
The framework used here models smoking status over time. At the start of the model, the cohort entering
the model is deﬁned by proportions (distribution) in states for ‘smoker’ and ‘former smoker’. The model is
developed here to support analyses for the EARS smoking-cessation intervention, as described in this
report. In applying the modelling framework to EARS and comparators, in a decision-analytic context, we
have a distribution (comparison of differing starting distributions) of people entering the model where a
proportion will be recent quitters, that is to say former smokers. In the current analyses data from the end
point of the EARS pilot RCT is used to inform the starting distribution of smoking status for cohorts
modelled over time. In the ﬁrst 12 months of the model, former smokers face a relatively high risk of
relapse (to smoker); thereafter, in years 2 to 8 of the model, these former smokers face a continued, but
relatively lower, risk of relapse. Data to inform transition from former smoker to smoker have been taken
from the current literature,101,117,121 informed by our review of the literature on modelling methods.Relapse/continuous quit rate at 12 months
In order to estimate the continuous quit rate at 12 months, and the related relapse rate, we use data from
the published literature, applying data from Coleman et al.101 in the base-case analyses. In practice, we do
not know how many successful quitters within the EARS trial reported at 4 weeks post quit will relapse at
12 months (a future long-term trial may inform on this). Coleman et al.101 report a high-quality systematic
review, presenting estimates of abstinence rates and relapse patterns in smokers who had made
pharmacologically aided quit attempts with NRT, bupropion and varenicline (see previous discussion). In
the current model we use a relapse rate of 28% for the ﬁrst 12-month cycle of the model. This input/
assumption is informed by data from Coleman et al.101 on relapse (continued abstinence) in RCTs reporting
on NRT. Data on difference in abstinence between 3 months (post intervention) and 12 months is used to
inform the current analyses (see Coleman et al.; Table 35; Figure 7), with a relapse rate of 28% applied,NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4taken from data on ﬁve RCTs for NRT. Coleman et al.101 report a relapse rate of 40% (years 2–8) in
combined analyses, using 16 RCTs; however, in some of these RCTs the intervention was over a duration
of up to 52 weeks; this latter estimate is used in sensitivity analyses.Relapse/long-term quitters beyond 12 months
Data to inform on longer-term smoking-cessation status, and relapse, beyond 12 months are sparse. A
high-quality literature review has been reported by Etter and Stapleton.121 From the literature review, we
identiﬁed long-term continuous cessation data (8 years post quit) from a study by Yudkin et al.117 who report a
longitudinal study of 1686 trial participants (NRT) based in Oxfordshire, UK. Yudkin et al.117 report a relapse rate
of 46% for former smokers to smokers, over the period after a 1-year trial, up to 8 years (the rate was 44% for
placebo and 47% for those in the NRT arm of the trial). The median time to follow-up was 8.3 (SD 0.35) years.
Of the 153 participants who had stopped smoking for 1 year in the trial, 83 were still not smoking at follow-up,
giving a relapse rate of 46%. The study assumed that all those lost to follow-up were still smoking. We use the
data from Yudkin et al.117 (46% relapse) in the base case of the model. In sensitivity analyses we apply data
from the meta-analysis reported by Etter and Stapleton,121 which includes the study by Yudkin et al.,117 in which
a relapse rate of 30% is reported, over an average follow-up of 4.3 years (after year 1).
In order to apply these data, on rate of continued abstinence and on rate of relapse over years 2 to 8,
in the framework of the decision model developed, using a 1-year model cycle, we derived a proﬁle for
continued abstinence and relapse rate by year over years 2 to 8. Data were derived using an exponential
survival function for remaining smoke free (time to event analyses). It would be possible to use other
functional forms here but the rationale for using the exponential function is that it is consistent with
evidence suggesting that the proportion of quitters follows a decreasing trend.
We calculate the hazard or (instantaneous event rate) within the 7-year period of follow-up as
h = –[ln(Sm/S0)]/(tm – t0)] (Box 1), representing a constant hazard rate over years 2 to 8. The hazard rate forBOX 1 Technical appendix
In order to estimate the proportion of the cohort who have quit at other time points, St, within the interval
for which we have data (i.e. t = 2, 3, . . . 7, etc.) one option is to assume that proportion of quitters follows a
decreasing trend. One of the simplest models that can be used to represent a decreasing trend is the
exponential function
St = S0e–ht
where S0 = proportion of quitters at time t = 0.
In order to calculate this exponential function from data used to inform current analyses, we used the
following steps:
l From existing data sources (Yudkin et al.117), calculate the proportion of quitters at the start and end of
the follow-up period (S0 and Sm).
l Calculate the hazard rate to be applied to the model over the time period (years 2–8),
i.e. h = –[ln(Sm/S0)]/(tm – t0) = –[ln(0.051/0.094)]/(8 – 1) = –[ln(0.542)]/7 = (0.611)/7 = 0.0874 (SE 0.043).
The hazard rate is applied using the following: St = S0 e–t(0.0874), applied to the speciﬁc state occupancy (former
smokers) in the model over time. We applied this to our estimate of former smokers at S0 (corresponding
to 52 weeks from entry to the model). This allows us to calculate the proportion of the modelled cohort
to quit at time t. This is best illustrated by example. For example, where t = 3 years, and where the proportion
of non-smokers at time S0 = 0.103, St = (0.103)e–(3)(0.0874) = 0.103 (0.769) = 0.0791.
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108relapse is applied to the number of people in the health state of ‘former smoker’ from 12 months.
Applying these methods in the modelling framework provides outputs over time (number who relapse and
revert to smoking) that are consistent with the implicit relapse rate used from Yudkin et al.117
The model framework assumes that smokers who are abstinent at 8 years post quit would remain
abstinent. The model does not allow non-smokers [or cut-downers (at trial follow-up)] to make a
subsequent quit attempt if they failed to do so within the prior trial (prior to entering the model). Both
assumptions are potential limitations with this model and studies of this type. Any future modelling,
alongside a full RCT and economic evaluation, will explore the impact of these assumptions. The current
literature commonly refers to the spontaneous quit rate at around 2% per year (see Coleman et al.101).
However, it is expected that in the EARS target population, of hard-to-reach smokers who are not
planning a quit attempt, spontaneous quit rates will be relatively low, and the differences between
comparisons (EARS vs. brief advice in current context) will be very small/negligible.Modelling mortality over time by smoking status
The model estimates life expectancy over time, survival in each model cycle, using methods presented by
Coleman et al.101 for estimating mortality by age, sex and smoking status (see the earlier evidence review
for discussion/detail of the approach used by Coleman et al.). Methods presented by Coleman et al.101
have been adapted for the current model, in order to use data from Doll et al.113 (Coleman et al.101 used
data reported by Doll et al.111). As discussed earlier, Doll et al.111 report mortality in British doctors over
time by smoking status. We adapt methods in order to model mortality by smoking status, and to model
mortality rates dependent on time since quit, in order to model the relation between sustained abstinence
(in deciles age bands) and smoking-related mortality.
The estimation of mortality data by smoking status uses (1) current mortality rate data, by age group and
sex and (2) data on the prevalence attached to smoking status; the data from Doll et al.113 on mortality by
age and smoking status is used to represent the ratio of mortality rate by smoking status, the latter
analogous to a RR of mortality by smoking status and age group (and here referred to as RR). Mortality is
modelled from age 35 upwards, using age groups reﬂecting 10-year age groups (e.g. 35–44 years),
aligned to the data reported by Doll et al.113 (Doll et al. report that mortality by smoking status below this
age is subject to wide random variation. Evidence from actuary life tables suggest that total mortality prior
to the age of 30 is low, in the region of < 1 per 1000, and that while mortality rates between smokers and
non-smokers begin to diverge at this age the divergence in mortality rates between former and current
smokers starts at age 35) (Table 37).
As the approach described by Coleman et al.,101 RRs are derived from data presented by Doll et al.113 to
reﬂect relative mortality rates by smoking status (see Table 37). The RRs derived in the current analyses, forTABLE 37 Mortality by age, per 1000, by smoking status and by years abstinent (from Doll et al.113)
Age now (years)
Status
Lifelong non-smokers
Years (t) since stopped smoking
Continuing cigarette smokerst < 10 10≤ t <20 20 < t
35–44 1.6 2.0a – – 2.7
45–54 3.8 5.4 – – 8.5
55–64 8.4 16.4 9 – 21.4
65–74 18.6 36.4 31.7000 22.7 50.7
75–84 51.7 – 78.9 69.1 112.2
–, no derived value available.
a Data point from Doll 1994111 reﬂects data not available in Doll 2004.113
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data are combined with mortality data reported in current life tables, sorted by age decile, in the general
population (see Table 7) (www.ons.gov.uk/ons/rel/lifetables/decennial-life-tables/no-16-–2000–2002-/index.
html) and data on the prevalence of smoking for each age and sex category, using data presented in the
Health Survey for England,119 (see Table 40). Data were not available, to our knowledge, on prevalence of
former quitters (in terms of time in deciles since quitting in general population statistics), and therefore we
apply a simplifying assumption, that prevalence is uniformly distributed between quit ages 35–44, 45–54
and 55–64 years.
The above data for former smokers can be presented using years of smoking abstinence as the
independent variable. This cross-tabulation facilitates the calculation of time dependent state transitions
based on years since quitting.
Applying the methods used by Coleman et al.,101 we estimate/derive the mortality rates for use in the
model by smoking status using the above data. We model mortality data for each potential combination
of age, sex and smoking status category, using the formula below. This is an adaptation of the formula,
from Coleman et al.,101 described earlier.TABLE 39 Annual mortality rates UK general population. Adapted from ONS Decennial Life Tables, No.16
(2000–2002)
Age now (years) Male Female
35–44 0.0010 0.0004
45–54 0.0016 0.0010
55–64 0.0040 0.0026
65–74 0.0105 0.0064
75–84 0.0289 0.0175
TABLE 38 Relative mortality (RRs) by age, per 1000, by smoking status and by years abstinent (derived from
Doll et al.113/aDoll111)
Age (years)
Status
Current smoker
Years (t) since stopped smoking
Never smokedt < 10 10≤ t < 20 20 < t
35–44 1.0000 0.7407b 0.5926
45–54 1.0000 0.6353 0.4471
55–64 1.0000 0.7664 0.4206 0.3925
65–74 1.0000 0.7179 0.6252 0.4477 0.3669
75–84 1.0000 0.7119a 0.7038 0.6164 0.4612
a Data point from Doll 1994111 reﬂects data not available in Doll 2004.113
b This value imputed by estimating the trend from data provided for other time points. Trend line y = 8768e-0.198x
Note: same rate assumed to apply to both men and women.
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TABLE 40 Prevalence by smoking status for men (for women) in the general population. Adapted from Health
Survey for England119
Smoking status
Current age (years)
35–44 45–54 55–64 65–74 75+
Prevalence of smoking (males)
Current smoker 0.2600 0.2500 0.1900 0.1000 0.0700
Former smokera
t < 10 0.2100 0.30 0.2200 0.1867 0.2033
10≤ t <20 – – 0.2200 0.1867 0.2033
20 < t – 0.1867 0.2033
Non-smoker 0.5300 0.4400 0.3600 0.3400 0.3200
Prevalence of smoking (females)
Current smoker 0.2700 0.2500 0.2000 0.1300 0.0900
Former smokera
t < 10 0.2100 0.24 0.1500 0.0967 0.1133
10≤ t <20 0.1500 0.0967 0.1133
20 < t 0.0967 0.1133
Non-smoker 0.5300 0.5100 0.5000 0.5700 0.5700
a Indicates assumption based on the assumption of uniformly distributed smokers among former smoker subgroups.
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110For each age and sex population mortality rate, Q, we use the Coleman et al.101 formula to derive mortality
rate by smoking status:
EcPc þ EnPn þ EfPf ¼ Q ð10Þ
As applied in Coleman et al.,101 in order to solve for mortality risks associated with current (Ec), non (En),
and former smokers (Ef) we deﬁne ratios for mortality rates between smoking status categories as
En/Ec = RRn and Ef /Ec = RRf.
We adapt this formula to estimate mortality rates for former smokers according to time since quit, using
the data reported from Doll et al.113 (see Table 37). In the younger age group(s), those aged 45–54 years
(and below), former smokers will have quit smoking too recently (1 year < quit time > 10 years) to derive
statistically signiﬁcant variations in mortality for the current ages, while for older age groups, such as those
aged 55–64 years, former smokers will include those who have quit smoking for less than 10 years
(1 year < quit time < 10 years) and for between 10 and 20 years. (Note: the beneﬁts of early quitting are
realised in terms of higher mortality rates as the cohort ages within the model. See the following section
for a description of how these rates are implemented in the model.)
To illustrate the approach taken, consider the example of a female who is 55–64 years old. The mortality
rate for former smokers in this formula, EfPf, can be represented by the following expression:
EfPf ¼ Eft1Pft1 þ Eft2Pft2 ð11Þ
where time since quit is represented by t1 < 10 years and 10 < t2 < 20 years.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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EcPc þ EnPn þ ðEft1Pft1 þ Eft2Pft2Þ ¼ Q ð12Þ
Information on Q is taken from (given by) mortality life tables; in addition, data on the expected ration of
mortality rates by smoking status (RR) are available from Doll et al.,113 and therefore by adapting the
methods presented by Coleman et al.,101 it is possible to solve the equation for E (by smoking status) by
replacing RRs by smoking status relations, for En and Ef, solving for Ec.
Substituting En = EcRRn and Eft1 = EcRRft1 and Eft2 = EcRRft2:
EcPc þ EcRRnPn þ ðEcRRft1Pft1 þ EcRRft2Pft2Þ ¼ Q ð13Þ
and rearrange to
Ec ¼ Q/½Pc þ RRnPn þ ðRRft1Pft1 þ RRft2Pft2Þ ð14Þ
Using date from the above tables (female aged 55–64 years), when Pc = 0.19, RRn = 1, Pn = 0.36,
RRft1 = 0.7664, Pft1 = 0.22, RRft2 = 0.4206, Pft2 = 0.22, Pft and Q = 0.0026, then Ec = 0.004389; and
substituting back into equation (13) solves for En = 0.3925, Eft1 = 0.003363 and Eft2 = 0.001846. Using
these data, the mortality rate for a former smoker in this category is Ef = Eft1Pft1/Pf + Eft2Pft2/Pf.
Using the above methods, we derive estimates of mortality by smoking status for age and sex age bands,
stratiﬁed by time since quit for former smokers (Table 41).
Health-related quality of life/quality-adjusted life-years
As described above, the model developed and used here predicts mortality over the (cycles) time horizon,
up to maximum age of 85 years. In addition, in order to consider health-related quality of life over time,
using the QALY approach, for each year in the model a health-state value is attached by smoking status,
and according to age and sex characteristics. The health-state values are used as QALY weights to reﬂect
health-related quality of life in each smoking category. Data used on health-state values are from a recentTABLE 41 Derived adjusted mortality rates by age, sex and smoking status
Age (years) Current smoker
Former smoker by age stopped
Non-smoker< 10 years < 20 years ≥ 20 years
Males
35–44 0.001302 0.000964 – – 0.000772
45–54 0.002479 0.001575 – – 0.001108
55–64 0.006684 0.005123 0.002811 – 0.002624
65–74 0.018818 0.013510 0.011766 0.008425 0.006904
75–84 0.045752 0.032571 0.032202 0.028202 0.021101
Females
35–44 0.000987 0.000731 – – 0.000585
45–54 0.002460 0.001563 – – 0.001100
55–64 0.006878 0.005271 0.002892 – 0.002700
65–74 0.021015 0.015087 0.013139 0.009409 0.007709
75–84 0.054728 0.038961 0.038520 0.033735 0.025240
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112study published by Vogl et al.126 Vogl et al.126 also present date by smoking intensity, and the base-case
inputs used in the current analyses are for ‘heavy smokers’. Vogl et al.126 estimate health-state values
through use of the EQ-5D, the generic preference based measure recommended by NICE for their
‘reference case’ analyses.129 Table 42 presents data on health-state valuations from Vogl et al.126
The above rates are used to inform risk of death in each 1-year time cycle of the model, and to therefore
estimate mortality over time (in a cohort analysis).Smoking attributable (related) mortality
In sensitivity analyses, where the model is used to inform CEAs, we use an estimate of ‘smoking-related’
mortality to capture potential costs associated with smoking-related morbidity. In order to determine
mortality attributable to smoking and not to other causes, the excess risk of death for a smoker over and
above a non-smoker is calculated by subtracting En (risk of death non-smoker) from Ef (risk of death formerTABLE 42 Health-state values by smoking status, age, sex and smoking intensity. Data from Vogl et al.126
Smoking status/age (years)
Men Women
Mean SE Mean SE
Former smokers
35–44 0.9058 0.0041 0.8872 0.0041
45–54 0.8596 0.0042 0.8479 0.0041
55–64 0.802 0.005 0.7827 0.0051
65–74 0.7802 0.0059 0.7709 0.0057
75–84 0.7358 0.0059 0.6987 0.0067
Light smokers
35–44 0.9002 0.0059 0.8814 0.0059
45–54 0.8526 0.0063 0.8418 0.0062
55–64 0.7917 0.0071 0.7748 0.0071
65–74 0.7684 0.0077 0.7631 0.0073
75–84 0.7229 0.0079 0.6896 0.0082
Moderate smokers
35–44 0.8899 0.006 0.8716 0.006
45–54 0.8422 0.0063 0.8317 0.0062
55–64 0.7815 0.007 0.7648 0.007
65–74 0.7575 0.0079 0.752 0.0076
75–84 0.7112 0.0082 0.6778 0.0087
Heavy smokers
35–44 0.8728 0.0089 0.8522 0.0093
45–54 0.8529 0.009 0.813 0.0093
55–64 0.7647 0.0095 0.7466 0.0097
65–74 0.7395 0.0103 0.7336 0.0104
75–84 0.6925 0.0104 0.6586 0.011
SE, standard error.
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4smoker) and Ec (risk of death current smoker), for each category. This allows the model to estimate
smoking attributable mortality. This outcome also allows calculation of the cost of smoking-related disease
leading to death (see ‘Costs’).Applying the model in a decision-analytic context
The modelling framework described above is applied here to consider the cost-effectiveness of the EARS
intervention compared with brief advice, in a decision-analytic context. The perspective for the analyses is
stated above, as is the model structure. While there are currently some simpliﬁcations and limitations with
the modelling framework set out, and data inputs are uncertain in some areas, the analyses described here
are aligned to the exploratory research being undertaken alongside the EARS pilot RCT, in preparation for,
and to develop methods for, a future full RCT with economic evaluation alongside.Intervention(s)
The interventions compared in the CEA are the EARS intervention, versus brief advice. Interventions have
been described in detail earlier in this report (see Chapter 1).Effectiveness: comparing alternative intervention strategies
The model as simply set out produces estimates of outcomes (and costs) over time for a given cohort of
people described by age, sex and smoking status. The distribution by smoking status will differ where
intervention strategies differ, assuming that people are subject to an intervention prior to the modelling of
longer-term outcomes, and associated costs. The model is conﬁgured in this way for the development
stages of research; however, it is possible to integrate intervention strategies within the ﬁrst cycle of the
model where appropriate. In this simple modelling framework, outcomes over time are compared in
different cohort by intervention scenarios, yet it is possible, in developments of this model, to introduce
other mechanisms for comparing effectiveness (e.g. applying adjustment, such as a relative risk, to transit
probabilities in a base/control cohort).Base-case cohort characteristics
The modelling framework is developed to predict outcomes, and related costs, associated with a given
starting distribution for smoking status for a cohort (deﬁned by the decision-making context) of people
over time. The modelling framework estimates average (expected) outcomes against speciﬁc baseline
characteristics; in the current framework it is by age and sex groups. In the current exploratory analyses we
run the model for the distribution of smokers and ex-smokers reported at the ﬁnal follow-up of the EARS
pilot RCT, and also for a cohort with the distribution by smoking status reported in the control participants
having brief advice (the EARS trial reports the number of participants achieving expired air CO-conﬁrmed
abstinence at 4–8 weeks post quit date). Table 43 presents these starting distributions for smoking status.
We undertake analyses by age and sex stratiﬁcation to represent these population data available to inform
the model and to reﬂect policy-relevant analyses. However, we apply the trial end point distributions
uniformly across the age-/sex-speciﬁc analyses. In future analyses it is possible to use age-/sex-speciﬁc
results, and to model a weighted average result, based on stated demographics in the overall population
cohort (e.g. using population weights from national data).
Costs
The additional cost associated with delivery of the EARS intervention has been estimated at a mean
cost of £192 (described in Table 33). This is the only additional cost included in this exploratory CEA.TABLE 43 Cohort distribution by smoking status, at start of the model
Cohort
Proportion ‘former smoker’ (recent quitter/RCT;
conﬁrmed quit, in EARS pilot) Proportion ‘smoker’
Control – brief advice 4% 96%
Intervention – EARS 14.3% 85.7%
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114The intervention cost reﬂects the additional resource use and cost associated with delivery of the
intervention. We introduce uncertainty around this cost estimate in the probabilistic CEA, reported in the
cost-effectiveness plane and acceptability curves, through the use of a potential range of costs £154 to
£230, reﬂected via a standard error input of £19.61.
The model framework here does not include a description of, or modelling over time of, smoking-related
morbidity. These costs can be considered in future development of the model, for example using the
methods applied and described by Coleman et al.101 In the current analyses, a simple and crude estimation
of costs associated with smoking-related morbidity is introduced in a sensitivity analysis where death
attributable to smoking is associated with an increased cost. The cost of smoking-related death used in
sensitivity analysis is a mean cost of £27,120 as reported by Bauld et al.110 This was applied to the
smoking-attributable deaths in both the comparator and intervention scenarios.Discounting
Future outcomes and future costs (beyond the ﬁrst year) are discounted at 3.5% in the base-case analyses,
consistent with common practice in the UK, and with the reference case for analyses recommended by
NICE.109 Sensitivity analyses also report estimates where future costs and outcomes are not discounted.
Note that intervention costs were not discounted as they were accrued in the base year.Cost-effectiveness analyses: methods/presentation
In order to estimate the relative effectiveness and cost-effectiveness of EARS versus brief advice, we
compare the outcomes from the model, quit rate over time, life-years and QALYs over time (up to a
maximum age of 85 years) and we combine incremental effects with incremental costs to present the ICER
associated with the comparison of interventions, for the base-case scenario and for scenarios considered in
sensitivity analyses. The formula for the ICER is:
ICER ¼ cost intervention ðEARSÞ  cost comparator ðbrief adviceÞ
effect intervention effect comparator
Results are presented in a tabular form for comparative analyses, showing data in a disaggregated form
(by intervention), and as incremental costs and effects.
Analyses are undertaken using deterministic and probabilistic methods.130 Probabilistic analyses are used to
propagate uncertainty associated with parameter inputs simultaneously, in order to reﬂect joint uncertainty
in model inputs. This is undertaken in an exploratory way in the current analyses/framework, applying data
on distribution (standard error) by parameter input, and using assumptions on the nature of the
distribution (e.g. normal, beta or gamma distributions). Appendix 9e reports these data inputs with
distributions used for probabilistic analyses.
Estimates from probabilistic analyses allow presentation of CEA results via the cost-effectiveness plan, and
via cost-effectiveness acceptability curves (CEACs). In these presentations of these data we use the net-
beneﬁt statistic,130 alongside assumptions on decision-maker willingness to pay per QALY gained, to
represent the proportion of analyses (in simulations undertaken) where the net-beneﬁt statistic shows the
intervention to be cost-effective, that is to say where the incremental cost per QALY is equal to or lower
than the decision-maker’s willingness to pay. These methods are consistent with good practice in
economic evaluation, as presented by Drummond et al.131Sensitivity analyses/assumptions
Sensitivity analyses are reported to assess uncertainty in model parameter inputs. Probabilistic sensitivity
analyses capture uncertainty in input parameters, although many input parameters have small standard
errors (see Appendix 9). To address uncertainty over the choice of input parameters we set out a range ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
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used. The key areas for sensitivity analyses (to date, can do others) are:
i. start point distributions by smoking status (base case informed by EARS pilot RCT)
ii. relapse rate in ﬁrst 12 months post quit (base case at 28%)
iii. relapse rate over years 2–8 (base case derived from rate of 46% over 2–8-years)
iv. use of discount rate of 3.5% in base-case analyses
v. estimate of EARS intervention cost (base case at £192)
vi. assumption (simplifying) that there are no smoking-related morbidity costs
vii. alternative QALY weight data used.
Other key simplifying assumptions, not subject to sensitivity analyses in current exploratory modelling/
results, include:
i. no spontaneous quit rate included in the model (focus on EARS effectiveness only)
ii. time horizon up to maximum of age 85 years
iii. no speciﬁc smoking-related morbidity events/costs included
iv. simple method used for estimating smoking-attributable mortality
v. health-state (QALY) values from Vogl et al.;126 no sensitivity analyses undertaken.Results
The addition of the EARS intervention to support smoking cessation, compared with brief advice in current
analyses, results in additional costs associated with the intervention. Here we estimate a mean participant
cost of £192, assuming that the EARS intervention is delivered by HTs (as above), and that the EARS
intervention is implemented as part of a model of service provision that is multifaceted and covers a range
of smoking-cessation and/or health promotion public health services, that is to say not as a stand-alone
EARS service. Given the difference in quit rate reported in the pilot RCT (4% vs. 14.3%), a net quit rate of
10.3%, a simple short-term cost analysis would suggest an additional investment of £1864 per additional
person with conﬁrmed quit at 4–8-week post-quit follow-up.
Table 44 presents the estimated outcomes, costs, and cost-effectiveness ratios by age and sex categories
for base-case CEAs, using the decision-analytic modelling framework set out in earlier sections.TABLE 44 Base-case results: mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.78 0.044 192 4367
50 16.92 16.97 0.054 192 3573
60 13.35 13.40 0.047 192 4119
QALYs 40 9.78 9.81 0.02 192 7705
50 8.51 8.54 0.03 192 6315
60 6.94 6.97 0.03 192 5563
Females
Life-years 40 20.43 20.46 0.030 192 6525
50 17.73 17.77 0.037 192 5267
60 14.24 14.27 0.031 192 6162
QALYs 40 15.89 15.94 0.05 192 3607
50 13.18 13.23 0.05 192 3550
60 10.19 10.24 0.04 192 4342
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116In all comparative scenarios with base-case assumptions, the EARS intervention is cost-effective compared
with commonly used decision-maker willingness-to-pay estimates (cost-effectiveness thresholds).129 The
difference in start point distribution by smoking status results in incremental gains in life-years, and
incremental QALY gains, for a relatively low intervention cost.
Table 44 presents estimates of cost per life-year and cost per QALY ranging from £3573 to £7705, across
age and sex analyses (ages 40 years, 50 years, 60 years). Incremental life-year gains and QALY gains are
relatively modest, with mean QALY gains ranging from 0.02 to 0.05, and mean life-year gains ranging
from 0.031 to 0.054 across age and sex analyses. These mean differences reﬂect the context of the public
health intervention, with a relatively large treatment group where only a small proportion of people
change smoking status. However, the pay-offs associated with each successful quit (former smoker) are
signiﬁcant. The impact of a difference in the distribution of smoking status by group is reﬂected in a
long-term health gain, from a relatively low cost intervention, that reﬂects value for money, against
commonly applied thresholds for decision-maker willingness to pay per health outcome (QALY).
The assessment of uncertainty, using probabilistic analyses, presented using the cost-effectiveness plane
(example in Figure 9, other age and sex analyses presented in Appendix 9e), provides a positive cost-
effectiveness proﬁle for EARS versus brief advice, across age- and sex-speciﬁc analyses, consistent with the
base-case results presented above. Probabilistic estimates of mean cost per QALY are similar to the
deterministic results presented above (see Table 44), and Figure 10 presents the CEAC, showing that
where a decision-maker is willing to pay £20,000 per additional QALY the EARS intervention is expected to
be a cost-effective intervention in greater than 87% of simulations (in the probabilistic analyses).
The predicted proﬁle by smoking status over time, by age and sex, is presented in Table 45 and Table 46
(these tables report estimates for males; however, similar patterns are seen for females). In the EARS
intervention (cohort), the starting distribution, using the EARS pilot results (ﬁnal follow-up), shows 14.3%
start in the former smoker state, compared with control at 4%. This difference narrows over the early
years of the model, where relapse risk is high/higher, with a difference of 3–5% persisting over the longer
term. In the longer term, the difference in the number of former smokers is relatively small, again
demonstrating the public health context of the intervention and analyses.
Sensitivity analyses
In order to consider the sensitivity of cost-effectiveness results to inputs and assumptions, sensitivity
analyses have been undertaken to assess alternative data inputs/assumptions. Tables 47 and 48 present a
range of sensitivity analyses, with CEA results (i.e. a cost-effective proﬁle) being robust to most changes/
variations in model inputs and assumptions.– 0.04 – 0.02 0.00
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FIGURE 9 Cost-effectiveness plane, showing incremental costs and QALYs for males aged 40 years.
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TABLE 45 Health state occupancy, smoking status or death, (percentages) by time point, for males aged 35–44 years
(note: there is a similar pattern for state occupancy in female age group)
Time point
Control EARS
Former smokers Smokers Dead Former smokers Smokers Dead
Entry 4.0% 96.0% 0.0% 14.3% 85.7% 0.0%
Year 1 2.9% 97.1% 0.0% 10.3% 89.7% 0.0%
Year 8 1.6% 97.2% 1.2% 5.6% 93.2% 1.2%
Year 10 1.6% 96.7% 1.7% 5.6% 92.7% 1.7%
Year 20 1.5% 92.4% 6.1% 5.5% 88.6% 6.0%
At age 85 1.0% 46.2% 52.7% 3.7% 44.3% 51.9%
At end of each time period.
TABLE 46 Health state occupancy, smoking status or death, (percentages) by time point, for males aged 55–64 years
(note: there is a similar pattern for state occupancy in female age groups)
Time point
Control EARS
Former smokers Smokers Dead Former smokers Smokers Dead
Entry 4.0% 96.0% 0.0% 14.3% 85.7% 0.0%
Year 1 2.9% 97.1% 0.0% 10.3% 89.7% 0.0%
Year 8 1.5% 90.5% 8.0% 5.5% 86.6% 7.9%
Year 10 1.5% 87.1% 11.4% 5.4% 83.4% 11.2%
Year 20 1.2% 62.7% 36.1% 4.4% 60.0% 35.6%
At age 85 1.1% 49.6% 49.3% 3.8% 47.5% 48.7%
At end of each time period.
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TABLE 47 Sensitivity analysis, base-case results with ‘no discounting’: mean participant outcomes,
costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 38.25 38.39 0.143 192 1349
50 28.90 29.03 0.130 192 1473
60 20.03 20.12 0.087 192 2203
QALYs 40 29.88 30.03 0.15 192 1294
50 21.76 21.89 0.13 192 1467
60 14.59 14.68 0.09 192 2084
Females
Life-years 40 40.55 40.64 0.097 192 1978
50 30.94 31.03 0.089 192 2149
60 21.74 21.80 0.059 192 3265
QALYs 40 30.55 30.68 0.13 192 1494
50 22.55 22.66 0.11 192 1759
60 15.38 15.45 0.07 192 2618
TABLE 48 Sensitivity analysis, base-case results with EARS cost ‘at £500 per participant’: mean participant outcomes,
costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.78 0.044 500 11,362
50 16.92 16.97 0.054 500 9296
60 13.35 13.40 0.047 500 10,718
QALYs 40 9.78 9.81 0.025 500 20,048
50 8.51 8.54 0.030 500 16,430
60 6.94 6.97 0.035 500 14,474
Females
Life-years 40 20.43 20.46 0.029 500 16,978
50 17.73 17.77 0.036 500 13,705
60 14.24 14.27 0.031 500 16,032
QALYs 40 15.89 15.94 0.053 500 9384
50 13.18 13.23 0.054 500 9236
60 10.19 10.24 0.044 500 11,297
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a greater mean health gain over time, especially relevant in analyses such as these where expected gains
are accrued over the longer-term time horizon.
Table 48 presents sensitivity analysis in which the mean participant cost is assumed to be much higher, at
£500, compared with a base case of £192, with EARS versus control continuing to show a cost-per-QALY
range of between £9400 and £20,000 across age and sex groups.
Tables 49 and 50 present sensitivity results where the effectiveness of EARS versus control has been varied
by ± 25% through adjustment of expected starting in which by smoking status, compared with control
with 4% former smokers. These analyses indicate that results are robust to these variations. In later
scenario analyses, exploratory threshold analyses examine this area further.
Tables 51 and 52 present results from sensitivity analyses in which different data sources have been used
to inform the relapse rate, in the ﬁrst 12 months (see Table 51) and over years 2–8 (see Table 52). The
adjustment to the 12-month relapse rate, from 28% to 40%, using data from Coleman et al.101 is a more
pessimistic assumption, while the adjustment to the longer-term relapse rate, from 46% to 30%, using
data from Etter and Stapleton,121 reﬂects a more optimistic assumption. In univariate analyses, neither of
these assumptions shows a big impact on the overall estimates of cost-effectiveness. These rates are
applied uniformly across comparison interventions, to a relatively small proportion of the overall cohort,
and so mean estimates of difference have not shown sensitivity.
Table 53 presents results from sensitivity analyses in which costs associated with smoking-related morbidity
have been considered via a cost payoff associated with deaths attributable to smoking-related causes.
Base-case results are not sensitive to this change; it does introduce other cost inputs in addition to the
EARS intervention cost, but these reﬂect minimal changes when applied over the cohort model
comparisons, where the majority of people are similar in a ‘smoker’ health state over time.TABLE 49 Sensitivity analysis, base-case results with EARS ‘less effective’ by 25% (at starting distribution): mean
participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.76 0.029 192 6689
50 16.92 16.95 0.035 192 5474
60 13.35 13.38 0.031 192 6310
QALYs 40 9.78 9.80 0.02 192 11,804
50 8.51 8.53 0.02 192 9673
60 6.94 6.96 0.02 192 8522
Females
Life-years 40 20.43 20.45 0.019 192 9996
50 17.73 17.76 0.024 192 8069
60 14.24 14.26 0.020 192 9439
QALYs 40 15.89 15.92 0.03 192 5525
50 13.18 13.21 0.04 192 5438
60 10.19 10.22 0.03 192 6651
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TABLE 50 Sensitivity analysis, base-case results with EARS ‘more effective’ by 25% (at starting distribution):
mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.79 0.059 192 3241
50 16.92 16.99 0.072 192 2652
60 13.35 13.41 0.063 192 3058
QALYs 40 9.78 9.82 0.034 192 5719
50 8.51 8.55 0.041 192 4687
60 6.94 6.98 0.047 192 4129
Females
Life-years 40 20.43 20.47 0.040 192 4843
50 17.73 17.78 0.049 192 3910
60 14.24 14.28 0.042 192 4574
QALYs 40 15.89 15.96 0.072 192 2677
50 13.18 13.25 0.073 192 2635
60 10.19 10.25 0.060 192 3223
TABLE 51 Sensitivity analysis, base-case results with relapse rate for ﬁrst 12 months at 40% (compared with 28%):
mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.73 19.77 0.037 192 5240
50 16.91 16.96 0.045 192 4288
60 13.35 13.39 0.039 192 4943
QALYs 40 9.78 9.80 0.02 192 9246
50 8.51 8.53 0.03 192 7577
60 6.93 6.96 0.03 192 6676
Females
Life-years 40 20.43 20.45 0.025 192 7830
50 17.73 17.76 0.030 192 6321
60 14.24 14.27 0.026 192 7394
QALYs 40 15.88 15.93 0.04 192 4328
50 13.17 13.22 0.05 192 4260
60 10.19 10.23 0.04 192 5210
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TABLE 52 Sensitivity analysis, base-case results with relapse rate for years 2–8 at 30% (compared with 46%):
mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.80 0.056 192 3427
50 16.92 16.99 0.068 192 2834
60 13.35 13.41 0.058 192 3321
QALYs 40 9.79 9.82 0.03 192 6364
50 8.51 8.55 0.04 192 5061
60 6.94 6.98 0.04 192 4633
Females
Life-years 40 20.43 20.47 0.037 192 5108
50 17.74 17.78 0.046 192 4177
60 14.25 14.28 0.039 192 4971
QALYs 40 15.89 15.96 0.07 192 2904
50 13.18 13.25 0.07 192 2876
60 10.20 10.25 0.05 192 3573
TABLE 53 Sensitivity analysis, base-case results with addition of a cost for smoking-related death (morbidity) from
Bauld et al.:110 mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.78 0.044 181 4116
50 16.92 16.97 0.054 161 2991
60 13.35 13.40 0.047 134 2862
QALYs 40 9.78 9.81 0.025 181 7262
50 8.51 8.54 0.030 161 5286
60 6.94 6.97 0.035 134 3866
Females
Life-years 40 20.43 20.46 0.029 181 6144
50 17.73 17.77 0.036 160 4374
60 14.24 14.27 0.031 130 4179
QALYs 40 15.89 15.94 0.053 181 3396
50 13.18 13.23 0.054 160 2947
60 10.19 10.24 0.044 130 2944
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122Tables 54 and 55 present results from sensitivity analyses in which health-state values (QALY weights)
associated with smoking status have been informed from estimates for light smokers and moderate
smokers (see Table 42), compared with the use of data on heavy smokers in the base-case analyses. Data
for all scenarios are taken from the study presented by Vogl et al.126 As expected, where differences
between non-smoker and smoker health-state values are smaller, the estimated mean QALY gain reduces
over time; however, changes still reﬂect ICERs that are £13,000 per QALY gained.
Multivariate sensitivity analysis
In addition to the above one-way sensitivity analyses, we present here two multiway analyses, reﬂecting a
representation of a ‘pessimistic’ and an ‘optimistic’ scenario, where there is uncertainty over data inputs.
Table 56 presents results where the pessimistic scenario reﬂects adjusted effect size (–25% of EARS effect),
a relatively high relapse rate over year 1, a higher intervention cost, and health-state values reﬂecting
‘moderate smokers’, with other base-case assumptions remaining the same. This scenario shows the
potential for the EARS intervention to be at an estimated cost per QALY between £23,000 and £43,000.
These assumptions are in some places arbitrary, and for illustrative purposes, but indicate potential
boundaries for CEAs.
Table 57 presents results with a more optimistic scenario reﬂecting a greater effect size (+25%) compared
with EARS base case (pilot RCT data), a 20% relapse rate over year 1 (vs. base case of 28%), a relapse rateTABLE 54 Sensitivity analysis, base-case results with use of data on QALYs from ‘light smokers’ (compared with
data on heavy smokers): mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
QALYs 40 9.97 9.99 0.015 192 12,788
50 8.72 8.74 0.021 192 9003
60 7.20 7.22 0.021 192 9163
Females
QALYs 40 16.47 16.49 0.026 192 7322
50 13.68 13.71 0.030 192 6355
60 10.61 10.63 0.024 192 8011
TABLE 55 Sensitivity analysis, base-case results with use of data on QALYs from ‘moderate smokers’ (compared
with data on heavy smokers): mean participant outcomes, costs and cost-effectiveness
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
QALYs 40 9.85 9.87 0.021 192 9156
50 8.61 8.64 0.027 192 7128
60 7.10 7.13 0.026 192 7360
Females
QALYs 40 16.26 16.30 0.036 192 5366
50 13.50 13.54 0.039 192 4941
60 10.45 10.48 0.031 192 6101
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TABLE 56 Multivariate sensitivity analysis: pessimistic scenario, where 25% lower trial efﬁcacy, 40% short-term risk
of relapse in ﬁrst 12 months, base-case hazard rate, £500 intervention cost, health-state values for moderate
smokers. Other parameters as per base case
Outcomes Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.73 19.76 0.024 500 20,886
50 16.91 16.94 0.029 500 17,090
60 13.35 13.37 0.025 500 19,702
QALYs 40 9.85 9.86 0.011 500 43,794
50 8.61 8.62 0.015 500 34,095
60 7.10 7.11 0.014 500 35,201
Females
Life-years 40 20.43 20.45 0.016 500 31,210
50 17.73 17.75 0.020 500 25,194
60 14.24 14.26 0.017 500 29,472
QALYs 40 16.26 16.28 0.019 500 25,663
50 13.49 13.52 0.021 500 23,631
60 10.45 10.47 0.017 500 29,181
TABLE 57 Multivariate sensitivity analysis: ‘optimistic’ scenario, where 25% higher trial efﬁcacy, 20% short-term
risk of relapse in the ﬁrst 12 months, Etter and Stapleton hazard rate, £150 intervention cost, heavy smokers.
Other parameters as per base case
Outcome Age (years) Brief advice EARS Difference Cost difference (£) ICER (£)
Males
Life-years 40 19.74 19.83 0.084 150 1787
50 16.93 17.03 0.102 150 1478
60 13.36 13.44 0.087 150 1732
QALYs 40 9.79 9.83 0.045 150 3319
50 8.52 8.57 0.057 150 2639
60 6.94 7.00 0.062 150 2416
Females
Life-years 40 20.44 20.49 0.056 150 2663
50 17.74 17.81 0.069 150 2178
60 14.25 14.30 0.058 150 2592
QALYs 40 15.89 15.99 0.099 150 1514
50 13.18 13.28 0.100 150 1500
60 10.20 10.28 0.081 150 1863
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124of 30% over years 2–8 (base case at 46%), and a lower intervention cost at mean cost of £150 (base case
at £192), with other base-case assumptions remaining the same. This scenario shows the potential for the
EARS intervention to be at an estimated cost per QALY between £1500 and £3400. These assumptions
are in some places arbitrary and for illustrative purposes, but indicate potential boundaries for CEAs.
Scenario/threshold analysis
In addition to the other sensitivity analyses, Tables 58 and 59 present threshold analyses to indicate at
what level of effectiveness (difference in distribution by smoking status) and intervention cost the EARS
intervention would be cost-effective, compared with a decision-maker willingness to pay of £20,000 per
QALY gain. For example, for males aged 40 years a quit rate of 8% compared with control at 4% would
provide a basis for suggestion that EARS is cost-effective, using the modelling framework and base-case
assumptions applied here.
Chapter summary
The research and economic analyses presented here have provided an estimate of the resource use and
cost associated with the EARS intervention, compared with brief advice, and have considered how to
assess the cost-effectiveness of the EARS intervention alongside a future RCT. The exploratory analyses
above, limited through uncertainty in the pilot RCT effectiveness data, have estimated cost-effectiveness of
EARS versus control, and a wide range of sensitivity analyses are presented for consideration alongside the
EARS pilot RCT and associated research.
The methods used to estimate the cost of the EARS intervention require some development prior to the
conduct of a full RCT and economic evaluation; however, the routine recording of HT activity alongside
the trial, together with a more comprehensive approach on work sampling methods, should provide a
sufﬁcient basis upon which to estimate the resource use associated with the intervention, where data are
collected in a robust and comprehensive manner.TABLE 59 Threshold analyses: maximum intervention cost for EARS to be cost-effective at £20,000 willingness to
pay per QALY gained,a by age and sex analyses
Age (years) Males, £ Females, £
40 499 1066
50 609 1083
60 691 885
a Assumptions made based on 4% quit rate with brief advice, 3.5% discount rate and all other model parameters as per
base case.
TABLE 58 Threshold analyses: 4-week CO2 quit rate required by EARS intervention, compared with base-case
control (4%, to be cost-effective at £20,000 willingness to pay per QALY gaineda), by age and sex analyses
Age (years) Males, % Females, %
40 8.0 5.8
50 7.2 5.8
60 6.9 6.2
a Assumptions made based on 4% quit rate with brief advice, 3.5% discount rate and all other model parameters as per
base case.
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search and review of the literature on cost-effectiveness in smoking cessation, this being outside the
resources and remit of the present exploratory analyses. The modelling framework developed here is
simple and parsimonious, and provides sufﬁcient insight for the present exploratory analyses, but could be
strengthened for future use through identiﬁcation of data inputs using systematic search and review
methods, and through investigation of some of the simplifying assumptions. However, given the
expectation that EARS will be a relatively low-cost intervention, the framework set out here for modelling
differences in life expectancy and QALYs over time, by smoking status, could be regarded as sufﬁcient in
scope to demonstrate cost-effectiveness, where the EARS intervention is expected to demonstrate a
signiﬁcant difference in proportion of quitters, at trial follow-up, at around 4% difference compared with
control (see Table 58).
The smoking-cessation model set out here, for use in future CEAs, indicates that there are signiﬁcant
beneﬁts associated with quitting smoking in terms of health beneﬁts, although the current model does not
include smoking-related morbidity and differences in costs associated with smoking cessation. The model
does not consider the beneﬁts associated with cutting down/reducing smoking, the beneﬁts of increasing
PA or the potential health risk associated with smoking cessation (e.g. weight gain). In addition, the model
does not consider speciﬁc health outcomes related to reduced morbidity. It is also appropriate to
acknowledge that the potential beneﬁts from smoking cessation, at a wider societal perspective, have not
been considered, such as increased productivity, potential reduction in absenteeism from the workplace,
and the impacts on others, and as such the overall impact of EARS/smoking-cessation interventions are
likely to be underestimated in the modelling framework (analytical perspective) used here. However, as
demonstrated in other studies, this model framework shows the potential pay-offs from smoking
cessation, and indicates that low-cost interventions (such as EARS) are likely to be cost-effective.
As with any model, or economic evaluation, there are a number of limitations inherent in the analyses and
methods used. It has not been possible, within the current research, to develop a de novo model, and the
model presented here adapts the methods previously presented by Coleman et al.101 However, as with all
modelling studies in this area, there are limitations with the methods and data available to model mortality
by smoking status, and to consider the impact of smoking related comorbid conditions, as well as
limitations in data and methods to consider wider societal impacts.
As discussed above, there are limitations in the data available to speciﬁcally consider ‘hard-to-reach’
smokers, and to speciﬁcally analyse costs and outcomes related to that target group, where there is no
intention to make a quit attempt in the immediate future.125
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Chapter 7 Discussion and conclusionsContextFew studies have evaluated the effectiveness and cost-effectiveness of behavioural support for smoking
reduction among smokers who do not wish to quit in the immediate future, and none explicitly for
disadvantaged adult smokers (see NICE Public Health Draft Guidance on ‘Tobacco: harm reduction
approaches to smoking’: http://guidance.nice.org.uk/PHG/52). The few reported studies involving adults
have shown no evidence for any effectiveness and vary in terms of counselling alone, or counselling in
combination with pharmacological support. This study is therefore timely as interest grows in interventions
for harm reduction, and ones that may reduce health inequalities.
This pilot RCT was not formally powered to detect plausible differences in outcomes or to undertake
between-group (intervention vs. control) comparisons of outcomes at follow-up. However, to help inform
the power of a future deﬁnitive trial we did estimate the intervention effect size (and its precision) for the
primary outcome. The quantitative and qualitative ﬁndings provide some preliminary support for a
behavioural approach to help disadvantaged smokers (who do not wish to quit in the immediate future) to
reduce their smoking and, to some extent, use PA as an aid for smoking reduction.
There is little evidence that smoking reduction alone reduces health risk so our aim was to support
smoking reduction, knowing that that those who smoke less are more likely to quit. Hence, our main
research outcome was quitting, with secondary interest in smoking reduction, as well as changes in PA.Intervention content, design, acceptance and feasibilityFollowing extensive background research (over many years) on the interactions between PA and smoking,
we engaged with smokers, lifestyle advisors and service providers in disadvantaged communities, as well as
with a range of academic expertise, to establish an appropriate intervention.
One of the primary aims of the EARS study was to develop an acceptable and feasible intervention for
disadvantaged smokers who wish to reduce but not quit, using PA as an aid to smoking reduction. To
avoid the potentially confounding effects of NRT, we asked participants to not use NRT during the
intervention; those in the intervention arm would have used more NRT than the control arm if we had
encouraged this and any effects on smoking may not have been attributable to PA. We found in the study
that no more than two participants did use NRT during the intervention. We expected participants to use
NRT after quitting and 11 of the 14 quitters did so.
Both quantitative and qualitative data indicated that the intervention was well received. A focus on
reduction, rather than quitting, was a fundamentally important aspect of the intervention as identiﬁed by
participants and HTs. Many would not have engaged with the study had it been introduced as a
smoking-cessation programme. The number and timing of counselling sessions received, the way support
was offered (by telephone or face to face), the location where sessions took place, the speed of progress
in changing smoking and PA, and additional tailored support (e.g. subsidies for exercise facilities and use
of local walking groups) all contributed to the delivery of a client-centred and empowering intervention.
The biggest challenge we faced was integrating the promotion of both PA and smoking reduction.
Substantial effort was invested in how the participant information sheet presented the intervention
content, how HTs introduced PA as a potentially facilitating behaviour for smoking reduction, and how
they used behaviour change techniques to support both behaviours. Quantitative and qualitative127
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128information suggest that a number of intervention participants did increase PA (measured objectively and
subjectively), at least during the intervention, but that not all participants used PA as an aid to smoking
reduction. The intervention focused more on smoking-reduction strategies than increasing PA for
many participants.
We have learned a lot about how the intervention was delivered and received from both quantitative and
qualitative data. With further reﬁnement to training and delivery, the acceptability and effectiveness could
be further enhanced and ﬁdelity improved. The following speciﬁc suggestions could be considered to
improve the intervention delivery:
l Train the EARs practitioners using case studies, and audio and role-play examples drawn from the
present pilot study.
l Use mobile telephone texts (that do not cost the smoker) and other technology to prompt smoking
reduction (if acceptable to individual smokers) and use of PA.
l Enhance the quality of tools that may support behaviour change (smoking reduction and PA) and
intervention understanding (e.g. self-monitoring sheets, behavioural prompts, a case study and/or
self-help guide to show how the intervention works and what behavioural options may be available)
and ensure that these are available to smokers.
l Consider further incentives and increasing uptake of subsidies to engage in PA that is sociable,
fulﬁlling and self-determined.
l Offer the use more sophisticated pedometers to assess and memorise step counts on a daily basis,
between sessions, to enhance the utility of self-monitoring.
l Consider allowing smokers to receive support for longer, especially if they are making progress
with reduction.Trial design and methodsThe study was designed as a pilot RCT due to uncertainty about the recruitment of disadvantaged
smokers, the acceptance of trial methods, and the likely effects on the primary outcomes (in order to
adequately power the study). Given the paucity of research on behavioural support for smoking reduction
and cessation induction we could only speculate on the proportion, in both arms of the trial, who would
make a quit attempt and remain abstinent.
This study provides support for the trial design and methods being acceptable and feasible among
disadvantaged smokers, as indicated by our ability to recruit 100 participants (with the resources available
over 12 months) from our target groups, and retain over 60% of participants up to 16 weeks. Overall, the
methods performed quite well for a pre-deﬁned disadvantaged population. We have learned a lot about
the optimal design and methods to conduct a fully powered trial, as well as the resources needed to do
this in a timely manner, from both quantitative and qualitative data. We brieﬂy consider some of these
lessons in terms of personnel, location, recruitment, and outcomes and data collection procedures.Discrepancies within this document
Readers may ﬁnd different information reported with regard to the design and methods in different
sections of this document. This is due to the sequential development from the initial proposal and protocol
(see Appendix 2) through to the ﬁnal analyses and reporting. Below are some examples:
1. Inclusion criteria by number of cigarettes smoked. The aim of the inclusion criteria (≥ 15 cigarettes per
day) was to ensure that we had moderate to heavy smokers who have been reported to have a greater
interest in reduction. We achieved this in terms of number of cigarettes smoked, but recruitment and
assessment methods made the criteria hard to apply. From GP records patients were identiﬁed as
smokers if they smoked at least 10 cigarettes per day. It seemed inappropriate to invite all those
recorded as smokers into the trial and then exclude them when they showed interest in participating ifNIHR Journals Library www.journalslibrary.nihr.ac.uk
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be > 60%) smoked roll-ups. We adopted the conversion of 0.45 g per roll-up based on the most
rigorous published approach although other conversion rates ranging from 0.38 to 0.8 g have been
informally identiﬁed. We did seek to recruit those smoking ≥ 15 but given uncertainties about the
accuracy of GP records and the conversion from grams/ounces to rolled number of cigarettes our
researchers were trained to apply a more lenient inclusion criteria of≥ 10 and that is what we reported.
Some of the above only became apparent as the study progressed or at the end of the study. So in the
context of a pilot study, in which we sought to test our methods, we have learned that in a future
study aimed at supporting reduction we should aim to recruit those smoking≥ 10, to match GP records
and accommodate uncertainty about the precise number of cigarettes smoked. The lowering of the
inclusion criteria on cigarettes smoked per day may have reduced the impact of the intervention (in
terms of scope for reduction of cigarettes smoked) but also increased the generalisability to include a
broader range of smokers.
2. Exclusion of people with mental illness or ongoing substance abuse. Within the context of a pilot study
involving ‘hard-to-reach’ participants we needed to strike a balance between including as broad a
range of participants across diverse deﬁnitions of ‘hard-to-reach’ as possible, while also safeguarding
our research team. To achieve the latter, we put in place a number of checks, including the following:
all participants had to be registered with and approved suitable for the study by the GP; our research
team followed a lone worker policy which involved them meeting participants only in NHS facilities and,
if working late, informing another member of the team prior to and after each session with a
participant. We also wished to test the trial methods and intervention with smokers who were able to
respond so while we had broad exclusion criteria to ensure the above, there were a small number of
participants with mental health and substance abuse problems who were deemed suitable for the study
by the GP. For example, one participant with serious mental illness was deemed suitable but then
withdrew after the initial session due to emerging difﬁculties, as advised by a mental health care
worker. All of the above issues were widely discussed among the research team, including four GPs.
3. Number of people to be recruited into the study. As a pilot study we estimated, to the best of our
ability, what resources would be needed to recruit n = 120. We have learned that, despite our best
efforts, the necessary resources were insufﬁcient for the time scale and approaches set. One member of
the research team (0.4 fte) took compassionate leave for 2 months, and another (0.5 fte) was on sick
leave for 3 months during the ﬁnal period of recruitment. We conducted an interim analysis (with the
ﬁrst 60 participants) of the implications of recruiting n = 100 versus seeking an extension to achieve our
initial target of n = 120. We concluded that given the small numbers making a quit in the control arm,
and the numbers quitting in the intervention arm, the study would provide the information we were
seeking to gain within the aims of the study. The NHS Research Ethics Committee and National Institute
for Health Research (NIHR) were informed and accepted this.
4. Recruitment of participants through the community to include mailed invitations from SSSs. As we
described in the initial proposal/protocol and Chapter 2 (see Trial design and methods), we involved a
wide range of potential community stakeholders (though smokers who want to reduce but not quit
may not necessarily regard themselves as a clinical population like with other medical conditions) to
inform how best to engage with participants. Distinct from the 50% recruited via primary care, we
regarded the recruitment, by mailed invitation of those failing to quit (in the previous 2 years) with SSS
support in Devonport and Stonehouse, as community recruits.
5. The capturing of the primary outcome. Within the context of this pilot trial we had intended that all
those deciding to quit, in both arms of the trial, would contact the SSS to receive support (usual care) in
the form of 6 or 7 weekly contacts during which CO would be monitored along with self-reported
abstinence. This occurred for only two participants who decided to quit. We also offered to provide HT
support while attending the SSS after quitting in the original protocol. A few participants chose this but
not all. We also built into the study design an assessment (of self-reported abstinence and conﬁrmed
expired air CO) of those who we knew had set a quit date after 4 weeks. We did our best to ensure
that all participants were contacted at 4 weeks after their quit date and that a measure of expired air
CO and self-reported absence of smoking was obtained. For some participants this did not happen due
to missed appointments until up to 8 weeks post quitting. All reported successful quitters did provide129
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130self-reported abstinence since the quit day (having smoked no more than ﬁve cigarettes since quitting)
and expired air CO-conﬁrmed abstinence between 4 and 8 weeks post quit.Personnel
The EARS pilot trial and intervention was implemented through a dual HT/researcher role. In our initial
proposal we argued that this could provide a more seamless interface between the disadvantaged smoker
and the research team, compared with engaging with a practitioner to deliver the intervention and a
researcher to collect data. A disadvantage was that the trial involved no blinding in the data collection
at follow-up.
While interviews with participants suggested that they were generally in favour of this seamless approach,
they had little or no experience of other research to make comparisons. We have identiﬁed a number of
reasons why a future study should consider separating the roles of practitioner and researcher.
l Capturing the primary outcome proved to be more complicated than initially envisaged (in part due to
low uptake of SSSs by quitters) resulting in an overburdening of the HTs’ work capacity. A designated
researcher role could focus more explicitly on following up and capturing the data outcomes without
the time implications of having to deliver the intervention. This could potentially increase the standard
and rate of data completion at follow-up.
l The HTs found it very difﬁcult to withhold any support from participants allocated to the control arm as
they were trained in delivering the intervention, and withholding support and advice went against their
instincts, something they reported as being morally challenging. A researcher, not trained in
intervention delivery, would not face similar tensions.
l The HT found the routine collection of data in some weeks, prior to proceeding with the intervention
in a session, disruptive to establishing rapport. Thus a sole practitioner role may help the focus on
intervention engagement.
l It was a challenging dual role for our HTs and with this in mind they were appointed at a professional
level more senior and experienced than the typical HT. If a future study was to evaluate the
effectiveness of the intervention delivered by a typical HT then the roles would have to be separated,
with designated researchers with different skill sets.
l Our EARS training manual seeks to build on the skills and competencies of a HT. It may be that other
lifestyle advisor roles (see Carr et al.47) could also be adapted to deliver the intervention.
l We did not fully utilise a trial administrator for arranging appointments and assisting with the
monitoring of intervention sessions and assessments. A better use of such a resource could allow the
HTs and a researcher to focus on their own roles.
We had planned to employ two HTs/researchers, each as 0.7 fte. Instead we had employed three, adding
up to 1.4 fte. Shared supervision and team building took place for 2 hours on most weeks. This was very
beneﬁcial to the study as ideas and experiences were exchanged and during times of sick leave we could
mostly provide some continuity of support for participants. We also implemented a ﬂexible working policy
and many support sessions with participants took place in the evening, using mobile telephones.Location
We had originally envisaged conducting assessments and intervention sessions in a wide range of settings,
such as in GP surgeries, SSS buildings, community centres, participants’ homes, and leisure facilities. We
considered the implications of these settings on perceptions of the study and intervention, and the safety
and risks posed to the research team. Eventually, following extensive consultation with local stakeholder
groups and service users, a centralised NHS community minor injury and outpatient centre (with available
clinical space) was selected to house the research team and conduct sessions.Recruitment
Targets for recruiting subgroups of ‘hard-to-reach’ or disadvantaged smokers were set out in our research
proposal, based on guidance from local GPs (also co-applicants) RA and RB, and their awareness of theNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4demographics and smoking prevalence in Devonport and Stonehouse. These targets were at least met in
this study in terms of employment and mental health status. The sample, overall, were heavy smokers but
tended to be quite active, relative to the general population, due to manual employment and daily walking
for transport. We aimed to explore the feasibility of recruitment and the resource implications. Once again,
we learned a great deal about recruiting through mailed invitations, from both GP surgeries and the SSS.
Between 5% and 11% of those invited can be recruited in this way, depending on the resources invested
in reminders and reminder telephone calls. Finding available expertise to conduct searches of patient
databases was challenging. There was variability in how surgeries wished to screen participants (i.e.
everyone invited or only those responding to the invitation), which affected timescales relating to the
mailing of invitations. We tried to reduce risk to both participant and HT through our screening procedures
and this appeared to be effective as we encountered no adverse or serious adverse events or incidents that
threatened the safety of our HTs.
Currently, the SSS only reaches a similar proportion (i.e. c. 5%) of smokers and new approaches are
needed to increase the reach to more treatment-resistant smokers. Our blanket invitation to all smokers to
join the trial included both those presently wishing to reduce (c. 60%) and those not interested in
reducing (c. 40%). Therefore, in effect we recruited c. 15% of those wishing to reduce at the time of
invitation, which increases the generalisability somewhat. The reported differences in smoking status in the
present study, if conﬁrmed in a larger study, would support this low-cost intervention as a way of
providing support to the large numbers of smokers who do not wish to quit. Speculatively, similar trial
methods in another study with fewer ‘hard-to-reach’ smokers would result in an even greater response
rate. One may also speculate that outside the remit of a RCT the EARS intervention, if offered in primary
care or the community, may appeal to a larger proportion of smokers.
Other approaches to community recruitment involved considerable effort and produced few recruits in
return. This mirrored the experiences of SSS advisors who had previously sought to provide support for
abrupt quit attempts in the same area of Plymouth.
A future study should consider the following:
l A larger trial should recruit from a more ethnically diverse sample to enhance generalisability and
explore subgroup effects.
l Other outreach approaches to recruitment such as subcontracting personnel/agencies outside the
research team, taking more time to develop relationships with community-based organisations and
worksites, and the costs associated with such approaches.Study retentionWhile the loss of 38% of participants to follow-up assessment is a potential threat to internal validity, our
assumption that those who did not return for assessments remained smoking is based on previous
research and widely accepted protocols (i.e. Russell Standard). The loss to follow-up was comparable in
both arms of the trial but this does not conﬁrm that the reasons for study attrition were the same. In
reporting descriptive baseline data for those who completed the study and those who withdrew we tried
to identify any clear baseline factors that may have threatened internal validity but none were evident
given the small sample size.
In phase 1, during consultations with stakeholders, we did identify that participants would be more
motivated to take part if there was a ﬁnancial incentive. However, we chose not to adopt this approach
due to budgetary, pragmatic and ethical issues that may arise. For example, some participants did not have
a bank account and others feared losing beneﬁt allowances by taking money. We also wanted to
maximise external validity by working only with participants who were interested in the study and the
possibility of receiving the intervention. As we note in the report, we did pay participants £10 for wearing131
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132and returning an accelerometer for 1 week, increasing to £30 later in the study, which did increase
compliance to wearing. Without placing any emphasis on this when inviting participants into the study
only a few participants anecdotally came for the ﬁrst assessment to receive the money and did not return.
A fear would be that a greater emphasis on incentives may confound intervention effects.Outcomes and data collectionWe originally expected to capture our primary outcome (4 weeks’ post-quit date expired air CO
abstinence) with the help of a SSS advisor after referral of any participant who wished to quit. Only two of
the participants who wished to quit used support from the SSS. This created a challenge for us to capture
the most robust or conservative outcome measure possible. We identify the criteria used in Chapter 3 and
Chapter 4 to provide the most conservative outcome. The number of successful quitters was also
conﬁrmed with data for 16-week point prevalence.
We report that in the intervention and control arms, respectively, 22% versus 6% had at least a 24-hour
quit attempt, 14% versus 4% had expired air CO-conﬁrmed abstinence at 4–8 weeks after quitting, and
10% versus 4% were abstinent at 16 weeks. Also, 31% versus 16%, and 39% versus 20% had reduced
by at least 50% by weeks 8 and 16, respectively.
A future study should consider the following:
l the measurement of variable quit dates and ﬂoating abstinence for trials involving behavioural support
l use of differing process measures for those who quit and those who do not
l consider a longer-term follow-up smoking outcome (e.g. 6 months post intervention).
Intervention adherence appeared to be associated with the main smoking outcomes, though no inferential
statistics were conducted. A future study should consider the following:
l consider ways to maximise adherence to the intervention
l conduct sensitivity analysis to determine the effects of dose of intervention received on the main outcomes.Strengths and limitations
Strengthsl This is the ﬁrst study to explore the effectiveness of a behavioural intervention to increase PA as an aid
for smoking reduction and cessation induction.
l The study provided valuable information to inform a future trial design and methods. Our scenario
analysis conducted to determine a sample size for the present study closely resembled the ﬁndings in
the study.
l The mixed methods approach provided valuable information to further develop and deliver
the intervention.
l Targets were met for recruiting disadvantaged smokers.
l The very detailed health economic analysis provides a solid basis for designing the economic analysis
for a full-scale trial.Limitationsl The study involved 97% white British participants, which may limit the generalisability of the ﬁndings.
l The expired air CO-conﬁrmed 4 weeks’ post-quit outcome was not as robust as planned, though is
supported by data collected at 16 weeks.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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collection procedures.
l We describe the intervention as one delivered by a HT. Because of the dual role of HT and researcher
we adopted for the study, our researchers were probably more skilled and experienced in behaviour
change than many working as HTs. The ﬁndings (albeit not intended to inform practice and policy)
may therefore not generalise to other HTs.
l We did not systematically identify the extent to which the planned BCTs outlined in the protocol were
delivered and during what phase of the intervention.
l Cost-effectiveness analyses are exploratory, with uncertainty around effectiveness data inputs and
other parameter inputs, and their policy relevance is limited.Implications for health care
It is premature for any guidance to be derived from the present study for health professionals, policy
makers and commissioners because the ﬁndings provide only preliminary support for the EARS intervention
with a relatively short follow-up and sampled from a non-ethnically diverse population. The future of HTs
may be uncertain, so any health professional could be involved in delivering the intervention with little
impact on the apparent cost-effectiveness. The Health and Social Care Act of 2012132 creates uncertainty
about where such an intervention would be delivered but if a deﬁnitive trial demonstrated the EARS
intervention to be effective then a wide range of professionals could be trained to do so.Implications for future research
A larger, fully powered trial with a longer follow-up is needed to conﬁrm the effectiveness and
cost-effectiveness of the EARS intervention. Minor reﬁnement of the intervention is needed. There will be a
need for further initial exploratory work (e.g. 4 months) on adapting the intervention for a more ethnically
diverse sample. A larger study could help to add further information about the core effective components
of the intervention, and any moderators and mediators of any effects. The framework set out here for
future cost-effectiveness analyses appears sufﬁcient where the EARS intervention is low cost and
demonstrates modest effectiveness; however, further complexity in modelling could be useful to further
demonstrate the broader potential beneﬁts of the EARS intervention.
We are not aware of any research on weight gain associated with smoking reduction (i.e. not cessation).
The present study suggests that this should be considered carefully in future research. If indeed reduction
is associated with weight gain then this may provide a rationale for more support for smokers to further
increase PA to minimise the risk of weight gain.
Future research should consider the reward of vouchers or other non-monetary incentives to increase study
retention. In terms of stafﬁng, a dedicated administrator should be used to arrange appointments and
issue prior reminders, and thus add to the resources available to increase recruitment and retention.ConclusionsThrough a mixed methods approach, this study aimed to develop and evaluate the feasibility and
acceptability of a novel PA and smoking-reduction counselling intervention (for disadvantaged smokers
who do not wish to quit in the immediate future but do want to reduce their smoking) and the methods
to inform the design of a fully powered deﬁnitive RCT.
Sufﬁcient quantitative and qualitative data were gathered to indicate that the intervention was acceptable
for participants and seemed to facilitate an increase in PA and reduction in smoking, as well as inducting
more quit attempts and more short-term abstinence. Evaluation of the methods suggested that it is
feasible to recruit, randomise and retain disadvantaged smokers in a trial with up to 16 weeks’ follow-up.133
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134Important lessons were learned that may enhance the intervention delivery and the training of HTs. Some
reﬁnements of the trial methods could also help to enhance recruitment and retention of participants and
improve the efﬁciency of the procedures, particularly in terms of stafﬁng roles.
We estimated that the EARS intervention cost approximately £192 per participant. A full trial would
provide greater conﬁdence in modelling the costs and cost-effectiveness as a smoking-cessation induction
intervention which could be delivered in disadvantaged communities to help address health inequalities.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 42 The EARS ProjectEARS: Exercise Assisted Reduction then Stop smoking2.1 Background and objectives
2.1.1 NHS stop smoking servicesl NHS Stop Smoking Services aims to help smokers to remain abstinent after an abrupt quit attempt
and behavioural and pharmacological support increases success rates by four fold (compared with
self-initiated attempts) but as few as 22% are still abstinent one year later.
l No more than 5% of smokers receive NHS Stop Smoking Services when attempting to make an abrupt quit.
l Little or no NHS support is currently available for the 60% of smokers who typically report that they
would like to reduce the number of cigarettes smoked.
l Almost half of adults in Devonport and Stonehouse, in Plymouth, smoke. This is double the prevalence
across Plymouth as a whole.
l New options are needed to help smokers who wish to reduce smoking but not quit . . .
l Those who do reduce smoking are more likely to decide to quit, and remain abstinent.2.1.2 Physical activity and smoking cessationl Physical activity can help to increase cessation rates among abrupt quitters (Ussher et al, 2008), though
less is known about effects for ’hard-to-reach’ smokers.
l Physical activity (structured exercise and short bouts of movement) reduces cravings and withdrawal
symptoms, limits increases in cravings associated with smoking cues, and delays the time between
smoking cigarettes.
l Extensive pilot work has taken place to see how best to promote physical activity as an aid to making
an abrupt quit attempt, in Plymouth and other NHS Stop Smoking Services (SSS), with input from
advisors and smokers.
l This involved a self-help guide, pedometers, and behaviour change strategies, such as setting goals and
reviewing progress.
l Physical activity has not previously been rigorously assessed as a strategy to help smokers to reduce,
then possibly quit and remain abstinent.2.1.3 Introduction to EARSl The Department of Health wish to determine if smokers who wish to cut down but not quit, can be
supported in this adjustment with a Health Trainer, providing behavioural support.
l The Health Trainer role will be to support both a reduction in smoking, using a variety of options, and
to help smokers to increase their physical activity, again through a variety of personal choices.
l Smokers who reach the point where they wish to quit will be offered the full range of NHS Stop
Smoking Service professional support, with maintained support from the Health Trainer.
l In Phase 1 of the study (from September 2010-March, 2011), we will identify the best way to engage
with smokers who wish to reduce smoking but not quit, within Devonport and Stonehouse, through
interviews and discussions with a variety of relevant stakeholder groups and individuals.
l In Phase 2 of the study (from April, 2011-April, 2012), we aim to recruit 120 such smokers in these
areas of Plymouth, equally from GP practices and non-primary care sites (e.g. community centres).
l All will be asked to provide information about lifestyle, health and related thoughts initially and at
several points in the study, over 4 months. Through a procedure called randomization volunteers will
be allocated to one of two groups.
¢ Sixty smokers will be encouraged to cut down as they normally would, and given information
about NHS Stop Smoking Services, to access if they wish to quit.149
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150¢ Sixty smokers will be offered the weekly support of a Health Trainer, in person or by phone, to
reduce smoking and increase physical activity. There will be a variety of options offered to support
both smoking reduction and increasing physical activity.2.1.4 How do smoking and physical activity link?l When smokers cut down they ﬁnd it easier to breathe and this helps them to become more active,
doing some of the things they haven’t enjoyed for a while.
l Increasing physical activity can help in several ways:
¢ It can reduce an urge to smoke as the period between cigarettes increases while reducing smoking.
¢ It can reduce withdrawal symptoms such as stress and anxiety, low mood, irritability, restlessness,
and hunger, in the absence of a cigarette.
¢ It can serve as a distraction and become a new interest to replace the habitual need for a cigarette
in certain situations.
¢ If a quit attempt is made, it may be easier to become more physically active ﬁrst, rather than trying
to change two behaviours at the same time.
¢ Doing some physical activity can remind a smoker just how breathless they have become, and this
can prompt a desire to quit.
¢ Fears about quitting, such as inability to cope with life’s demands, and weight gain, can be
reduced as physical activity helps with both of these.
¢ Becoming more physically active can lead to a shift in identity away from that of a smoker.2.1.5 Will smokers be interested in EARS?l A survey of 178 smokers in a Plymouth GP practice found 62% were prepared to gradually cut down, of
whom 70 (39% overall) were ’interested in taking part in a research study to see if physical activity is
useful to reduce the amount you smoke.’ We added in the survey: ‘(The study would include support such
as professional support, a self-help booklet, a free pedometer, and free access to an exercise facility).’
But a big part of this study is also to answer this question. How can we recruit people from different
backgrounds with different needs, into such a study, and to engage in the intervention?2.2 Summary of Research Protocol
EARS has been designed as a pilot, pragmatic, randomised controlled trial (RCT), to which participants
who wish to reduce their smoking but not quit within the next month will be recruited and randomly
assigned to one of two groups:
1. Brief Advice provided at baseline by the Health Trainer (HT) in the form of written and verbal
information on the NHS SSS with information on the beneﬁts of quitting and how to quit. Those
expressing a desire to quit will be subsequently referred to the NHS SSS.
2. Health Trainer behavioural support in the form of written and verbal information on NHS SSS with
information on the beneﬁts of quitting and how to quit provided at baseline. Smokers will select one of
4 strategies for smoking reduction while also being encouraged to become more physically active through
about 3 face-to-face and 5 telephone communications, over 8 weeks. Client-centred counselling, will focus
on exploring beliefs about increasing physical activity and its use to reduce smoking, action planning (or
SMART goal setting) and supporting behaviour change. The HT will seek to develop a supportive relationship,
and provide guidance on using a free pedometer, an MP3 player (with an isometric exercise recording),
self-monitoring and other self-regulating techniques, and signpost smokers to local exercise opportunities with
subsidised access as required. Those expressing a desire to make a quit attempt will subsequently be referred
to a professional NHS Stop Smoking Service advisor, with concurrent HT support over a further 6 weeks.
Standardised brief advice to be given to all participants after randomisation:NIHR Journals Library www.journalslibrary.nihr.ac.uk
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1522.3 What changes are we looking for?
All individuals who receive the EARS intervention are hoped to achieve the following changes:NIHRMain outcomes:
We want to see more:l Quit attempts (during period up to 12 weeks)
l CO-conﬁrmed abstinence (at 4 weeks post quit)
l Smokers achieving a 50% reduction in smokingSecondary outcomes:We want to see more:l Moderate and/or vigorous minutes of physical activity (self-reported and from accelerometer recordings)
l More favourable beliefs about the value of PA as an aid for smoking reduction
l More positive beliefs about conﬁdence to do PA
l More positive beliefs about conﬁdence and importance of quitting.
We want to see less:l Weekly Self-reported cravings and withdrawal symptoms
l Cigarettes smoked and lower CO readingsMethodological outcomes:We want to see:l At least 120 smokers recruited and randomised within the study
l Maximise contacts with participants.
l Evidence of ﬁdelity to delivery of the intervention as per protocol (from sessional recordings,
ﬁeld notes, etc).2.4 EARS and the role of the Health Trainer
What follows is a brief overview of the role of the EARS Health Trainers. A more detailed description and
session-by-session breakdown is provided from Section 3 onwards.
From the participants’ perspective the intervention will last for up to 8 weeks + 6 weeks additional support
during a quit attempt.2.4.1 The Intervention
The initial session will be held at either a community venue, a GP practice, or other clinical setting. It is
expected to last around 1 hour.
Working together the HT and participant will discuss feelings and attitudes towards smoking behaviour
and physical activity. Being heavily client-centred, the HT and participant will agree on goals for the
participant to work towards in terms of smoking reduction and physical activity. The goals should beJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4tailored to the individual participant, with week-by-week short-term goals building in to a longer 8 week
goal. General indicators would be a smoking reduction of 50% over 4 weeks with further reduction in the
following 4 weeks, and an increase in PA to the maximum of the individual’s desire/capability. Over the
next 6 weeks the HT will provide weekly phone calls to offer support and guidance for the participant in
achieving their goals, and at 8 weeks the HT will meet the participant again for a ﬁnal face-to-face session
to review progress and discuss maintenance plans.
Whilst it is not within the aims of the HT to support a quit attempt, if at any time (up to 8 weeks from
initial session) the participant desires to quit the HT will refer them to NHS SSS.
The HT will also make weekly support phone calls for 6 weeks during the quit attempt.
The aims of the intervention package are to:
l Promote sustained increases in physical activity
l Encourage sustained smoking reduction
l Empower individuals to control cravings through PA
l Provide information on local PA opportunities as necessary
l Promote positive experiences and rewards from PA
l Refer to appropriate services and provide support through any quit attempt3 Core Knowledge and SkillsThe concept of the Health Trainer (HT) was originally proposed in the 2004 Department of Health White
Paper: Choosing Health: Making Healthy Choices Easier. HTs are traditionally people drawn from local
communities and are trained to reach those who want to adopt healthier lifestyles but have little contact
with services. HTs develop an understanding of the needs of people from deprived communities and apply
basic behaviour change techniques. They typically embed themselves in communities in order to increase
the reach of their service to the more ‘hard to reach’.
This section assumes the trainee has developed the core HT competencies with respect to:
1. Making relationships with communities.
2. Communicating with individuals about promoting their health and well-being.
3. Enabling individuals to change their behaviour to improve their own health and well-being.
4. Managing and organising own time and activities.3.1 The role of the EARS Health Trainer
The role of the HT has been adopted in the EARS study because a client-centred intervention is planned
for ‘hard to reach’ smokers.
Whilst the traditional health trainer assesses the client’s desire to address a particular behaviour from a
choice of usually four behaviours (alcohol consumption, diet, smoking and physical activity) the EARS HTs
will only focus on smoking reduction and cessation and physical activity, and their interaction. The EARS
HTs will draw upon the skills and knowledge equivalent to the City and Guilds Level 3 HT qualiﬁcation, but
will adapt these skills in line with the EARS protocol and this training manual.
In summary, the present manual particularly builds on HT competency number 3 (see above), described in
detail in the NHS Health Trainer Handbook, ‘Improving Health: Changing Behaviour.’ Department of153
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154Health & British Psychological Association, 2008. This competency (see p. 18 in this Handbook) is about
enabling individuals to:
1. Identify how behaviour affects their health.
2. Develop a Personal Health Guide (action plan).
3. Change and maintain a health behaviour.3.2 Smoking Addiction and Treatment
Smoking is the single biggest preventable cause of death in the world and the World Health Organisation
predicts it will account for 8 million deaths per year globally by 2030. Half of those who smoke will die
from, or succumb to disease directly resulting from, their smoking habits.
In the UK, the NHS spent £73 million on Stop Smoking Services in 2008/09, not including
pharmacotherapy costs. The amount invested in services has risen steadily over the last decade, yet despite
his fewer people successfully made a quit attempt in 2008/09 than in 2007/08.NIHRSuccess rates among those who attempt to quit alone, without behavioural support or pharmacotherapiesare extremely low – only around 3–5% will still be non smokers 12 months after quittingThe UK has also seen greater resources directed towards helping ‘hard to reach’ groups in an attempt to
address health inequality. Yet, despite this, smoking prevalence is reducing at a slower rate among the
social grades C2-E than social grades AB-C1 (1.3% and 2.3% between 2007-08, respectively).
New approaches are needed to increase the number of ‘hard to reach’ smokers making a quit attempt
with the best available support and hence successfully quit. With no provision available for the 57-66% of
smokers who wish to cut down, and the evidence that those who cut down are more likely to make a quit
attempt, the EARS intervention aims to assess whether a smoking reduction programme is a successful
way to engage with ‘hard to reach’ smokers, and subsequently increase the number of people making a
quit attempt.3.2.1 Nicotine
Nicotine is a highly addictive psychoactive stimulant. Cigarette smoking is a highly effective delivery
method for nicotine, with a lag time of only 7-15 seconds from inhalation to reaching the brain (compare
this to up to 20 minutes for nicotine gum).
Thus use of NRT in different forms does not have the same addictive properties (though may still have
consequences for health) and is licensed to support smoking reduction and cessation. It does have side
effects (see Appendix 7.5.11) and may not be suitable for everyone.3.2.2 Mood and negative affect
As time increases between each cigarette, a smoker’s withdrawal symptoms and cravings will begin to rise.
This leads to an increase in negative mood states such as low mood, irritability, anxiety, tension, hunger
and stress. Drug seeking behaviour (needing to smoke a cigarette) in order to alleviate these negative
feelings is common. In a sense, a smoker’s satisfaction from a cigarette comes from the alleviation of
negative mood states – they smoke to feel normal (see Figure 1).
It is worth noting that reported reasons for smoking are often paradoxical in nature – people will smoke
both for stimulation and for relaxation. Nicotine is a stimulant which can increase perceived alertness and
concentration, and yet also relieve stress. Despite reports that smoking relieves stress, it has been shownJournals Library www.journalslibrary.nihr.ac.uk
Mood
Time
Fig. 1 Graphical representation of smoking and mood
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4that smokers generally exhibit higher stress levels than non-smokers. There is no evidence of a causal
relationship (whether people with high stress levels tend to be drawn towards smoking or if smoking
causes higher stress levels), but it has interesting implications for physical activity as discussed in
Section 2.5.3.2.3 Cue Reactivity
People often smoke as a result of being exposed to a certain situation or cue (such as having a drink in the pub
or after a meal). The desire for a cigarette is stimulated by a learned response to a given stimulus. This form of
classical conditioning where a conditioned response follows a conditioned stimulus is often developed over a
long period of time and can be very hard to break. Psychological stress is often cited as a cue to smoking.
Cues provide opportunities for impulsive behaviour, which is not planned. So self-regulation and inhibiting
a learned response (e.g. having a cigarette when offered one) is challenging. Learning ‘what-if’ strategies
are often an important weapon to avoid lapses triggered by cues.3.2.4 Reasons for smoking/Barriers to quitting
The reasons people smoke and the barriers which prevent people from quitting are often complex and
numerous. Whilst EARS is primarily concerned with supporting people to cut down and not helping them
to decide to quit, it is worth noting possible why people start and the barriers to them stopping as they
can relate strongly to the role of physical activity.Table 1 Reasons for smoking and barriers to quitting
Reasons for smoking Barriers to quitting
Boredom
Smoking is part of a social activity
Smoking is used as a coping strategy for when things get
stressful or difﬁcult
Used as a weight management strategy
Enjoyment
Exposure to conditioned stimulus
For stimulation
For relaxation
Lack of conﬁdence to quit (previously failed
quit attempts)
Fear of withdrawal symptoms
Motivation
Desire
Belief that smoking isn’t dangerous
Peer pressure
Social exposure
Loss of smoking as a stress management tool
Lack/cost/availability of support and NRT
Powerful addiction to nicotine
155
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156One important reason for sustaining smoking and for relapsing from a quit attempt is weight gain.
Nicotine increases metabolism and suppresses appetite, so when someone stops smoking they will gain,
on average, 7kg in 12 months. The weight gain is compounded by the potential replacement of the
nicotine ‘hit’ with indulgent snacking and emotional eating. For many, even minimal weight gain is
unacceptable, so strategies to prevent weight gain after smoking cessation are required. There is no
evidence for what effects smoking reduction has on weight gain.3.3 Abrupt quitting
At this time, the NHS Stop Smoking Service largely advocates abrupt approaches to quitting. With the
support of a qualiﬁed stop smoking advisor, those wishing to quit will work to set a quit date, following
which they will attempt to not smoke another cigarette. They will be offered the option of using a variety
of pharmacotherapies (Nicotine Replacement Therapy (NRT), Bupropion, Varenicline etc) to help manage
cravings and withdrawal symptoms. Even the most optimistic data suggests that with the best
pharmacological and behavioural support, the chance of remaining abstinent 1-year post quit only rises to
around 20% from around 3% unaided.
It is estimated the NHS SSS only engages with around 5% of smokers at any one time. The reach of the
NHS could be limited by the fact it only engages with those who express a desire to quit abruptly, as well
as a perception that smoking is not a clinical problem which required ‘treatment’.3.4 Advanced reduction and cessation
3.4.1 Why quit?
Appendix 7.4.2 shows some of the advantages of quitting, over different time periods. The DoH HT
Handbook also includes a Health Beneﬁts card (see p. 17), which can be used to elicit smoker beliefs.3.4.2 Why is it hard to quit?
There are many reasons, but the main ones are failure to cope with cravings and withdrawal symptoms
(particularly during times of stress, or in the presence of smoking cues), difﬁculty in breaking a habit or
conditioned responses in certain environments and situations, lack of conﬁdence in avoiding smoking
perhaps developed from previous failed attempts, being surrounded by others who offer limited
support to quit, and weight gain. Alcohol consumption has also been linked to difﬁculties in
avoiding smoking.3.4.3 What support is available that is effective?
Appendices 7.5.11, 7.5.12 and 7.5.13 provide information on the use of NRT, Champix and Zyban which
are the main pharmacotherapies with an evidence for effectiveness. These are most often prescribed by a
clinical practitioner or fully trained Stop Smoking Service advisor. NRT is also available over the counter.
Behavioural support is available through Stop Smoking Services and other trained professionals, which is
also effective, and often delivered in conjunction with pharmacotherapies.3.4.4 Building on the DoH Health Trainer Handbook
Smoking cessation is one behaviour that HTs are encouraged to support. However, without extensive
training, if a client wishes to quit then an HT would normally refer a client to a professional with the skills
to provide the support described above. The focus in the HT Handbook is on helping smokers to abruptly
quit by setting a quit date and completely abstaining. There is little or no mention of smoking reduction in
as a shift towards this approach is fairly recent, and is only recommended in conjunction with NRT. Since
60-70% of smokers want to cut down but not quit smoking reduction interventions are seen as a
way of increasing the number of smokers who potentially get to the point, after reduction, of wanting
to quit.
EARS aims to increase physical activity in the absence of NRT, but in conjunction with behavioural
approaches to smoking reduction. In the following sections, different smoking reduction approaches areNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4described, before we consider how physical activity can be promoted, and particularly in a way that could
support smoking reduction, and cessation.3.5 Behavioural approaches to smoking reduction
Smoking reduction has not been advocated as an appropriate technique for quitting as it has been widely
believed that increasing the amount of time between cigarettes will only increase the reward and
satisfaction obtained from the cigarette when it is smoked, thus increasing the value and desire of
each cigarette.
Research in this area is still in its infancy, but a recent review by Aveyard et al (2010) has reported that
there is no difference between abrupt quitting and cutting down to quit on long term cessation, but this is
based on interventions involving Nicotine Assisted Reduction then Stop (NARS).
Several potential strategies for cutting down have been developed and proposed over recent years.
Crucially they all hinge on breaking the conditioned responses to smoking stimulus. Unlike abrupt quitting,
they aim to gradually breakdown learned routines and break habits which may increase conﬁdence and
desire to stop completely. The different strategies are presented in the following sections.3.5.1 Hierarchical reduction
Certain cigarettes offer higher reward value than others and as such are harder to give up. The ﬁrst
cigarette in the morning (following overnight abstinence) is routinely reported to be the hardest to give up.
It has even been suggested that the only question of importance in assessing a person’s level of smoking
dependence is ‘how soon after waking do you smoke your ﬁrst cigarette?’
Hierarchical reduction works by asking people to rank cigarettes in order of the easiest to the hardest to
give up. Starting with the easiest, smokers plan which ones they will give up on a speciﬁed time scale. It
may be one a day over a two week period or however the person feels best to progress, eliminating the
easiest and eventually beginning on the harder cigarettes to give up, as conﬁdence to go without a
cigarette increases.157
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 43.5.2 Smoke free periods
The Smoke free periods approach works by breaking an individual’s day up into blocks of speciﬁed time
periods (e.g. 30 mins). Depending on their routine (work etc) there may be periods where they do not
smoke anyway, and periods where they smoke more. Using chart, smokers then go on to block out certain
times of the day where they will not smoke (perhaps increasing by one 30 minute smoke free period per
day) until they have reached a certain goal.
Importantly with the smoke free periods approach, there is no speciﬁed number of cigarettes which are
being cut out or smoked. They can smoke as much as they like, but ONLY in the periods not identiﬁed as
smoke free. This approach aims to break the behavioural pattern of smoking which will result in a
decreased desire for smoking and a natural reduction.159
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 43.5.3 Scheduled reduction
The aim of the scheduled reduction approach is to systematically reduce at a speciﬁed rate, breaking habit
and routine gradually. It begins with identifying how many cigarettes a person smokes in a day, and
calculating how much time between each cigarette is needed to space them evenly through the day. For
example, a 40 a day smoker, who is awake for 16 hours a day, would need to smoke a cigarette every
24 minutes to get through 40 in one day. Targets are then set to gradually increase the time between
each cigarette with a speciﬁc end goal in sight.
Important to this method is the necessity to smoke at every speciﬁed time point, whether it’s desired or
not, which again helps to break the habit of smoking.161
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Perhaps one of the simplest ways to plan reduction, this approach works by setting targets for how many
cigarettes will be smoked each day. Then each day begins with that number in their pocket, and
purchasing additional ones is to be avoided.
The rate at which they reduce is determined by them and ultimately how much they want to reduce by
and over what period. This approach ﬁts particularly well with goal setting and action planning processes
described in the HT Handbook.163
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4All the above approaches have their pros and cons. The key will be to enable smokers within EARS to
choose an approach to experiment with, and to help set a timescales for rate of reduction, as part of the
action planning process. Our ideal would be to reduce by 50% over no more than 4 weeks, and then
consider further reductions. But there will be considerable variation in participants’ responses and success.3.6 Physical activity and health, optimal dose and promotionFig.
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SciencIf some of the benefits accruing from regular physical activity could be procured by any one medicine,
then nothing in the world would be held in more esteem than that medicine.
Francis Fuller, 1705Physical activity is widely accepted to beneﬁt health both physically and mentally. Being regularly active
decreases the risk of developing an extensive range of medical conditions such as: cardiovascular disease,
diabetes, cancer, depression, anxiety, dementia, high blood pressure, osteoporosis, osteoarthritis, lower
back pain and lowers the risk of falls among the elderly.
The Department of Health recommends that adults achieve at least 30 minutes of moderate intensity
moderate-intensity physical activity on at least 5 days of the week, 3 × 20 mins of vigorous physical activity
for cardiovascular health. Activity does not have to be continuous for 30 minutes but can be in shorter
10 minutes bouts throughout the day.
The dose for improving mental health is less clear, although 1 study suggested this same dose would be
necessary to reduce depression. Short bouts of moderate physical activity can relieve stress and tension,
whilst improving a sense of pleasure and activation. The ﬁgure below shows how regular short bouts
throughout a day can help to elevate overall mood.
Importantly, by breaking physical activity into short bouts, it may become easier to meet the daily
recommended dose in a sustainable way.
Using a Decision-Balance sheet, as shown in the DoH HT Handbook (p.26), it is easy to identify the pros
and cons of becoming more active. But the commonly cited barriers shown below are largely a function of
how we introduce or use the terms sport, exercise and physical activity. Short bouts of brisk walking do
not have the same barriers as signing up for an exercise class or joining a sports club.
Commonly cited barriers to different types of physical activity.
l I’ve never done it
l I wasn’t good at sports at school
l I would feel silly
l Other people would make fun of me
l It won’t help unless it hurts - ‘No pain, no gain’Mood
Time
6 Graphical representation of physical activity and mood.
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166l It’s sweaty and uncomfortable
l I’m too tired
l I would rather do something else
l It’s expensive
l I think it will make me feel worse
l I don’t have anyone to do it with
l I don’t know where, when or how to start.
There are a number of factors which can inﬂuence how people relate to and perceive different types of
physical activity. Typically activity is thought of in four or ﬁve different dimensions: Frequency, Intensity,
Duration and Type. Timing is less commonly considered but may also be important in the context of using
physical activity to speciﬁcally help cope with cigarette cravings.
Frequency: How often does the behaviour occur? Is it better to do some physical activity every day or just once
in a longer block at weekends? For cardiovascular health, it does seem to be important to regularly exercise.
Long periods of sedentary behaviour are increasingly being linked to increased risk of some health problems
such as diabetes. The evidence is less clear for other conditions but we do know that even short bouts of activity
can increase activation or energy levels, increase positive affect and reduce our natural psychological and
physiological responses to stress or threatening situations. Therefore, repeated bouts may lead to an
accumulated beneﬁt over a period of time which one longer single session per week may not provide.
Intensity: How intense is the activity? How much effort or physical and mental discomfort does a person
experience? The experience of how intense an exercise is can be highly individual, and may depend on
several factors such as cardiovascular ﬁtness, fatigue, previous experience, mood, and any existing
physical disability.Table 2 Pros and cons of physical activity of different intensities
Intensity What is it? PROS CONS
VIGOROUS E.g. Running,
hard cycling, squash,
aerobics, circuit training,
hard manual work, team
sports
An activity that leaves you
feeling (extremely) out of
breathe and unable to
hold a conversation. Your
heart rate will rise
signiﬁcantly and will often
lead to high levels of
perspiration. Breathing
will become very rapid
and heavy.
Evidence suggests it
offers the most physical
beneﬁts for those who
complete it.
Can offer a greater sense
of achievement and ‘feel
good factor’ for the right
person.
Extremely off putting to
most, especially people new
to physical activity.
Can cause delayed muscle
pain (not necessarily serious,
just uncomfortable)
The risk of injury is greatly
increased.
Often needs specialised
equipment and environments
(cost) to do it, with high
levels of supervision.
For smokers it may
exacerbate symptoms of
breathlessness.
MODERATE
E.g. Brisk walking
(complete 1 mile in around
15 minutes), cycling,
effortful housework,
gardening, golf, tennis,
dancing, tai chi.
An activity which still
allows you to hold a
conversation, but you will
still feel your heart rate
rise, your skin warm and
your breathing become
slightly faster.
Is easily achievable for
nearly everyone.
Easily accessible and can
be done without high
levels of supervision.
Still has signiﬁcant beneﬁts
for health (national
guidelines promote
MODERATE activity)
People may not think of
moderate activity as having
any beneﬁts (too easy)
Slightly increased risk of
physical injury, but it is
minimal
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Table 2 Pros and cons of physical activity of different intensities (continued )
Intensity What is it? PROS CONS
LOW
E.g. slow walking/ strolling,
easy housework, light
gardening, yoga.
An activity which is very
easy to complete, only
slightly raises heart rate
and does not require
faster breathing.
It can be a good starting
point for increasing
motivation and conﬁdence
to complete physical
activity for those with little
or no experience.
Can increase conﬁdence
and self belief in moving
onto moderate activity.
Very small risk involved.
Any energy expenditure
is better than sitting.
Conveys little or no health
beneﬁts.
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Duration: How long does the activity have to take place for? Is it in one long block or broken into
smaller chunks?
l Presenting people with the task of walking or cycling continuously for an hour or even 30 minutes can
seem daunting and lowers motivation and conﬁdence. Breaking activity up can make it seem more
achievable and easier to ﬁt into people’s lives.
l The national guidelines suggest 30 minutes of daily moderate activity can be achieved in blocks of
10 minutes. Therefore, someone could walk briskly to work or shops in the morning, take a short
10 minute walk at lunch time and walk home again and they would meet the minimal recommended
guidelines for physical activity. This can often be perceived to be far more achievable than one longer walk.
Timing: What time of the day, or maybe week, are people completing physical activity? This is perhaps
one of the less considered aspects of physical activity, but remains important none the less.
l It could be that a person aims to complete a walk ﬁrst thing in the morning, but in reality they are
pushed for time in the morning and simply cannot sustain it. Or, perhaps more detrimentally, the idea
of going for a walk in the morning becomes a burden and adds pressure to them at a time when they
feel they simply cannot ﬁt it in, resulting in feelings of guilt for having not done it.
l It could also be that exercising vigorously or in a way that is unfamiliar in the evening can result in
disturbed sleep as a result of a raised body temperature and hormonal responses.
l A person may also gain enjoyment from completing the same activity at different times of day. For example,
they may enjoy walking the dog early in the morning compared to late at night because of the different
environments (light vs dark) and feelings of safety. They may also want to do it after a busy day to ‘unwind’.
Mode: Physical activity takes many different forms and can serve many different purposes. It is important
to know what type of physical activity a person believes they may enjoy/have enjoyed in the past. Running
can be completely off putting for one individual, but potentially rewarding and enjoyable for another.
l Promoting an activity which a person does not enjoy will likely limit adoption and maintenance of
that activity.
l It is important to consider that although an individual may not enjoy an activity of a certain intensity
(such as jogging), they may however enjoy an alternative activity of a similar intensity but different
mode (eg cycling).
l Certain modes of activity can also have time implications. For example, arranging a game of
badminton can require travelling time, perhaps a minimum court booking of an hour, and may depend
on facility opening times. Compare this with taking a walk, which needs little preparation and planning
and can be completed at most times of the day.167
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168l Different modes of activity can also have different cost implications. Cost is often a large barrier to the
adoption and continued participation in certain activities. The cost of going for a walk is minimal
compared to going for a cycle if the person does not own a bike.
There are some other important psychosocial factors surrounding physical activity which can strongly
inﬂuence its successful adoption and enhance the positive experience of being physically active:
Environment: It is entirely plausible that the location in which an activity takes place will inﬂuence how
an individual experiences that activity. Walking on a treadmill in a gym will provide an entirely different
experience to walking through a country park, despite being the same physical activity. The experience of
one exercise or yoga class may be entirely different to another class with a different instructor elsewhere.
It is also important to consider how an environment has the potential to damage an individual’s
conﬁdence and motivation. For example, attending a heavily strength and weights orientated gym can be
a highly off putting experience for a beginner or somebody with low physical self-esteem. A bad
experience of a physical activity environment can make it highly unlikely for the behaviour to re occur.
Social Support: Can be considered in two forms – in terms who the activity is done with and support
from others for completing the activity.
Going for a walk with a friend can enhance the enjoyment of the activity, and agreeing to attend a new
exercise class with a friend will enhance the motivation and conﬁdence for continued attendance. Whilst it
can often be reported that completing physical activity alone can offer enjoyment (a chance to ‘get away
from it all’, to ‘clear your head’), completing it with others can go some way to fulﬁlling the psychological
need to feel connected with others.
Support from signiﬁcant others (friends, family, partners, etc) in relation to completing an activity is also
important in adopting and maintaining new behaviours. It is important to explore ways that support can
be found and elicited from those close to the people around them. For example, ask how a partner feels
about them trying to become more active. If the people close to them understand their reasons for
adopting new behaviours it is less likely they will be a negative inﬂuence or inadvertently create additional
barriers. A person’s conﬁdence is also likely to grow if the people around them are supportive and
encouraging of them trying new behaviours.
One of the most successful and sustainable forms of physical activity was called ‘Mums on the Run.’ Given
the barriers for exercise and needs for companionship for parents of pre-school children a group of up to
10 met weekly at a different person’s dwelling for coffee. Half the group went out for a jog/walk, leaving
the others to enjoy a chat and look after the children. They switched roles after 30 mins and everyone’s
needs were met at no cost.3.7 Advanced Physical Activity Promotion
3.7.1 Why increase physical activity?
The general health beneﬁts of increasing PA are shown on a Health Beneﬁts card in the DoH HT
handbook (p. 18). Clients may identify with these and other potential beneﬁts when they see this list.
These potential beneﬁts may also be elicited using the Decision-Balance sheet. Smokers are often aware of
the link between smoking and weight management. One of the particularly relevant beneﬁts of increasing
PA may be to prevent weight gain once smoking is reduced or stopped.3.7.2 Barriers to increasing physical activity?
It is not difﬁcult to elicit a client’s perceived barriers to doing more PA in general. A more fruitful approach
is to identify speciﬁc forms of PA and then seek to elicit perceived barriers to that dose and type of PA,
which may be preferred. Negotiation with a client should go back and forth until ultimately goals are setNIHR Journals Library www.journalslibrary.nihr.ac.uk
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insurmountable: They can be overcome. Setting goals which are unrealistic is inviting failure.3.7.3 What support is available that can help a client to increase PA?
There are three ways of looking at supporting increases in PA:
1. Working with a client to change cognitions (such as beneﬁts and barriers, and self-efﬁcacy/conﬁdence).
2. Build an empathetic relationship with the client, and encourage them to seek and gain support from
others to achieve PA goals.
3. Direct clients to sources of information and opportunities for PA. Also, help a client to develop behavioural
skills (e.g. self-monitoring using a pedometer) to enable them to achieve goals. To remove ﬁnancial barriers
to doing PA, participants in the EARS intervention will be offered incentives (e.g. free access to gyms).3.7.4 Building on the DoH Health Trainer Handbook
The approaches for supporting clients to increase physical activity in the HT Handbook are largely sufﬁcient for
setting and evaluating goals, avoiding relapse and resetting goals over time. The HT may be able to extend
initial discussions by asking clients to think about beneﬁts and perceptions associated with different doses
(frequency, intensity, duration, type, and timing). This may help to identify a client’s preference for types of PA.
The HT Handbook does not consider when best to do PA. If the value of PA for regulating mood is
recognised then a client may be helped to identify when it may be most valuable to engage in PA. The HT
Handbook also does not consider how to support an increase in PA while reducing or stopping smoking at
the same time. There is a view held by some that it may overload clients if too many behaviour changes
are tackled at the same time, though others have suggested this does not have to be the case.3.8 Physical Activity and Smoking Behaviour
3.8.1 Chronic physical activity and smoking cessation
Cross sectional data reveals that those who are more active are less likely to smoke, and smokers are
typically less active as shown below. Does this mean that by increasing PA there will be a tendency to
reduce or stop smoking? And do smokers become more active when they reduce or stop smoking?
Several well conducted trials have considered what happens when a smoker who quits increases physical
activity, with encouraging results. In one study, vigorous intensity structured (gym-based) exercise on three
days a week over 15 weeks increased the number of female quitters at 12 months, relative to controls. But
smokers may be more interested in moderate rather than vigorous activity.Ph
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Fig. 7 Graphical representation of physical activity levels and the chance of being a smoker
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1703.8.2 How can physical activity help with smoking reduction and cessation?
Physical activity could inﬂuence smoking behaviour through either EXPLICIT or IMPLICIT processes. Smokers
have told us that they deliberately use exercise such as going for a walk after a meal, to distract them from
smoking when they would otherwise have smoked. Others have said that they were afraid of gaining
weight so started doing more physical activity. Using physical activity as a method of directly compensating
for the negative effects of smoking and quitting would be explicit.
In contrast, general increases in physical activity that may have indirect effects on smoking behaviour
would be implicit. The table below lists some examples.able 3 Explicit and implicit processes
EXPLICIT processes IMPLICIT processes
l Weight gain management.
l Acute craving and tobacco withdrawal symptom
management.
l Focus on a increasing a positive behaviour (i.e. PA)
rather than reducing or quitting smoking.
l General enhanced mood and reduced depression and
anxiety from PA, reduces urge to smoke.
l General sense of enhanced mastery and self-perceptions,
provides conﬁdence to reduce smoking.
l Reduced importance and reward from a cigarette.
l Identity shift from a smoker to a non-smoker/exerciser.
l Being in new environments where people don’t smoke
helps reduce conditioned response to smoke.
l Money for sport and exercise participation may lead to a
re-evaluation of money spent on cigarettes.
l Feeling breathless when exercising may trigger fear
appraisals about health status.TThese processes all have implications for promoting PA to help smokers to reduce and quit smoking.
Given that coping with cravings and withdrawal symptoms is one of the main reasons why smokers ﬁnd it
difﬁcult to cut down or quit, using PA as a coping strategy may be important. Just generally increasing PA
may also have valuable indirect beneﬁts.3.8.3 Acute physical activity management of cravings and
withdrawal symptoms
Studies have consistently shown that during temporary smoking abstinence, when cravings are high, a
short bout of PA (e.g. a brisk 15 min walk or 5 mins of seated isometric exercise) reduces cravings and
withdrawal symptoms. The effects last beyond the exercise, for at least as long as the exercise itself.
When smoking cues are introduced, PA has been shown to limit the increases in cravings. Also, a session
of PA delays ad libitum smoking. It would therefore appear appropriate for smokers to explicitly use short
bouts of PA to aid smoking reduction and quitting.
If smoking is based on the need to relieve negative mood states then a single bout of physical activity can
help control withdrawal symptoms and relieve cravings, as shown in the Figure below. Repeated exposure
to physical activity, with enhanced mood, may help to increase a belief in the value of exercise for
managing cravings and withdrawal symptoms.
3.8.4 Physical activity and weight gain
After smoking cessation, smokers (and particularly women) experience an average of 5-7kg weight gain
within a year of quitting. Fear of this weight gain prevents many people from quitting. The effects on
weight gain from smoking reduction are not known. Weight gain is a result of a slower metabolic rate
without nicotine in the body and also emotional eating.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Fig. 8 Graphical representation of negative mood states and smoking withdrawal symptoms
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Increasing PA while cutting down (and quitting) may reduce weight gain not only by increased energy
expenditure but also through improved control of energy intake (particularly via emotional eating).3.9 Advanced elements of supporting behaviour change
As a HT working within EARS there is an opportunity to develop a more advanced understanding of how
best to support behaviour change. In any attempt to support behaviour change there is a chance, indeed a
high possibility of several things:
1. That clients may fear or experience failure to achieve goals.
2. That clients feel they are changing for someone else and not because they really want to.
3. That they are doing something which is not in line with what others feels they should do.
Such emotional responses minimise the chance of sustained engagement in an intervention, like the one
planned in EARS, and also successful changes in behaviour.
In contrast, HT support that limits failure, encourages ownership and control of the behavioural change,
and provides or facilitates opportunities for social support, may be more likely to result in sustained
engagement in the intervention, and hence successful changes in behaviour.
Here we consider the value and process of promoting self-determined behaviour. Self Determination
Theory (SDT) predicts that real shifts in behaviour result from satisfying three essential psychological needs
(called the 3 Cs), which are having a sense of:
1. Competence: When an individual feels capable to affect a desired behavioural outcome.
2. Control: When an individual feels to have a sense of personal choice in deciding what to do.
3. Companionship: When an individual feels secure within an environment while also fulﬁlling a need to
feel connected to others.
Goal setting is a core part of the role of the HT. It is very easy to see how goals could be set that
undermine all these needs. A HT could also communicate in a way that undermines these needs.
So there are two key elements for developing advanced behaviour change skills:
1. Negotiate with clients to ensure the actions planned will satisfy these core needs (i.e. 3 Cs).
2. Communicate with clients in a way that will satisfy these core needs (i.e. 3 Cs).3.9.1 Promoting physical activity to satisfy the 3 Cs
Supporting a client’s increase in physical activity provides an opportunity for that individual to satisfy the
three ‘C’s as follows:171
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172COMPETENCE – By setting and achieving realistic goals an individual can build a sense of competence.
[Equally, inappropriate goals can undermine a sense of competence, and clients with initially low self-
efﬁcacy may be quick to say, ‘I told you so’ when they experience failure.] Goals that are measurable
provide an opportunity to gain a sense of achievement. Help the individual to identify these achievements
and link them to the client’s efforts. Short-term goals can help to build into long-term achievements and
again, with reﬂection, provide a sense of achievement.
CONTROL – Through a client-centred approach, the client is involved in the goal setting process, and
encouraged to link effort and success. Achievements linked to the role of the HT rather than the individual
does not enhance a sense of control. Giving advice and information, when the individual could ﬁnd this
out for themselves can also undermine a sense of ownership and control or autonomy. The client should
choose what activity to do, when, and where to do it.
COMPANIONSHIP – Quality PA experiences often involve other people, and the connection felt with
others can be a strong motivator for that behaviour. The individual can also feel companionship in the
environment they are in – a sense of belonging where they feel secure and competent.
Physical activity experiences which provide the individual with the satisfaction of these three Cs will see
higher adherence rates. Activities which meet these needs for each individual will be vary greatly as
different people put different values on different experiences. There is no ‘one size ﬁts all’ activity, and
tailoring action plans is crucial in developing an intrinsic motivation and sustained change.3.10 Communicating with patients
Overall Aim: To maximise sustained behaviour change with a variable amount
of the intervention.
Objectives
1. Achieve ﬂexibility in the programme based on each individual’s readiness to be introduced to and try
participating in physical activity (PA) and reducing smoking – negotiate the type, intensity, duration, and
frequency of activity the patient believes they can achieve.
2. Highlight and enable patients to access physical activity opportunities that minimise barriers, provide
rewarding experiences, and result in sustainable physical activity.
3. Use compiled regional current information on physical activity opportunities matched to the patients’
preferences and motivation/readiness to change.
4. Recognise the boundaries of the facilitator and be aware of risk assessment in case of the need of
referral back to the GP (and informing trial coordinator).
Outcomes
l Enable patients to access physical activity opportunities that minimise barriers
l Provide rewarding experiences through negotiation & reinforcing positive events
l Achieve sustainable increases in physical activity (however subtle)
l Acquire self-regulatory skills in managing smoking cravings and withdrawal through the use of
physical activityKey principles
The following are key principles to follow when working with patients:Allow choicel Ensure that the patient understands the approach/model and acknowledge this approach makes sense
to the patientNIHR Journals Library www.journalslibrary.nihr.ac.uk
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l Be aware that not all patients will embrace physical activity after initial session
l Be aware that any activity will be beneﬁcial regardless of smoking habit and the patient may not
achieve the government recommended levels of activity by the end of the contact time. But the
physical activity patterns will have been established.Develop rapportl Listen to the patient. Make sure you have understood what they have said. Ask questions if you are
not sure.
l Don’t be judgemental. Respect their point of view. Do not disagree with a patient.
l Summarise what the patient has said. Don’t assume you have understood what they have said. Make
sure you repeat back what they have told you.Avoid disagreement, lecturing or naggingl Ask questions rather than give instructions
l It is a collaboration, make sure you work with your patient
l Never disagree or argue with a patient
l Don’t nag, ask how you can help them achieve their plans
l Ask what stopped them achieving things this weekMake sure the patient understands the rationalel Refer back to the patient’s list of problems
l Make the link between their desire to cut down and the beneﬁts of physical activity
l Repeat the rationale
Many of the above principles and techniques for developing rapport with clients are common sense and
come naturally to a good communicator. They also overlap with an approach that you may have heard
about called Motivational Interviewing (MI). It also links well the 3 Cs from Self-Determination Theory. The
key thing is that in EARS the HT should adopt a client-centred communication style, which is compatible
with the techniques and approaches described in the HT Handbook.
There may be times when clients request information and direction but, while this may have short term
effects, it may not help sustainable changes in health behaviour.
The EARS intervention is not, however, about the effects of MI on smoking reduction and cessation, but
we will borrow principles and techniques commonly used in MI.
The following 4 pages highlight some of the key aspects of MI.3.10.1 Motivational interviewing© Que
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SciencDeﬁnition of brief motivational interviewing: a directive, client-centred negotiating style for helpingpatients explore and resolve ambivalence about exercise (and other health behaviours)
(Rollnick, 1992)173
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174Motivational interviewing (MI) is a philosophical approach to behaviour change based around the idea that
motivation to change behaviour will be enhanced, negotiated and directed by the interpersonal interaction
between the patient and facilitator or professional. It is important to understand the philosophy behind
motivational interviewing in order to correctly use techniques and work through ambivalence with
patients. As a patient centred approach, MI assists patients in articulating their concerns and arguments
about behaviour change. MI is a ﬂexible approach, with a number of strategies to choose from to match
the level of readiness to change within each individual.
The goal of motivational interviewing is to help patients with their ambivalence towards changing
behaviour through a series of techniques.
Ambivalence: Conﬂict between two different actions both having perceived costs and beneﬁts. The main
concept used is decision balance, weighing up the pros and cons of remaining inactive as compared to the
pros and cons of being active.
Readiness to change: Determining where the patient is on a continuum of motivation and being ready to
change their behaviour is also crucial for the facilitator to interpret. The readiness to change is an
important factor to address in order to negotiate the patient through from not being prepared to change
to already changing stage. Key questions to ask regarding this are ‘How important is it to you to change?’
and ‘How conﬁdent are you in making that change?’ These two questions will provide indication of the
levels of readiness to change and are also extremely useful tools for you to use as the facilitator to
encourage discussion around ambivalence.Key principles
Roll with resistance – As facilitator it can be useful to offer new perspectives, but it is important not to
impose them on the patient.
Express empathy – the key is to actively listen to the patient’s point of view and accept it even if you
don’t approve of it.
Avoid argument – remember not to ‘label’ the patient as it encourages defensiveness and resistance
from the patient.
Develop discrepancy – negotiate with patient to consider the consequences of their health behaviour
and develop an awareness of the importance of the consequences.
Support self-efﬁcacy – Assist patient through determining their own choices and understanding their
own capabilities, pushing the boundaries progressively but only with their permission.Skills you need as facilitatorl Asking open ended questions
l Use reﬂective listening
l Summarising/paraphrasingGolden rules of Motivational Interviewing
l R: Roll with resistance
l E: Express empathy
l A: Avoid argument
l D: Develop discrepancy
l S: Support self-efﬁcacyNIHR Journals Library www.journalslibrary.nihr.ac.uk
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There are three main reasons why patients may be resistant to behaviour change. The ﬁrst reason is that
they may feel like they are having their control taken away from them. A good way to deal with this is to
emphasise personal choice and control.
A second reason may be that you as the facilitator have misjudged or misinterpreted the patient’s
readiness to change, how important and/or how conﬁdent they are in changing. By revisiting these issues,
the facilitator will have an opportunity to make a clearer judgment regarding these points.
The third reason may be that you as the facilitator have been a bit too confrontational, confronting force with
force. This may occur when discussion around issues that the facilitator may consider straightforward in one
instance turns out not to be so straightforward in the patient’s view. To manage this, it’s best to back off and
essentially ‘come alongside’ the patient, not agreeing with them but changing tack and emphasising their
own control and choice in the matter and negotiating the idea of change back into the discussion.Menu of strategiesl Opening strategy: Lifestyle, stresses, health
l A typical day
l Assess motivation and conﬁdence
l Good things and less good things about behaviour
l Providing information
l Future and present
l Exploring concerns
l Helping with decision making
l Modiﬁed barrier approach: reasons why do you want to and reasons why not
¢ Explore reasons
¢ Emphasise personal control and choice
¢ Re-assess readiness, importance and conﬁdence
l Social support – social beneﬁts of exercise, group exercise3.10.2 Counselling techniques
Breakdown tasks
People often tend to be discouraged by large tasks and any difﬁculties or problems seem overwhelming.
The main strategy to prevent this is to break down large tasks into smaller tasks that are easier.
For some people, it might be important to suggest doing a limited number of these tasks during a week.
For example, agree to perform steps 1–4 above in the ﬁrst week.For example, someone might suggest attending an exercise/dance class. A breakd
this task might be as follows:
1. Find information on local classes
2. Identify sessions which could be attended
3. Speak to friend/s about attending with them (if appropriate)
4. Contact class to book/check availability
5. Obtain suitable footwear/clothing
6. Arrange transport to and from class
7. Agree a date for the ﬁrst class
8. Attend class
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OR, someone might suggest walking more regularly. A breakdown of this task might be
as follows:
1. Identify times in the week when a walk could take place
2. Locate possible walking routes
3. If transport is needed (rural walks) obtain information on travel options
4. Speak to friend/s about walking together (if appropriate)
5. Find suitable footwear and clothing
6. Find information on walking groups (if appropriate)
7. Plan a date for the ﬁrst walk
8. Go for walk
APPENDIX 1
176Agree achievable goals
The goals for activity need to be agreed with the patient. It is a collaborative activity. People often set unrealistic
goals that are too ambitious. If someone has not been exercising for some time they might set a target more
appropriate for when they were more active in the past. Therefore make sure that you agree a realistic goal,
particularly one that is easy to achieve. If people fail to achieve their goals then it can be discouraging.
Be aware that sometimes, people might achieve the goal but still come back and describe it as a disaster.
This is because they have added on extra aims that you were not aware of at the time. For example, they
might say ‘I went for a run around the park but had to stop twice’. The original agreed task was to run
around the park but on return they have added an extra goal, to carry out the run without stopping.
Remind the patient of the original aim and suggest that you include the additional aims in next week’s tasks.Treat the activity as an experiment
Make sure you have elicited expectations about the activity that has been agreed. This is important to
ensure that you agree with the patient what to achieve.
There are two aspects to the possible psychological beneﬁt from exercise:
1. Enjoyment
2. Sense of achievement
If you treat the exercise as an experiment, you could suggest that the patient rates their expected
enjoyment and sense of achievement before they carry out the agreed task. Then complete the same
ratings after the task. Quite often, the patient either enjoys or has a greater sense of achievement than he
or she expected. However, this is an experiment and everyone is different. It might also help them to
choose the kind of things that they get the most beneﬁt from.4 The InterventionWhilst the message being portrayed by the intervention is not one of smoking cessation but rather
reduction, the main desired outcomes from the intervention are concerned with quitting and remaining
abstinent. It is important to remember this and quitting should not be discussed with the participants
unless they express a desire to do so (i.e. it is on their agenda, not the HT’s agenda). The focus should
always remain on reducing smoking behaviour and increasing physical activity.4.1 Multiple behaviour change outline
Smokers who quit are generally advised not to change PA and diet at the same time by the Stop Smoking
Service advisors. However, simultaneous multiple behaviour changes at the time of quitting does appear toNIHR Journals Library www.journalslibrary.nihr.ac.uk
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rather than structured, facility-based exercise on 2-3 occasions per week.
The goal of the EARS intervention is to support multiple behaviour changes in a way that limits mental
overload, but uses PA to facilitate smoking reduction. The Figure below shows clearly the ideal scenario,
and captures the dual aims of EARS.
It is important that the participants appreciate how physical activity can impact on smoking; some clients
will already accept this based on past experiences. Others will need more persuasion and experimentation.
But it is a key component of EARS.
This Figure is available as a tool for generating initial discussions with smokers, alongside a Decision
Balance sheet for the advantages and disadvantages of PA. Table 3 on p.32 also highlights how PA may
explicitly and implicitly support smoking reduction and cessation, and these could be used as a tool to
prompt clients.4.2 Structure of the intervention
The EARS intervention sits inside a black box if you like, as shown in the Figure below. Ideally, we have
inactive smokers coming in and active non-smokers going out, based on the efforts of the HT in what is a
complex intervention.
We would like to be able to describe it in a way that others could reproduce in future health services. But
we accept that this may not be easy.
To be a truly client-centred intervention we need ﬂexibility in how much support each smoker receives and
when; it will not be a ‘one size ﬁts all’ approach.
The study aims to determine what and how much support smokers want.
Nevertheless, we had to set a target for what support to offer and how to structure it, for the purposes of
resource/stafﬁng allocation. The EARS intervention will initially aim to consist of 2 face-to-face andInactive
smoker
Active
non-smoker
Fig. 10 Graphical representation of the EARS intervention as a black box
Time
Le
ve
l o
f 
b
eh
av
io
u
r
Non-smokerInactive
Physically activeModerate or
heavy smoker
Fig. 9 Graphical representation of ideal simultaneous multiple behaviour change
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1786 telephone communications, over 8 weeks, after baseline assessment and randomisation. We expect that
many smokers will not want weekly contacts for 8 weeks. There will therefore be capacity to offer more to
some people as required.
If at any point smokers express a desire to quit within those 8 weeks, they will be referred to a NHS SSS
advisor for up to 6 weeks of support for quitting, using the usual pharmacotherapy and behavioural
support. Six concurrent sessions will be delivered by the HT during this quit attempt to support the
maintenance of PA?4.3 Progression
Behaviour change is rarely a linear process, as the Figure on p. 11 of the HT Handbook shows. HT will help
smokers to prepare for setbacks. Clients will increase PA and reduce smoking in a variable way, and could
decide to quit at any point, if at all, within the initial 8 weeks of support. For one person, a 30 min walk
on 5 days a week could be a great achievement that is worked towards over the 8 weeks, whereas others
may accumulate shorter bouts within days. Reducing from 40 to 10 a day will require different progression
compared with reducing from 20 to 10 a day.
Our early experiences of delivering the EARs intervention suggest that many smokers want to focus on
smoking reduction initially, and already have ideas of which cigarettes to eliminate ﬁrst. It then becomes a
challenge to enhance any beliefs that physical activity maybe useful, as the remaining cigarettes pose a
greater challenge to eliminate. HTs should not forget the focus of EARS on increasing physical activity.
4.3.1 Face-to-face meetings
Face-to-face meetings will take place in variety of locations acceptable to the participants. This could be
in a community location, or in a GP practice or similar. The location will be negotiated with the
participant. For the initial settings a community location or GP practice is preferable, and thereafter at
the patient’s home if the HT feels comfortable. It is the responsibility of the HT to book/arrange locations
for meeting the participant. For any lone visits the LONE WORKER POLICY must be adhered to.
See section 8.1.
The sessions can take place out of normal ofﬁce hours in order to maximise participant attendance and
retention, to be negotiated with the participant.4.3.2 Telephone sessions
Each Health Trainer will be supplied with a mobile phone. This must be used for each contact made with
the patient. The number should not be withheld and should be easily identiﬁable for the participant.
Again, the timing of the sessions should be ﬂexible to suit the participant’s needs.
Telephone sessions must be completed in a conﬁdential manner where no one can over hear your
conversation. If the participant has others around them that is their choice, check they are happy to
continue, but the HT must be in a private space.4.3.3 Keeping in contact
ALL contacts and attempted contacts with participants must be recorded. This is to be able to calculate
how much of the planned intervention has been delivered and hence how much has it cost.
Each participant may have a different preference for ways of keeping contact. Email, text messaging,
postal letters and telephone calls are all acceptable.
Every effort should be made to ensure successful contact – this could include postal reminders of
appointments, text messages before calling or calling in the morning of an appointment as a gentle
reminder. It is a frustrating waste of your time and project time if somebody does not keep theirNIHR Journals Library www.journalslibrary.nihr.ac.uk
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Fig. 11 Graphical representation of the EARS trial process in detail
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4appointment, but it will happen, so do not be disheartened and continue to make attempts to rearrange
the appointment in line with the operating procedures.5 Recruitment/Referral ProceduresAn important part of the trial is to examine whether hard to reach smokers can be recruited into a
smoking reduction trial such as EARS. The outlined recruitment strategy is to aim for 60 participants179
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180recruited through primary care (GP Practice lists) and 60 recruited through community-based approaches
(NHS SSS lists, outreach work etc).
Of the 120 participants recruited and randomised, over 12 months from March/April 2011, we would like
approximately 75% (n=80) of the sample to be unemployed, receiving beneﬁts, or in social class C2-E;
30% (n=36) from single parent families; 20% (n=24) with mental health problems, with some overlap
between sub-groups. As the study progresses we will get a feel for whether we are meeting these targets,
and hence if speciﬁc strategies need to be adopted to achieve them.5.1 Primary Care Referral
Two GP practices have agreed to take part in the study:
Marlborough Surgery, 1 Marlborough St., Devonport
PL11 4AE
Adelaide Surgery, 20 Adelaide St, Stonehouse
PL1 3JF
With support from the Primary Care Research Network (PCRN) the practice lists will be systematically
searched. GP practice lists contain information on smoking status: It is this information which will be used
to identify potential participants who will be sent an invitation letter. To prevent the possibility of having
too high an inﬂux into the trial, this will be done in batches of 50 letters per practice every week.
Depending on response/uptake rate this may change.
The study is adopting an ‘opt out’ approach in order to not exclude those with low literacy levels. After
the letter is sent there are ﬁve possible next steps:
1. The participant contacts the HTs expressing an interest in taking part and is recruited.
2. The participant contacts the HTs expressing no desire to take part.
3. There is no contact from the participant within one week, then the HT makes contact by telephone and
they are screened and if suitable recruited into the trial.
4. There is no contact from the participant within one week and the HT makes contact with the
participant and they decline to take part.
5. There is no contact from the participant within one week and the HT fails to make contact with
the participant.5.2 Community Recruitment
Community recruitment approaches will be explored and developed throughout the trial. They will need to
be well documented as reporting on effective community approaches is of great interest in a study of this
nature. It is likely to consist of a very diverse range of approaches, including:
l NHS SSS Lists
NHS SSS possess lists of all those who have attempted to make an abrupt quit attempt using their service
but have failed in the past. Invitation letters will be sent to those who meet the inclusion criteria, and the
same 5 possible next steps as for the primary care referral will follow.
l Community Centres
l Community Events
l Outreach work
l Voluntary groups
l ‘Health Champion’ referralNIHR Journals Library www.journalslibrary.nihr.ac.uk
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success of different type of contacts and approaches will be maintained.6 Session by sessionOverview of each session:Session Aim
Content (may be transient across sessions
depending on individual progress)
1 (face-to-face) Introduction and assessment.
Build rapport with patient.
Explore patient beliefs about PA and
smoking reduction.
Enhance intrinsic motivation.
Planning and goal setting.
Enhance conﬁdence for change.
Discuss collaborative approach and explore nature of
the patient’s smoking and physical activity habits.
Build belief in the value of and importance of
cutting down.
Explore pros and cons of change.
Present 4 possible approaches to cutting down and ask
participant to identify which is most appropriate to
them.
Explore PA history, interests, pros and cons of different
forms of PA.
Explore beliefs in PA as an aid to cutting down
(explicitly – past experience?, and implicit effects).
Develop intrinsic motivation for PA and cutting down.
Present treatment structure, ﬂexibility of sessions,
organization of sessions.
Explore tasks for next session, self-monitoring with
weekly worksheet.
This content can extend into and be repeated in
subsequent sessions depending upon patient’s
readiness to change.
2 (phone call) Building commitment to increase PA and
reduce smoking.
Planning and goal setting.
Provide feedback.
Review progress (tasks, new tasks, changes and
barriers).
Work through pros and cons of increasing and
maintaining PA.
Encourage self-monitoring with a weekly worksheet to
identify PA level, and strengthen perceived links
between PA and smoking levels.
Support client in planning and goal setting for PA and
continued reduction.
Signpost client to PA opportunities if needed.
Encourage a different reduction approach if the ﬁrst
approach has been unsuccessful.
Revise strategy and plans if necessary (phone vs in
person session).
This content can extend into and be repeated in
subsequent sessions depending upon patient’s
readiness to change.
continued
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(continued )
Content (may be transient across sessions
APPENDIX 1
182Session Aim depending on individual progress)
3 (phone call) Discussion of progress, outcomes and
barriers. Support psychological needs
associated with PA (the three Cs).
Encourage belief in value of PA as a tool
for coping with reduction.
Provide feedback.
Assess progress with goals set at last session
Facilitating PA experience – explore ways to build
competence, autonomy and relatedness in an enjoyable
way
Discuss completion of goals, what they found easy or
difﬁcult and why (autonomy)
Discussion of ‘barriers and facilitators’
Discuss revision of goals, plan new goals (competence)
Discuss how to progress with new goals to increase
interaction with signiﬁcant others (relatedness)
4 (phone call) Revise progress, discuss medium/long
term goals.
Continue to support psychological needs
Encourage belief in value of PA.
Review previous goals, reﬂect on achievements and
plan new goals – building a sense of competence
Explore ways to build a sense of control
(self-regulation) over PA behaviour and mood.
Explore ways to build relatedness or companionship
through PA
5 (phone call) Discuss progress/changes in well-being.
Barrier management and continuing
activity.
Establish/maintain (or progress to) PA
and reduction targets.
Promote self-regulatory skills and ownership of PA
decisions/choices and reﬂect on progress on reduction
Encourage quality social opportunities (companionship)
through PA participation.
Maintain use of goal setting (worksheets if used)
Discuss potential strategies to help maintain activity.
6 (phone call) Review maintenance strategies.
Reinforcing activity and revision.
Highlight patients’ control over PA choices and effects
on mood and smoking behaviour.
Reinforce any changes in self-conﬁdence related to PA
and smoking reduction.
Review progress and explore how to manage relapse.
Encourage reﬂection on situations which illicit
undesirable behaviour (increases smoking) and explore
ways to deal with these
7 (phone call) Review maintenance strategies.
Reﬂect on achievements.
Consider long term maintenance/goals.
Reinforce positive changes in behaviour to this point
Reﬂect on the beneﬁts gained from changing
behaviour
Emphasise distance travelled and achievements made,
no matter how small
Begin to discuss potential strategies for long term
maintenance (eg identifying relapse)
8 (face-to-face) Final discussions.
Exit strategy.
Discuss triggers/cues to changes in PA and smoking
behaviour
Explore management and modiﬁcation to strategies
Consider positive experiences and how to re-engage in
PA if relapse or smoking increases.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
(continued )
Session Aim
Content (may be transient across sessions
depending on individual progress)
The sessions during a quit attempt may begin at any time up to session 8 or after session 8 if they express a
desire to quit during that session. Although the main outcome measure (expired air CO) is taken 4 weeks post
quit, 6 weeks of support will be provided to allow for lag time between expressing a desire to quit and
accessing NHS SSS support and then setting a quit date. There is an element of uncertainty in these timings and
ﬂexibility is essential.
START OF QUIT
ATTEMPT 1
(face-to-face)
Goal setting.
Support psychological and behavioural
needs.
Coping with cravings
Discuss explicit use of PA as a coping strategy
for cravings
Build link between inactivity and elevated cravings
(weekly worksheets on cravings and PA)
Revise activity goals in line with quit attempt
QUIT ATTEMPT
2 (face-to-face)
Review of progress.
Revision of goals.
Building three ‘c’s of activity
Review progress of goals – what was easy what
was hard.
Explore situations and behaviours which elevated
cravings and strategies to cope with these in future
Reﬂect on nature and quality of PA (is it satisfying the
three ‘c’s of Control, Competence, and
Companionship?)
QUIT ATTEMPT
3 (face-to-face)
Review of progress.
Revision of goals.
Building three ‘c’s of activity
Overcoming barriers
Review progress of goals – what was easy what
was hard.
Explore situations and behaviours which elevated
cravings and strategies to cope with these in future
Reﬂect on nature and quality of PA (is it satisfying the
three ‘c’s of Control, Competence, and
Companionship?)
QUIT ATTEMPT
4 (face-to-face)
Review of progress.
Revision of goals.
Building three ‘c’s of activity
Overcoming barriers.
Identifying smoking cues.
Review progress of goals – what was easy what
was hard.
Explore situations and behaviours which elevated
cravings and strategies to cope with these in future
Reﬂect on nature and quality of PA (is it satisfying the
three ‘c’s of Control, Competence, and
Companionship?)
QUIT ATTEMPT
5 (face-to-face)
Review of progress.
Revision of goals.
Building three ‘c’s of activity
Overcoming barriers.
Identifying smoking cues.
Relapse prevention planning
Review progress of goals – what was easy what was
hard.
Explore situations and behaviours which elevated
cravings and strategies to cope with these in future
Reﬂect on nature and quality of PA (is it satisfying the
three ‘c’s of Control, Competence, and
Companionship?)
QUIT ATTEMPT
6 (face-to-face)
Review of progress.
Revision of goals.
Building three ‘c’s of activity
Overcoming barriers.
Identifying smoking cues.
Relapse prevention planning
Review progress of goals – what was easy what
was hard.
Explore situations and behaviours which elevated
cravings and strategies to cope with these in future
Reﬂect on nature and quality of PA (is it satisfying the
three ‘c’s of Control, Competence, and
Companionship?)
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1847 Appendices
7.1 Reflective checklists
7.1.1 Session 1 checklistNIHR Journals Library www.journalslibrary.nihr.ac.uk
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1867.2 Problem-solving worksheets
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Study Protocol
HTA no: 07/78/02
ISRCTN no: 13837944
UKCRN Study ID: 8937
LREC no: 10/H0106/59List of AbbreviationsCI Conﬁdence Interval
CO Carbon Monoxide
DMEC Data Monitoring and Ethics Committee
DRCP Devonport Regeneration Community Partnership
ES Effect Size
FTND Fagerström Test for Nicotine Dependence
GP General Practitioner
HT Health Trainer
HTA Health Technology Assessment
mCEQ Modiﬁed Cigarette Evaluation Questionnaire
MI Motivational Interviewing
MPSS Mood and Physical Symptoms Scale
NARS Nicotine Assisted Reduction then Stop
NHS National Health Service
NRT Nicotine Replacement Therapy
PA Physical Activity
PAR-Q Physical Activity Readiness Questionnaire
PCRN Primary Care Research Network
PCT Primary Care Trust
PI Principal Investigator
PM Project Manager
QALY Quality Adjusted Life Years
RCT Randomised Controlled Trial
SPSS Statistical Package for the Social Sciences
SSS Stop Smoking Services
TSC Trial Steering Committee213
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
APPENDIX 2
2143 Summary of studyTitle: An exploratory trial to evaluate the effects of a physical activity intervention as a smoking
cessation induction and cessation aid among the ‘hard to reach’.
Short Title: Exercise Assisted Reduction then Stop (trial acronym: EARS)
Objectives: Primary Objective: To develop a multi-component PA intervention aimed at helping smokers
(not intending to quit in the next month), among ‘hard to reach’ groups, to cut down.
Secondary Objectives: (i) To assess via interview the acceptability of such a PA intervention as
an aid to cutting down, among ’hard to reach’ smokers.
(ii) To assess via interview the acceptability of recruitment, assessment and randomisation
procedures within a pilot pragmatic randomised controlled trial to compare the effects of a PA
intervention versus brief advice (usual care) on quitting, among ’hard to reach’ smokers.
(iii) To obtain an estimate of the intervention (PA v brief advice) effect size, relative risk and its
precision to inform sample size calculations for a fully powered trial, from a pilot randomised
trial to assess carbon monoxide conﬁrmed abstinence at 4 weeks post-quit date.
(iv) To assess process measures at 4, 8 and 16 weeks post-baseline including: self-reported
cigarettes smoked; number of quit attempts; self-reported quality of life; mood & physical
symptoms; cravings; PA by self-report and accelerometer (in a sub-sample); pharmacological
and behavioural support used; and weight.
(v) To estimate the resource use and costs associated with delivery of the intervention, and to
pilot methods for determining future cost-effectiveness analyses.
Design: A randomised Controlled Trial involving 120 heavy smokers (>15 cigarettes per day) from ‘hard
to reach’ groups who wish to cut down the number of cigarettes they smoke but do not wish
to quit within the next month. Randomised equally to brief advice or PA intervention.
Week 1: Screening/Baseline Assessment: demographics, height and weight, expired CO
measurement, randomisation, questionnaires, accelerometer (1 week, sub sample),
Week 4: Questionnaires
Week 8 (or start of quit attempt): Questionnaires, height and weight, expired CO
measurement, accelerometer (1 week, sub sample)
Week 16 (or 4 weeks post quit): Follow Up Assessment: Questionnaires, height and weight,
expired CO measurement, accelerometer (1 week, sub sample)
Treatment Schedule: Brief Advice: Written and verbal information on NHS Stop Smoking Service (SSS) with
information on the beneﬁts of quitting and how to quit provided at baseline. Those expressing
a desire to make a quit attempt will subsequently be referred to NHS SSS.
PA Intervention: Written and verbal information on NHS SSS with information on the beneﬁts
of quitting and how to quit provided at baseline. Smokers will select one of three strategies for
smoking reduction and receive weekly support to attain this. Face to face physical activity
support sessions will be conducted at weeks 1, 4, and 8 along with supportive phone calls in
each intermediate week. The communications will involve tailored physical activity counselling,
guidance on using a free pedometer to achieve SMART goals, and signposting to local exercise
opportunities with subsidised access as required, with the aim of increasing the amount of
regular physical activity completed by each participant for both implicit and explicit purposes as
an aid to quit. Those expressing a desire to make a quit attempt will subsequently be referred
to NHS SSS.
Treatment Groups: (i) Brief Advice; (ii) Brief advice + PA Intervention
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 44 Main research questionWhat is the effect of a physical activity intervention designed to aid ‘hard to reach’ smokers wishing to cut
down, but not quit, on smoking reduction and cessation, when compared to brief advice?5 Plain English Summary
5.1 Background
NHS smoking cessation treatment aims to help people to remain abstinent after an abrupt quit attempt
but even with the best available behavioural and pharmacological support as few as 22% are abstinent at
12 months. The addition of physical activity to usual care has been shown, among sufﬁciently large
studies, to increase quit rates[1].
For an abrupt quit attempt recruitment into an NHS SSS is difﬁcult among ’hard to reach’ smokers.
However, surveys suggest that between 57-66% of smokers would like to cut down but are not yet ready
to quit. Nicotine Assisted Reduction then Stop (NARS) studies have shown increased quit attempts and
cessation rates[2], but NICE guidelines do not recommend NRT products for smoking reduction and only
one study (pre-post one group design) has suggested that physical activity may help in cessation
induction[3]. Exercise Assisted Reduction then Stop (EARS) could be effective for several reasons:
(1) Increasing physical activity before tackling a quit attempt may be easier; (2) physical activity related
breathlessness may prompt a desire to quit; (3) it builds conﬁdence to use physical activity to cope with
cravings, stress and low mood, before and after quitting; and (4) it may attenuate the stronger
reinforcement value from each cigarette, observed when smokers try to cut down. We therefore wish to
examine if physical activity v brief advice enhances smoking reduction attempts and successful quitting for
4 weeks, among ’hard-to-reach’ smokers from lower-socio-economic groups, building on the experiences
of a wide range of professionals and residents in Plymouth.5.2 Intervention design
In Phase 1 we will establish appropriate ways to increase physical activity while reducing smoking among
’hard-to-reach’ smokers, using an individually tailored counselling intervention, which can be described in a
manual and replicated elsewhere. From our extensive previous quantitative and qualitative information on
client preference and needs and professional views, and new information from interviews in the present
study with smokers and community action-type leaders (e.g. health promotion specialists) we will develop
and pilot the EARS intervention targeted at ’hard to reach’ heavy smokers (>15 cigarettes per day) wishing
to cut down but not yet quit.5.3 Methods
Phase 1 will explore the utility of various approaches (e.g. GP invitation, community advertising) to recruit
’hard to reach’ smokers, and pilot the intervention and assessment procedures. Phase 2 will aim to provide
information from which to plan a larger trial. In an exploratory trial involving 120 smokers (wishing to cut
down) will be randomly allocated equally to: (i) brief advice on cutting down; (ii) physical activity
intervention + brief advice; with support from an NHS SSS for those wishing to quit, with on-going
support for physical activity, for those in (ii). After baseline screening and assessments those in (ii) will
receive the EARS intervention package (Health Trainer counselling, use of pedometers and guidance into
free physical activity options). Smokers wishing to quit in both conditions will be offered support by the
Plymouth NHS SSS for up to 6 weeks. Those in (ii) will receive additional parallel weekly Health Trainer
support to remain physically active. The smoking status of all participants will be assessed, using expired
carbon monoxide measures, and self-reported continuous abstinence, at 8 and 16 weeks after baseline,
and at 4 weeks after any quit attempt. This will provide information to estimate expected effects at longer
follow-up points. Secondary outcomes at 8 and 16 weeks (and at 4 weeks after any quit attempt) will
include: number of quit attempts; self-reported quality of life; withdrawal symptoms, cravings, readiness to
quit, conﬁdence to quit and stay quit, use of NHS SSS after quitting and pharmacological support; physical215
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216activity and weight. All assessments will be conducted by a Health Trainer/researcher (in a GP surgery or
community setting). Taped interviews will be conducted with GPs, stop smoking advisors and smokers to
establish information on feasibility and acceptability of the recruitment, randomisation, intervention and
assessment procedures.
Smokers will be recruited with the support of the Primary Care Research Network, community advertising
and community outreach workers. Trial management will be with the support of the Peninsula Medical
School’s accredited Clinical Trials Unit, and follow Good Clinical Practice. A 0.7 Project Manager (for
27 months) will co-ordinate the study, lead Phase 1, support recruitment in Phase 2, and help with data
analysis and report writing. Two 0.7 FTE Health Trainers/researchers (for 19 months) will recruit, and do
baseline screening, randomisation, all assessments and provide the PA intervention.6 Background and rationale
6.1 Reducing heath inequalities
NHS priorities for helping people to quit smoking focus on identifying a quit date and abrupt cessation,
with pharmacological and behavioural support[4]. After one year, only about 4% of those who attempt to
quit alone succeed[5], whereas that ﬁgure is almost doubled (7%) with NHS support in primary care and
almost quadrupled (15%) with the support of NHS specialist stop smoking services[6]. In recent years
greater resources have been directed towards helping ‘hard to reach’ groups to quit in an attempt to
address health inequalities[7]. These groups include the unemployed, those in social class grade C2-E
(among whom smoking prevalence rates reduced only 1.3% compared with 2.3% for grade AB-C1, from
2007-8[8]), people with mental health problems, ethnic minorities, and young single parents. However, it is
challenging to recruit such smokers into NHS services that focus on abrupt cessation[9]. New approaches
are needed to increase the number of ‘hard to reach’ smokers who make a quit attempt with NHS support
and hence successfully quit, such as locating services in community settings with most need[4], developing
roles for NHS outreach workers (e.g. Health Trainers)[10], and developing complex behaviour change
interventions that target multiple behaviours among ‘hard to reach’ groups[11].6.2 Abrupt cessation versus Cut down then quit
Abrupt cessation is the preferred NHS approach because it is believed that if smokers cut down prior to
quitting they may gain greater reward from each cigarette and hence ﬁnd quitting even more difﬁcult[4].
Yet, in the English Smoking Toolkit Study, 57% of current smokers reported they were in the process of
cutting down, of whom a quarter were using NRT, with no difference across social class[5]. This suggests
that the majority of smokers are using other cognitive and/or behavioural approaches to cut down. In a US
survey interest in reduction was highest among those who were less interested in quitting and heavier
smokers [12]. There is also evidence from epidemiological studies that cutting down is associated with an
increased probability of trying to quit. Recent evidence suggests that smokers who do not intend to quit in
the next month, but cut down with the use of nicotine replacement therapy (NRT), are more likely to make
a quit attempt and be abstinent at follow-up[2]. However, there is a lack of research on behavioural
support programmes for those wishing to cut down, to inform NHS policy and practice.6.3 Why reduction programmes may work
There are several reasons why a reduction programme may work, namely:
(1) Increasing the length of time between cigarettes may reﬂect steps in moving from the identity of a
heavy or moderate smoker to that of a light then non-smoker. Identity shifts are important in smoking
cessation. (2) Increasingly longer periods between smoking a cigarette may progressively raise conﬁdence
to abstain, which may generate intentions to actually quit and reduce the risk of relapse. (3) With fewer
and fewer cigarettes the association between environmental cues and conditioned response (to smoke)
weakens, which will lead to low urges to smoke when abstinent. (4) A lower drug intake might reduce
drug dependence thus increasing the ability to abstain completely. Nicotine assisted reduction then stopNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4(NARS) programmes aim to facilitate these changes by providing a dose of nicotine to relieve cravings and
withdrawal symptoms. Other behavioural strategies for reducing cravings and withdrawal symptoms may
also be efﬁcacious but little is known about their effectiveness.6.4 PA as an aid to smoking reduction and cessation
Theoretically, increasing PA may help reduction in several ways:
1. Systematic reviews of 20[1] and 14[13] studies showed that during temporary smoking abstinence, a short
bout of PA (e.g. a brisk 15 min walk or 5 mins of seated isometric exercise) reduces cravings and
withdrawal symptoms. PA also appears to reduce reactivity to smoking cues, which have been shown
to predict lapses and relapse during a quit attempt,[14] and delays ad libitum smoking[14–17]. It would
therefore appear appropriate for smokers to explicitly use short bouts of PA to aid smoking reduction
and quitting.
2. PA enhances mental health which has been associated with reduced smoking. Also, doing more PA
may cause a shift from the identity of a smoker to that of an exerciser; consequently increasing PA may
have implicit positive effects on smoking habits.
3. Increasing PA while cutting down (then quitting) may reduce weight gain. In prospective population
surveys and trials weight gain and fear of weight gain is associated with quitting smoking, especially
among women and initially heavier smokers[18–20], with an average of 7kg gained within a year of
quitting[21]. Increasing PA has been suggested as a useful strategy to prevent weight gain[22], not only by
increased energy expenditure but also through self-regulation of energy intake, particularly emotional
snacking in response to withdrawal symptoms such as depression and anxiety[23,24]. The effects of
exercise on preventing weight gain are likely dependent on the exercise dose[25].6.5 Chronic effects of exercise as an aid to smoking cessation
Four adequately powered RCTs have assessed physical activity as an aid for smoking cessation after an
abrupt quit attempt[1] with encouraging results. One study[22] showed that vigorous intensity structured
(gym-based) exercise on three days a week over 15 weeks plus behavioural support produced signiﬁcantly
higher cessation rates at 12 months, relative to controls, among female smokers (Odds Ratio = 2.4, 95%
CIs = 1.0 to 5.6). However, smokers may be more interested in moderate rather than vigorous activity.
Three studies have investigated the effects of promoting moderate intensity exercise. One study showed
that four sessions of supervised exercise produced higher abstinence rates, versus controls, at the end of
12 weeks of treatment (EOT) (OR = 3.2, 95%,CIs = 1.6 to 6.6), but not at 6 or 12 months[26]. Another study
found that supervised weekly exercise for 8 weeks signiﬁcantly increased abstinence rates at 3 months
(OR = 2.8, 95%, CIs = 1.3 to 6.8), but not at 12 months, among women smokers[27]. However, women
achieving at least 110 minutes/week of activity were signiﬁcantly more likely to achieve cessation at 12
months. A ﬁnal study, involving 3 of the researchers, found that, although there were some increases in
unsupervised activity levels, physical activity counselling alone (7 sessions) did not increase abstinence rates
at EOT or 12 months[28,29]. The latter study was the only one to focus on unstructured PA, but this was
equivalent to only 5-10 mins per week of cognitive–behavioural physical activity counselling, incorporating
decision balance sheets, goal-setting, relapse prevention planning and self-monitoring, embedded within
standard smoking cessation counselling, and advice to use 15 mg 16 h nicotine patches after quitting,
throughout the treatment program. The target was to accumulate 30 mins of moderate intensity PA per
day on at least 5 days per week and among those remaining in the study at 4 weeks after quitting (i.e.
were abstinent at the end of the intervention) those in the PA group had increased time doing moderate
and vigorous intensity exercise by an average of 120 mins compared with 24 mins in the control group.
There is wide variation in the timing of the start of the exercise programme in the studies reviewed that
focused on smoking cessation[1]. For those beginning exercise either on or after the quit date[26,30–32]
success rates may have been hampered by the demand to cope simultaneously with two major changes in
health behaviour[31,33,34]. Furthermore, where the exercise programme started after a period of smoking
abstinence the potential for exercise to moderate withdrawal symptoms during this period was lost[35,36].
Increasing PA prior to any quit attempt (planned or otherwise) may address concerns about simultaneous217
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218health behaviour changes. Indeed NHS guidance for stop smoking advisors is to avoid changing diet and
exercise during a quit attempt[4], and as a result advisors generally spend little time promoting PA[37],
although recent evidence suggests that simultaneous health behaviour changes may not be detrimental[38].
However, a sample of advisors who did advocate simultaneous health behaviour changes had developed
integrated strategies for using one behaviour change to positively support a quit attempt
(Taylor et al, in press).6.6 Trials involving PA promotion among smokers
Taylor et al[39,40] reported no effect of increasing PA on self-reported smoking but did ﬁnd that smokers in
a GP exercise referral scheme were more likely to increase their readiness to quit smoking. A similar ﬁnding
was reported by Hardcastle et al[41] (and personal communication) in response to a PA and dietary
motivational interviewing intervention, in which participants with multiple coronary heart disease risk
factors (e.g. mean body mass index was 34, some smokers) were offered up to 5 sessions of lifestyle
counselling. The ﬁndings of these two studies are limited by the numbers of smokers involved but support
the idea that physical activity interventions are acceptable to many and may implicitly change thoughts
about smoking.6.7 Interest in using PA as an aid to quitting
109 Canadian community dwelling people with mental health problems, who were receiving smoking
cessation treatment, completed a survey assessing perceived interest in physical activity and a 24-item
decisional balance questionnaire reﬂecting potential advantages and disadvantages of becoming more
physically active[42]. In the only literature to have considered the use of physical activity speciﬁcally among
such smokers, 63% reported being interested in assistance in becoming more active and there were
generally positive beliefs about the beneﬁts.
Patten and colleagues[43,44] reported on two studies involving exercise targeted at smokers with a history of
alcoholism. While the studies were not strongly designed to determine the effects of exercise, they did
demonstrate that the participants were willing to increase their physical activity. In one study[43],
behavioural counselling plus exercise was as effective as standard treatment, or behavioural counselling
plus nicotine gum in reducing cigarettes smoked, prior to quitting.
In a survey of 181 smokers attending an NHS Stop Smoking Clinic in England and Scotland, 22% of
quitters reported currently using PA to control their smoking, and 34% of those who had made a previous
quit attempt reported having used PA as an aid[45]. Those more ready to use PA as a cessation aid and
more physically active, held more positive beliefs regarding conﬁdence to do more PA and expected value
of doing more PA to aid quitting. The survey involved participants attending stop smoking services but
little is known about the acceptability of PA as an aid to cutting down. In an audit of 178 smokers in a
Plymouth GP practice, in a mainly deprived area, 39% were prepared to both gradually cut down over
8 weeks and were interested in taking part in research involving exercise as an aid to cutting down.
Several cycles of collaborative action research with advisors in Plymouth and South Birmingham helped us
to develop and pilot our ‘Walk-2-Quit’ intervention, embedded within NHS SSS. In brief this involved
providing all clients with a Self-Help Guide (SHG) and a pedometer prior to quitting. A variety of cognitive-
behaviour approaches were used to increase client’s beliefs in the value of PA as an aid, and in their own
conﬁdence to use PA as it may best help them with quitting smoking. In a group setting, it was not
possible to stage-match the intervention on an individual basis but the Transtheoretical Model[31,46]
provided the framework in which to direct focus towards changing cognitions about PA as an aid. In a
later section our proposed intervention will refer to and build on this extensive feasibility work (developed
for the context of supporting abrupt quitters).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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after temporary abstinence[47] Al-Chalabi and colleagues[48] examined the acceptability and feasibility of
using MP3 ﬁles with guided isometric exercises (e.g. placing the palms of the hands together and pushing)
to manage urges to smoke within a pilot randomised trial. While the study was not designed to detect
differences in quit rates, about 80% of quitters reported using the isometric exercises each week, intended
to continue doing so and would recommend these techniques to others trying to stop.6.8 Other smoking reduction techniques with behavioural support
There are several techniques which have been proposed for smoking reduction which are still under
evaluation. These include:
1. Setting a smoking time at equally spaced intervals throughout the day depending on the number of
cigarettes smoked (e.g. a 16 a day smoker smokes on the hour every hour during a 16 hour day).
2. Identify half hour blocks where smoking occurs each day and attempt to reduce the blocks over time.
3. Rank the least to most important cigarettes of the day and aim to cut them down in order, although
this can be problematic as smokers can easily identify the least and most important cigarettes but not
the ones in the middle.
4. Schedule a per cent reduction in cigarettes each week.
5. We plan to offer smokers speciﬁc choices (1 or 2 from above) to take place as a reduction strategy
alongside increasing PA.6.9 Summary
Much of the above research has taken place in the context of helping smokers following an abrupt quit
attempt. However, given the potential mechanisms for how physical activity may be beneﬁcial and the
need to consider behavioural approaches to helping smokers to cut down, and possibly quit, the proposed
study seeks to provide the ﬁrst scientiﬁc study on using PA for smoking reduction, then as an aid for
quitting if a quit attempt is made. Given that physically active smokers are more likely to have attempted
cessation in the past year, than inactive smokers[49], it seems justiﬁed to explore if helping smokers to
become physically active will lead to more quit attempts and successful quitting. In the context of health
behaviour change for ‘hard to reach’ smokers support to overcome environmental, ﬁnancial, social,
cognitive and emotional barriers to increase PA and reduce smoking will be needed.7 Aims and objectivesWe aim to perform an RCT of the effects of behavioural counselling to reduce smoking and increase PA to
make it easier for ‘hard to reach’ smokers to cut down then quit, compared to brief advice on SSS and the
beneﬁts of quitting.7.1 Main outcome measure1. Conﬁrmed expired CO concentration (Bedfont Smokerlyzer) abstinence at 4 weeks post-quit (if a quit
attempt is made).7.2 Other outcome measuresl Self-reported cigarettes smoked per day (in past week) (to derive a ﬁgure for N (%) reducing cigarettes
by ≥ 50% and CO by ≥ 25%)
l Prolonged abstinence[50,51]
l Quality of life (EQ-5D)219
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2207.3 Process measuresl Conﬁdence to quit and importance of quitting
l Subjective stress[52]
l MPSS[53]
l Strength of desire to smoke[54]
l mCEQ[55]
l Body weight7.4 Baseline measures and demographicsl Age
l Gender
l Marital status
l Highest education qualiﬁcation
l Ethnicity/race
l Occupational status
l Co-habitation with other smokers
l Cigarettes smoked per day
l Type of cigarette smoked
l Quit attempts within the previous 8 months
l Fagerström Test for Nicotine Dependence (FTND)
l Self-reports of smoking and expired CO levels7.5 Other measuresl Reasons for withdrawing from the study
l Reasons for missing pre and post quit support sessions
l Adverse or serious adverse events
l Number of pre- and post-quit sessions completed with the HT (and if a quit attempt is made with a
SSS advisor) in the intervention arm
l Alcohol consumption8 Ethical approvalR & D approval to undertake the study will be obtained from Plymouth Teaching Primary Care Trust.9 Population
9.1 Proposed sample size
Given the lack of research involving behavioural smoking reduction interventions in the ‘hard to reach’
population, the effect size of our intervention is uncertain (see above). We will therefore use the pilot trial
in order to provide a quantitative estimate of the intervention impact (relative to control) in order to inform
the sample size estimation for a deﬁnitive trial. Using data from a recent HTA meta-analysis of trials of
smoking cessation[2] we have undertaken a scenario analysis in order to examine the impact on our
estimation of effect size precision given differing pilot trial sample sizes and plausible effect sizes (see
table). In the case of recruiting 120 participants (60 in each arm) if 5% are successfully quit after 4 weeks
of making an attempt, in the control group, then we would need an effect size of 4 for the conﬁdence
interval to not include 1.0. With a smaller ES in the pilot RCT, clearly, for the CI to not include 1.0, the N
would have to be considerably larger.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 1 Sample size in relation to effect size
Control quit rate*
Sample size^
(control : Rx)
Effect size
Relative risk
Precision of effect size estimate
(95% CI)**
5% 60 (1 : 1)
60 (1 : 1)
2.00
4.00
0.19 to 20.89
0.47 to 33.72
5% 120 (1 : 1)
120 (1 : 1)
2.00
4.00
0.52 to 7.63
1.18 to 13.46
5% 160 (1 : 1)
160 (1 : 1)
2.00
4.00
0.63 to 6.38
1.28 to 11.41
* based on the meta-analysis of control arm quit rates in HTA report.
^ combined intervention and control group sample size
** based on a 2-sided Fischer’s exact test
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4We believe this sample size provides an acceptable level of precision of effect size estimation i.e. upper
estimate that is within the range of relative risk reported in the HTA report. Although a larger sample size
(160) would offer greater precision, we believe that would not be feasible within the constraints of the
time and resources sought for this pilot study.9.2 Recruitment of ‘hard to reach’ smokers
In searching through the literature we have identiﬁed several ways of deﬁning ‘hard to reach’ but broadly
it refers to sections of the community that are difﬁcult to involve in public participation. Such sections may
include: (1) Minority groups; (2) Those ‘Slipping through the net‘; (3) Those who are ‘service resistant.’
Local data conﬁrm that the proposed geographical location for the research has a higher prevalence of
people who are unemployed, in social class C2-E, single parents, and have mental health problems, than
in most other areas in the South West and the UK as we previously described. Residents also have a higher
prevalence of smoking, lower use of NHS Stop Smoking Services, and lower levels of PA. We therefore
implicitly expect our recruitment to be targeted at ‘hard to reach’ smokers, but will also explicitly aim to
recruit smokers who have these characteristics. Further liaison with the local community in Plymouth will
determine if the following recruitment targets would be realistic: 75% (n = 80) of the sample to be
unemployed, receiving beneﬁts, or in social class C2-E; 30% (n = 36) from single parent families; 20%
(n = 24) with mental health problems, with some overlap between sub-groups. As noted above we will
also target diverse ethnic minority groups.
A range of strategies will be explored in Phase 1 of the study, particularly through initiating a community
advisory group (including smokers and community workers), to inform Phase 2. There is a wealth of
experience for the best ways to try to reach the most difﬁcult to engage with and promote health in the
proposed areas of Plymouth, and we will also draw on other evidence from evaluations involving
interventions delivered by HTs across the UK. Broadly, the strategies will include:
1. Networking and making links with other professionals who have offered services to ‘hard to reach’
groups.
2. Speciﬁcally targeting members of hard-to-reach groups and formally inviting them to participate in
consultations (e.g. through GP lists).
3. Outreach work in community venues where hard-to-reach groups could be identiﬁed, approached and
consulted (e.g. job centres).221
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222Regarding the targeting of ethnic minorities, we accept that this will be more challenging than in other UK
locations, due to the low proportion of minorities in Plymouth, but we will involve such groups in the
advisory group to ensure as heterogeneous a sample in the pilot trial as possible.
In many ways, our study implicitly focuses on ‘hard to reach’ smokers simply because we intend to recruit
smokers who are not wishing to quit but who wish to cut down and are typically heavier smokers. NHS
Stop Smoking Services have traditionally focused on those wishing to make an abrupt quit attempt, who
may be more successful and hence help to meet challenging targets for quit rates. The proposed work will
target those for whom NHS support is not currently available.9.2.1 The context
Recruitment will take place in and around Devonport and Stonehouse, the two most deprived
neighbourhoods in Plymouth. In 2004, Devonport’s health deprivation score (within the Index of Multiple
Deprivation) was 1.59; above the New Deals for Communities (NDC) average of 1.23[56], with a population
of about 7000. In Devonport 49% smoke (MORI Household Survey, 2006) compared with 27% across
Plymouth, and 23% nationally. In 2004, targets were set within the scope of the Devonport Regeneration
Community Project (DRCP) to reduce smoking prevalence to 39% by 2010. Limited numbers accessing
NHS Stop Smoking Services were thought to be due to delivery in clinical settings (e.g. Nufﬁeld Clinic,
Lipson Rd) and inadequate tailoring of services for local residents. In 2007-8, only 79 patients from the
two Devonport GP practices (Marlborough St Surgery and Cumberland Centre) were recorded as having
set a quit date by a specialist stop smoking advisor, of whom 43% were still quit after 4 weeks, veriﬁed by
standard CO monitoring. In response, as part of the DRCP in July 2008, a level 3 specialist stop smoking
advisor and registered nurse were appointed, and they have developed new outreach and community
development approaches to service recruitment (e.g. cold approaches outside a supermarket with follow-
up calls to respondents about NHS services, visits to the Salvation Army centre, home visits, providing
drop-in opportunities within non-clinical community facilities, attending local events). By the end of 2010,
the Brickﬁelds Healthy Living Centre (HLC) is expected to be completed in Devonport, to complement
similar facilities (e.g. Jan Cutting HLC) with access to exercise classes, catering, health promotion and
community development initiatives in neighbouring areas. This information gives an indication of the
prevalence and scope for conducting the proposed study among ‘hard to reach’ smokers in Plymouth.
There is strong interest from the Public Health team (K Elliston, S. Thomas, personal communication), local
GPs (R. Jones, R. Ayres, R. Byng personal communication) and NHS SSS (R. Moody – Manager of Services,
M. Cheshire, personal communication) in the proposed study, as a novel approach to possibly increasing
quit rates among ‘hard to reach’ groups.9.2.2 Describing the study and intervention to potential participants and its
impact on recruitment
An audit in 2008 of 178 smokers in a GP practice (in a mainly deprived area of Plymouth), revealed that
39% were not interested in quitting but were prepared to gradually cut down over 8 weeks, and were
also interested in joining a study ‘to see if physical activity is useful for helping you to reduce the amount
you smoke. [The study would include support such as professional support, a self-help booklet, a free
pedometer, and free access to an exercise facility]’. Initially we will begin by describing the intervention as
one involving behavioural support for reducing smoking, with additional support to increase PA to be
delievered by a person (Health Trainer) with local knowledge of opportunities for engaging in PA or
exercise. The initially planned Patient Information Sheet is shown in Appendix X.
Recruitment will be through both Primary Care (1) and community-based (2) approaches (with
approximately equal numbers from each) as follows:
1. The HTs, with Service Support from the Primary Care Research Network (PCRN), will identify heavy
smokers on GP practice lists (though not necessarily attending GP surgeries on a regular basis) in
Devonport, Stonehouse and adjacent neighbourhoods. Smokers will be contacted by a letter signed by
the patient’s GP, inviting them to take part in the study, and a brief Information Flyer. They will beNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4asked to return a reply slip to the GP practice or phone (to a mobile) the HT directly indicating interest
in the study. The HT will contact the participant, conﬁrm eligibility for the study, arrange a time to meet
them at the GP surgery if suitable, and also mail a more detailed Patient Information Sheet. At the
meeting, the study will be further explained and Informed Consent provided if appropriate. This may
limit recruitment based on literacy, and we will take advice from our user advisory group on reﬁning
such an invitation.
2. The HTs will circulate a brief Information Flyer and posters, about the study to appropriate NHS staff
(e.g. health visitors, specialist and non-specialist stop smoking advisors, public health workers) working
outside primary care. Posters and public adverts will be circulated throughout the respective
neighbourhoods (e.g. pubs, media, community centres), guided by consultation with community leaders
(e.g. MIND centre and other charity managers) and smokers or recent quitters identiﬁed as possible
champions for promoting PA and healthy living. There may be scope to identify people with speciﬁc
skills and attributes who are able to engage in recruitment activities (e.g. giving out ﬂyers in pubs and
job seeking centres). Interviews in Phase 1 will inform the selection of such approaches. The PI will work
closely with Dr Richard Ayes (Medical Advisor to the Devonport Community Regeneration scheme, and
lead for health inequalities in Plymouth Teaching PCT), to establish a working group with relevant
community stakeholders, to speciﬁcally identify recruitment strategies, and scope for intervention
delivery by an HT.
A recent evaluation of the ﬁrst HT service in the UK[57], speciﬁcally seeking to determine if the most
disadvantaged groups were being seen, revealed that 83% were referred by a GP or practice nurse, 11%
were self-referrals, 1% by a pharmacist, and 5% from ‘other’ sources including dietitian, midwife, GP
receptionist, attendance at a health promotion event or other health promoting service. A high proportion
(53% vs 24% nationally) of those seen by the HT in the central London service, were smokers, which
probably reﬂected the gatekeepers’ priorities for referral. Socio-economic characteristics of the sample
indicated that recruitment had successfully reached a considerably higher proportion of people with
income from beneﬁts, living in rented accommodation, and with no qualiﬁcations, compared with London
generally, and nationally. In contrast to this London HT service, we will seek to recruit 50% of the sample
from the community.9.2.3 Recruitment Rate (Phase 2)
We will recruit 3 smokers per week (12 per month for 10 months) which will result in a maximum number
of 48 participants in the trial (after 16 weeks) at any one time, 24 of whom will be in the PA arm. Not all
patients will be in contact with the HT at any one time, through participant choice, so we expect that
this workload will be sufﬁcient for 1.4 full-time equivalent Health Trainers. Recruitment will take from
2/2011 - 12/2011 (10 months). During the middle of the trial the Research Fellow will also be available to
conduct some assessments.9.3 Inclusion criterial Written informed consent
l People who are currently smoking at least 15 cigarettes a day and have done for a minimum of
3 years;
l are at least 18 years of age;
l and are not motivated to quit smoking in the next month but do wish to cut down the number of
cigarettes they do smoke9.4 Exclusion criterial Are contra-indicated for moderate physical activity;
l have an injury or illness that might be exacerbated by exercise;
l are pregnant;
l or wish to use Nicotine Replacement Therapy (NRT) as an aid for smoking reduction223
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22410 Informed consentPatients will receive their information sheet at least seven days prior to the screening assessment in order
to allow sufﬁcient time for consideration of participation.
At the screening visit the details and implications will be explained and the opportunity will be given for
the participant to ask questions. Written informed consent will be obtained by the Researcher/Health
Trainer prior to screening or any study procedures being undertaken. Participants will also be asked to
agree to their GP being informed of their involvement in the study.11 Study procedureSee Appendix II.11.1 Study week (1): Screening/Baseline assessment and randomisation
Suitable participants will be assessed by the Researcher/HT at an agreeable location (e.g. GP practice,
community centre):
l Expired CO (p.p.m.)
l Weight and height (BMI)
l Accelerometer use (1 week, in sub sample)
l Questionnaires:
¢ Smoking History
¢ PAR-Q
¢ Demographics
¢ Self-reported quit attempts in past 8 months lasting at least 24 hours, use of cessation aids and
length of prolonged abstinence
¢ Self-reported cigarettes, pipes, and cigars currently smoked in the past week
¢ Current readiness to quit smoking
¢ Cigarettes smoked in past week
¢ FTND
¢ Urge to smoke (single item)
¢ Mood and Physical Symptoms Scale (MPSS) (7 items)
¢ Perceived Stress Scale (PSS)
¢ Conﬁdence to quit, cut down, and importance of quitting
¢ Cigarette Evaluation Questionnaire (mCEQ)
¢ Self-reported Physical activity (PA)
¢ Alcohol consumption
¢ SF36
¢ Self-reported use of NRT products or smoking related aids11.2 Study week (2) and (3): Behavioural intervention arml Pedometer step count (diary)
l Adverse or Serious Adverse events
l Questionnaires:
¢ Conﬁdence to quit, cut down, and importance of quitting
¢ mCEQ
¢ Self-reported PANIHR Journals Library www.journalslibrary.nihr.ac.uk
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¢ MPSS (7 items)
¢ Urge to smoke (single item)
¢ Self-reported use of NRT products or smoking related aids
¢ Cigarettes smoked in past week
¢ Prolonged abstinence
¢ Self-reported cigarettes, pipes, and cigars smoked11.3 Study week (4): Phone call measure at 4 weeks post-baselinel Adverse or serious adverse events
l Questionnaires:
¢ Conﬁdence to quit, cut down, and importance of quitting
¢ mCEQ
¢ Self-reported PA
¢ PSS
¢ MPSS (7 items)
¢ Urge to smoke (single item)
¢ Self-reported use of NRT products or smoking related aids
¢ Cigarettes smoked in past week
¢ Prolonged abstinence
¢ Readiness to quit smoking
¢ Self-reported cigarettes, pipes, and cigars smoked11.4 Study week (5), (6) and (7): Behavioural intervention arml Pedometer step count (diary)
l Adverse or Serious Adverse events
l Questionnaires:
¢ Conﬁdence to quit, cut down, and importance of quitting
¢ mCEQ
¢ Self-reported PA
¢ PSS
¢ MPSS (7 items)
¢ Urge to smoke (single item)
¢ Self-reported use of NRT products or smoking related aids
¢ Cigarettes smoked in past week
¢ Prolonged abstinence
¢ Self-reported cigarettes, pipes, and cigars smoked11.5 Study week (8) or start of quit attempt
To be conducted by the Researcher/HT in person at an agreeable location:
l Expired CO (p.p.m.)
l Weight and height (BMI)
l Accelerometer use (1 week, in sub sample)
l Adverse or serious adverse events
l Questionnaires:225
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton
Science Park, Southampton SO16 7NS, UK.
APPENDIX 2
226¢ Self-reported cigarettes, pipes, and cigars smoked
¢ Prolonged abstinence
¢ Readiness to quit smoking
¢ Cigarettes smoked in past week
¢ FTND
¢ Urge to smoke (single item)
¢ MPSS (7 items)
¢ PSS
¢ Conﬁdence to quit, cut down, and importance of quitting
¢ mCEQ
¢ Self-reported PA
¢ Alcohol consumption
¢ SF36
¢ Self-reported use of NRT products or smoking related aids11.6 Weekly (6 weeks) during quit attempt with NHS SSS support:
Behavioural intervention arm
To be conducted by the Researcher/HT in person at an agreeable location:
l Expired CO (p.p.m.)
l Adverse or serious adverse events
l Pedometer step count (diary)
l Questionnaires:
¢ Self-reported PA
¢ Self-reported use of NRT products or smoking related aids
¢ Urge to smoke (single item)
¢ MPSS (7 items)
¢ Perceived stress
¢ Prolonged abstinence11.7 Study week (16) or 4 weeks post-quit if same: All participantsl Expired CO (p.p.m.)
l Weight and height (BMI)
l Accelerometer use (1 week, in sub sample)
l Adverse or serious adverse events
l Questionnaires:
¢ Self-reported cigarettes, pipes, and cigars smoked
¢ Prolonged abstinence
¢ Readiness to quit smoking
¢ Cigarettes smoked in past week
¢ FTND
¢ Urge to smoke (single item)
¢ MPSS (7 items)
¢ PSS
¢ Self-reported PA
¢ Alcohol consumption
¢ SF36
¢ Self-reported use of NRT products or smoking related aidsNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 412 RandomisationRandomisation will occur following a successful screening assessment where participants will be allocated
a study number and randomised equally into either (i) brief advice on cutting down; or (ii) to receive the
behavioural intervention. Randomisation will be completed by random number generation using a
computer held in Vesey Building, Salmon Pool, Lane, PCMD, Exeter. The randomisation code will be kept
in a sealed envelope inside a locked cabinet inside the Principal Investigator’s ofﬁce at the School of Sport
and Health Sciences at The University of Exeter.13 The EARS intervention
13.1 Phase 1: Developing and piloting the intervention
Professionals from public health, primary care, The Jan Cutting Healthy Living Centre, and NHS Stop
Smoking Services working in the targeted areas of Plymouth have been consulted on the proposed study
and several ideas have already emerged for developing an appropriate intervention with speciﬁc groups.
The Plymouth YMCA is also keen to be involved, given the acceptability of recruiting smokers into a
YMCA exercise programme in a deprived community in the US[3]. A co-applicant, Dr Richard Ayres is
Medical Advisor for DRCP, and lead in Plymouth Teaching PCT for Health Inequalities has also provided
valuable information. We will establish a working group, prior to the project formally beginning to identify
appropriate stakeholders from the respective neighbourhoods, as well as identifying potentially suitable
candidates for the HT/researcher role.
The intervention will be delivered by a Health Trainer (HT). The 2004 Department of Health White Paper
Choosing Health: Making healthy choices easier proposed the development of a new role for improving
health and reducing health inequalities – accredited HT. HTs are drawn from local communities and are
trained to reach those who want to adopt healthier lifestyles (e.g. reducing or quitting smoking, increasing
PA), but who have little contact with services[10,11]. HTs develop an understanding of the needs of people in
deprived communities, while applying basic health behaviour change strategies. Co-applicant SM helped
to develop the competences and the national training programme for HTs and is involved in their
evaluation. Our intervention manual (and the subsequent intervention to be tested in the exploratory trial)
will describe approaches that build on the competences that an HT would be expected to have.13.2 What is the best approach to changing PA and smoking?
Research on multiple health behaviour change has tended to focus on how best to change several
individual behaviours. In the present context there may be two types of processes involved in how
increases in physical activity inﬂuences smoking, namely implicit and explicit ones. Implicit processes may
be involved particularly if the focus is on increasing PA, rather than smoking reduction, with an
expectation that PA will, through previously identiﬁed mechanisms, inﬂuence smoking behaviour. For
example, increasing PA may enhance mood and reduce stress, which reduces the urge to smoke, or
additionally becoming involved in exercise initiates an identity change (perhaps through new non-smoking
social networks). There is considerable research on the effectiveness of interventions for increasing PA in
general (e.g.[58]) though relatively little has focused on ‘hard to reach’ groups[11]. Explicit processes may be
involve if the focus is on how best to cut down smoking, or support a quit attempt, speciﬁcally using PA.
For example, exercise sessions (e.g. seated isometric exercise, aerobic exercise) could be recommended as a
coping strategy for managing cravings and withdrawal symptoms or weight management. In the former,
the focus is mostly on a single behaviour and in the latter there is a need to think about increasing PA
while also managing a change in smoking (i.e. multiple behaviour changes). It may be that both processes
play a part, but each has implications for designing an intervention, which may be inﬂuenced by the target
group, and the individual’s ability to take on simultaneous multiple behaviour changes. In Phase 1 we will
interview smokers from different ‘hard to reach’ groups about how PA could be used to reduce smoking,
and their preferences for just focusing on increasing PA, with the possibility that smoking will decrease, or
focusing on how best to cut down, explicitly using PA as an aid to reduce cravings and increasing the
duration between cigarettes (as employed with nicotine assisted reduction to stop programmes).227
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228The PA and abrupt smoking cessation trials, reviewed above (see[1]), largely focused on the effects of
structured exercise in addition to smoking cessation advice. Less is known about promoting PA for
smoking reduction, and in developing and then trying our intervention, prior to the pilot RCT, we will
monitor how smokers view the utility of PA and exercise as they attempt to cut down. In particular, we will
seek to identify if PA has utility to help smokers to achieve SMART goal oriented behaviour (e.g. cutting
down by 50% over 2-4 weeks) as described in the HT training manual[10], and at a later stage, staying quit
on a weekly basis, and if increases in PA increases conﬁdence to cut down (and make a quit attempt). As
ideas emerge from target groups, academic literature will also be reviewed to consider best practice for
health promotion activity among ‘hard to reach’ groups. For example, voucher-based reinforcement
therapy has been shown to be an effective treatment across a wide range of substance use disorders,
including smoking cessation[59,60]. The intervention will eventually be deﬁned in a manual with ﬂexibility to
tailor the intervention to participant needs and the local environment/facilities. The table below provides a
guide to how the intervention may build on the typical approaches used by a HT, with an integrated
approach to promoting PA as an aid to smoking reduction and quitting. We also identify speciﬁc process
and outcome variables that may indicate how the intervention is working. HTs are trained to adopt a
motivational interviewing (MI) counselling style (i.e. client-focused, non-judgemental) which also draws on
psychological theories (e.g. Self-determination Theory; suggesting individual’s motivation is driven by basic
needs to feel competent, in control and for companionship or relatedness) to help promote health
behaviour change[61].TABLE 2 Components of the EARS intervention
Intervention
component Aim Content
Process and outcome
evaluation
Use MI principles and
strategies in counselling
sessions.
Develop rapport with
smoker, building trust, and
shared respect.
Effective communication
skills. Exhibit empathy,
listen, reﬂect, summarise.
Participant feedback on
HT-led support.
Explore initial beliefs about
cutting down, and quitting
(e.g. pros & cons,
conﬁdence, triggers for
smoking).
Identify readiness to quit,
and ambivalence towards
quitting. Increase self-
awareness and build
conﬁdence to cut down.
Smoker identiﬁes why it is
important to cut down and
quit, and identiﬁes the
challenges. The role of PA
as an aid may emerge.
A shift towards stronger
intentions to not only cut
down but also quit over
the early sessions. Smoker
self-monitors own
smoking behaviour.
Introduce PA as a healthy
behaviour and aid to
cutting down and quitting.
Increase beliefs in pros of
PA alone and as an aid to
cutting down & quitting.
Introduce PA as a
behaviour that may
regulate smoking. Explore
beliefs about PA.
Participant increases
beliefs in PA as a coping
strategy and aid to cutting
down.
Set goals to reduce
smoking and increase PA.
Develop strategies to
reduce smoking and
increase PA.
Set SMART goals with
smoker to reduce smoking
and increase PA. Signpost
to PA/exercise
opportunities & remove
barriers to do PA.
Goals identiﬁed and action
plans developed.
Self-monitoring used (e.g.
smoking and PA diary
kept). Rewards and
reinforcement
contingencies established.
Review and reﬂect on
behaviour change.
Build conﬁdence and
perceptions of control,
& ability to self-regulate.
Smoker reﬂects on PA
successes and sets new
targets; perhaps to quit.
Participant increases
beliefs in conﬁdence to cut
down, and quit.
Maintenance and relapse
prevention. Using NHS
Stop Smoking Services.
To strengthen
self-regulatory skills. To
identify identity shifts.
Smoker reﬂects on own
skills and strategies for
avoiding relapse, including
use of PA. Ready to quit?
Participant seeks support
for a quit attempt, possibly
using NHS specialist
support.
On-going phone support
provided for quit attempt
in addition to NHS
support.
To reinforce participants
shift to non-smoker and
more physically active.
Reﬂect on achievements
and explore future needs
for support to maintain PA.
Successful quit attempt
and increase in PA.
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 413.3 Phase 2: Exploratory trial13.3.1 Standard treatment: Brief advice for quitting
After completing baseline assessments and random assignment, all control participants will receive written
and verbal information on what the NHS Stop Smoking Services offer, including some brief information on
the beneﬁts of quitting smoking and how to quit in line with NICE guidelines. No information will be given
on how to cut down the number of cigarettes smoked. If smokers wish to quit at any time they will be
encouraged to contact the trial staff who will arrange for a member of the NHS Stop Smoking Services to
contact them for individual or group standard 6/7 week (or matched to the participants needs) behavioural
and pharmacological support for a quit attempt.13.3.2 Behavioural intervention
Phase 1 will help us to develop a participant-centred framework. As shown in the table above, we
envisage that it will involve multiple components that aim to address real and perceived environmental
(e.g. nowhere to do PA), social (e.g. no one to do it with), ﬁnancial (e.g. too costly), cognitive (e.g. not
conﬁdent to do PA), and emotional (e.g. feel too tired) barriers to increase PA and reduce smoking, as
considered above.
After completing baseline assessments and random assignment (by the HT/researcher), all PA participants
will be offered a 45 min face to face PA support session in week 1, 4 and 8, and a supportive phone call
in each intermediate week. The communications will involve tailored PA counselling, guidance on using a
free Digi-Walker SW-200 pedometer to achieve SMART goals, and signposting to local exercise
opportunities with subsidised access as required. The counselling will follow principles described in the HT
manual[10], adapted in response to ﬁndings from Phase 1. If a smoker wishes to quit at any time they will
be offered a meeting with a specialist NHS SSS advisor for individual or group standard 6/7 week (or
matched to the participants needs) behavioural and pharmacological support for a quit attempt. At the
same time, those attempting to quit will receive parallel weekly telephone support to maintain (or increase)
physically activity.
Behaviour change strategies will focus on self-regulation and may involve the following: (1) A choice of
alternatives for reducing cigarettes smoked as discussed previously (see 6.8). (2) Identiﬁcation of situations,
cues and moods/affect that elicit urges to smoke; (3) Increase perceived expectancy that PA may help to
regulate mood and affect (instead of a cigarette); (4) Raise awareness of PA or sedentary patterns (what,
where, when, who with) overall and in relation to smoking through self-monitoring (using a pedometer
and daily diary); (5) Build conﬁdence to increase PA primarily as a lifestyle behaviour (i.e. brief bouts of
10 mins) but not exclusively (i.e. can include structured PA), using standard cognitive-behavioural
techniques; including goal setting, and self-monitoring (daily diary and pedometer). After a baseline period
of pedometer wearing for 2 weeks, smokers will be encouraged to increase pedometer step counts by
10% from one week to the next (or at a self-determined rate) until achieving 10,000 steps per day or the
participant’s target. At the same time they will be encouraged to monitor mood/affect and smoking
patterns. Counselling sessions will seek to reinforce the smoker’s beliefs in the value of PA as an effective
self-control strategy for reducing cigarette cravings and withdrawal. Up to £100 vouchers per smoker will
be offered to support involvement in PA and minimise barriers to access. MP3 players (c. £15) will be
provided to those interested, with a recording of a guided seated isometric exercise programme. Research
suggests that such a programme can reduce momentary urges to smoke.
Financial subsidy will be available to support involvement in structured, supervised moderate-vigorous
intensity exercise in gyms/leisure centres for example. This intensity of exercise may well reduce cigarette
smoking and lead to increases in quit attempts for several reasons, such as: it may raise awareness of
symptoms of breathlessness associated with smoking which may trigger a stronger motivation to quit; it
places smokers in environments with fewer smokers, which reinforces reduced smoking and a non-
smoking identity; and there may be a greater sense of achievement from doing more strenuous exercise.
However, heavier smokers are more likely to do less moderate-vigorous physical activity and our229
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230experiences suggest that most smokers prefer walking. In contrast, moderate intensity exercise is more
pleasurable[62], creates fewer perceived barriers (e.g. cost, convenience and time, and social) and hence is
likely to be more sustainable, and has similar effects in reducing cigarette cravings and withdrawal
symptoms to more vigorous exercise[63,64]. It is also used by about 35% of quitters as a smoking cessation
aid[45] and promoted by over half of NHS SSS advisors[37].14 Withdrawal from the studyParticipation in the study is entirely voluntary and participants will be free to withdraw at any time.15 Ethical Considerations
15.1 Risks to Subjects
Moderate intensity physical activity is safe and is recommended for most adults. It is anticipated that most
smokers will increase walking and walking has no contraindications for most. Other physical activities will
also be offered in the community and participants will be advised on the suitability of these (see below).15.2 Adequacy of protections against risks
During the screening process those smokers who are contraindicated for moderate intensity physical
activity or who have injury or illness which might be aggravated by exercise, will be required to gain
approval from their GP before engaging in the study. Vigorous intensity activity can acutely and transiently
increase the risk of sudden cardiac death and acute myocardial infarction in susceptible persons,[96] so the
focus of all recommendations for increasing PA will be on moderate intensity PA. Participants will be given
clear guidance on exercising at this intensity (i.e. something that increases the heart and breathing rate but
not to the point of breathlessness or unable to maintain a conversation). Participants will be advised to
seek approval from their GP prior to engaging in any vigorous intensity PA, regardless of age and gender.
The smokers will be monitored for contraindications to exercise, for adverse events (see section (v) ‘Data
and safety monitoring plan’ below) including physical symptoms (e.g. chest pain, extreme breathlessness),
or change in health status at each counselling session and follow-up appointment. If there is any further
doubt about the involvement of a participant in the study the Trial Manager will liaise with the
participant’s GP.15.3 Potential benefits of the proposed research to the participants
and others
The smokers participating in the study may have a greater chance of stopping smoking and remaining
abstinent, relative to those who try to stop without behavioural support. Though we do not plan to test
the hypothesis in this pilot study, we may expect that those in the exercise condition will have an
enhanced opportunity of stopping smoking. Those who increase and maintain regular physical activity
during and following the study will receive many general health beneﬁts, including a reduced risk of
developing cardiovascular disease, stroke, hypertension, obesity and some cancers, even if they
continue smoking[65].15.4 Importance of the knowledge to be gained
Little is known about if and how behavioural support can help smokers to cut down, and if cutting down
then leads to more quit attempts and continuous abstinence. The planned study seeks to inform the
feasibility and acceptability of a behavioural intervention to be tested against brief advice (usual care) in a
future large scale trial. This pilot trial will allow us to estimate if a full trial is justiﬁed, from both an
effectiveness and cost-effectiveness perspective. If such a physical activity intervention was shown in a full
trial to be effective and cost-effective for increasing quit attempts and smoking cessation it would offer
important evidence for the design of behavioural interventions which are not currently available in the
NHS. Smokers are typically less active than the general population[66] and evidence from interventions thatNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4help change multiple health behaviours are urgently required. Weight gain is common among quitters [67,68],
but nothing is known about the effects of smoking reduction on weight gain or weight concern. The
proposed study may provide unique information on changes in a variety of psychological variables
(e.g. cravings and withdrawal symptoms) and weight gain and weight concerns among those who cut
down and quit.16 Adverse EventsIt is anticipated that there will be few, if any, adverse events in response to the behavioural intervention.
Any adverse events (AEs) will be monitored by the researchers and practitioners. If necessary these events
will be discussed with one of the GPs (Dr Jones, Dr Ayres, Dr Aveyard, Dr Byng or Prof Campbell) on the
research team. Where necessary AE Reports will be produced and will be forwarded to the Data
Monitoring and Ethics Committee (DMEC) or to the TSC if a DMEC is not considered necessary for the
trial. This will include, reviews of the research protocol and any recommendations for changes to the
safety monitoring procedures. In addition, any AEs which could possibly be related to the study will be
followed up.17 Data Management
17.1 Data Security and Confidentiality
Data management will follow study speciﬁc data management standard operating procedures, and will
operate in accordance with the Data Protection Act (1998).
All computers holding study data will be password protected. Files containing study data and information
will be accessible to only the study team, and all ﬁles containing personally identiﬁable data will also be
password protected. Backup copies of the study data will be kept in a locked ﬁling cabinet.
The data will be entered on to an Access database by the research staff, and will be later transferred to
SPSS for analysis. The ACCESS database will be held on a secure internet server. The participants will be
assigned a study number and will be identiﬁed on the database only by this number and will not be
identiﬁed by name. Access to the database will be password protected and will be permitted only by the
researchers, the PI and the trial statistician (Prof Rod Taylor). Only these individuals will have the
information linking the study numbers to the participants’ names. The clinical record forms and a copy of
the database on CD will be stored in a locked ﬁling cabinet in the Department of Primary Care, PCMD,
Plymouth. Only the researchers, the PI and the trial statistician will have access to these records.17.2 Long Term Storage of Data
Data will be stored in the Principal Investigator’s ofﬁce in the School of Sport and Health Sciences at the
University of Exeter, St Lukes Campus, Magdalen Road, Exeter.17.3 Data Analysis
Analysis will be undertaken to provide an estimate of the intervention (vs control) effect size and its
precision based on continuous abstinence at 4 weeks post quit. Given the pilot nature of the trial, it is
anticipated that hypothesis testing will not be undertaken on the primary outcome of interest. We will
however, explore differences in other measures at the respective follow-up assessment, after determining
if groups were comparable at baseline. For example, we will compare the groups on the number of quit
attempts and readiness to quit 8 weeks post-baseline, number achieving at least a 50% reduction in
cigarettes, and importance of, and conﬁdence for, quitting. We will explore if FTND, perceived stress and
strength of cravings and withdrawal symptoms at baseline predict outcomes, and whether amount of
physical activity is associated with changes in outcomes.231
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232The data analysis will be completed by the Principal Investigator (Prof Adrian Taylor) in the School of Sport
and Health Sciences in The University of Exeter and by the Trial Statistician (Prof Rod Taylor) in the Clinical
Trials Unit, PCMD, at The University of Exeter.18 Cost effectivenessThe research will identify the key areas of resource use and costs (e.g. Health Trainer time, subsidised
access to exercise, recruitment of those ‘hard to reach’) associated with the delivery of the intervention
(and control, where appropriate), and will test/develop methods for the collection of data in a future trial
(e.g. through use of ‘work-sampling’ methods, person-level recording of resource use via either routinely
collected data, and/or self report methods). Identiﬁcation of resource use, and methods for measurement
of resource use, will include areas covered by NHS stop smoking services.
Any future economic evaluation alongside a RCT is expected to involve presentation of costs and beneﬁts
(e.g. in the form of a cost-consequences analysis), and will also involve modelling of longer term policy-
relevant outcomes (i.e. impact on life-expectancy), from trial outcomes, to estimate cost per life-year and
cost per QALY gained, and these requirements will set the context for pilot research proposed here.
Research proposed here will include a general literature review of the data required for cost-effectiveness
analyses, and evidence synthesis will be used to inform exploratory modelling of cost-effectiveness analyses
(e.g. building on the work of Wang[2]), with simulation modelling and the related approach of ‘value of
information analysis’[69] used where possible to investigate areas of uncertainty. It is anticipated that the
pilot research will offer a good indication of the expected costs of delivering the intervention, but we
acknowledge that any economic modelling will involve assumptions, and ‘what if’ analyses, in a number of
areas (including measure of effectiveness). Therefore, research will assess both the issue of potential value
in terms of commissioning future research (e.g. RCT)[70], and the issues of design (framework for CEA) for
future research.
Current estimates are that it costs approximately £250 per smoker (for recruitment, and behavioural and
pharmacological NHS support) who is still abstinent 4 weeks after quitting. Our cost effectiveness work will
provide estimates of whether the intervention would cost more than this, and lead to discussion about the
merits of proceeding to a full trial. Also, data from the SF36 may allow us to estimate the cost of
improvements in quality of life.19 Qualitative aspectsIn the Table below we identify a framework for conducting the proposed qualitative work. After training,
semi-structured interviews (focus groups and individual) led by the PM will be digitally recorded,
transcribed and anonymised (with the consent of participants). Interview schedules (topic guides) will be
developed with reference to existing literature on assessing the feasibility and acceptability of trial methods
and /or behavioural interventions[71] and on developing behavioural interventions[72,73].
For most qualitative issues, the data will be subject to thematic analysis using constant comparison
techniques to extract concepts and themes[74] (and using NVivo to manage the data). The transcripts
relating to smoker experiences of the intervention will also be analysed to produce individual narratives,
allowing an increased insight into the processes of recruitment/engagement and the processes of
supporting behaviour change[75]. These will inform modiﬁcation of the recruitment techniques and the
intervention/behaviour change process model to tailor the intervention better to the needs of
hard-to-reach participants[76]. Second coding of a sample of the transcripts and discussion of the emerging
coding framework, as well as techniques such as negative case-ﬁnding and hypothesis testing will be used
to increase the depth of analysis and enhance the likely objectivity of interpretation[77]. Interviews will be
conducted in community locations acceptable to those involved.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 3 Framework for conducting proposed qualitative work
Phase: (1) Pre-trial
Key issues Who Content/focus
Recruitment Focus groups with professionals, community
workers (and volunteers) and smokers. Individual
interviews with HTs working outside Plymouth.
Deﬁning ‘hard to reach’; how to identify and
recruit them (in primary care and the
community); snowball sampling (who, where,
when).
Study design
& methods
Focus groups with professionals, community
workers (and volunteers) and smokers.
Assessments (adapting to sample); How best to
conduct assessments in PA and control group
(where, when, who), including self-report,
accelerometers and CO monitoring.
Intervention
development
Focus groups with professionals, community
workers (and volunteers) and smokers from
different ‘hard to reach’ groups.
General behavioural strategies used by smokers
for smoking reduction.
Selecting core behavioural change components
(initial and progressive support), implicit (focus on
just increasing PA) v explicit (focus on increasing
PA as a coping behaviour) PA promotion, PA
opportunities and support in community, links to
NHS SSS, integrated post-quit support. Training
HTs and treatment ﬁdelity.
Intervention
pre-pilot trial.
Recipients of the intervention and HTs. Smokers: Acceptability of intervention. What
worked and didn’t? Perceived value of
intervention for cutting down (and quitting).
Suggestions for additional support.
HTs: Discussion of sample of video replays of
sessions with smokers with PM and PI, with focus
on ﬁdelity (counselling style, content,
motivational strategies).
Phase: (2) Pilot trial
Recruitment During and after pilot RCT. HTs and others in a
position to recruit (e.g. practice nurses, Stop
Smoking Services). Decliners from different ‘hard
to reach’ groups.
Feasibility and engagement: Which groups were
harder to reach and why? What worked and
didn’t to recruit the most resistant? How did
primary care v community recruitment compare?
Intervention HTs and smokers from different ‘hard to reach’
groups. Also, sample smokers who: were able to
cut down but not quit; cut down then quit;
didn’t cut down or quit; didn’t cut down but
attempted to quit.
Acceptability of intervention. What worked and
didn’t. Perceived value of intervention for cutting
down (and quitting). Suggestions for additional
support.
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 420 Quality controlA quality control plan will be implemented as follows:20.1 Phase 1
Interviews will be digitally recorded and transcripts produced and stored securely as below. Any samples of
quotes will be linked to the securely stored transcripts, using a securely stored coding system. Transcripts
will be subject to thematic analysis and veriﬁed by the PI.20.2 Phase 2
20.2.1 Sampling and Recruitment
20% of screening forms will be checked by the project manager. If it is found that a smoker has failed to
meet the inclusion criteria and has still been recruited, the smoker will be immediately withdrawn from the233
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234study, but will continue to be offered smoking reduction support. If more than a 1% error rate is detected
all the screening forms will be checked.20.2.2 Intervention and Delivery
Audio recordings will be made of a sample of intervention sessions to check for treatment ﬁdelity.20.2.3 Data Collection
10% of all clinical record forms (CRFs) will be checked by the project manager. If any baseline data on
demographics or smoking characteristics are missing the smokers will be contacted and the data will
be entered.20.2.4 Data Entry
10% of all data entered will be checked against the hard data (in the CRFs) by a second researcher. If the
error rate is greater than 1% all the data will be checked against the hard data. 100% of the data for
self-reports of continuous smoking abstinence at 4 weeks post-quit (or 16 weeks post-baseline) will be
checked against the hard data.20.2.5 Expired CO
Using the manufacturers’ recommendations, the performance of the CO measure for expired air will be
regularly checked and calibrated accordingly.21 Trial management and supervision
21.1 Trial Steering Committee (TSC)
A TSC will be established to provide overall supervision of the trial. This committee will include key
personal and independent members who are experts on exercise or smoking cessation, as well as at least
one smoker or ex-smoker who would fall into our categories of ‘hard to reach’ smokers. The steering
committee will convene during preparation for the trial to contribute to and approve the ﬁnal study
protocol and every six months during the ﬁrst year of the study and yearly thereafter, or as deemed
necessary. The committee’s responsibilities will include monitoring: recruitment rates, adherence to the
interventions and retention in the study, as well as monitoring research developments which may impact
on the merit of the scientiﬁc output from the study.21.2 Data monitoring and Ethics Committee
Given the lack of safety concerns and the lack of stopping rules for the trial, we do not anticipate a DMEC
will be necessary but this will be to the discretion of the TSC.21.3 Project management
Bi-weekly progress meetings will be held involving AT (PI), the PM, the 2 HT/researchers, and RA, in
Plymouth. Quarterly meetings will be held, in addition to Phase 1 interviews/focus groups, involving the
above plus RT, CG, & AR, as appropriate, plus representatives from Public Health network in Plymouth and
local community groups (e.g. Devonport Regeneration Community Partnership). The expertise of other co
applicants (see below) will be drawn upon at appropriate times during the project.21.4 Project Manager (PM)
The PM will work in collaboration with the PI to ﬁnalise the protocol and assessments, manage ethical
approval processes, approval to manage the day to day running of Phase 1 and 2, manage the HT/
researchers, maintain the central database and coordinate management meetings. RA will provide local
support for the PM and HT/researcher staff, and RB will also serve as a conduit for working with primary
care in Plymouth. The PM, HTs/researchers, and will be housed in a PCMD ofﬁce in Plymouth, but it is
envisaged that the HTs will spend a considerable amount of time engaging with participants and other
relevant personnel in and about the Devonport, Stonehouse and adjacent neighbourhoods.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 422 ExpertiseAT will lead the study as PI (0.2 FTE). He has been PI for 3 trials (including ‘Walk to Quit’, an RCT of a GP
exercise referral scheme, and HEALTH – a COPD and exercise RCT), and co-applicant on 3 other funded
RCTs involving PA promotion. He also has experience in conducting collaborative action research, and
qualitative studies. Design and data analysis support will be provided by RT, in the PCMD’s Clinical Trials
Unit (CTU), and has extensive experience in trial methodology and statistics, and works with AT & JC on 2
RCTs. CG is a Senior Lecturer in Health Economics and has expertise in cost-effectiveness analysis. JC has
experience with both exercise and primary care trials, including TREAD (HTA 03/45/07), GETuP (RDA 02/
06), HEALTH (IPCRG funded) all with AT. RJ has experience of conducting trials and is clinical lead for
Plymouth Respiratory Care services. MU has experience as PI for 3 trials on exercise and smoking cessation,
including an HTA trial, LEAP, currently underway with pregnant smokers. PNA & RW have experience with
smoking cessation trials, and have worked with MU and AT on previous trials. PNA has co-authored a
recent HTA review on Cut Down Then Quit trials. AR has extensive expertise in measuring PA with
accelerometers. SM has extensive expertise in designing and evaluating complex behavioural interventions,
particularly among the ‘hard to reach.’ On-going trials include the evaluation of promoting walking in
primary care, and the effects of a bespoke smoking cessation intervention for people with severe mental
illness. She is on Department of Health committees for developing and evaluation of the Health Trainer
professional, and advising on complex behavioural interventions. We do not envisage any difﬁculty in
recruiting suitable personnel for the roles of project manager and Health Trainer/researcher. RA has
worked closely in and with the neighbourhoods where the study will take place in his capacity as part-time
GP, Medical Advisor for Devonport Community Regeneration Project and as lead for Plymouth Teaching
PCT for Health Inequalities. RB is a clinical academic with a specialism in mental health and is based in
Primary Care, PCMD, Plymouth.23 DisseminationThe results will be published in peer review journals and presented to at relevant conferences, nationally
and internationally. The production of a manual for the physical activity intervention will enable us to
provide speciﬁc guidance on the training that would be needed and the nature of the intervention for a
larger scale trial. Findings on acceptability and feasibility of the trial procedures will inform the design of a
future larger scale trial. The ﬁndings will also be disseminated locally (via workshops and conferences)
among health professionals and those working for community agencies, in a professional and
voluntary capacity. An HTA report will also be produced, and published within the HTA series of peer
review publications.24 CostingTOTAL (£)
STAFF COSTS 231,559
NON-STAFF COSTS
Travel/Subsistence 14,540
Equipment 5,660
Consumables 13,100
Consultancy 4,000235
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236Indirect Costs 251,257
RESEARCH GRANT TOTAL (80%) 416,093
NHS Costs 19,443
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Recruitment by GP letters
and
community advertising
Baseline assessment and
informed consent
(n = 120) 
PA intervention
(≤ 8 weeks to quit and
during 6-week
quit attempt)
(n = 60)
Brief advice at baseline
(n = 60) 
Telephone assessment at
4 weeks post-baseline
Telephone assessment at
4 weeks post-baseline
Record any 4-week post-
quit CO confirmed
abstinence using NHS
support
Record any 4-week post-
quit CO confirmed
abstinence using NHS
support
16-week assessment
(All in PA condition)
16-week assessment
(All in control condition)241
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242Appendix II: Measures to be taken and schedule of assessmentsMeasure Wk 1
Week
2-3
in PA
arm
Phone call
measures
at 4 weeks
post-baseline
Week
5-7
in PA
arm
At start
of quit
attempt
or 8 wks
post-baseline
Weekly,
6 weeks
during quit
attempt (with
NHS support)
Week 16
post-baseline
(or at 4 wks
post-quit
if same)
Demographics ✗
Smoking history ✗
Self-reported quit
attempts in past
8 months lasting
≥ 24 hrs
✗
Self-reported
cigarettes (pipes,
cigars) smoked
✗ ✗ ✗ ✗ ✗ ✗
Prolonged
abstinence
✗ ✗ ✗ ✗ ✗ ✗ ✗
Readiness to
quit smoking
✗ ✗ ✗ ✗
Expired CO ✗ ✗ ✗ ✗ (primary)
FTND ✗ ✗ ✗
Urge to smoke
(2 items) + other
MPSS items
✗ ✗ ✗ ✗ ✗ ✗ ✗
PSS ✗ ✗ ✗ ✗ ✗ ✗ ✗
Conﬁdence to
quit, cut down
& importance
of quitting
✗ ✗ ✗ ✗ ✗
mCEQ ✗ ✗ ✗ ✗ ✗
Self-reported
physical activity (PA)
✗ ✗ ✗ ✗ ✗ ✗ ✗
Pedometer step
counts (diary)
✗ ✗ ✗
Accelerometer
(1 week)
✗ ✗ ✗
Weight & height
(BMI)
✗ ✗ ✗
Alcohol
consumption
✗ ✗ ✗
SF36/EQ5-D ✗ ✗ ✗
Self-reported use
of NRT products or
smoking-related aids
✗ ✗ ✗ ✗ ✗ ✗ ✗
Adverse or serious
adverse events
✗ ✗ ✗ ✗ ✗ ✗
Measures to be taken from participants in both arms of the trial shown in shaded columns.CO = Carbon Monoxide;
MPSS = Mood and Physical Symptoms Scale; FTND = Fagerstrom Test for Nicotine Dependence; SF36 = quality of life
measures; FTND = Fagerstrom Test for Nicotine Dependence. mCEQ = Modiﬁed Cigarette Evaluation Questionnaire.
PSS = Perceived Stress Scale. Demographics = gender, age, SES, co-habiting smokers.
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244Appendix IV: Recruitment ﬂowchartTrial Manager (TM) approaches General Practices
Informs partners and Practice Managers about Study
Practices agree to assist with recruitment of patients from patient lists
TM rings practice to introduce him/herself and arrange visit
TM Visits Practice
TM explains procedure for recruitment
Practice staff identify suitable patients for study according to inclusion and exclusion criteria
Practice staff provide details of interested patients to TM
Support for reduction participants return for first contact session
GP/Practice staff send out letter of invitation and participant information and
consent form
Interested patients asked to complete consent form and return consent form to
practice, or contact TM/PI for further information.
Consent confirmed
Eligibility confirmed (inclusion/exclusion criteria)
Date made for attendance at baseline assessment
Patient attends and completes baseline assessment
Patient randomly assigned
Control participants receive simple information on cutting down and quitting
Practice receives completed informed consent forms
Consent forms checked for signatures
Research Fellow/Health Trainer (HT) contacts patient by telephone
Study explained: patient given opportunity to ask questionsNIHR Journals Library www.journalslibrary.nihr.ac.uk
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A study of the effects of local support for smokers who wish to cut down
but not quit.
Are you a moderate or heavy smoker?
Do you wish to cut down but not make an abrupt quit attempt?
Many smokers want to cut down the number of cigarettes they smoke but few are ready to make an
abrupt quit attempt. Little is known about the best way to cut down, but those who do try often don’t
succeed. Some smokers have given us some ideas and we want to see if they work.
So who are we?
We are researchers at the Peninsula College of Medicine and Dentistry and funded by the government.
Is this a genuine study?
We have NHS ethical approval and will follow the strictest guidelines on conducting research with the
general public.
What’s in it for you?
Cutting down (and quitting) can really help your health.
We may be able to help you cut down by increasing physical activity with free pedometers and access to
exercise facilities if you want.
Where can I found out more about taking part?
Please read the enclosed Participant Information Sheet before you decide whether or not you are
interested in taking part. If you would like more information, please contact the study team on one of the
following telephone numbers or by e-mail:Appendix VI: Phase 1: Invitation to participantDate
Ref: A study of the effects of local support for smokers who wish to cut down but not quit.
I am writing to ask if you would be interested in taking part in a research study run by researchers in the
Peninsula College of Medicine and Dentistry and the University of Exeter, here in Plymouth. This study is
funded by the National Institute of Health Research.
The overall study involves two parts:
Phase 1, preliminary work to establish how best to conduct the research.
Phase 2, a larger trial to determine the effects of local support for smokers who wish to cut down but
not quit245
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246In this Phase 1, we are interested in your views concerning how moderate to heavy smokers who wish to
cut down but not make an abrupt quit attempt (in the next 4 weeks) can be recruited into a study and
would engage in a local intervention to provide support to cut down.
It is important that we capture the views of a range of people, including smokers, professionals who help
people to quit and others who work alongside smokers. The best way to do this is to conduct individual
and group-based interviews.
Many smokers want to cut down the number of cigarettes they smoke but few are ready to make an
abrupt quit attempt. However, little is known about the best way to cut down, but those who do try
often don’t succeed. Some smokers and people who help people to quit have already given us some ideas
and we want to explore them a bit more before finally offering this as part of a larger randomised trial
involving 120 smokers, 60 of whom will be offered the support.
Participation in the study is entirely voluntary, and if you decide not to participate this will not affect your
treatment in any way. Any information that you provide will be treated with confidentiality and will not be
disclosed to anyone without your prior permission. Any published information will be fully anonymised.
Please read the enclosed Participant Information Sheet before you decide whether or not you are
interested in taking part. If you would like more information, please contact the study team on one of the
following telephone numbers or by e-mail.
Project Manager:
Tom Thompson
Peninsula College of Medicine and Dentistry:
Telephone number: 01752 437 300
E-mail: T.P.Thompson@exeter.ac.uk
Or:
The Principal Investigator:
Professor: Adrian Taylor:
School of Sports and Health Sciences (University of Exeter):
Telephone number: 01392-264747.
E-mail: A.H.Taylor@ex.ac.uk
Thank you,
Yours faithfully <GP Name>Appendix VII: Phase 1: Participant information sheetA study of the effects of local support for smokers who wish to cut down but not quit.
Before you decide whether or not to take part it is important for you to understand why the research is
being done and what it involves. Please read the following information carefully, and take time to decide.
Please ask if you would like more information.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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In this Phase 1, we are interested in your views concerning how moderate to heavy smokers who wish to
cut down but not make an abrupt quit attempt (in the next 4 weeks) can be recruited into a study and
would engage in a local intervention to provide support to cut down. It is important that we capture the
views of a range of people, including smokers, professionals who help people to quit and others who
work alongside smokers. The best way to do this is to conduct individual and group-based interviews.
What will happen if I want to take part?
You will be invited to attend 30-60 min individual or group-based interviews/discussion about how to
recruit smokers into such as study, and about how best to design the intervention or support package to
help smokers cut down, and possibly quit. This will take place in a convenient location. Any reasonable
expenses incurred will be reimbursed.
What are the possible benefits of taking part?
As a smoker you may gain an insight into how best to cut down or quit smoking, as one of the best ways
to improve your health. As a non-smoker you can help us to improve the services offered to smokers in
helping them to reduce and/or quit.
Do I have to take part in this research?
No, it is entirely voluntary. If you do not, you will still be entitled to the same NHS support and treatment.
Will any information I provide be confidential?
Yes. Information relating to your participation will be kept confidential and will not be disclosed without
your prior permission. Confidential information will be stored safely in a locked cabinet. The study will be
written up in scientific journals in such a way that none of the people taking part can be identified.
Where can I get more information about this study?
By contacting:
Project Manager: Tom Thompson
Peninsula College of Medicine and Dentistry:
Telephone number: 01752 437 300
E-mail: T.P.Thompson@exeter.ac.uk
Or:
The Principal Investigator: Professor: Adrian Taylor:
School of Sports and Health Sciences (University of Exeter):
Telephone number: 01392-264747.
E-mail: A.H.Taylor@ex.ac.uk247
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from GP<GP address>
Date
Dear <Patient Name>
Ref: A study of the effects of local support for smokers who wish to cut down but not quit.
I am writing to ask if you would be interested in taking part in a research study run by the Peninsula
College of Medicine and Dentistry and the School of Sports and Health Sciences at the University of
Exeter. This study is funded by the National Institute of Health Research.
You are being invited to take part in this study because you are a moderate or heavy smoker according to
our records held in your GP practice. We wish to recruit smokers who wish to cut down but not make an
abrupt quit attempt (in the next 4 weeks). Please read on before deciding whether this is something you
are interested in or not.
Many smokers want to cut down the number of cigarettes they smoke but few are ready to make an
abrupt quit attempt. However, little is known about the best way to cut down, but those who do try
often don’t succeed. Some smokers have given us some ideas and we want to try them out to see if
they work.
We are interested in whether providing some simple support in your local community can make a
difference to successfully helping smokers, who want to cut down but not quit, to reduce their smoking.
That support will be for setting plans to reduce smoking and also increase physical activity which may help
with withdrawal symptoms. We plan to remove as many barriers to becoming more physical activity as
possible, as part of the support you may receive.
Participation in the study is entirely voluntary, and if you decide not to participate this will not affect your
treatment in any way. Any information that you provide will be treated with confidentiality and will not be
disclosed to anyone without your prior permission. Any published information will be fully anonymised.
Please read the enclosed Participant Information Sheet before you decide whether or not you are
interested in taking part. If you would like more information, please contact the study team on one of the
following telephone numbers or by e-mail.
Project Manager:
Tom Thompson
Peninsula College of Medicine and Dentistry:
Telephone number: 01752 437 300
E-mail: T.P.Thompson@exeter.ac.uk
Or:249
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250The Principal Investigator:
Professor: Adrian Taylor:
Sports and Health Sciences (University of Exeter):
Telephone number: 01392-264747.
E-mail: A.H.Taylor@ex.ac.uk
Thank you,
Yours faithfully <GP Name>Appendix X: Phase 2: Participant information sheet
A study of the effects of local support for smokers who wish to cut down
but not quit
You are being invited to take part in a research study which is being funded by the National Institute of
Health Research. Before you decide whether or not to take part it is important for you to understand why
the research is being done and what it involves. Please read the following information carefully, and take
time to decide. Please ask if you would like more information.
What is the purpose of this study?
Many smokers want to cut down the number of cigarettes they smoke but few are ready to make an
abrupt quit attempt. Those that do, with NHS Stop Smoking Service support, are four times more likely to
successfully quit. However, little is known about the best way to cut down, but those who do try often
don’t succeed.
The purpose of this study is to investigate whether providing some simple support in your local
community can make a difference to successfully helping smokers, who want to cut down but not quit in
the next 4 weeks, to reduce their smoking. The effects of different approaches, supported by a local
Health Trainer, will be compared with normal guidance. One hundred and twenty moderate to heavy
smokers will take part, half will be allocated to receive support from a community health trainer and half
will continue with normal care. You have been asked to take part because you are currently a moderate
to heavy smoker, and you may wish to reduce your smoking but not quit just now.
What will happen if I want to take part?
You will be invited to attend an assessment to check your suitability to join the study, and complete some
simple questions about your smoking and other behaviours that have been linked to health, including
alcohol consumption and physical activity. A computer will be used to randomly (by chance) allocate
various study numbers to receive either the support for reduction programme or normal care.
If you are allocated to the support for reduction programme, you will be able to receive three face to face
sessions with a Health Trainer for up to 45 mins, in week 1, 4 and 8, plus 15 min phone calls in weeks 2,
3, 5, 6 and 7. The phone support will be extended for a further 6 weeks if you choose to quit. If you do
choose to quit you will be given information on how to seek support to quit from the National Health
Service (NHS) Stop Smoking Services.
The support from a Health Trainer will include help with deciding how best to reduce your smoking, from
several alternatives from which you can choose, plus support to increase your physical activity or exercise.
The latter may include setting targets, using a free pedometer, and having subsidised access to exercise
facilities and opportunities.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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down and quitting and information on how to seek support to quit from the NHS Stop Smoking Services.
At the end of the study (after 4 months) you will be given further material that may help you cut down or
quit if you wish.
All participants will attend assessments at a convenient local place in weeks 8 and 16 weeks, and be
asked similar questions on the phone in week 4, after the initial assessment. Each assessment session will
last about 20-25 mins,
What are the possible benefits of taking part?
Reducing smoking and increasing physical activity are two of the most important things that you can do
to improve your health and quality of life. The support you may receive could help you to do both. Less
heavy smokers are more likely to have the confidence to quit smoking, and give up for good. The
information you provide may help to design better support to help you and others to cut down in the
future and possibly quitting. Cutting down does not offer the same protection for your future health
as quitting.
Will taking part in this research affect my treatment?
No, you will be entitled to the same NHS support and treatment whether you take part in this study
or not.
Are there any side effects?
As you may well have experienced, reducing or stopping smoking may cause some moderate or intense
withdrawal symptoms. Failure to cope with these often leads to a return to previous smoking levels. The
study aims to provide support with strategies to deal with these withdrawal symptoms. One approach is
to use physical activity to reduce withdrawal symptoms, such as low mood and irritability. Moderate
intensity physical activity will be recommended, which has few if any side effects. You will be given
guidance on how best to avoid stiffness after exercise. You will be advised to check with your doctor if
you wish to engage in vigorous exercise which may be associated with greater risk of health problems,
particularly if you have existing poor health and have been inactive for some time.
What will happen if I do not want to take part in the study?
Taking part is entirely voluntary. If you do not wish to take part, this decision will not affect your medical
care in any way. Even if you are recruited into the study you are free to withdraw at any time without
explanation. However it would be helpful for the study team to know why you do not wish to continue.
Your withdrawal will not affect the progress of the study.
Under what circumstances will the study be stopped?
If the Principal Investigator considers it necessary he will stop the study in the interest of the safety and
well being of the participants.
Will any information I provide be confidential?
Yes. Information relating to your participation will be kept confidential and will not be disclosed without
your prior permission. Confidential information will be stored safely in a locked cabinet. The study will be
written up in scientific journals in such a way that none of the people taking part can be identified.251
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252What should I do if something goes wrong during the study?
If you feel unusually unwell you should contact your GP in the first instance. If you have a medical
emergency at any time you should ring 999 and request an ambulance.
Problems relating to your participation in the study should be reported to the person who conducts your
initial assessment as part of the study. Details of how they can be contacted will be provided at the
beginning of the study.
If you have received an invitation to join the study from your GP, does your GP receive any
financial reward for your participation in the study?
A small payment will be paid to the practice in respect of the administrative costs involved in assisting
with the study. This is the normal procedure for research with NHS patients.
Where can I get more information about this study?
By contacting:
Project Manager:
Tom Thompson
Peninsula College of Medicine and Dentistry:
Telephone number: 01752 437 300
E-mail: T.P.Thompson@exeter.ac.uk
Or:
The Principal Investigator:
Professor: Adrian Taylor:
School of Sports and Health Sciences (University of Exeter):
Telephone number: 01392-264747.
E-mail: A.H.Taylor@ex.ac.ukNIHR Journals Library www.journalslibrary.nihr.ac.uk
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GP recruitment method summary
Three stages of ﬁltering were applied to identify candidates to be approached for recruitment to the study.
Great care was taken to protect sensitive patient information.
1. An initial potential candidate list was generated using MIQUEST searches (ﬁlter #1).
MIQUEST (Morbidy Import QUEry SynTax) is a standard query engine that runs on the majority of
GP IT systems. It can be used to run similar queries across a group of practices.
A set of MIQUEST queries were assembled and tested.
(a) Identify all patients who may be potential members of the study group© Queen
Health. Th
provided
addressed
Science Pi. Smokers
ii. Aged 18-69 years(b) Identify all patients who are in potential exclusion groups.
i. Coronary heart disease
ii. Stroke
iii. Exercise intolerant/refused
iv. Stopped smoking
v. NRT therapy(c) Merge a and b (set a NOT set b) to produce a list of candidates (group c) and exclude anyone clearly
not eligible.
(d) Generate a report on group c, including health data on mental health and cardiovascular disease
that could be used to ﬁlter for eligibility.
2. The candidate list (group c) was pseudo-anonymised (personal information was removed and replaced
with a coded identiﬁer) and this coded list was supplied to the research team.
3. The research team scrutinised the coded list to select potential candidates based on health data
(ﬁlter #2). Selected coded patient ID’s were passed back.
4. The research analyst decoded the anonymous ID list supplied by the research team and passed it back
to the practice as a set of names and addresses.
5. The practice scrutinised the list to remove any further names based on speciﬁc knowledge of the
patients (ﬁlter #3).
6. The practice wrote to patients to invite them to participate in the study.
7. All data was destroyed as soon as it was no longer required.
Since the list of names and addresses of selected candidates contained no data that could be linked to the
initial data set (health data and coded identiﬁers only), no identiﬁable health information about individuals
was disclosed to the research team. The only deﬁnite knowledge the research team had on individuals
was that they met the eligibility criteria for the study.
*QRY_WDATE,20110428,28/04/2011
*QRY_SDATE,20110428,28/04/2011
*QRY_TITLE,EARS,SUBSET : All eligible smokers
*QRY_ORDER,001
*QRY_MEDIA,D,Disk
*QRY_AGREE,LOCAL,
*ENQ_IDENT,LOCAL,257
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258*QRY_SETID,RA5B,RA 5 BYTE
*ENQ_RSPID,L83624,Marlborough Street Surgery
*QRY_CODES,0,9999R2,Read version 2
DEFINE AGE AS @YEARS("28/04/2011",DATE_OF_BIRTH)
# Select all eligible smokers at practice
SUBSET EARS1
FROM JOURNALS (LATEST FOR PATIENT)
WHERE CODE IN ("1374","1375","1376")
AND AGE IN ("18"-"69")
*QRY_WDATE,20110428,28/04/2011
*QRY_SDATE,20110428,28/04/2011
*QRY_TITLE,EARS,SUBSET : Deﬁnite exclusions
*QRY_ORDER,002
*QRY_MEDIA,D,Disk
*QRY_AGREE,LOCAL,
*ENQ_IDENT,LOCAL,
*QRY_SETID,RA5B,RA 5 BYTE
*ENQ_RSPID,L83624,Marlborough Street Surgery
*QRY_CODES,0,9999R2,Read version 2
DEFINE AGE AS @YEARS("11/10/2006",DATE_OF_BIRTH)
# Select all deﬁnite exclusions at practice
SUBSET EARS2
FROM JOURNALS (ONE FOR PATIENT)
WHERE CODE IN ("137J","137K","137L","8B2B","8B3Y","8B3f","8I3S","33BE","G3%",
"G6%","Gyu%")
AND AGE IN ("18"-"69")
*QRY_WDATE,20110428,28/04/2011
*QRY_SDATE,20110428,28/04/2011
*QRY_TITLE,EARS,SUBSET : Potentialy eligible
*QRY_ORDER,003
*QRY_MEDIA,D,Disk
*QRY_AGREE,LOCAL,
*ENQ_IDENT,LOCAL,
*QRY_SETID,RA5B,RA 5 BYTE
*ENQ_RSPID,L83624,Marlborough Street Surgery
*QRY_CODES,0,9999R2,Read version 2
# Select all potentially eligible patients
FOR EARS1 NOT EARS2
SUBSET EARS3
FROM PATIENTsNIHR Journals Library www.journalslibrary.nihr.ac.uk
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*QRY_SDATE,20110428,28/04/2011
*QRY_TITLE,EARS,REPORT : Eligibility Reference
*QRY_ORDER,004
*QRY_MEDIA,D,Disk
*QRY_AGREE,LOCAL,
*ENQ_IDENT,LOCAL,
*QRY_SETID,RA5B,RA 5 BYTE
*ENQ_RSPID,L83624,Marlborough Street Surgery
*QRY_CODES,0,9999R2,Read version 2
# Report all potentially eligible patients
DEFINE AGE AS @YEARS("28/04/2011",DATE_OF_BIRTH)
FOR EARS3
REPORT
# Patient summary data
PRINT SURNAME,FORENAME,SEX,AGE,ADDRESS_1,ADDRESS_2,ADDRESS_3,ADDRESS_4,POSTCODE,
FROM PATIENTS
# Smoking Data
PRINT CODE,RUBRIC,DATE,VALUE1
FROM JOURNALS (LATEST FOR PATIENT)
WHERE CODE IN("137%")
# Potentially relevant exclusion data
PRINT CODE,RUBRIC,DATE
FROM JOURNALS (ALL FOR PATIENT)
WHERE CODE IN("G%","E%","H%","9h%")259
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Appendix 5 Feedback from the health trainersFeedback on training procedures in the EARS studyThe table below shows the training plan for HTs. A selection of the interviews with HTs early and later
during intervention delivery is shown after the table.TABLE 1
Session
(AM= 9–12)
(PM= 1–4) Topic Aims Content
AM EARS
COMPETENCIES
Introduce advanced behaviour
change skills and logistics
Intro to EARS Manual. Participant
progression and keeping in touch
PM Build advanced PA behaviour
change skills
Multifaceted role for PA (counselling,
support and signposting). Using
pedometers and MP3 players
AM Build advanced PA behaviour
change skills
Building three Cs for PA (competence,
control and companionship)
PM Smoking reduction with exercise Smoking reduction and physical
activity: targeting implicit and explicit
processes
AM Build advanced Smoking reduction
skills
Smoking-reduction strategies
PM SMOKING
CESSATION
Identifying professional support for
quitting. Smoking data collection
Referral to NHS SSS or other options.
CO, self-report. Participant (subsidising
exercise, travel, etc.)
AM Other data collection Video role-play
PM Review counselling skills Review role-playsThe training aimed to check the HT’s existing skills and knowledge and build on these to allow them:
(a) to deliver the research process including recruitment, baseline assessment and outcomes measurement;
(b) to deliver the EARS intervention.
Key: HT1 = health trainer 1; HT2 = health trainer 2; HT3 = health trainer 3; CG = interviewer.
((. . .)) = transcriber’s notes; ((. . . )) = summary.
Training and partnership working was generally good:© Que
Health
provid
addres
SciencHT2: ((Felt reasonably well-prepared by end of training.)) Um . . . I suppose reasonably prepared, I
think that’s when you sort of learn, when you have the real clients come in and have all the sort of
dilemmas and . . . yeah, no I think reasonably prepared. Again in an, um, it’s then getting the
feedback on what you’ve done I think is the most valuable part of that really . . .HT3: I found it all useful, but it’s just getting that confidence thing to use it all and remembering
to use it all . . .269
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270NIHR. . . I think for, for me being involved in the writing of stuff you know, and the set up right at the
beginning, very beginning, it just means that we have a, we’re involved from the very beginning and
we feel part of the project.CG: So when it came to going live with recruitment and real live clients, how well prepared did
you feel?HT3: Um . . . ((long pause)) daunted! But, you know, it’s new –CG: Yeah, there’s never going to be a time when you’re ready, but ready enough to –HT3: I think so . . .However, it seemed unstructured:HT1: For me it seemed to lack structure really. At the time I felt a bit confused about what was going
on really; we had a programme and then we didn’t stick to it. And it seemed like we spent quite a bit
of that time on looking at things that weren’t really particularly important . . .. . . One minute we’re trying to do things to help develop the project and then another minute we’re
having sort of training. It just felt like, perhaps it just felt a bit too messy for me . . .HT2: Yeah, I think the training was a bit disjointed. Nothing particularly missing though . . .. . . I think the training was a bit ‘bitty’, it was a little bit all over the place. I mean the practice
participants were good, that was good. But I think it was just, it’s actually it’s doing it and then sort
of, because you do come across different scenarios and different barriers and what have you, and sort
of knowing how to deal with those or the best way to sort of deal with those really . . .HT3: It wasn’t fluid. You know, it was very, very haphazard . . .What worked well?
Practice sessions, reﬂecting on practice (recorded consultations) with a health psychologist, the
intervention manual:HT1: I think some of the . . . what was quite useful was when [participant]’s friend came in and we,
just the three of us had a session with her, and then talked about it afterward with Adrian and Tom.
That seemed like really quite a good learning process . . .. . . I enjoyed those [practice sessions], I thought they were useful and I thought it was good to have
those . . .. . . The sessions with Colin [Greaves] were quite good as well, particularly the talking about using
physical activity to deal with cravings, you know, that side of it . . .T2: It was all obviously very relevant, going through the manual.CG: Was the manual useful in itself, as a document?HT2: Yes. Yeah, I thought it was.Journals Library www.journalslibrary.nihr.ac.uk
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SciencHT2: Having access to Adrian and Tom for supervision and advice was helpful. More formative
feedback would have been helpful . . .HT1: I guess what I would have liked to have done in terms of the training would have been actually
a lot more practising amongst ourselves, and a lot more input really about the techniques that youwanted
us to use once we are doing the intervention . . .. . . I think we should have done it on the third day and on the fourth day. Yes, there should have
been more of it throughout the thing. We could have done it with each other as well as the practice
participants, but it felt there wasn’t enough emphasis on that side of it . . .. . . I wonder if it could have been a bit more interactive, because I can remember some of those days
we were sat, the five of us in a room for a whole day together. It could feel very dry and heavy . . .
Set us a task, like, ‘Go off, read it and you’ve each got to come back, present a bit about the things.’
Something like that . . .However, in contrast, one HT would have preferred a more tutorial style and less interactive practice:HT3: I’m not keen on listening to recordings; that’s not my way of learning. I’m very much a
classroom based, you know, tutorial-based person . . .. . . No, I did find those quite useful. Would I have used so many, for as long? I’m not sure . . .Need more on techniques beyond getting motivated:HT: I felt prepared to a certain extent in that we’d looked at what the core things you’d need to do to
go through a typical day, discuss different strategies, you know, talk about importance and
confidence, so I felt confident about doing all those things. But what then happens is you have clients
who come back and say it didn’t really work, and then we hadn’t really explored how you actually
work with people past that first session. I feel like I was prepared for that first session –CG: But not the second.HT: But not the subsequent eight ((laughs)).What didn’t work well?
Early recording was challenging/would be better post learning:HT1: I think the first day – or was it the second day? – suddenly we were being recorded and it felt
like . . . I suppose it’s about, if you’re going to do role play, for me it’s, people have to know what it is
that they’re practising . . .HT2: I felt quite negative about the simulation of intervention at second meeting . . . ((This was
perceived to be a bit scary and perhaps was too challenging at this stage.))HT3: I didn’t like the video recording, being thrown right in it right at the very beginning without, you
know . . . week one, when we were recorded I thought that was a bit . . . you know. We didn’t know
what we were expecting, we didn’t know what the training was, then we got thrown right in . . .271
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272Gap between end of training and starting with clients:NIHRHT1: It’s that thing, ‘training’, and it sounding meaningful when it’s relevant, isn’t it? And you can
train me in March and if I don’t encounter the problem until August, I’m still gonna say, ‘What do
I do?’. . . And then I sort of came in and we started, so that was okayOK. But I guess, I just think we just
all wanting to get started at that point really. It just seemed to be quite a long time before we actually
started getting participants in . . .HT2: The large gap between end of training and start of intervention wasn’t helpful.CG: So before you got your first client there was a big gap?HT3: I think, you know, if we left it much longer the interest would have phased and it would have
been, ‘What do we cover?’ There was quite a gap anyway between starting the project and getting
deployed, and starting . . .Practice effects
At the early stages, some of the HTs were struggling with the new concepts introduced:HT3: I’ve not done any motivational interviewing before in any of my capacities, so that area was totally
new to me. And to be honest, I’m still kind of struggling . . .. . . I mean for me, it’s a very, very different way of delivery from what I’m used to because of course
NHS courses are taught a different way of delivery.CG: So these techniques for just getting people to talk and encouraging them to talk, are you happy
with using those and do you use those quite often?HT3: [Pause] I wouldn’t say it comes naturally. I’ll use them if it comes to mind.. . . You know, the more you do it, the easier it gets.However, conﬁdence built up through practice:HT1: You can give people the theory, an opportunity to practice, but at the end of the day it is just
doing it; going over and over again with people that actually it increases your confidence . . .. . . Yeah, yeah, I definitely think I improved over the time. Yeah.CG: So you kind of learned from your own experience, is that what you . . . ?HT1: Yeah. But I think that that could have been speeded-up, could have been better if I’d had more
input, yeah.CG: So we could have facilitated more, the actually learning on the job in practice?HT1: Mm.HT2: I think it probably got easier as we’ve got used to it. Yeah, I think it has become sort of, it does
become easier to deliver it. Yeah, definitely.Journals Library www.journalslibrary.nihr.ac.uk
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SciencCG: I’m just thinking whether those techniques, you were using them consciously or you were aware
of them?HT2: Probably, yeah, and I think obviously I guess after a while they sort of come automatic anyway in
a way, so you’re not thinking about it quite so much.HT3: You know, as time goes on, about three years down the line you’ll just roll with it, it becomes
natural, you know, it’s part of your job. At the moment it’s still two and a half days a week and it’s a
balancing act, it’s still quite new but it’s getting easier.Other training ideas:HT2: ((Practising the protocol for collecting the data; having a ten minute reflection at end of
each session.))HT3: Maybe we should have modelled what we wanted to start with and say what we’re kind of
expecting . . .. . . Just put the cogs right in the correct order . . .. . . Definitely include more in the motivational stuff. Yeah, and give backgrounds of, you know, why
it’s done, and what you can gain from doing it that way or rather than from doing it that way.
((explaining purpose/contrasting communication styles))Feedback on recruitment procedures in the EARS studyKey: HT1 = health trainer 1; HT2 = health trainer 2; HT3 = health trainer 3; CG = interviewer.
((. . .)) = transcriber’s notes; ((. . .)) = summary.Recruitment strategies
Recruiting through GPs was relatively easy:HT1: Sending letters out from a GP surgery seems a good way.HT3: Well, a lot of it’s done because I’m working with GP surgeries, so the background work’s been
done before I get the work because of course all the records have been gone through, they’ve been
sifted, they’ve been, you know, identified, they’ve been checked . . .. . . I’ve got a very good relationship with them and they are very open . . .. . . Yeah, it’s been smooth running, you know I’ve been able to phone them up and say, ‘I need this
consent,’ you know, ‘Can I have a room for the interview?’ . . .However, there were some challenges: identifying the right contact and some problems with checking
exclusion criteria:HT1: There is a problem in working with the practice in that it’s a very busy practice, so when Tom
and I went along, first of all we met the Practice Manager and she said she would be the main person
I should liaise with whereas in fact, that wasn’t right. And she said, ‘Oh, you need to speak to the
head receptionist,’ or something, so once I had her, and I’d hardly even met her, so once I had her
pointed out to me, ‘She’s the person to talk to,’ it’s kind of gone a bit more smoothly . . .273
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NIHRHT2: ((Some less appropriate patients coming through from the GP with severe arthritis etc.)) Some of
them weren’t actually capable of increasing their physical activity, so I don’t know if the GPs,
although they weren’t giving us the correct information, or . . .Recruiting in the community was much harder:HT1: I guess it’s been . . . an experience, I was going to say ‘of two halves’, but I guess it’s probably
three. The period from last summer up to Christmas it felt very dynamic and enjoyable, and then we
entered a slump after Christmas where we were trying to engage with people from the community
and things and it just felt like nobody was interested. And then there’s been this third period where
we’ve had some interest and some engagement . . .. . . And then the community recruitment, you know, it seemed like we put a lot of effort into going
to groups, standing outside the job centre, giving our flyers and things to various people, engaging
with community leaders, for very, very little result; well, I had two people that came through that
route . . . so most of our community recruitment has come through the Stop Smoking Service . . .HT2: The wider community has been a lot harder, we’ve put a lot of posters up, flyers, been around
to see lots of people, but we haven’t seemed to have much luck with those . . .. . . There was a lot of effort. Yeah, it was an awful lot of effort, going along to Mother-Toddlers
groups and, actually I think that we were eleven hours there and actually we didn’t get one . . .But engaging key contacts was helpful:CG: What would be a better way of engaging people than going to the groups?HT2: I don’t know, I mean we did . . . I’ve forgotten the name of it now, but I asked sort of the
organiser if she could sort of promote it and she did get a couple. Um . . . it’s trying to get them on
board I think and-CG: Right, getting people that they know-HT2: Yeah, sort of leaders on board and having the time to have them try and sort of promote the
study really . . .HT1: . . . Say, if you think about we targeted some parent-toddler groups, well I think you would
probably perhaps need to have, um, more joined-up working between say the people running the
group and us going in there . . .It may also take more time to build relationships with the communityHT2: And I think, I think we might have done it a little bit the wrong way around by going to GPs
and that first. I think we could have done with building a bit more of a rapport with them right from
the start . . .. . . Because I feel like we, I mean we could have started trying to recruit from the community much
earlier, you know, I think that if we were serious about actually trying to hit a target from the
community in terms of the research project we should have started trying to do it earlier. Because if
you look at the GP surgery, say for every hundred letters we sent out we had about four responses.
In terms of the community I think the returns were much lower, so you had to work that
much harder . . .Journals Library www.journalslibrary.nihr.ac.uk
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SciencCG: What do you think attracts the ones who do want to take part? What attracts them?HT1: Mostly, well, mostly I think they want to try and do something about their smoking. Some of
them are attracted by the idea of the physical activity and frustratingly those are the ones that always
get put into the control [laughs] and some I think are interested I think in the study –CG: What, just taking part in the research?HT1: Yeah.HT2: The support? I think the one-to-one support. Um, a different approach maybe, slightly different
to what they’ve actually done before, and I think it wasn’t about quitting, it’s about trying to reduce
rather than them quitting . . .HT3: . . . But it seems that they are not hearing the physical activity side of it. They’re only coming in
because we’ve said reducing smoking, rather than quitting and I think that’s what is getting them
into the surgery . . .Reasons for non-engagement: Already quit; other priorities; illness.HT1: A lot of people seemed to suddenly have crises occurring in their lives ((laughs)) you know, like,
which interferes with them wanting to take part . . .HT2: Some people say they’ve quit. Um . . . some people just say they’ve got too much going on or
they just, um, or they’re unwell . . .HT3: Others, it’s not the right time, but some just say they’re not interested, it’s not something they are
considering . . .Reasons for dropoutHT: I think where their levels of motivation to change were high they were more likely to engage . . .
Whereas where they are perhaps still in that stage of feeling then should change but they’re still
struggling then they perhaps don’t want to talk to me because actually I’m making them think about
something they don’t want to think about, do something they don’t want to . . . I think it’s about
whether they want to quit smoke, reduce their smoking or not or increase their physical activity or
not really isn’t it? At the end of the day . . .Making contact by phone: generally this was comfortable to do, but with mixed views from different HTs.
We need to avoid hassling people.HT1: I haven’t really had any problems contacting people by and large.Most people are very polite, um, they’ll either just say, ‘No thanks, I’m not interested,’ or they’ll give
me a bit of their life history and then say, ‘No thanks,’ ((laughs)) or, um, but I haven’t had anybody
being rude really . . .. . . I kind of feel like after I have called them or left a message and rung them again, I kind of feel
that, ‘Oh, do I have to ring them again?’CG: Do you feel uncomfortable [making contact by phone] at all, in any way?275
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276NIHRHT2: No, I don’t feel uncomfortable doing it . . . ‘cause I don’t think I’m forceful, as soon as they just
say they’re not interested that’s that, I just sort of thank them for listening to me and that’s it, so, um
. . . Yeah, I’m not uncomfortable about doing the phone calls.CG: And contacting the patients, what’s that been like?HT3: Um . . . ((long pause)) hard. Um . . . I feel like a salesman. Then you start phoning and it’s not
always received well . . . Some of them don’t. Yeah, ‘I don’t know where you get this number from,’
but that’s only about two patients out of . . .And it is time-consuming:CG: Do you find it time consuming or just difficult to get hold of people in the first place?HT3: Um, especially with phoning during the day . . . It’s quite hard. You can phone evening, and it’s,
‘I’m doing dinner now.’HT2: No, it’s very time consuming.Control group allocation often led to disappointment:CG: And did you get any sense of that when people were allocated to the control group, of them
being disappointed?HT1: Yeah. Yeah. Definitely. You can just kind of see it in people’s faces, and I mean . . . and then one
woman just said, ‘Oh, well there’s no point me doing it then,’ and wouldn’t even take the
accelerometer, she just withdrew from the study there and then . . .HT2: I feel a little bit uncomfortable, not, well if uncomfortable’s the right word, but when you’re
doing the baseline and you can really see someone really wants to have this intervention and they get
the control group, that is the, I think that’s the hardest bit . . .. . . I know a lot of them were disappointed. They were disappointed that they were in the control
group. They’d come into the study thinking they were going to get this help and ((silence)) . . .HT3: What I don’t like about it is I know it’s a randomised controlled study, but it just seems that the
ones that really, really want to take part always get control, and that’s a bitch.Other ideas on recruitment:
1. Could offer them intervention at the end of the study, possibly in groups.
2. Need a strategy for what to say if someone else answers the phone:The most uncomfortable thing is when somebody else answers the phone and then you think, God,
they’ll want to know who I am and I say I’m ringing from the GP surgery and I want to say, there is
nothing to worry about, it’s not important. That kind of gets a bit of an uncomfortable thing.
HT11. Talking about PA during recruitment stage might be counter-productive as it ‘sort of confuses
people’ (HT2).
2. Possible ‘near-patient’ delivery:Journals Library www.journalslibrary.nihr.ac.uk
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SciencYeah. I think that could work more, and you might have one or two people who think, ‘Yeah, we’re
happy to talk to the smoking lady.’ You know, “If we can leave Johnny singing ‘Wheels on the Bus’
and we can escape for five minutes to talk about our smoking, that might be quite nice.
HT1The interviewer asked about problems with access or non-attendance or workload (for participants after
being enrolled), but no major problems were reported.Feedback on intervention delivery procedures in the
EARS studyKey: HT1 = health trainer 1; HT2 = health trainer 2; HT3 = health trainer 3; CG = interviewer.
((. . .)) = transcriber’s notes; ((. . .)) = summary.Intervention techniques/delivery issues
The health trainers reported no problems in using most of the intended intervention techniques, including
exploring a typical day; encouraging self-monitoring (which was seen as particularly useful);
problem-solving; empathy-building/person-centred counselling; exploring importance (including pros and
cons and using 1 to 10 scales); exploring conﬁdence; using motivational interviewing techniques (including
afﬁrmation and reﬂective listening); reviewing progress; assessing existing smoking; offering alternative
strategies for smoking reduction; setting realistic/SMART goals (usually verbally, or with the HT writing
them down) and making coping plans.
What worked well? Regular contact, self-monitoring, MI techniques, pedometers, behavioural strategies
for quitting.HT2: What worked well? Um, I think people did like the week-to-week contact, and I think trying to
sort of make things to being their ideas sort of did help. Um . . . I think maybe the flexibility that they
could come to the Cumberland to do a face-to-face assessment, some wanted phone, so there was
that choice . . . Um . . . I think what works with a lot of the participants is actually, is sort of doing
their diaries and then realising how much they actually do smoke. And just going through them,
going through with them, the different strategies that they sort of make a choice on which one or
what they might sort of amalgamate a few and come up with their own strategy, it’s trying to, them
having the ownership of what they’re actually doing really. Um, and it is, a lot of it is supporting them
through the lapses and what have you.CG: How useful was it to explore motivation?HT2: I think that was very useful really. Not everybody was motivated. But I think it is going through
the pros and the cons and their confidence and the important sort of things, that was useful. And
then sort of going back to those things sort of in a few weeks, further down the line as well. Yeah, I
think that was, although all those things were really useful . . . Most people liked to wear the
pedometer and I think were quite happy to wear the pedometer and seeing how many steps and that
sort of, and by increasing their steps a little bit. So that was quite a useful tool.HT1: . . . What else, what else felt good? Um . . . ((long pause)) Well, and you know, exploring the
different strategies with them, that they were going to use for cutting down . . . I think I felt um that I
used those strategies more in the last period.277
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278What works well: self-monitoring; PA as a distraction (but not as a way to reduce cravings).NIHRHT1: What I’m finding is that people find that monitoring their smoking is very useful and that in
itself provides a huge incentive or something for them to think like, ‘Oh my goodness, this is how
much I’m smoking, why am I smoking these cigarettes, I don’t really need them,’ and that’s been
much, much more beneficial to them than I would have anticipated . . . Thinking about in terms of,
you know, smart goals, how are they going to measure their success if they’re not actually recording
the smoking, you know, how are they going to know how many they’re smoking? . . . And then the
thing about the physical activity is they see the benefit of it in terms of it being a distraction but not
in the ways that I would have thought.HT2: Actually I’m finding that sometimes it’s just people keeping themselves actually busy, busier,
being more sort of physically active, in the house.CG: As a distraction?HT2: Yes, as a distraction, that’s sort of working as well.CG: So these arguments about reducing cravings . . . that doesn’t really appeal to people?HT3: I mean, we’ve mentioned that and you know, a lot of people that I work with, what I find is
they smoke out of habit and so it’s, you know, it’s talking about, you know, ‘Got to break that habit,’
you know, ‘If you have to, if you’re bored, it’s finding that something else to do,’ . . .Introducing PA:HT1: Most of them are willing to try and do some physical activity, a bit more walking, um . . .CG: Do you present it to them as a bit of an experiment to, say, some people?HT3: Yeah, no, I tend to say, ‘That’s what the study is looking at,’ . . .Making the link to PA through experiences:HT1: I do try and ask them questions about you know, if they’ve been out walking and things and
how have they felt about smoking then or when they stopped and things, and hoping that they’ll say,
‘No, I didn’t feel any cravings or urges,’ or whatever, you know, the thing that they do usually say is,
‘I’m really ready for a cigarette,’ when I’ve said that . . . I haven’t had people noticing that or
commenting on that second point about reducing the intensity of the cravings overall.CG: [Making the link to PA] as a way to reduce urges for smoking, so do they engage with that . . . ?HT3: Well, they engage with that, as I said, in terms of it being a distraction or as something to do to
fill time or . . . um, rather than anything else.Exploring the general health beneﬁts of PA, enjoyment of PA and perception about what PA entails was
also sometimes useful:HT2: I guess it depends on their perceived ideas of what physical activity is, so I think it’s trying to get,
finding out what they perceive sort of physical activity is, um, and then sort of discussing that with
them really . . . I think it’s sort of generally, gradually sort of then using it as a coping strategy, trying
to, sort of get them to, ‘What do you think about trying this as a kind of . . . ?’ or, ‘Try and do some
more walking, see if it makes any difference on how much you smoke or how you feel.’ Or finding
things that they actually like to do and encouraging them to do those sorts of things.Journals Library www.journalslibrary.nihr.ac.uk
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SciencHT1: I kind of expected people to buy into it more. You know, I’d expected that people would find it
difficult to stop smoking or to cut down their smoking or whatever, but I didn’t anticipate that they
would find it difficult to incorporate physical activity into their lives . . . I found a lot of people don’t,
or didn’t find that it was a benefit . . . You know, it might postpone them wanting to have a cigarette
for a while. I mean . . . yeah. Um . . . I’m not sure whether people understood what I was trying to say
. . . I think that the association that people were able to make was that if you were going to do a lot
of sport you probably wouldn’t want to be smoking, because that would impair your physical
performance, so I think they could understand it that way round, and I don’t, and . . . uh, you know
from a point of view of say, ‘I’m doing physical activity as a way of coping with cravings,’ very few
people kind of seemed to get that, even want to try it or do that.HT2: I don’t tend to push the physical activity, it depends on how they react really . . . we’ll offer them
a pedometer and then I’ll probably, as the telephone con-, I talk more, a bit more about the physical,
as far as I, I then try, I sometimes, introducing the two things together sometimes . . . I don’t know
how, I think, I think the main reason they’re coming into the study is because they want to reduce the
amount that they smoke, they don’t want to become more physically active and trying to make that
link, although it’s sort of, it’s linking the two together can be quite hard . . . Some people were quite
resistant, I think it’s trying to then look on it as a, if they’re keeping the diaries and they’re keeping a
step diary or an activity diary with their smoking diary, it’s trying to sort of, or make it like an
experiment, seeing if you do more activity or more steps do you smoke less on those sort of days?
Um, I think it was quite difficult to try, I found it quite difficult to get that link . . . No, it did [work] for
some people, some people, yeah. It did work. Others . . . it didn’t work for everyone. Some people
would be walking an awful lot but if they smoked and walked or, I mean it was trying to get them
out doing that, but it didn’t, not for everyone. The majority of people I think they did notice, some
people weren’t going to buy into it at all . . . It’s just with the physical activity it’s knowing when you
bring that in, it might just be mentioning it in their very first session ‘cause some sort of buy into it
straight away, others are a bit more reluctant and it’s just trying to coach them.HT3: The chap that I had quit, who’s finished the study, he did see the link and he, you know, he
found that link and he used it quite well, and so he added extra walking into his day. And then
there’s, you know, ‘Will that walk become habit?’. . . But she [participant] does realise when she goes for a walk she doesn’t have that cigarette
because she can’t walk and smoke at the same time.. . . It’s that, you know, ‘I can go to the gym, have a really good workout, I go outside and the first
thing I do is light up.And for individual tailoring more generally:HT2: . . . And if you become confident, and sort of developing your own, your own way I think as
well, I think we probably tried so hard to do it exactly, well I did anyway, on exactly how sort of
Adrian or Tom wanted it, but I think you have to adapt it to the actual participant as well a little bit.. . . I mean everybody’s very, very different aren’t they? Sort of receptive to different things, and it’s
trying to sort of gauge that, you can’t sort of just go by set criteria and just sort of like, ‘This is what
you’re doing, this is cessation,’ and what have you.CG: You have to adapt to the person in front of you.279
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NIHRHT2: Yeah, yeah . . .HT3: What I found with smoking, what I found with the strategies is they don’t pick one strategy over
another; it tends to be a combination of a couple of strategies.CG: OK, sure. Mix them up a bit.HT3: It’s down to trial and error. And you are able to change and you know, if it’s a mixture of two
then that’s, you know, an individual thing . . .HT1: . . . You know, challenging to, er, work out the best way of engaging individuals because they’re
all different.CG: Can you give me some examples of that?HT1: Um . . . well I suppose, you know, when we started Colin [Greaves] said, ‘What I want you to do
is go through a typical day with people, get them to tell you about a typical day.’ Well, that’s all very
well, but when you’ve got a client that is very defensive and closed and they’re thinking, ‘I don’t
want to tell you how I spend my day,’ then that approach isn’t going to work at all. So, as a sort of
model it’s all very well, but –CG: You need an alternative.HT1: You need alternative strategies, yeah.. . . So I feel like I tried to be creative with the different problems that were presenting themselves
with people . . .. . . I didn’t feel constrained by it [the session plan], no. I think that it felt safe to have that as an
agenda because you knew, ‘OK, I’m supposed to go in and do this,’ but it also . . . I suppose I felt I
had the confidence to abandon if I didn’t feel it was working . . .. . . I might think, ‘Oh,’ you know, ‘They talked about X, Y or Z, I’ll try and pick up on that next time,’
but it doesn’t always happen that way. Obviously the sessions are quite effected by the person and
what’s, you know, going on for them . . .Tailoring for the ‘hardest-to-reach’ sectors of the study population:HT1: If you like, the higher up the social scale that you go the easier it was to work with people. ‘Cause
they’ve got more capital, more resources to work with.CG: And what was the key, were you still able to have some success with people who were more off the
target group?HT1: Yeah, I think so. You know, I had three men that I can think of that I was working with who
were certainly the sort of target group. Um, two of them, one of them stopped smoking altogether,
not within the timeframe but he did stop smoking, and another one was down to three or four a day.
Another one was all over place, bless him, but he did make some changes. I think they got a lot out
of being involved in the study.CG: So what made it more difficult to work with the people who were more of the target group?Journals Library www.journalslibrary.nihr.ac.uk
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SciencHT1: ((pause)) Well, because they’ve got more problems going on in their lives. They haven’t got, say,
the analytical skills, self-awareness etcetera that –CG: So what would you adapt to that? I guess I’m going, what are the skills we need to teach people to
adapt to that kind of challenge? Working with, you know, low literacy, not used to thinking about their
own situation . . .HT1: I guess it’s about just keeping it more simple, simplistic. Just . . . I’m just trying to think . . .
((pause)) I guess it’s about looking for the strengths within them . . . and . . . you know, understanding
the way they think and manage their lives. So, one chap that I’m thinking about, he had a very
structured life generally, and so it was very much about doing that typical day approach, doing that,
‘When do you have cigarettes?’ targeting the ones to cut out, structuring in the physical activity and
just really going with that structure thing because that was a feature of his life. Somebody else who
was completely unstructured, he had a very clear target of wanting to smoke later in the day, he was
very clear about people who he smoked with more, and so it was about – well, and people who he
smoked with less – so it was about strategies he could develop to delay that first cigarette, because
that was his main goal, and also ways of getting him to spend more time with the people that he
smoked with less; so it’s about just taking the information from their lives, you perhaps doing the
analysing and then kind of –CG: Exploring specific strengths and barriers?HT1: That’s what I think I’m saying is actually, you’re doing the analysis, you’re developing a clear
picture of them becoming as self-aware as you can of them, and then supporting them in what’s the
best way for them.CG: And with those people, again it’s that challenge of explaining; do you have to explain the physical
activity link to these people?HT1: No, those guys got it. Those guys were into it.CG: So you just said, ‘We think this is the case,’ and they’d just be prepared to experiment with it
and go off-HT1: Yeah. And they found it useful, if they went out walking for hours on end [laughs] and didn’t
take their cigarettes with them then they wouldn’t smoke them. [laughs] You know, it’s a sort of
simplistic approach as well . . .HT2: In many cases, they just don’t get it – so it is a challenge to make this link understandable.HT2: . . . And I can say that a lot of other people have said that they’ve been out for, or it’s been said
that they’ve gone for walks and they haven’t smoked quite so much. But then she’ll [participant] still
come up, ‘Well, I smoke even more when I go for a walk.’CG: It’s not that it’s difficult to actually use the techniques in that situation, it’s just that basically they
just still don’t get it. Would that be a fair summary?HT2: Yeah, yeah. Yeah. And I think it’s, for the majority it is quite hard for them to actually get it.CG: So that’s the bit we need to work on –HT2: Yeah . . .281
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282The link may be subconscious though:NIHRHT2: I think some people are increasing their physical activity but it’s sort of subconsciously really, I
think. I’ve got a lady that’s now walking at lunchtimes and so she’s only having one cigarette instead
of two . . .There were mixed views about delivering the process measures alongside intervention interviews (NB: this
was noted as being a potentially difﬁcult process when reviewing the consultation recordings):HT2: ((Said that implementing the research measures did not seem to interfere with empathy
building, but listening to the consultation tapes suggested otherwise))CG: Does that interfere in any way with actually delivering the intervention? Or kind of establishing
the relationship with the client?HT2: What, collecting the data? No, I don’t think so.HT1: It kind of felt like, in some way I’ve used asking the questions as a way of structuring an
interview with somebody if I’ve felt, you know, like this one woman who was very defensive, I felt,
‘Actually, if I go in and use the questions that can feel safe.’ Because it’s asking these kind of
structured questions and then I can put the intervention in around it. But otherwise it felt like it was,
uh, obstructive because it’s getting in the way, because you’re always having to think about doing
that and the time that that takes and you know, actually, how much time have people got to talk to
you on the phone?. . . In terms of exploring confidence to change, because it’s a question within the template, I’m
focusing on getting, doing the questions rather than possible sticking with this question and really
exploring confidence to change with them . . .. . . I think there are problems with delivering the intervention which are because it’s part of a
research project, which actually if you were just delivering the intervention wouldn’t kind of exist.
Because there wouldn’t be the pressures that there are to recruit or to record information; there
wouldn’t be perhaps that tension between the health trainer and the researcher role and things. So, if
there was to be a bigger trial I think it would be important to have a different person doing the first
session, and then somebody else who delivers the intervention . . .Timescale: sometimes not enough/could use some ﬂexibility:HT2: The timescale of the intervention is not long enough to get people to the point of making the link
with PA ((she reported that it may take 8 sessions to get them to try some additional PA in
some cases)).. . . ((She said that weekly sessions good, but suggested spreading out the later ones to every two
weeks to allow more time for learning from experience.)) I think it might be better if the support was
for a longer period, maybe tailing it off but just for a longer period . . .HT3: . . . And getting to know the person, I mean, what I’d like is rather than working with them, as
we only we physically work with them for eight weeks unless they make a quit attempt; sometimes I
feel that’s too short a period because, sometimes we’re just starting to make headway, and then
that’s it . . .. . . So, I think . . . I think at the end of the eight weeks if we could go possibly every two weeks,
every three weeks and carry on ‘til week sixteen, but not necessarily engage it, I think that might . . .
it’s just having that extra support there . . .Journals Library www.journalslibrary.nihr.ac.uk
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Sciencflexible with the sixteen weeks. Because, you know, we can see that quit, that reduction and possiblya quit attempt to be two, three weeks down the line, but we haven’t got that flexibility . . .
Implementing social support can be problematic as not everyone has any support, so it can be provocative:HT2: That is slightly, that’s a bit more difficult. I think that for some of the group of patients that we’ve
got, that I find has been a bit of an issue.CG: In what way?HT2: Well, one gentleman just doesn’t really sort of interact with many other people at all, or even
answer his phone or anything, so he’s quite hard. So a lot of it’s just him really . . . he hasn’t got a lot of
social support. Another lady won’t do anything in groups and she just tends to, when she’s shut
her door that’s it, she doesn’t really go out very much. So there’s not much support. Doesn’t like any
sort of group work at all.CG: So if you mention social support it kind of puts their backs up a bit?HT2: Yes, because they might just sort of say, ‘Well, there’s nobody that really sort of cares what
I do.’ . . .Also not high on the agenda:HT3: I’ve talked about with one chap, I talked about it because then he started going out but not
having a cigarette when he wanted a drink. But it’s not on one of the important things I talk about
when I discuss things with the group. It’s not something that I think of all the time . . .But was acknowledged as important in the end-of-intervention interview in one case:HT2: I guess having support from others as well, doing things with, having support from others . . .Making action plans speciﬁc was sometimes difﬁcult, although this was recognised as being important:HT1: . . . Yeah, yes. Because sometimes that can be very difficult because sometimes they might just
say, ‘Well, I’m going to reduce by one in the morning,’ and I’ll have some discussion with them to try
and kind of pin down when they are going to cut that one down or which one it’s going to be, but if
I don’t, if they don’t come up with a specific cigarette or something, then I will usually say, ‘Well, OK,
you’ve managed to do some so, in your way . . . ‘ you know . . .. . . I mean I think it’s helpful, yeah. The more specific people are. The more specific I’ve pushed them
to be as well, I guess. You know, the more . . . ((pause)) Well, the more you know what’s going on . . .Using problem-solving techniques versus solution-focused approach:HT1: I try not to talk about problems too much, because I try to adopt more a focused approach rather
than a problem solving approach.CG: In order to find a solution you need to know what the problem is though.HT1: Yeah, but I would tend to, um, build on the things that go well rather than those and getting them
to go into too much detail about the things that have gone wrong . . .283
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NIHRCG: What about the coping plan stuff, where you say ‘what ifs’? ‘What are going to be the difficult
situations when you can be tempted to have a cigarette?’?HT3: Um . . . I probably don’t explore that as much as I should. I’d probably explore it after
the event . . .Managing expectations about the PA component at the start of the study:HT1: I think that people, when they come into the study they perhaps have higher expectations of
what would be required of them in terms of physical activity and that we might make them do
something or other . . .Identity change:HT1: I guess I had thought they might buy into a bit more of, ‘I’m not a smoker,’ seeing themselves
differently; instead of seeing themselves as a smoker, thinking of themselves as somebody who does a
lot of activity, and that would grow and grow and increase. They don’t seem to be making as big a
leap in that direction as I thought they would . . .HTs enjoyed the experience /being part of the study:CG: You feel generally positive about the experience?HT3: Yeah, I do . . . yes, it’s been a really good experience. Yeah, I think it has been positive.
Yeah, definitely.CG: Would you like to do some more if we . . . ?HT3: Yeah, absolutely. I would do . . .CG: If we advertised another job that was more permanent, would you apply for it?HT1: Yeah, maybe, yeah, I mean, yes I would. I’m enjoying the experience of being part of the
project, yes. I would say that, yes. And I have learned quite a lot as well about the people of
Devonport and ((laughs)) about smoking and engaging with people, and I’ve enjoyed doing it, yeah.CG: Any final comments?HT1: No, thank you very much for letting me do the job. ((laughs))] I’ve enjoyed it overall.Some of the HTs struggled initially with the idea of exchanging information and had the idea that they
weren’t allowed to offer information . . .HT3: . . . But what I find hard is to do it with making no suggestions. And that’s what I’ve, that’s what
I struggle with.. . . but this was improved by the end of the intervention (following further supervision/feedback):HT2: . . . And sometimes it is sort of about putting some ideas to them, as in, ‘Other people have
suggested that this has worked for them,’ or what have you . . .Journals Library www.journalslibrary.nihr.ac.uk
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Training ideas:
1. How to rein people in if they go off track: ‘Maybe need to encourage participants to take a longer term
to judging the beneﬁts of PA. Not focusing on how they feel immediately afterwards – usually the ﬁrst
thing they want to do is have a cigarette! – maybe monitor both over a few weeks . . . ’ (HT2).
2. How to respond if the patient asks for advice or wants to be told what to do (HT2). We need to
address the misconception that if you are using motivational interviewing you cannot offer (or
exchange) information.
3. How to avoid or minimise dependence somehow: ‘I guess one problem that did, I think, occur is that
some participants sort of become . . . I don’t know if they’re doing it because they’re trying to please
you as well, that’s sort of a danger, and become reliant, in a way reliant on you . . . ’ (HT2).
4. How to deal with people who are already active: ‘I think all of us had some people that were like,
especially if they have a sort of manual jobs, building and things like that, would consider themselves as
being physically active’ (HT2). ‘So many people that we’ve recruited do physical jobs as well . . . that felt
quite unsatisfactory really, all that whole physical activity side of it really . . . ’ (HT1).
5. How to deal with cannabis use as a related behaviour: ‘I think we did have a few problems when I
think people were coming and they were actually smoking cannabis as well. That was an issue with a
few participants . . . ’ (HT2).
6. How to deal with passive resistance/participants who are evasive: ‘I suppose the other difﬁcult client I’ve
had this last bit is one that’s just been very evasive and very vague, and she seems to be saying
something different every time, and I don’t think I’ve been successful in working with her. I probably
needed to challenge her more . . . There’s a big challenge in that sense, and also with the other guy. I
sort of said to him, you know, ‘This is week four, how have you found it, what have you got out of it?’
and got him to reﬂect on it and then re-engage . . . ’ (HT1).
Regarding the delivery of the intervention, the HTs noted that text reminders were useful to remind people
about appointments. Being ﬂexible to the individual’s needs or preferences is another important element
that we should emphasise. Suggestions were made regarding further supervision: ‘I think the quality of the
intervention would have been improved if we’d had better supervision . . . ’
There was a further suggestion that some type of debrieﬁng supervision might be useful, where the HTs
could discuss difﬁcult cases or their own feelings about certain difﬁcult clients:© Que
Health
provid
addres
Scienc. . . The sort of thing that really I need to sort of discuss with somebody. What I would think is that I
would need one-to-one every couple of weeks, and in that time I should be able to talk through, you
know, who my clients are and what I’ve done with them, what problems I’ve got with them, what I
think I’ve done well with them; and get some feedback and support around any clients that I’m
struggling with. So that could be that the person I’m having supervision with might have listened to
the tapes as well, and might have something to kind of say about me, what they hear me doing . . .There was also a suggestion from one HT that at the baseline interviews, participants often wanted to talk
about their experiences with smoking cessation and it was difﬁcult not to get drawn into intervention. This
might result in some contamination of the control group (albeit quite low level) if the data collection is not
separated from the intervention. There was a tension between the need to build empathy at this stage
and the need not to engage therapeutically.285
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process fidelity scalesThe rating scaleThe present six-point scale (i.e. a 0-6 Likert scale) extends from 0 [where the HT did not deliver the
intervention element appropriately – either they didn’t do it well or didn’t do it sufﬁciently (low ﬁdelity)] to
6 where there is the element is delivered appropriately (high ﬁdelity). Thus, the scale assesses a composite
of adherence to the intended intervention method and skill of the HT. To aid with the rating of items, an
outline of the key features of each item is provided at the top of each section. A description of the various
rating criteria is given in Figure 1. The examples are intended to be used as useful guidelines only,
providing illustrative anchor points, rather than prescriptive scoring criteria.Adjusting for the presence of participant difﬁcultiesAdjustments may be needed when participant difﬁculties are evident (e.g. excessive avoidance or
resistance). In such circumstances, the rater needs to assess the HT’s therapeutic skills in the application of
the methods. Even though the HT may not facilitate change, credit should be given for demonstrating
appropriate skilful interaction.Incompetent
0
1
2
3
4
5
6
Absence of feature and/or highly inappropriate performance
Minimal use of feature and/or inappropriate performance
Evidence of competence, but numerous problems
Competent, but some problems or inconsistencies
Good features, but minor problems or inconsistencies
Very good features, minimal problems or inconsistencies
Excellent performance
Competent
Proficient
Expert
Novice
Advance
beginner
Competence level* Scoring Examples* The scale incorporates the Dreyfus system (Dreyfus, 1989) for denoting
competence. Please note that the ’top marks (i.e. near the ‘expert’ end of the continuum) are reserved for those HTs
demonstrating highly effective skills, particularly in the face of difficulties (i.e. smokers with high resistance to
change; high levels of emotional expression; and complex situational barriers). Please note that there are 5
competence levels but six potential scores.When rating the item, you should ﬁrst identify whether some of the ‘Key Features’ are present. If the HT
includes most of the key features and uses them appropriately (i.e. misses few relevant opportunities to
use them and delivers them well), the HT should be rated very highly. It is important to remember that the
scoring proﬁle for this scale should approximate to a normal distribution (i.e. mid-point 3), with relatively
few scoring at the extremes.
Dreyfus, H. L. (1989). The Dreyfus model of skill acquisition. In J. Burke (ed.) Competency based education
and training. London: Falmer Press.287
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288ITEM 1: Active participant involvement
Key features: The HT should encourage the smoker to be actively involved in the consultation. The idea is
to maximise the smoker’s autonomy as the main agent of change, developing intrinsic rather than extrinsic
motivation, and encouraging her /him to be the person coming up with ideas for improving the situation.
However, the smoker should not be allowed to ramble in an unstructured way and the consultation should
be guided. A collaborative /shared decision-making style is appropriate and the HT may share his /her own
expertise and ideas, using techniques such as elicit-provide-elicit (below). Overall, the smoker should be
increasingly empowered to take control of her/his smoking and related physical activity behaviour.
Interactions should be encouraging, respectful and non-judgemental (the opposite of a didactic, telling
or persuading style of interaction). The smoker should ideally talk for at least half of the time. The
interaction should also be individually tailored to the participant’s speciﬁc information needs, beliefs,
motivations and barriers. The HT should engender a clear sense of warmth, genuineness and empathy
(within professional boundaries).
Intervention techniques: OARS (Open questions, Afﬁrmation, Reﬂective listening, Summaries). Reﬂective
listening may include simple reﬂections of content but may also be more sophisticated (e.g. ampliﬁed
reﬂection; reﬂection with a twist) and used to direct the conversation or highlight key strengths or barriers.
The Ask-Tell-Discuss (elicit-provide-elicit) technique should be used to exchange information (e.g. to
address misconceptions, or offer helpful new information). The above empathy-building techniques
and Individual tailoring should be used throughout the consultations - from the initial consultation
through action-planning through to review /maintenance sessions.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence of active participant involvement techniques. A highly didactic /practitioner-led or ‘lecturing’
style of interaction, which may increase or sustain client’s resistance
1 Minimal participant involvement or use of active participant involvement techniques. The practitioner
dominates the discussion
2 Appropriate use of participant involvement techniques, but not frequent enough. The practitioner
sometimes dominates the discussion
3 Appropriate and frequent use of participant involvement techniques. Teamwork evident, but some
difﬁculties in content or method of delivery
4 Appropriate and frequent use of participant involvement techniques. Minor problems evident (e.g. some
reﬂection opportunities missed)
5 Highly appropriate and regular use of participant involvement techniques, facilitating shared
understanding and decision making. Minimal problems
6 Excellent/expert use of participant involvement techniques throughout all consultations. A clear sense of
collaborative alliance is developed.ITEM 2: Motivation-building for cutting down/quitting
Key features: The HT should work with the smoker to explore initial beliefs about cutting down, and
quitting (importance and conﬁdence, triggers for smoking). The smoker’s motivation and conﬁdence for
cutting down is built up/enhanced through the exchange of information and techniques to assess and
enhance motivation – i.e. to enhance the perceived beneﬁts (importance) of cutting down /quitting and
conﬁdence (self-efﬁcacy) to take the actions needed.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Intervention techniques: OARS (Open questions, Afﬁrmation, Reﬂective listening, Summaries) should be
used speciﬁcally to explore current and past smoking behaviour, the pros and cons of cutting down and to
develop discrepancies between current behaviour and desired behaviour (or outcomes). The decisional
balance technique or 0–10 questions may be used to explore importance and conﬁdence. Information
should be exchanged on the pros and cons of cutting down and this and other techniques (exploring
possible futures; discussing past quitting attempts) should be used to explore barriers and possible
solutions to increase conﬁdence about cutting down/quitting. Motivation-building should ideally happen
around the start of the intervention process, although it can be further explored and reinforced at later
(action-planning, review and maintenance) stages. Establishing self-rewards or incentives (e.g. saving
money in a jar, planning rewards) may be part of the process for maintaining motivation.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process. NB: achieving a strong motivation is not necessary to score highly
here – the aim is to explore motivation sufﬁciently to allow the client to be able to make an informed
choice (which may be not to make any changes at this point in time)
0 Absence (or very poor delivery) of motivation-building techniques. Motivation to cut down or quit
smoking is assumed or not discussed
1 Minimal use of (or poor delivery of) motivation-building techniques. Minimal exploration of either
reasons for change or conﬁdence about making changes.
2 Some use of motivation-building techniques, but the exploration of motivation to cut down or quit is
not of sufﬁcient depth or detail
3 Appropriate use of motivation-building techniques. However, some difﬁculties evident (e.g. moving on
to change talk before motivation is fully established)
4 Appropriate and frequent use of motivation-building techniques relating to cutting down or quitting
smoking. Minor problems evident (e.g. some inconsistencies)
5 Highly appropriate and sufﬁcient use of motivation-building techniques, facilitating a clear
understanding of reasons for change and conﬁdence issues. Minimal problems
6 Excellent/expert use of motivation-building techniques, facilitating a clear understanding of reasons for
change and conﬁdence issues. No real problemsITEM 3: Motivation-building for physical activity
Key features: The HT should work with the smoker to introduce PA as an aid to cutting down and
quitting. They should explore initial beliefs about increasing physical activity (importance and conﬁdence).
The smoker’s motivation and conﬁdence for introducing new physical activity behaviours should be built
up through the exchange of information and techniques to assess and enhance motivation – i.e. to
enhance the smoker’s perceived beneﬁts and usefulness (importance) of physical activity and conﬁdence
(self-efﬁcacy) to take the actions needed.
Intervention techniques: OARS (Open questions, Afﬁrmation, Reﬂective listening, Summaries) should be
used speciﬁcally to explore current and past physical activity behaviour, the pros and cons of increasing PA
and to develop discrepancies between current behaviour and desired behaviour (or outcomes). The
decisional balance technique or 0–10 questions may be used to explore importance and conﬁdence.
Information should be exchanged on the pros and cons of physical activity and this and other techniques
(exploring possible futures; discussing past quitting attempts) should be used to explore barriers and
possible solutions to adopting PA strategies /increasing PA. Motivation-building should ideally happen289
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290around the start of the intervention process, although it can be further explored and reinforced at later
(action-planning, review and maintenance) stages.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process. NB: achieving a strong motivation or any changes is not necessary
to score highly – the aim is to explore motivation sufﬁciently to allow the client to be able to make an
informed choice about whether to change or not.
0 Absence (or very poor delivery) of motivation-building techniques. Motivation to adopt physical activity
strategies is assumed or not discussed
1 Minimal use of (or poor delivery of) motivation-building techniques. Minimal exploration of either
reasons for change or conﬁdence about making changes.
2 Some use of motivation-building techniques, but the exploration of motivation for physical activity is not
of sufﬁcient depth or detail
3 Appropriate use of motivation-building techniques. However, some difﬁculties evident (e.g. moving on
to change talk before motivation is fully established)
4 Appropriate and frequent use of motivation-building techniques relating to physical activity. Minor
problems evident (e.g. some inconsistencies)
5 Highly appropriate and sufﬁcient use of motivation-building techniques, facilitating a clear
understanding of reasons for change and conﬁdence issues. Minimal problems
6 Excellent/expert use of motivation-building techniques, facilitating a clear understanding of reasons for
change and conﬁdence issues. No real problemsITEM 4: Set goals and discuss strategies to reduce smoking
Key features: The HT should work with the smoker to discuss a range of strategies for reducing the
amount of cigarettes smoked. They should agree a verbal plan of action, seeking to make this as speciﬁc
as possible. They should discuss the use of self-monitoring to keep track of progress.
Intervention techniques: Goal-setting (with gradual /graded progression), Action Planning, Self-
Monitoring, Deconditioning strategies. Any or all of the four distinct EARS strategies for cutting down (based
on breaking the conditioned/automated link between smoking and reward and replacing this with consciously
mediated strategies) may be presented and discussed. The action plan should normally be made verbally, but
the HT should seek to make this as speciﬁc as possible in terms of ‘What, Where, When and Who with’ and
making the goal as SMART (Speciﬁc, Measurable, Achievable, Relevant and Time-related) as possible. The HT
should introduce and discuss with the smoker the usefulness of self-monitoring of behaviours (number of
cigarettes smoked, pattern of use). A speciﬁc plan for self-monitoring should be included in the action plan.
The HT may also encourage self-monitoring of the contexts (social or environmental or emotional
circumstances) in which problems/relapses might occur. Pre-empting and thinking of solutions for possible
problems (making a coping plan) is also appropriate here and may involve the use of other recognised
behaviour change techniques (e.g. engaging social support, stress-management).
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence (or very poor delivery) of action-planning techniques or discussion of smoking-reduction strategies
1 Minimal use (or poor delivery) of action-planning techniques or discussion of smoking-reduction strategiesNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 42 Some use of action-planning techniques or discussion of smoking-reduction strategies, but not in
sufﬁcient depth or detail
3 Appropriate use of action-planning techniques and discussion of smoking-reduction strategies. However,
some difﬁculties evident (e.g. not setting up self-monitoring; plan generated more by the HT than by
the smoker)
4 Appropriate use of action-planning techniques and discussion of strategies. Minor problems evident
(e.g. the plan is a bit less speciﬁc than it could be)
5 Highly appropriate and sufﬁcient use of action-planning techniques and discussion of smoking-reduction
strategies. Minimal problems
6 Excellent/expert use of action-planning techniques and discussion of smoking-reduction strategies.
No real problemsITEM 5: Set goals and discuss strategies to Set goals to increase
Physical Activity
Key features: The HT should work with the smoker to discuss ideas for introducing new physical activities
that might help to reduce smoking. They should agree a verbal plan of action, seeking to make this as
speciﬁc as possible. They should discuss the use of self-monitoring to keep track of progress, including
offering a pedometer as a means of monitoring walking activity if appropriate.
Intervention techniques: Goal-setting (with gradual/graded progression), Action Planning, Self-
Monitoring. Ideas for introducing relevant physical activities should be discussed. The action plan should
normally be made verbally, but the HT should seek to make this as speciﬁc as possible in terms of ‘What,
Where, When and Who with’ and making the goal as SMART (Speciﬁc, Measurable, Achievable, Relevant
and Time-related) as possible. The HT should introduce and discuss with the smoker the usefulness of self-
monitoring of behaviours (using memory, a diary and/or a pedometer). A speciﬁc plan for self-monitoring
should be included in the action plan. Pre-empting and thinking of solutions for possible problems
(making a coping plan) is also appropriate here and may involve the use of other recognised behaviour
change techniques (e.g. establishing prompts or cues to do physical activity).
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence (or very poor delivery) of action-planning techniques in relation to physical activity
1 Minimal use (or poor delivery) of action-planning techniques
2 Some use of action-planning techniques relating to physical activity, but not in sufﬁcient depth or detail
3 Appropriate use of action-planning techniques. However, some difﬁculties evident (e.g. no
self-monitoring; plan generated more by the HT than by the smoker)
4 Appropriate use of action-planning techniques relating to physical activity. Minor problems evident (e.g.
the plan is a bit less speciﬁc than it could be)
5 Highly appropriate and sufﬁcient use of action-planning techniques. Minimal problems
6 Excellent/expert use of action-planning techniques relating to physical activity. No real problems291
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292ITEM 6: Review efforts to cut down smoking/problem-solving
Key features: The HT should work with the smoker to reﬂect on progress with smoking reduction. The
HT should afﬁrm/reinforce any successes. The smoker and HT should discuss any setbacks (reframing to
normalise them, identifying barriers and exploring ways to overcome them). The HT and smoker should
then set new targets (possibly including making an attempt to quit).
Intervention techniques: Use of OARS (Open questions, Afﬁrmation, Reﬂective listening, Summaries)
speciﬁcally to reinforce successes, to discuss setbacks, to identify barriers (including social or environmental
contexts which increase cravings) and explore ways to overcome them (problem-solving). Reframing should
be used to normalise setbacks. Goals/action plans should then be reviewed. There may also be some
reﬂection on, and reinforcement of the smoker’s skills in avoiding or managing relapse (building skills and
self-efﬁcacy). Problem-solving may involve the use of other recognised behaviour change techniques
(e.g. engaging social support, stress-management).
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence (or very poor delivery) of progress review or problem-solving techniques in relation to
smoking reduction
1 Minimal use (or poor delivery) of progress review or problem-solving techniques
2 Some use of progress review and problem-solving techniques in relation to smoking reduction, but
lacking sufﬁcient depth or detail
3 Appropriate use of progress review and problem-solving techniques. However, some difﬁculties evident
(e.g. not reinforcing successes, providing rather than eliciting possible solutions to problems)
4 Appropriate and frequent use of progress review and problem-solving techniques in relation to smoking
reduction. Minor problems evident
5 Highly appropriate and sufﬁcient use of progress review and problem-solving techniques, facilitating a
clear understanding of the current situation and how to move forward. Minimal problems
6 Excellent/expert use of progress review and problem-solving techniques in relation to smoking reduction,
facilitating a clear understanding of the current situation and how to move forward.
No real problemsITEM 7: Review efforts to INCREASE physical activity /problem-solving
Key features: The HT should work with the smoker to reﬂect on progress with introducing relevant
physical activities. The HT should afﬁrm/reinforce any successes. The smoker and HT should discuss any
setbacks (reframing to normalise them, identifying barriers and exploring ways to overcome them). The HT
and smoker should then revise the smokers PA-related goals.
Intervention techniques: Use of OARS (Open questions, Afﬁrmation, Reﬂective listening, Summaries)
speciﬁcally to reinforce successes, to discuss setbacks, to identify barriers and explore ways to overcome
them (problem-solving). Reframing should be used to normalise setbacks. Goals/action plans should then
be reviewed. There may also be some reﬂection on, and reinforcement of the smoker’s skills in avoiding or
managing relapse (building skills and self-efﬁcacy).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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has delivered this intervention process
0 Absence (or very poor delivery) of progress review or problem-solving techniques in relation to the
physical activity component of the intervention
1 Minimal use (or poor delivery) of progress review or problem-solving techniques
2 Some use of progress review and problem-solving techniques in relation to physical activity, but lacking
sufﬁcient depth or detail
3 Appropriate use of progress review and problem-solving techniques. However, some difﬁculties evident
(e.g. not reinforcing successes, providing rather than eliciting possible solutions to problems)
4 Appropriate and frequent use of progress review and problem-solving techniques in relation to physical
activity. Minor problems evident
5 Highly appropriate and sufﬁcient use of progress review and problem-solving techniques, facilitating a
clear understanding of the current situation and how to move forward. Minimal problems
6 Excellent/expert use of progress review and problem-solving techniques in relation to physical activity,
facilitating a clear understanding of the current situation and how to move forward. No real problemsITEM 8: Integration of concepts: Building an association between PA and
smoking reduction
Key features: The HT should work with the smoker speciﬁcally to help her/him gain an appreciation of
the relationship between physical activity and smoking. A clear rationale should be presented for how PA
might be relevant to reducing smoking (e.g. as a distraction, as a way to reduce withdrawal symptoms
such as stress or cravings, as a way to prevent weight gain when reducing smoking). However, both
explicit processes (explanations) and implicit processes (learning from experience, disrupting usual patterns
of smoking behaviour; reductions in withdrawal symptoms that the smoker is not consciously aware of)
should be facilitated by the HT.
Intervention techniques:
Explicit integration techniques might include (a) developing (ideally using the Ask-Tell-Discuss
information-exchange technique) an appropriate conceptualisation or rationale for increasing PA as an aid
to reducing smoking (b) setting up an experiment (to do some extra PA) and encouraging self-monitoring
of links between physical activity and cigarette cravings, as well as on cigarette use. Implicit techniques
might include (a) setting up an experiment to see if it helps reduce smoking, with monitoring only of
outcomes (cigarette use) and without trying to make a conscious link between PA and strength of cravings.
Review of experiences with using PA and its impact on cravings or smoking behaviour may also be used
in later sessions.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
The absence (or very poor delivery) of techniques to link PA to cravings or amount smoked
1 Minimal use (or poor delivery) of techniques to link PA to cravings or amount smoked. No clear rationale
linking PA to smoking reduction is understood by the client293
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2942 Some use of techniques to link PA to cravings or amount of cigarettes smoked, but not of sufﬁcient
depth or detail. Only a limited rationale linking PA to smoking reduction is understood by the client.
3 Appropriate use of techniques to link PA to cravings or amount of cigarettes smoked. The rationale is at
least partly understood by the client. Some difﬁculties evident (e.g. not addressing misconceptions, not
using Ask-Tell-Discuss)
4 Appropriate use of techniques to link PA to cravings or amount of cigarettes smoked. The rationale is
understood by the client. Minor problems evident (e.g. minor inconsistencies)
5 Highly appropriate use of techniques to link PA to cravings or amount of cigarettes smoked. The
rationale is well developed and understood. Minimal problems
6 Excellent/expert use of techniques to link PA to cravings or amount of cigarettes smoked. The rationale
is well developed and understood. No real problemsITEM 9: Identify and reinforce any identity shifts towards being a more
‘healthy person’ or ‘healthy living’
Key features: The HT should pick up on any opportunity to reﬂect or reinforce statements that the
smoker makes relating to becoming or wanting to become a more healthy person in general.
Intervention techniques: Open questions, Afﬁrmation, Reﬂective listening. Reﬂective listening may
include simple reﬂections of content but may also be more sophisticated (e.g. ampliﬁed reﬂection;
reﬂection with a twist) and used to direct the conversation or highlight key changes in thinking that may
generalise to a change in the client’s self concept or identity, particularly with regard to being a healthy
person or living a healthy lifestyle.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process. It is recognised that there may only be a few, if any opportunities
to deliver this aspect of the intervention. Hence, we expect scores to be relatively low for this item.
0 Absence (or very poor delivery) of identity-building interactions
1 Minimal (or poorly delivered) identity-building interaction
2 Some identity-building interaction
3 Several examples of identity-building interaction. However, some difﬁculties evident (e.g. missed
opportunities, talking at odds with the participant)
4 Appropriate use of identity-building interactions, taking almost all opportunities. Minor problems evident
5 Highly appropriate and sufﬁcient use of identity-building interactions. Minimal problems
6 Excellent/expert use of identity-building interactions. No real problemsITEM 10: Engaging social support and managing social influences on
smoking reduction
Key features: The HT should encourage the smoker to engage social support (to assist on making or
carrying out plans) or manage social inﬂuences on smoking behaviour. Social support can be informational
(helping to make plans, providing ideas), emotional (not putting pressure on the person to smoke/
accepting their decision to cut down or quit), or practical (e.g. helping to monitor progress).NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Intervention techniques: Open questions, Afﬁrmation, Reﬂective listening and Summaries may be used
to explore social inﬂuences and to identify possible problems and solutions relating to social inﬂuences.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence (or very poor delivery) of interactions around engaging social support or managing social
inﬂuences on smoking behaviour
1 Minimal (or poorly delivered) interaction around engaging social support or managing social inﬂuences
2 Some interaction around engaging social support or managing social inﬂuences on smoking behaviour,
but not in sufﬁcient depth or detail
3 Several examples of interaction around engaging social support or managing social inﬂuences. However,
some difﬁculties evident (e.g. missed opportunities, talking at odds with the participant)
4 Appropriate use of interactions to engage social support or manage social inﬂuences on smoking
behaviour, taking almost all opportunities. Minor problems evident
5 Highly appropriate and sufﬁcient use of interactions to engage social support or manage social
inﬂuences. Minimal problems
6 Excellent/expert use of interactions to engage social support or manage social inﬂuences on smoking
behaviour. No real problemsITEM 11: Engaging social support and managing social influences on
physical activity
Key features: The HT should encourage the smoker to engage social support (to assist on making or
carrying out plans) or manage social inﬂuences on physical activity. Social support can be informational
(helping to make plans, providing ideas), emotional (not putting pressure on the person to smoke/
accepting their decision to cut down or quit), or practical (e.g. helping to monitor progress).
Intervention techniques: Open questions, Afﬁrmation, Reﬂective listening and Summaries may be used
to explore social inﬂuences and to identify possible problems and solutions relating to social inﬂuences.
Mark with an ’X’ on the vertical line, using whole and half numbers, the level to which you think the HT
has delivered this intervention process
0 Absence (or very poor delivery) of interactions around engaging social support or managing social
inﬂuences on physical activity
1 Minimal (or poorly delivered) interactions around engaging social support or managing social inﬂuences
2 Some interaction around engaging social support or managing social inﬂuences on physical activity, but
not in sufﬁcient depth or detail
3 Several examples of interaction around engaging social support or managing social inﬂuences. However,
some difﬁculties evident (e.g. missed opportunities, talking at odds with the participant)
4 Appropriate use of interactions to engage social support or manage social inﬂuences on physical activity,
taking almost all opportunities. Minor problems evident295
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2965 Highly appropriate and sufﬁcient use of interactions to engage social support or manage social
inﬂuences. Minimal problems
6 Excellent/expert use of interactions to engage social support or manage social inﬂuences on physical
activity. No real problemsITEM 12: REFERRAL TO SMOKING CESSATION SERVICES
Was the issue of making an attempt to stop smoking raised and the response appropriately addressed
(i.e. if desired, to make a referral to NHS SSS)?
Yes □ No □NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Reduction then Stop Intervention
Training and set-up costs
Experience in the pilot trial indicates that training for HTs in EARS intervention delivery requires 30 hours of
training time (5 × 6-hour sessions), with an expectation that one lead trainer undertakes training for three
trainees. Table 1 sets out the cost estimates for training activity based on these assumptions.
Health trainer contact time with participants (electronic data)
Analysis of within-trial data (electronic data reportage by HTs) provided the following summary statistics:
l EARS participants n = 49
l Missing (no contact time) n = 0
l Using n = 49:
(a) mean number of intervention sessions attended = 4.10 (SD 2.69)
(b) mean number of DNA events = 0.65 (SD 1.13) (conservative)
(c) mean number of contacts with EARS (intervention + continued support for quitters) = 4.26.
Health trainer non-contact timeElectronic records
The data/information we have from HT electronic record suggest only a small proportion of non-face-to-
face activities delivering EARS (37% of HT time), the majority of which was captured in identiﬁcation and
recruitment of smokers for the EARS service. It is apparent that electronic methods of data reportage failed
to fully capture time spent in non-contact activities.TABLE 1 Training calculationa
Item Resource use Unit cost 1-year costs
HT training Three HTs × 30 hours £27 per hour £2430.00
Lead training 1 trainer × 37 hours £38 per hour £1406.00
Venue opportunity cost 5 days £100 £500.00
Materials £200.00
Travelb 50 miles per day (trainer) £0.21 per mile £52.50
Subtotal (based on three HTs) £4588.50
Training cost per HT £1529.50
Total training attributable to participant based on three HTs each working 42 weeks per year
Training/participant (assumed caseload = 250 per HT) £6.12c
a This represents additional training required for HTs to deliver EARS intervention. This estimate is based on the
assumption that experienced HTs or suitable equivalent staff being recruited into post. Note that implementation/set-up
costs other than training are assumed not to incur additional costs. Assumption that the EARS intervention can be
integrated within current service settings, and estimated cost for HT based on unit cost from PSSRU which includes
overheads and capital relating to standard care.
b Based on current NHS mileage rates for mid engine size and over 9000 miles per annum. URL: www.nhsemployers.org/
payandcontracts/agendaforchange/pages/afc-mileageallowances.aspx (accessed 29 October 2012).
c A caseload of 250 participants within a 1-year period was assumed. This approximation was based on the caseload of
intervention participants within trial (n = 49) covered by 1 × 0.7 FTE in a two month period, assuming that a HT works
42 weeks per year (based on PSSRU estimates for similar Agenda for Change band of worker and including annual
leave, statutory leave, sickness leave and training).
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TABLE 2 Breakdown of time spent delivering the intervention by health trainers. Mean time (minutes)
and standard deviation (where calculable) per participant (n=49)
Mean
(minutes) SD Comment
Face to face 86.6 73.4
Telephone contact 35.5 52.1
Face-to-face contact delivery time 122.1 –
E-mails 0.2 1.5 Based on 10-minute e-mail
Texts 2.7 3.5 Based on 2-minute text
Voicemail 1.9 2.4
Letters 1.8 5.9 Based on 10-minute letter
Non-intervention telephone calls 8.0 8.9
Total participant level contact time
(excluding supervision)
136.7
Supervision (per participant) 9.80 – Assumption based on 1-hour supervision
per HT per week and intervention turnover
of cases every 2 months; supervision time
60 minutes × 8 weeks = 480 minutes for 49
participants in the trial (estimate per
participant = 9.8 minutes)
Total contact time 146.50 –
APPENDIX 9
306Work sampling records
Work sampling of two HTs was carried out over a 2-week period. Data collection in the pilot indicated that
some developments were needed to the data collection form and also, given that data were collected
from only two HTs, it is difﬁcult to draw ﬁrm conclusions from the pilot study. However, the method was
tested out, it was acceptable to HTs, and the pilot study indicates that it is an important source of future
data (within cost estimates). In theory this approach is able to provide data that will allow an
approximation to be made over the ratio of contact/non-contact HT time in EARS delivery. In the pilot
data, we found the ratio difﬁcult to determine as feedback from HTs on work sampling indicated that HTs
used research-related data collection questions to launch into intervention delivery. Adjusting for this bias
by excluding all data collection activities suggests a considerable and substantial proportion of non-contact
activities for the two HTs sampled (57% of total HT time).Identification of ‘hard-to-reach’ smokers and recruitment
In the pilot trial, a number of different modes of identiﬁcation of participants for EARS were explored. In
addition, some identiﬁcation work (screening and searching for ‘hard-to-reach’ participants) was taken by
the principal investigator and trial manager, whereas in practice this work is likely to be done by a HT.
Within the trial, the most efﬁcient models of recruitment were from GPs and previous treatment failures
from SSS (in the region of 1–1.5 hours of recruitment activity per participant randomised). We therefore
assumed that a mean of 1.25 hours of recruitment-based activity might be required. This may be
conservative as anecdotal evidence suggests that recruitment into a trial is much more difﬁcult than
recruitment into a service.Supervision time
Current costs assume 1 hour’s supervision per HT per week and intervention turnover of cases every
2 months. The assumption is based on experiences in the trial with 49 EARS participants.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Data estimated within trial (electronic reporting) showed the per-participant costs to be in the region of
£19. The data/information we have from the trial suggested that only a low proportion of participants had
ﬁnancial subsidies. Further details are provided in Table 3. Accelerometers were used in the trial to
measure exercise outcomes, but unit cost of intervention was assumed to be for a cheaper pedometer.
Sensitivity analysis to explore inclusion of indirect costs associated
with intervention
Effect of implementation on Stop Smoking services
It is possible that the EARS intervention could increase the number of participants wishing to make a quit
attempt via SSS over and above control. The sample size of the pilot trial made it difﬁcult to make
inference on this, but a full RCT may be more informative. In the pilot trial, 2/49 participants in the EARS
active arm were referred to SSS compared with 0/50 in control. The analysis of intervention cost of EARS
at present makes no projection about how services could be integrated. Assuming a scenario where 50%
(rounded up) of the 11 making a quit attempt in EARS seek help through SSS, using a cost of SSS per
participant at £350 – as reported by Carr et al.1 – we explored including this data (along with
pharmacotherapies) with the components of the total service cost for EARS in a sensitivity analysis
presented in Table 4. The ﬁgures overestimate the cost of SSS within the trial period.
We restrict our base-case analysis of costs to those incurred as a direct result of the intervention on the
basis that it is questionable as to whether or not there would be additional indirect intervention costs over
time with EARS relative to comparator. Smoking is a chronic condition, and many smokers typically receive
multiple interventions before achieving long-term quit.Effect of implementation on pharmacotherapy usage
As with smoking services, it is plausible that the EARS intervention could result in additional usage of
pharmacotherapy compared with alternatives (NRT, buproprion and/or varenicline) to support a quit
attempt. It is also possible that an EARS-type intervention could result in lower usage of pharmacotherapy
if exercise alone proves effective at minimising cravings.TABLE 4 Additional indirect costs associated with EARS-type intervention
Other items Cost 1-year costs
Additional referrals to SSS 6 × £350 £2100.00
Additional pharmacotherapy prescription 6 × £62 £372.00
Subtotal £2472.00
Total indirect costs per participant based on three HTs each working 42 weeks per year
Indirect costs per participant (caseload based on trial intervention, n = 49) £50.45
TABLE 3 Estimated mean cost of exercise aids per participant
Exercise aid Cost (£) SD
Cost of subsidies 7.17 18.82
Cost of pedometers 10 –
Cost of MP3s 1.25 –
Cost of exercise bands 0.65 –
Total cost of exercise aids 19.07
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308In a sensitivity analysis, we assumed that an additional 50% of the 11 out of 12 making a quit attempt
made pharmacotherapy-assisted quit attempts on prescription. One course of pharmacotherapy equates to
£62 per participant; this assumption is based on cost of GP advice plus prescription by Wang et al.,2
inﬂated from 2006 prices using the PSSRU Hospital and Community Pay and Prices index.3Results
Including additional pharmacotherapy and SSS resource cost increases the total per-participant cost of the
EARS service by £50.45, that is to say a total of £242.62.
Effect of implementation on other services
For pragmatic reasons this is assumed to be zero cost.Economic evaluation search strategy used to identify
cost-effectiveness analysis studies in smoking cessationThe following electronic databases were searched from their inception up to August 2012: MEDLINE,
EMBASE (both via Ovid) and Cochrane Reviews and Dissemination (CRD). The search terms used included
smoking, tobacco and terms relating to types of economic evaluation.Search strategy (MEDLINE)
cost beneﬁt analysis/
cost effectiveness analysis/
cost minimization analysis/
cost utility analysis/
(technology assessment).tw.
(economic$ or pharmacoeconomic$ or price$ or pricing).tw.
or/1-6
(nicotine$ or smok$ or tobacco).ti.
and/ 8-9Search strategy (EMBASE)
cost beneﬁt analysis/
cost effectiveness analysis/
cost minimization analysis/
cost utility analysis/
(technology assessment).tw.
(economic$ or pharmacoeconomic$ or price$ or pricing).tw.
or/1-6
(nicotine$ or smok$ or tobacco).ti.
and/ 8-9Search strategy (CRD)
We searched for economic models and economic evaluations performed by a search of all publications
using the terms smoking, tobacco and nicotine.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Evidence review summary tableTABLE 5 Detailed/summary detail table for modelling studies discussed in evidence review
Wang et al.2 (UK)
(a) Model structure Aim: to assess the cost-effectiveness of making NRT available in the context of a CDTQ
programme for a suitable population of smokers
Model: decision-analytic model (structure reported – decision tree), parameters
estimated from published literature
Time horizon: lifetime
Viewpoint: UK NHS/Personal Social Services
Viewpoint justiﬁcation: none reported
Alternatives: No NRT. In the full model, for attempts made with NRT the attempts were
categorised as either ‘abrupt’ or CDTQ. Within each of these possibilities, the form by
which smokers CDTQ or quit modelled are OTC NRT, prescription NRT or a smokers’
clinic.
The authors also show a schematic for a mixed analysis. The reporting does not lend
itself to a clear distinction between the approaches
Study population: current smokers (previous quit attempts or exposure to other
interventions in the past not dealt with. Future quit attempts – assumption that risk of
relapse is independent of current quit attempt)
Evaluation method: cost-effectiveness analysis
(b) Data inputs – effectiveness
data
Effectiveness data: model refers to meta-analyses conducted elsewhere for probability of
successful quit attempt (at 6 months, 12 months and lifetime)
Method used to estimate effectiveness: sustained abstinence measures from
meta-analysis of individual patient data at 6 months. Evidence synthesis (meta-analysis
or other method, NR, for abrupt quitters) of relapse rates from 12 studies for the period
between 6 and 12 months using:
12 months’ sustained abstinence = 6 months’ sustained abstinence × risk of relapse
Lifetime abstinence estimated by assumption that 30% relapse after 12 months,
i.e. 70% of 12-month quitters succeed
Valuation of health beneﬁts: CQG (authors estimate the QALY gain using data from Doll
et al., they do not estimate aggregate/total QALYs as these data apparently unavailable)
Indirect beneﬁts: NR
(b) Data inputs – resource use Resource use: therapy and clinicians’ time, OTC treatments resulted in zero cost to NHS
as defrayed to patient
Unit cost data: reported in appendix
Resources reported separately from cost: yes
Currency (exchange rate): £
Price year (adjustment for inﬂation): 2008
continued
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TABLE 5 Detailed/summary detail table for modelling studies discussed in evidence review (continued )
Wang et al.2 (UK)
(c) Consideration of
uncertainty/consistency
Discount rate: 3.5% costs and QALYs
Uncertainty: simple deterministic analysis, main focus is on the CDTQ quit rate vs. the
abrupt quit rate. Authors refer presentation of ICERs by subgroup sensitivity analysis
The authors also perform a sort of threshold analysis to examine the trade-off (to
examine possible effect of smokers who would otherwise have made an abrupt quit
now cutting down vs. those making no attempt)
Authors’ conclusion: CDTQ delivers ICERs within margins considered cost-effective.
CDTQ is less effective and more costly than abrupt quitting but may address a different
population
(d) Presentation of CEA
ﬁndings
Outcome of model: (as identiﬁed by authors) expected lifetime QALYs. In reality, the
model only estimates the CQG associated with a quit attempt. The summary outcome
measure is the ICER and is therefore an incremental analysis (CQG)
Probability of lifetime quit rate: values reported for different options within the range of
0.0137–0.1119 (abrupt quit)
Total cost: (£0–153.79)
ICER: range of ICERs presented for different service strategies
NICE guidance PH14
(a) Model structure Aim: cost-effectiveness of brief intervention and referral (multiple scenarios) GP and
nurse delivered and referral to specialist SSS for smoking cessation
Model: decision tree, projection of ﬁnal outcomes
Time horizon: lifetime (analysis). Decision tree corresponds to 12 months
Viewpoint: NHS and Personal and Social Services
Viewpoint justiﬁcation: NICE guidance
Alternatives: various. Brief opportunistic advice from GP alone (with adjunct NRT,
telephone helpline, self-help material). Nurse-led brief interventions (30 minutes) in
primary or hospital setting
Study population: UK smokers
Evaluation method: CUA
(b) Data inputs – effectiveness
data
Probability data: 12-month quit rate
Method used to estimate comparative effectiveness: ORs applied to 12-month quit rates
for different types of brief intervention
Primary outcome measure: 12 month quit rate (in some instances calculated from ORs)
obtained from evidence synthesis of trial data.
Other outcome measures: adjustment for risk of longer-term risk of relapse from Yudkin
et al.5 Detailed methods not provided
Valuation of health beneﬁts: secondary EQ-5D data from an unpublished survey of
15,000 current and ex-smokers
Indirect beneﬁts: not considered
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NICE guidance PH14
(b) Data inputs – resource use Resource use: GP/nurse time, nurse training in brief advice, cost of self-help materials,
provision of telephone helpline service
Unit cost data: staff costs from Curtis and Netten,6 NRT costs from BNF 2005, other
overheads (telephone calls, literature) estimated, source not reported
Cost savings in terms of smoking-related diseases per long-term quitter estimated from
published source Godfrey7
Resources reported separately from cost: no; however, itemised resource use presented
alongside total costs
Currency (exchange rate): £
Price year (adjustment for inﬂation): 2005
(c) Consideration of
uncertainty/consistency
Key parameters varied: effectiveness and background quit rates, length of intervention.
Discussion of other factors: socio-economic deprivation, tobacco dependence, extending
model to include previous smokers not responding, alternative treatment settings
Discount rate: 3.5%
Uncertainty: deterministic – series of univariate scenario analyses. Threshold analysis to
explore minimum effect size required to remain cost-effectiveness
(d) Presentation of CEA
ﬁndings
Outcome: Cost per QALY (£)
Probability of lifetime quit rate: assumes maximal period of follow-up by Yudkin5 at
8 years reﬂects lifetime rate
Total cost: not presented
ICER: Dependent on age and sex the ICERs relating to a brief (5-minute) intervention
range from £636 to £1677
Authors’ conclusion: cost-effective results can be generated in all settings and
age-group for all forms of brief advice. ICERs tend to increase with cohort age
Bauld et al.8
(a) Model structure Aim: cost-effective analysis of smoking-cessation programs
Model: decision tree (52-week model) with a Markov model (lifetime model)
Time horizon: lifetime
Viewpoint: NHS health service perspective (NHS Scotland)
Viewpoint justiﬁcation: not explicitly discussed
Alternatives: both a pharmacy and a group-based SSS were compared against self-quit
attempts. The authors suggest that direct comparison of pharmacy and group-based
services would be inappropriate as they attract different ‘types’ of smoker
Study population: smokers using NHS smoking cessation services in Glasgow
Evaluation method: CEA
(b) Data inputs – effectiveness
data
Method used to estimate effectiveness: veriﬁed 52-week abstinence rates to determine
the numbers of current and ex-smokers in each cohort. Relapse rates applied for 8 years
post quit. Risk of smoking related mortality applied 12 years post quit.
Primary outcome measure: 52-week abstinence as veriﬁed by CO monitor
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Bauld et al.8
Other effectiveness data considered: relapse rates and risk of smoking related death in
ex-smokers. The methods for calculating smoking attributable mortality appear to be
based on methods based on Thun et al.,9 and are outlined in a report commissioned by
NHS Health Scotland
Valuation of health beneﬁts: secondary sources. Health state utility values from Tengs
and Wallace10 – 0.8 smoker, 0.87 ex-smoker
Indirect beneﬁts: not considered
(b) Data inputs – Resource use Resource use: all relevant health service costs associated with NRT, professional time,
overheads and materials
Unit cost data: BNF, PSSRU and within study
Resources reported separately from cost: in summary form
Currency (exchange rate): £
Price year (adjustment for inﬂation): 2007
(c) Consideration of
uncertainty/consistency
Key parameters varied in sensitivity analysis: scenario analyses based on (i) incorporating
the future cost of smoking-related disease, (ii) not discounting QALYS, (iii) including
self-reported quit, (iv) including a small cost (to the NHS) based on self-quit attempts
Probability data: 12-month quit rates from within-trial analysis
Discount rate: 3.5% QALYs only
Uncertainty: scenario analyses, one of which includes future health costs of smokers
(d) Presentation of CEA
ﬁndings
Outcomes: cost per client, cost per 52-week quitter, cost per QALY
Probability of lifetime quit rate: applied by calculating year-on-year transitions (time
dependent probabilities)
Total cost: pharmacy cost per client £79.00. Group cost £368.00
ICER: (vs. self-quit) pharmacy service cost per 52-week quitter = £7800, group-based
service cost per 52-week quitter = £9200
Authors’ conclusion: both pharmacy and group based services represent cost-effective
interventions to help smokers to quit. Observed quit rates were lower than in some
other studies; while this is commonly true in observational study designs, the lower
effectiveness rates may also reﬂect a greater resistance to smoking cessation in Glasgow
Howard,11 BENESCO model
(a) Model structure Aim: to assess the cost-effectiveness of varenicline vs. alternative smoking-cessation
strategies
Model: Markov
Time horizon: 20-year and lifetime
Viewpoint: US health care
Viewpoint justiﬁcation: US budget holders
Time horizon: 20-year and lifetime
Alternatives: Buproprion, NRT, unaided quitting
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Howard,11 BENESCO model
Study population: overall US population (of smokers)
Evaluation method: CEA, CUA, budget impact
(b) Data inputs – effectiveness
data
Method used to estimate effectiveness: continuous abstinence rates, hazard ratios
(published literature Thun et al.9) (used to calculate number of smoking related diseases
and deaths)
Valuation of health beneﬁts: QALYs from published literature (Fiscella and Franks12)
Indirect beneﬁts: not included
(b) Data inputs – resource use Resource use: cost of treatments
Unit cost data: drugs, dispensing fees, physician fees and treatment costs
Resources reported separately from cost: yes
Currency (exchange rate): $
Price year (adjustment for inﬂation): 2005 (inﬂation index detail not provided)
(c) Consideration of
uncertainty/consistency
Key parameters: costs, efﬁcacy rates, relapse rates, disease incidence, prevalence and
mortality rates
Time horizon: 2, 5,10, 20 years and lifetime
Discount rate: 3% per annum
Uncertainty: scenario analysis, probabilistic sensitivity analysis (details of distributions
provided)
(d) Presentation of CEA
ﬁndings
Outcomes: incremental cost and incremental QALYs, presented in disaggregated form
for the entire modelled cohort (just under 12 million smokers). No summary statistic
presented cost per QALY due to dominance of modelled intervention
Probability of lifetime quit rate: Relapse rates assumed to be higher in ﬁrst 5 years
Total cost: for the US health system and a cohort of 11.9 million smokers, the total
costs for varenicline were $328,541M over a lifetime compared with $330,958 for
bupropion, $332,662 for NRT and $333,283 for unaided cessation
ICER: varenicline dominated all alternatives in model base case
Authors’ conclusion: varenicline is very likely cost-effective (based on probabilistic output
presented in cost-effectiveness acceptability curves)
Comments: population-based US model with a focus on pharmacological aids to
smoking cessation
Hurley,13 Quit Benefits Model
(a) Model structure Aim: to create a tool to evaluate tobacco control programs when the number of quitters
is known
Model: Markov – model included four smoking associated diseases: MI, stroke, lung
cancer, COPD
Time horizon: 10 years (after quitting smoking)
Viewpoint: health care system (primary care)
Viewpoint justiﬁcation: Australian policy-makers and health program funders
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Hurley,13 Quit Benefits Model
Alternatives: N/A
Study population: simulated quitters (Australians aged between 15 and 74)
Evaluation method: CEA, CUA
(b) Data inputs – effectiveness
data
Method used to estimate effectiveness: relative risks from observational studies
(Australian)
Valuation of health beneﬁts: reduction in smoking related disease and death, life-years
saved, QALYs
Utilities of less than one for smoking related sequelae only. Utilities from CEA registry
Indirect costs/beneﬁts: not included
(b) Data inputs – resource use Resource use: cost of treating smoking-related diseases
Unit cost data: no, total cost of smoking-related diseases reported for direct health care
costs only. Some information about different cost categories
Resources reported separately from cost: no
Currency (exchange rate): $AUS
Price year (adjustment for inﬂation): 2001 (no inﬂation adjustments)
(c) Consideration of
uncertainty/consistency
Key parameters: relative risks
Probability data: some modelling of source data to derive transition probabilities (i.e.
using exponential models in the case of smoking-related diseases. Model and
assumptions well documented
Time horizon: 10 years (after quitting smoking)
Discount rate: 0, 3% and 5%
Uncertainty: univariate and multivariate sensitivity analysis of all model inputs (+/–) 10%
(d) Presentation of CEA
ﬁndings
Outcomes: life-years saved, QALYs, costs
Probability of lifetime quit rate: N/A
Total cost: average saving AUS $373,000 per 1000 quitters (men and women
combined)
ICER: not presented in a summary outcome measure as quitters had lower costs and
better outcomes than non-quitters
Authors’ conclusion: QBM highlights the clinical and economic beneﬁts of a tobacco
control programme showing the impact on the individual
Comments: this model was implicitly compared with no intervention, i.e. illustrates the
burden of disease and how it might be reduced by an effective tobacco control
programme
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Hurley,13 Quit Benefits Model
Woolacott et al.14
(a) Model structure Aim: to estimate the cost-effectiveness of NRT and/or bupropion sustained release for
smoking cessation
Model: decision-analytic (appears to be decision tree)
Time horizon: unclear; not lifetime
Viewpoint: UK NHS
Viewpoint justiﬁcation: not provided (HTA report)
Alternatives: brief advice alone and in combination with either buproprion-sustained
release or NRT. Counselling (individual or group)
Study population: primary care
Evaluation method: CEA, CUA
(b) Data inputs – effectiveness
data
Effectiveness data: from published studies
Method used to estimate effectiveness: continuous quit rate at 12 months
(control/treated)
Valuation of health beneﬁts: life-years saved (from published review). QALYS (from
Fiscella and Franks12)
Indirect costs/beneﬁts: not included
(b) Data inputs – resource use Resource use: resource use relating to intervention only
Unit cost data: yes, but not all intervention costs have sources which are referenced
Resources reported separately from cost: yes
Currency (exchange rate): £
Price year (adjustment for inﬂation): not reported – 2002?
(c) Consideration of
uncertainty/consistency
Key parameters: continuous quit rate p.a. (advice) = 3%
Continuous quit rate (counselling) p.a. = 9%
Spontaneous cessation p.a. = 1%
Probability data: for buproprion/NRT derived from meta-analysed or indirect comparisons
of ORs to calculate annual probabilities for decision tree nodes
Time horizon: unclear; not lifetime
Discount rate: not applied
Uncertainty: univariate and multivariate sensitivity analysis of all model
inputs (+/–) 10%
(d) Presentation of CEA
ﬁndings
Outcomes: ICER/life-years saved
Probability of lifetime quit rate: 40% risk of relapse (in what period?)
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Woolacott et al.14
Total cost: £67–202M (NHS England and Wales)
ICER: £1459–1777 when compared with advice alone
Authors’ conclusion: NRT/buproprion-sustained release are cost-effective
Comments: this model demonstrates the budget impact on a hypothetical NHS
population for England and Wales
Godfrey et al.7
(a) Model structure Aim: to assess the cost-effectiveness of English smoking treatment services
Model: not presented formally as a model, but analysis is conformant with
decision-analytic modelling. Epidemiological data was combined with observational/
survey data to form the basis of CEA. Regression-based techniques used to account for
within-service variations
Time horizon: lifetime (not explicitly stated)
Viewpoint: UK NHS (perspective of the unit of the smoking service, not the individual
smoker)
Viewpoint justiﬁcation: to establish if actual practice is cost-effective
Alternatives: as this was an evaluation of treatment services, this reﬂected variation in
actual practices (e.g. different service conﬁgurations, stafﬁng, interventions)
Study population: English NHS smoking treatment services
Evaluation method: CEA and regression based analysis of determinants of service-level
total and incremental costs (per life-years)
(b) Data inputs – effectiveness
data
Effectiveness data: from published studies
Method used to estimate effectiveness: epidemiological model
Valuation of health beneﬁts: Doll et al.15 as basis for estimating life-years saved
Indirect beneﬁts: not included
(b) Data inputs – Resource use Unit cost data: yes, relying on published sources (Curtis3)
Resources reported separately from cost: yes
Currency (exchange rate): £
Price year (adjustment for inﬂation): 2000–1
Costs of smoking-related diseases: included in sensitivity analysis
(c) Consideration of
uncertainty/consistency
Key parameters: background quit rate, relapse rate
Discount rate: varied at 0%, 3.5% (base case), 6%
Uncertainty: series of univariate analyses (varying background cessation, relapse after 4
weeks, life-years gained from smoking cessation. A worst- and best-case scenario
analysis was additionally performed
(d) Presentation of CEA
ﬁndings
Outcomes: cost per life-year saved, cost per person setting a quit data
Probability of lifetime quit rate: 65% of those quitting at 4 weeks relapse at 12 months.
54% relapse between 1 and 7 years (from Yudkin et al.5).
Total cost per person setting a quit date: mean cost of £123.40
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Godfrey et al.7
Summary measure of cost-effectiveness: average cost per life-year gained per smoker is
£684 (£483 if future savings in smoker’s health care costs are considered)
Authors’ conclusion:
Comments: this model demonstrates the cost-effectiveness of English smoking services.
As such, it presents evidence of cost-effective actual practice of English smoking
services. As such, it presents evidence of cost-effective actual practice. The use of
observational data from 10 years ago might render some of the studies estimates
slightly out of date, not least because it was conducted when SSS had only recently
been implemented. The model compares results with other studies
Coleman16
(a) Model structure Aim: to derive cost-effectiveness of interventions (NRT, buproprion, varenicline) for
preventing relapse in recently abstinent smokers
Model: cohort simulation
Time horizon: lifetime
Viewpoint: UK NHS
Viewpoint justiﬁcation: HTA standard
Alternatives: no intervention
Study population: England and Wales (hypothetical) smokers
Evaluation method: CUA
(b) Data inputs – effectiveness
data
Effectiveness data: from published studies
Method used to estimate effectiveness: Indirect comparisons of interventions
Valuation of health beneﬁts: Doll17 – mortality rates used to determine odds ratios and
smoking attributable deaths. Tengs and Wallace for the majority of comorbid states.10
Tilman and Silcock18 for former and current smokers
Indirect beneﬁts: not included
(b) Data inputs – resource use Unit cost data: partial, use of published sources
Resources reported separately from cost: partial (intervention cost)
Currency (exchange rate): £
Price year (adjustment for inﬂation): Not stated, but unit costs for therapies sourced
from 2008 formulary prices
Costs of smoking related diseases: included
(c) Consideration of
uncertainty/consistency
Key parameters: background quit rate = 2%, relapse rate
Discount rate: 3.5% (beneﬁts, as costs are incurred immediately)
Uncertainty: deterministic – changes in intervention cost, effectiveness and background
quit rates
(d) Presentation of CEA
ﬁndings
Outcomes: cost per QALY
Probability of lifetime quit rate: N/A
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Coleman16
Total cost per person setting a quit date: N/A
Summary measure of cost-effectiveness: no synthesis of dominant interventions. Very
cost-effective at commonly applied UK NHS threshold
Authors conclusion: interventions appear cost-effective and similar in magnitude to
other studies
Comments: paper discusses limitations: lack of data on comorbidities and smoking
status; only single interventions considered in projected ICERs; efﬁcacy from RCTs may
be better than routine clinical care; paper makes distinction that 1 QALY today (after
application of a 3.5% discount rate) is worth 0.25 QALYs in 40 years’ time – i.e. health
gains are reduced fourfold
Feenstra19
(a) Model structure Aim: estimate CEA of ﬁve face-to-face smoking-cessation interventions
Model: dynamic simulation model
Time horizon: 75 years
Viewpoint: Dutch (third-party payer) health care
Viewpoint justiﬁcation: to support Dutch smoking-cessation guidelines
Alternatives: face-to-face smoking-cessation interventions in community and primary
care
Study population: Dutch population (smokers, non-smokers, former smokers)
Evaluation method: CEA, CUA
(b) Data inputs – effectiveness
data
Method used to estimate effectiveness: detailed and complex demographic and
epidemiologic data. In terms of smoking cessation rates, 12-month continuous
abstinence rates (dynamic) converted to risk ratios for current and former smokers
Valuation of health beneﬁts: Dutch quality of life weights from published sources for
smoking-related diseases
Indirect beneﬁts: not considered
(b) Data inputs – resource use Unit cost data: Dutch sources
Resources reported separately from cost: yes, intervention
Currency (exchange rate): €
Price year (adjustment for inﬂation): 2000
(c) Consideration of
uncertainty/consistency
Key parameters varied in sensitivity analysis: national population statistics and disease
incidence
Discount rate: 4%
Uncertainty: univariate analyses including varying the: discount rate, time horizon,
resource usage and cessation rate
(d) Presentation of CEA
ﬁndings
Outcomes:
Probability of lifetime quit rate: NR as this was a dynamic model
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Feenstra19
Total cost: costs presented are for the entire population over time, so difﬁcult to
interpret. Costs per life-year gained are presented and in the region of 1400–6800
dependent on intervention and period of implementation
ICER: 1100–4900 for telephone and intensive counselling
Authors’ conclusion: all interventions considered were cost-effective compared with
current practice and minimal GP counselling was cost saving
Fiscella and Franks12 (US)
(a) Model structure Aim: to assess the cost-effectiveness of nicotine patch
Model: decision-analytic model (calculated analytically)
Time horizon: lifetime
Viewpoint: US health care payer
Viewpoint justiﬁcation: to inform payer decision re reimbursement
Alternatives: physician counselling alone
Study population: primary care population of smokers
Evaluation method: cost-effectiveness analysis
(b) Data inputs – effectiveness
data
Effectiveness data: quit rate from brief counselling. Quit odds rate from within trial for
nicotine patch
Method used to estimate effectiveness: quit odds ratio for the relative success of NRT
active/placebo (from within trial). Acceptance rate of the patch was considered
Lifetime abstinence estimated by assumption (35%)
Valuation of health beneﬁts: years of healthy life measure (YOLS)
Indirect beneﬁts: discussed, not included in analysis
(b) Data inputs – resource use Resource use: therapy and clinicians’ time, OTC treatments resulted in zero cost to NHS
as defrayed to patient
Unit cost data: yes
Resources reported separately from cost: yes
Currency (exchange rate): US$
Price year (adjustment for inﬂation): 1995 US$
(c) Consideration of
uncertainty/consistency
Discount rate: 3.5% costs and QALYs
Uncertainty: series of one-way sensitivity analyses. PSA using the normal distribution as
candidate for 10,000 trials
(d) Presentation of CEA
ﬁndings
Outcome of model: cost per quitter/cost per QALYS
Probability of lifetime quit rate: 35%
Total cost: $7332 per additional quitter (base case)
ICER: cost-effective at $2422–14,112 per QALY from (PSA)
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Feenstra19
HECOS/Orme et al.20
(a) Model structure Aim: to estimate the health and economic outcomes associated with smoking and the
beneﬁts of smoking cessation
Model: cohort-level Markov (complex) developed analytically via application of
difference equations
Time horizon: lifetime
Viewpoint: UK NHS
Viewpoint justiﬁcation: authors were tasked with creating a tool for use by health care
payers, government policy makers and health-care organisations
Alternatives: pharmacological, GP advice, group therapy
Study population: hypothetical UK population
Evaluation method: cost-effectiveness analysis
(b) Data inputs – effectiveness
data
Effectiveness data: populated with UK data. Details restricted to online appendices
Method used to estimate effectiveness: construction of an epidemiological model.
Reporting not transparent due to complexity of model and aim of paper
Lifetime abstinence estimated by assumption that a ﬁxed percentage relapse per year
Valuation of health beneﬁts: via consideration of change in health status to morbid
states and death. Life-years not adjusted for quality
Indirect beneﬁts: included
(b) Data inputs – Resource use Unit cost data: yes
Resource use: Not itemised, total cost only presented by cessation strategy
Resources reported separately from cost: no – relied on secondary source
Currency (exchange rate): £
Price year (adjustment for inﬂation): 1999
(c) Consideration of
uncertainty/consistency
Discount rate (varied): 6% (0–10%)
Uncertainty: extensive deterministic sensitivity analysis around base-case assumptions of
the model
(d) Presentation of CEA
ﬁndings
Outcome of model: cost per life-year saved/cost per death averted
Probability of lifetime quit rate: 30%
Total cost: intervention costs reported by strategy per participant (secondary source)
ICER: £1200 per life-year saved. £22,000 per death averted
CUA, cost–utility analysis; N/A, not applicable; NR, not reported; OTC, over the counter; CQG, cost per QALY gained.
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4Data used in probabilistic analysisTABLE 6 Parameter table
Parameters
Point estimates
(base case) SEa Candidate distribution
Quit rate control (proportion starting as ex-smoker) 0.04 0.20 Beta
Quit rate comparator (proportion starting as ex-smoker) 0.14 0.05 Beta
Intervention cost for EARS (total) £192 19.61 Gamma
Smoking-related disease (cost estimate) £27,120 £2767.40 Gamma
Relapse rate in year 1– (post intervention) 0.28 0.03 Beta
Hazard rate (annual) based on Yudkin et al. 0.0874 0.0089 Beta
Health state values/utilities (by age and sex cohort) See table 10 in chapter 4 Beta
Mortality rates (by age and sex cohort) See table 2 below Beta
SE, standard error.
a Correct to two decimal places.
TABLE 7 Adjusted age-speciﬁc annual mortality rates (as Table 42, Health state values by smoking status, age,
sex, smoking intensity) from Vogl et al.21 and estimated standard errors in a general population with no
long-standing illness
Adjusted mortality rates (SE)
Age (years) Current
Former smoker by age stopped
< 10 years < 20 years ≥ 20 years
Males
35–44 0.001302 (0.0434) 0.000964 (0.0001) – –
45–54 0.002479 (0.0001) 0.001575 (0.0002) – –
55–64 0.006684 (0.0003) 0.005123 (0.0005) 0.002811 (0.0003) –
65–74 0.018818 (0.0007) 0.013510 (0.0015) 0.011766 (0.0013) 0.008425 (0.0010)
75–84 0.045752 (0.0056) 0.032571 (0.0040) 0.032202 (0.0039) 0.028202 (0.0034)
Females
35–44 0.000987 (0.0434) 0.000731 (0.0047) – –
45–54 0.002460 (0.0001) 0.001563 (0.0001) – –
55–64 0.006878 (0.0003) 0.005271 (0.0002) 0.002892 (0.0003) –
65–74 0.021015 (0.0007) 0.015087 (0.005) 0.013139 (0.0012) 0.009409 (0.0009)
75–84 0.054728 (0.0019) 0.038961 (0.0014) 0.038520 (0.0033) 0.033735 (0.0029)
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FIGURE 1 Cost-effectiveness plane for 60-year-old male, base-case CEA. Scatterplot of costs and effects.
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FIGURE 2 Cost-effectiveness acceptability curve for 60-year-old male, base-case CEA.
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
5 10 15
Threshold cost per QALY (£000)
Pr
o
b
ab
ili
ty
 c
o
st
-e
ff
ec
ti
ve
20 25 30
FIGURE 3 Cost-effectiveness acceptability curve for 40-year-old female, base-case CEA.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18040 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 4FIGURE 4 Cost-effectiveness acceptability curve for 50-year-old female, base-case CEA.
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FIGURE 5 Cost-effectiveness acceptability curve for 60-year-old female, base-case CEA.References© Qu
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